HEART FAILURE HEART FAILURE - European Society of Cardiology

Credit Photos: © K. Holmner, I. Johansson
www.escardio.org/HFA
Heart Failure
Congress organised by the
Heart Failure Association of the ESC
Gothenburg - Sweden
21-24 May 2011
2011
FINAL PROGRAMME
Educational and Research
Programmes from the
Heart Failure Association
Educational
Training Programme
Delivering Patient Care in Heart Failure:
an update
29 September - 1 October 2011
The European Heart House,
Sophia Antipolis - France
Exercise rehabilitation and long term
management in Heart Failure
Endorsed by EAPCR
27- 29 October 2011
Bern University Hospital,
Switzerland
Nurse Training
Fellowship
Enhancing the future careers of heart failure nurses as
innovators and/or researchers in order to further
advance the �eld of nursing care for heart failure
patients as well provide added value to home
institutions.
Acknowledgment
According to another fundamental principle of our
University, interdisciplinary work, we appreciate this
application for the HFA Nurse Training Fellowship to
strengthen the important line of nursing research at the
University of Witten/Herdecke and in Germany.
Secondly we see a lot of potential while using the
knowledge of international experts in order to improve
the health care provision of people with heart failure in
Germany. This Fellowship can be the basis for
cooperative studies in the future.
Dipl. ÖK. Michael Anders
All information on Educational
Training Programme and Fellowships
available on www.escardio.org/HFA
Research Fellowship
Providing clinicians or scientists in the early stages of
their career with a high quality research experience
that will enhance their future career as well as provide
clear added value to their home institution.
Testimonials from awardees
“I am very grateful for this fellowship. It has allowed me to
develop as a good scientist and mentor for students. The
past 2 years have been extremely productive regarding
scienti�c results and output. In fact, during the time of the
fellowship I have generated 2 main experimental
publications as well as one review and one editorial.”
Paula Da Costa Martins
“I really think that this research fellowship ful�lled all my
expectations: it gave an excellent opportunity to gain more
experience in the basic research of heart failure and to build
up a long-term and fruitful collaboration between my
Hungarian department and the Dutch host institution.”
Attila Borbély
Coming soon - For you!
Online Educational
Programme

PrOGrAMME At A GLAnCE
14:30 - 16:00
• the Presidents debate: controversial issues in heart failure Malmö
device treatment
• Best Papers 2010/2011 and What did I miss at ESC2010, Uppsala
AHA2010 and ACC2011
• Heart failure with preserved ejection fraction Örebro
(HFPEF) - Is it really heart failure?
• Imaging heart failure Linköping
16:15 - 17:00
• Identification and treatment of central sleep apnea Linköping
in heart failure
Mini-Satellite Symposium organised by RESPICARDIA
08:30 - 10:00
• Impact of the new atrial fibrillation guidelines Gothenburg
on heart failure management
• update on anticoagulation therapy in heart failure Stockholm
• Elderly patients with heart failure - What is different? Malmö
• Patient-reported outcomes - What and how to measure? Uppsala
• the energy crisis of the failing heart Örebro
• Pulmonary hypertension in heart failure Linköping
10:00 - 11:00
• Moderated Posters Session 1 Moderated Poster Area
11:00 - 12:30
• update from the industry Gothenburg
• What should you know about exercise training? Stockholm
• drug therapy in heart failure: has the emphasis shifted? Malmö
• Surgery and device intervention for the elderly Uppsala
with heart failure: assessing the need
• MicrornAs on their way to the clinic Örebro
• nursing Investigator Award Linköping
12:45 - 13:30
• Improving the lives of patients with chronic heart Gothenburg
failure: iron matters
Satellite Symposium organised by Vifor Pharma
• the role of mineralocorticoid receptor (Mr) Stockholm
antagonists throughout the heart failure continuum:
evidence from laboratory to clinical practice
Satellite Symposium organised by Pfizer, Inc.
• Cardiac resynchronization therapy: from patient Malmö
selection to patient management
Satellite Symposium organised by Medtronic
• Patient-physician touch points: sharing perspectives Uppsala
and unmet needs in heart failure
Satellite Symposium organised by Novartis Pharma AG
• Are ventricular assist devices ready for the mainstream? Örebro
Satellite Symposium organised by Thoratec Corporation
SAturdAy 21 MAy 2011
16:15 - 17:45
• Personalizing biomarker strategies in heart failure Uppsala
management
Satellite Symposium organised by Abbott, Alere & BG Medicine
SundAy 22 MAy 2011
P
O
S
t
E
r
S
18:00 - 19:15
OPENING CEREMONY
Room Gothenburg
19:15 - 21:00
Welcome Cocktail
Exhibition
14:15 - 15:45
• Acute heart failure: assessment and management Gothenburg
of the difficult patient
• Late Breaking trials - Session I Stockholm
• the value of the heart failure registries Malmö
• do heart failure patients need guts? Uppsala
• new biological heart failure mechanisms or twists
to old ones? Örebro
• young Investigator Award for Clinical research Linköping
15:45 - 16:30
• Moderated Posters Session 2 Moderated Poster Area
16:30 - 18:00
• difficult cases in heart failure with preserved Gothenburg
ejection fraction
• novel device therapies for heart failure Stockholm
• Chronic heart failure and chronic obstructive pulmonary
disease: ignored common duel! Malmö
• How to talk to your patients Uppsala
• Inflammation in heart failure: biomarker, bystander
or mediator Örebro
• young Investigator Award for Basic Science Linköping
18:15 - 19:00
• Solutions for heart failure management: Linköping
the ever-growing role of device therapy
Mini-Satellite Symposium organised by Boston Scientific
18:15 - 19:45
• Ivabradine: a SHIFt paradigm in heart failure Gothenburg
management
Satellite Symposium organised by Servier
P
O
S
t
E
r
S
08:30 - 10:00
• the unstable patient who needs neurohormonal Gothenburg
blockade
• Anemia and iron deficiency Stockholm
• Palliative care for patients with end-stage heart failure Malmö
• teleMonitoring for heart failure - Latest evidence Uppsala
• new drugs on the horizon for heart failure Örebro
• Preventing heart failure in women pre and Linköping
post partum
10:00 - 11:00
• Moderated Posters Session 3 Moderated Poster Area
• HFA General Assembly Linköping
11:00 - 12:30
• Management of difficult cardiac patients in the Gothenburg
emergency room
• update on the treatment of chronic heart Stockholm
failure 2011
• Implantable cardioverter-defibrillator (ICd) therapy: Malmö
risks and complications.
• Systemic problems in cancer patients Uppsala
• Judges choice: Basic Science Örebro
• Controversies in the optimal management of Linköping
ischaemic heart failure
12:45 - 13:30
• transcatheter mitral valve repair therapy, a novel Linköping
approach for heart failure patients suffering from
mitral regurgitation
Mini-Satellite Symposium organised by Crossroads,
the Abbott Vascular education network
12:45 - 14:00
• Stroke prevention in atrial fibrillation: challenges Stockholm
and opportunities
Satellite Symposium organised by Bristol-Myers Squibb/Pfizer
08:30 - 10:00
• How to interpret the recent trials with expert Gothenburg
statisticians
• using biomarkers to sort out the complex patient Stockholm
• Personalised medicine and person-centred care Malmö
- What is the difference?
• Sleep apnea - the need to synchronize the heart, Uppsala
the lung and the brain
• Highlights of the congress: Basic Science translated Örebro
for the clinician
10:00 - 11:00
• Moderated Posters Session 5 Moderated Poster Area
MOndAy 23 MAy 2011
P
O
S
t
E
r
S
12:45 - 14:00
• remote disease management in the HF patient Malmö
Satellite Symposium organised by St. Jude Medical
• Point-of-care biomarkers in the real world of practice: Uppsala
managing the patients from the hospital to home
Satellite Symposium organised by ALERE
• Improving heart failure risk assessment Örebro
Satellite Symposium organised by GE Healthcare
14:15 - 15:45
• new medical treatment in acute heart failure Gothenburg
• Award Ceremony followed by a Symposium Stockholm
• therapeutic controversies in patients with diabetes Malmö
• diuretics in heart failure, friend or foe? Uppsala
• Systems medicine approaches in translational heart
failure research Örebro
• Judges choice: Clinical treatment research Linköping
15:45 - 16:30
• Moderated Posters Session 4 Moderated Poster Area
• HFA Forum HFA Forum
16:30 - 18:00
• Managing patients with hyperkalaemia during
rAAS-blockade Gothenburg
• Late Breaking trials - Session II Stockholm
• Management of heart failure patients guided
by implantable sensors Malmö
• the failing right heart Uppsala
• new drug targets in heart failure Örebro
- from EuGeneHeart -
• Judges choice: Clinical research Linköping
tuESdAy 24 MAy 2011
P
O
S
t
E
r
S
11:00 - 12:30
• new biomarkers for diagnosis and prognosis Gothenburg
in heart failure
• Highlights of the congress Stockholm
• Mortality or morbidity as target in acute heart Malmö
failure trials
• the dynamic social media wave: twitter, Facebook, Uppsala
Internet etc.
• Cardiac regeneration and repair - What’s new Örebro
P
O
S
t
E
r
S
P
O
S
t
E
r
S
OB1 d5048

WELCOME ADDRESS
Dear Friends and Colleagues,
It is our great pleasure to welcome you to the Heart Failure Congress 2011, organised by the Heart
Failure Association (HFA) of the European Society of Cardiology.
The Heart Failure Congress is an opportunity for everyone in the heart failure community to come
together. Our objective is to provide a complete picture of heart failure, covering many fields of
information, innovation and education. We will address the core topics and the associated technologies
linked to heart failure in order to provide health care professionals with the knowledge and experience
they require in their daily clinical practice.
The overall theme of this congress is co-morbidities because more and more patients
with heart failure present with other conditions such as diabetes, lung disease, renal
impairment, etc. There is no doubt that co-morbidities need to be optimally managed, as they
deteriorate the natural course of heart failure, thus often constituting real challenges for health care
professionals taking care of heart failure patients.
We will also bring you up to date on devices and technologies (ICD, CRT, LVADs), their management
programmes and novel diagnostic modalities, to ensure we meet your expectations and provide
adequate educational value to each and every participant. The sessions will address the topics in
different formats, from an expert lecture in a main session to an interactive educational session with
case presentations. Our faculty will also bring you a very practical and international perspective on the
Heart Failure Guidelines to incorporate in your clinical decision process.
The Heart Failure congresses have always focussed on the original scientific contributions received and
selected for presentation. The Oral Abstract sessions feature the best of the research presented and the
three Award sessions will recognise emerging scientists within our community. The Poster Area is the
ideal platform to meet colleagues and peers to discuss specific topics of research and interest.
This year, the Congress launches a new initiative to highlight contributions from Young Researchers.
We invite all attendees to take the time to join our Faculty and Board members and meet young
scientists to support their early contribution to the research in heart failure and related topics.
Also new this year, the HFA Forum on Level 1 is the place to interact with your association, discover
our mission, objectives and initiatives, and how you can play a part.
Thank you for being with us in Gothenburg this week. Enjoy your time, learn something new, meet
peers, colleagues and friends, and help us prepare an informative and rewarding programme by
giving your feedback.
Welcome to Gothenburg, welcome to your congress!
P. Ponikowski
(Wroclaw, PL)
HFA President
K. Swedberg
(Gothenburg, SE)
Heart Failure 2011 Scientific
Chairperson
1
S. Anker
(Berlin, DE)
HFA President-Elect
i. Ekman
(Gothenburg, SE)
Heart Failure 2011 Scientific
Co-Chairperson
gEnERAL
infORMAtiOn

gEnERAL
infORMAtiOn
Board of the Heart Failure Association of the ESC
Prof. P. Ponikowski FESC (Wroclaw, PL) President
Prof. S. Anker FESC (Berlin, DE) President-Elect
Prof. J. McMurray FESC (Glasgow, GB) Immediate Past-President
Prof. F. Zannad FESC (Dommartin-les-Toul, FR) Treasurer
Prof. G. Filippatos FESC (Athens, GR) Chairman Clinical Section
Prof. B. Pieske FESC (Graz, AT) Chairman Basic Sciences Section
Prof. A. Maggioni FESC (Florence, IT) Secretary
A. Hoes (Utrecht, NL)
I. Ekman NFESC (Gothenburg, SE)
T. Eschenhagen FESC (Hamburg, DE)
S. Janssens FESC (Leuven, BE)
T. McDonagh FESC (London, GB)
C. Maack (Hamburg, DE)
V. Mareev (Moscow, RU)
Scientific Committee
The members of the HFA Board are part of the Scientific Committee
European Society of Cardiology (ESC)
European Society of Cardiology
2035 Route des Colles - Les Templiers
06903 Sophia Antipolis - France
For general information, please contact:
Tel: + 33 4 92 94 76 00
Fax: + 33 4 92 94 86 29
Email: hfsecretariat@escardio.org
Website: www.escardio.org/hfA
2
A. Mebazaa FESC (Paris, FR)
L. Neyses (Manchester, UK)
Z. Papp FESC (Debrecen, HU)
J. Riley NFESC (London, GB)
F. Ruschitzka FESC (Zurich, CH)
M. Ryder NFESC (Dunlaoghaire, IE)
P. Seferovic FESC (Belgrade, RS)
Ex-offici
Prof. K. Swedberg FESC (SE),
Prof. D. van Veldhuisen FESC (NL) - Editor in Chief of the European Journal of Heart Failure
Sui Generi
Prof. D. Brutsaert FESC (BE), Prof. K. Dickstein FESC (NO), Prof. U. Dahlström FESC (SE),
Prof. G. Hasenfuss FESC (DE), Prof. A. Shah FESC (UK)
K. Swedberg FESC (Gothenburg, SE) Scientific Chairperson
I. Ekman NFESC (Gothenburg, SE) Scientific Co-Chairperson
B. Andersson FESC (Gothenburg, SE)
O. Bech-Hanssen (Gothenburg, SE)
K. Boman FESC (Skelleftea, SE)
F. Braunschweig FESC (Stockholm, SE)
U. Dahlström FESC (Linköping, SE)
M. Fu (Gothenburg, SE)
T. Jaarsma NFESC (Norrköping, SE)
A. Jeppsson (Gothenburg, SE)
C. Linde (Stockholm, SE)
L. Lund (Stockholm, SE)
E. Omerovich (Gothenburg, SE)
M. Pilhall (Gothenburg, SE)
A. Rosengren (Gothenburg, SE)
M. Schaufelberger (Gothenburg, SE)
H. Wedel (Gothenburg, SE)
G. Wikström (Uppsala, SE)
YOuR hOStS
heart failure Association of the ESC
ESC Specialty Centre
2035 Route des Colles - Les Templiers
06903 Sophia Antipolis - France
For general information, please contact:
Tel: + 33 4 92 94 76 00
Fax: + 33 4 92 94 76 01
Email: hfa@escardio.org
Website: www.escardio.org/hfA

gEnERAL COngRESS infORMAtiOn
Opening hours
Venue
Registration
Speaker Service Centre
Exhibition
friday 20 May Saturday 21 May Sunday 22 May Monday 23 May tuesday 24 May
14:00 - 18:00
12:00 - 21:00
08:30 - 19:30
12:00 - 18:30
17:15 - 21:00
Congress Badge
The congress badge gives access to the congress
from Saturday 21 May to Tuesday 24 May 2011.
For security reasons, please have your badge
visible at all times during the congress.
Lost badges: a fixed price of €35 will be charged
for the replacement of lost badges at the Assistance
Registration desks on the ground floor.
iMPORtAnt infORMAtiOn
Please note that by scanning your badge on
Exhibition Stands or at the entrance of an Industry
Educational session, you accept that the company
may contact you, using your contact details as
submitted to the European Society of Cardiology.
Registration
The Heart Failure 2011 registration fees (except
the Accompanying Person fee) entitle delegates
to the following:
• Entry to all scientific sessions and the Exhibition
• Entry to the Opening Ceremony and Opening
Cocktail on Saturday 21 May 2011
• A copy of the Final Programme and the Abstract
CD-Rom
• Refreshment breaks from Sunday 22 May
to Tuesday 24 May 2011
Delegate Bag
Each delegate is entitled to a congress bag to be
picked up from the dedicated desk opposite the
Registration Area. It contains the Final Programme,
Abstract CD-Rom voucher, notepad, pen, the HF
Pocket Guidelines (2008) and advertisements
from the industry.
Cloakroom
The cloakroom is located opposite the Registration
desks: 20 SEK (2,30 €) per jacket and 5 SEK (0,60 €)
per piece of luggage.
Certificate of Attendance
Certificates will be available at the Registration
desks from Monday 23 May 2011 at 12:00.
3
07:30 - 19:30
07:30 - 18:30
07:30 - 18:30
09:00 - 18:00
07:30 - 19:30
07:30 - 18:30
07:30 - 18:30
09:00 - 18:00
Abstract CD-Rom
The Abstract CD-Rom is
available in the Exhibition
Area from the Medtronic
07:30 - 13:00
07:30 - 13:00
07:30 - 13:00
CLOSED
Supported by Medtronic in the form of
an unrestricted educational grant
stand (C04:01). You will find a voucher in your
delegate bag to collect your copy.
Delegate Lounge
Located on Level 1, next to the HFA Forum, the
Delegate Lounge has been designed to offer
delegates an appealing area to sit down, relax
and connect to Wi-Fi in between sessions.
For those of you who left their computer at home,
a business centre is also available on Level 1 with
free internet connection and printers.
Journal
Delegates paying the standard fee will receive a
two-year subscription to the European Journal of
Heart Failure (valid for 2012 in paper and 2013 in
electronic version).
Language
The official language during the congress is
English. No translation is available.
Speaker Service Centre
All speakers giving a presentation in the scientific
sessions are requested to upload and validate
their presentation in the Speaker Service Centre
(SSC) on Level 1, a minimum of 3 hours before
the session starts or the day before if the session
is at 08:30.
Refreshment breaks
From Sunday morning to Tuesday morning, open
buffets are located in the Exhibition Area during
break hours. On Tuesday morning, buffets will
also be located on Level 1, in the HFA Forum.
first Aid
Participants in need of medical assistance should
refer to the ESC staff in the Registration area.
gEnERAL
infORMAtiOn

gEnERAL
infORMAtiOn
4
hfA Of thE ESC ACtiVitiES
What does the Heart Failure Association of the ESC do? Find out here!
HFA /ESC stand (C03:01) - Your platform for scientific material, membership, educational
opportunities and information on the Heart Failure Association of the ESC
• Apply for hfA Membership using the interactive terminals in our “membership online” corner.
• Discover all our activities such as guidelines, journals, educational courses and initiatives.
• Get information on heart failure 2012 in Belgrade, Republic of Serbia.
Special for HFA members
get a free copy of the ESC Pocket guidelines on focus hf/CRt devices
Opening hours:
Saturday 21 May 17:15 - 21:00
Sunday 22 May 09:00 - 18:00
Monday 23 May 09:00 - 18:00
HFA Reward for regular attendees
The HFA would like to acknowledge, recognise and thank all HFA Members
who have attended HFA congresses since 2005.
A special pin will be distributed from the HFA/ESC stand.
Find out who they are in the next HFA newsletter.
European Journal of Heart Failure (EJHF)
This is your journal - Read it, use it, publish your research in it.
2 years' subscription included in your standard registration (valid for 2012 in paper
and 2013 in electronic version).
Rapid impact factor growth for the official HFA journal has seen the EJHF reach
the top 3 cardiovascular sub-specialty journals.
Visit the HFA/ESC or Oxford University Press stands for full information.
How does the Heart Failure Association do it? Find out by attending the:
HFA General Assembly on Monday 23 May 10:00 - 11:00 in Room Linköping
As an hfA member, you have the right to take part in general hfA affairs.
During this meeting, essential information on Association day-to-day affairs is presented
by the Board, plus voting takes place for new hfA regulations. Don’t miss this opportunity
to voice your ideas or concerns.

MEEt thE ExPERtS At thE hfA fORuM
As in all Roman towns, the HFA Forum is located at the intersection of your
main routes through the Congress centre, to and from the Lecture Rooms,
Poster area and Exhibition. A gathering place of great social significance,
the Forum offers the opportunity for discussions and debates, rendez-vous and
meetings with the Heart Failure Association of the ESC.
NEW
The following Committees and Study Groups will be waiting for you on Monday 23 May from
15:45 to 16:15
national heart failure Societies
• It’s time to join forces. Find out how the HFA can help.
Acute heart failure
• Building relationships between health-care professionals involved in the management of AHF.
heart failure Surveys & Registries
• Improving the knowledge of the management of this disease across Europe. Can you help?
On-Line Education
• It’s new and exciting – and it’s for you. Come and look at what we’re planning.
industry
• Discussion and collaboration are the order of the day.
Preserved Ejection fraction
• Difficult diagnosis? Find out more about this interesting area.
External Affairs
• From the EU down – we try to get involved. Maybe you can too.
Patient Care
• The heart of the matter: our patients. Two new publications and an ETP to discuss.
translational Research
• Interested in applying basic science to clinically relevant questions?
Study group on Peripartum Cardiomyopathy
• An uncommon but devastating disease - help raise awareness.
Study group on Exercise training in heart failure
• Find out about the hands-on ETP in Bern.
hfA Patient Website: heartfailurematters.org
• Introduce this easy-to-use website to your patients. But come and test it first!
hfA fellowship and grants
• Research - Travel - Learning. Find out how to apply.
HFA
FORUM
5
gEnERAL
infORMAtiOn

gEnERAL
infORMAtiOn
6
SCiEntifiC infORMAtiOn
The Scientific Programme Committee has prepared an outstanding programme for Heart Failure
2011, with nearly 200 Faculty for over 70 sessions in 6 lecture rooms.
Designed for an audience of cardiologists, internists, general physicians, basic scientists,
epidemiologists, nurses, industry affiliates and other healthcare providers, the programme features
many different types of sessions from main sessions, to symposia and debates as well as the popular
interactive educational sessions.
Our ultimate objective is to help you manage - in your daily practice - the growing burden of
heart failure and to reduce the disease burden on heart failure patients in real life.
This year’s programme will focus on Co-morbidities and heart failure.
Explore in depth the topics of Co-morbidities and Heart failure - Chronic Obstructive Pulmonary
Disease (COPD), Diabetes, Hypertension, as well as new areas such as cancer, cardio-renal
syndrome, etc.
The programme also includes:
• Devices and Technology for heart failure in 2011
Discuss critical decision making in the role of ICDs and CRT implantations and therapies. Review
patient selection criteria for the use of implantable LVADS for heart failure treatment. Explore the
developments of Telemonitoring and other monitoring management.
• Education and Guidelines
Understand the management of patients with heart failure and be provided with guidelines to
improve outcomes in the heart failure population. Practical application of the HFA guidelines
to assist all heart failure professionals in their daily practice.
• Latest Updates
On devices and therapies, ongoing trials and research to understand the upcoming technologies,
drugs and development in heart failure. Hear about the latest clinical trial data and patient
registries.
• Basic Science, Basic Science translated for the clinician
When researchers meet and interact with clinicians to discuss the science that will lead tomorrow’s
translational initiatives.
Heart Failure 2011, the perfect opportunity to learn, share knowledge and
network with your colleagues and peers!
Poster presenters
Get your poster presentation certificate from the Poster Assistance Desk on the day you are
presenting. An easy and fast way to collect your certificate!
E-Slides
Catch highlight presentations hot off the press. The HFA Scientific Committee has specially chosen
a number of presentations to be available online for immediate consultation after the end of the
congress. Web link: www.escardio.org/HFA (Scientific Reports).

SCiEntifiC infORMAtiOn
NOT TO BE MISSED!
Clinical Interactive Educational sessions
Come and interact with your peers, share knowledge and develop your level of understanding.
These case-based interactive sessions have been specifically designed to answer the demand
for more educational and interactive sessions. 5 sessions, held in Room Gothenburg on Level 1,
based on practical clinical cases will address a core topic related to heart failure.
Best papers in 2010/2011
Find out what you've missed at ESC 2010, AHA 2010 and ACC 2011. Get an update on the key
papers published on heart failure in the past year.
Saturday 21 May, 14:30 - 16:00 in Room Uppsala.
The Presidents’ debate
A high profile debate with the Heart Failure Society of America.
Join us Saturday 21 May, 14:30 - 16:00 in Room Malmö.
Update from the Industry
Industry representatives will present highlights of their current programme of research in heart
failure. They will inform the audience about projects in the pipeline and phase II/III trials. Discover
more in Room Gothenburg, Sunday 22 May, from 11:00 to 12:30.
Late Breaking Clinical Trials
Presenters will share their trial results in front of an appreciative audience and their presentation
will be concluded by a review from an expert. One of our most popular sessions at the congress.
In room Stockholm, Sunday 22 May at 14:15 and Monday 23 May at 16:30.
Late Breaking Research - Basic & Translational
Three Late Breaking Research will be featured in the Basic Science Highlight Session on Tuesday
24 May 2011, in room Örebro at 08:30.
Make sure you also see the other Trials presented as posters on Level 1, where presenters will be
available to discuss their research during coffee breaks.
Young Researcher Poster Programme
We are delighted to start our new initiative for Young Cardiologists presenting an
abstract at the Heart Failure 2011 Congress in Gothenburg.
The Heart Failure Association and the Scientific Programme Committee have developed a programme
to support young researchers. Senior members of the faculty, HFA Board Members expert in the
topic presented will come to meet and discuss the research presented during the coffee break.
The poster will be easily identified with a HFA Young Researcher logo - to be collected from the
Poster Assistance Desk.
7
Yo e
CME Accreditation
The Heart Failure 2011 Congress is accredited by the European Board for Accreditation in
Cardiology (EBAC) for 17 hours of External CME credits. Each participant should claim
only those hours of credit that have actually been spent in the educational activity.
EBAC works in cooperation with the European Accreditation Council for Continuing
Medical Education (EACCME) which is an institution of the European Union of Medical
Specialists (UEMS).
EBAC credits are recognised by the American Medical Association towards the Physician’s Recognition
Award (PRA). Detailed instructions for converting these credits to AMA PRA Category 1 Credits are
available on the AMA website.
EBAC Certificates will be available at the Registration desks from Monday 23 May at 12:00.
gEnERAL
infORMAtiOn

gEnERAL
infORMAtiOn
gOthEnBuRg hAS SOMEthing fOR YOu!
A city built by trade
Trade, shipping and international contacts have
distinguished Gothenburg ever since the city
was founded in 1621 by Gustav II Adolf. It was
built by Dutchmen, and in the 17th century
the official languages were Dutch, German,
Swedish and English.
Modern-day Gothenburg with its wide
boulevards, parks and stone houses was built
around the end of the 19th century.
A city which has something for you!
Everything is close at hand in this compact city
on the west coast of Sweden. Whether you
yearn for the tranquillity of the coast and islands
or fascinating new culture, charming walks
in the city or an evening of good food and
nightlife, Gothenburg has something for you.
The range of shopping and entertainment
makes it feel like a big city, but when it comes to
atmosphere and warmth, Gothenburg has its
own special charm.
A city of entertainment
It is easy to be a tourist in Gothenburg. Lots
of fun things to do and almost everything is
within walking distance.
Whether you want to discover fine museums,
dine in the city, hit the shops or have fun at
Liseberg amusement park, there are a range of
sights and attractions waiting for you.
A city of music
Gothenburg has a rich music life - the
Gothenburg Symphony Orchestra is renowned
when it comes to classical music.
Bands like The Soundtrack of Our Lives and
Ace of Base are well known pop representatives
of the city.
8
A city by the sea
Its closeness to the sea makes Gothenburg
special. The coast and islands are famous
for their natural beauty and picturesque
habitation. A half-hour tram ride and a boat
onwards will take you straight out to the
southern archipelago.
Top things to do in Gothenburg
Wheel of gothenburg
Experience a breathtaking tour in The Wheel
of Gothenburg. Step onboard one of the glassenclosed
gondolas and let yourself be taken a
60 meter high round trip with a spectacular
360° view of the city.
Aeroseum
Discover one of the most secret military sites of
the Cold War and take a journey through the
history of flight.
nightlife
Avenyn is the street with the most restaurants
in Sweden. Vasastan and Linné are two other
areas filled with watering holes.
Boat tour to Vinga
Step aboard the M/S Walons and experience
the archipelago at its best. Enjoy a boat trip to
Vinga with fresh shrimp or a seafood buffet.
feskekôrka fish market hall
The Feskekôrka, (‘fish church’ in Swedish) as it
quickly became known, is an indoor fish and
seafood market where you can buy all kinds of
freshly caught seafood delicacies.
Credit Photos: © Dick Gi lberg - Bo Kågerud

tRAnSPORtAtiOn
In Gothenburg, almost everything is within walking distance. Due to the favourable location of
the Svenska Mässan, you will be able to walk from your hotel to the convention centre or take
advantage of the extensive and reliable public transportation system.
Get yourself a Gothenburg City Card when you arrive in Gothenburg! You will
get the best the town has to offer with just one card. This includes free entrance
to Liseberg, the Universeum Science Discovery Centre and free travel on all public
transport, entrance to many museums, not to mention great shopping deals.
Go to the information desk in the Registration area to get your Gothenburg City Card.
Airport Bus
From: Svenska Mässan
To: Göteborg-Landvetter Airport
Fixed price: SEK 80 / € 8.90 / $ 11.70
Travel Time: 20 min (22km, highway)
Frequency: 5 am to midnight
Airport bus departures are indicated
on the screens above the main entrance.
• Tram
Take a number 2 or 4 tram from Drottningtorget.
You can also take a number 5 tram from
Brunnsparken.
The trams stop at Korsvägen opposite Svenska
Mässan and Gothia Towers.
9
gEnERAL
infORMAtiOn

gEnERAL
infORMAtiOn
10
COngRESS fLOOR PLAn
Access possible only with badge - NO BADGE NO ENTRY!
Gothenburg
Uppsala
Estrad
Restaurant
Incontro Bar
& Restaurant
Clinical Trial
Forum
MP
Late Breaking
Trials
Mix Restaurant
MAIN ENTRANCE
HFA Forum
POSTER AREA
Ground Floor
EXHIBITION AREA
REGISTRATION
Gothia Towers
Hotel
First Floor
Stockholm
Delegate Lounge
SSC
Business
Centre
Malmö
Linköping
Meeting Rooms
MP
Snack Bar
Örebro
Press Working Area
Moderated Poster Area
Congress Bags
Cloakroom

HFA
FORUM
come, see, discover
The following Committees and Study Groups will be
waiting for you on Monday 23 May from 15:45 to 16:15
• National Heart Failure Societies
• Acute Heart Failure
• Heart Failure Surveys & Registries
• On-Line Education
• Industry
• Preserved Ejection Fraction
• External Affairs
• Patient Care
• Translational Research
• Study Group on Peripartum Cardiomyopathy
• Study Group on Exercise Training in Heart Failure
• Test the HFA Patient Website heartfailurematters.org
SATURDAY

SATURDAY 21 MAY 2011 - AFTERNOON
14:30 - 16:00 Debate Malmö
The Presidents debate: controversial issues in heart failure device
treatment
Joint session with the Heart Failure Society of America (HFSA)
Chairpersons: P. Ponikowski (Wroclaw, PL); B.M. Massie (San Francisco, US)
Devices and Technology for heart failure in 2011
14:30 Heart rate reduction beyond a beta-blocker effect is not effective in heart
failure - PRO. 1
B.M. Massie (San Francisco, US)
14:52 Heart rate reduction beyond a beta-blocker effect is not effective in heart
failure - CONTRA. 2
M. Bohm (Homburg/Saar, DE)
15:15 ICDs are overused in Europe? - PRO. 3
J.G.F. Cleland (Kingston Upon Hull, GB)
15:37 ICDs are overused in Europe? - CONTRA. 4
J.R. Teerlink (San Francisco, US)
14:30 - 16:00 Special Session Uppsala
Best Papers 2010/2011 and What did I miss at ESC2010, AHA2010 and ACC2011
Chairpersons: K. Swedberg (Gothenburg, SE); A.P. Maggioni (Florence, IT)
14:30 Biomarkers. 5
S.D. Anker (Berlin, DE)
14:48 Nursing. 6
J. Riley (London, GB)
15:06 Echocardiography. 7
O. Bech-Hanssen (Gothenburg, SE)
15:24 Devices. 8
F. Braunschweig (Stockholm, SE)
15:42 Drugs. 9
D.J. van Veldhuisen (Groningen, NL)
13
SATURDAY

SATURDAY
SATURDAY 21 MAY 2011 - AFTERNOON
14:30 - 16:00 Symposium Örebro
Heart failure with preserved ejection fraction (HFPEF) – Is it really heart failure?
Chairpersons: B.M. Pieske (Graz, AT); D.L. Brutsaert (Kontich, BE)
Education and Guidelines
14:30 What is HFPEF and how to diagnose it. 10
W.J. Paulus (Amsterdam, NL)
14:52 HFPEF and clinical outcomes: mortality, morbidity, symptoms and QoL. 11
J.J.V. McMurray (Glasgow, GB)
15:15 Treatment of HFPEF: evidence (or lack of it) and clinical approach. 12
A.A. Voors (Groningen, NL)
15:37 HFPEF in the future: new diagnostic techniques and treatments in the pipeline. 13
S. Solomon (Boston, US)
14:30 - 16:00 Symposium Linköping
Imaging heart failure
Joint session with the European Association of Echocardiography (EAE)
Chairpersons: P. Lancellotti (Liège, BE); U.G. Dahlstrom (Linkoping, SE)
Devices and Technology for heart failure in 2011
14:30 Echocardiographic and MRI assessment of systolic heart failure. 14
J. Magne (Liège, BE)
14:52 Echocardiographic and MRI assessment of diastolic heart failure. 15
M.P. Frenneaux (Aberdeen, GB)
15:15 Assessing valve disease in heart failure – Echocardiography results in the
decision tree. 16
P. Lancellotti (Liège, BE)
15:37 What does the surgeon need to know. 17
E.J. Birks (Louisville, GB)
14

SATURDAY 21 MAY 2011 - AFTERNOON
16:15 - 17:45 Satellite Symposium Uppsala
Personalizing biomarker strategies in heart failure management
Satellite Symposium organised by Abbott, Alere & BG Medicine
Chairpersons: J.G.F. Cleland (Kingston Upon Hull, GB);
F. Zannad (Vandoeuvre Les Nancy, FR)
16:15 Introduction. 18
J.G.F. Cleland (Kingston Upon Hull, GB)
16:20 Management of heart failure: current needs in defining prognosis and
stratifying risk. 19
K. Dickstein (Stavanger, NO)
16:40 Galectin-3: what do we know today and how should we use it? 20
D.J. van Veldhuisen (Groningen, NL)
17:00 Future roles for Galectin-3 and Natriuretic Peptides: a personalized approach
to selecting therapy and predicting response. 21
J.G.F. Cleland (Kingston Upon Hull, GB)
17:20 Faculty discussion and concluding comments. 22
F. Zannad (Vandoeuvre Les Nancy, FR)
16:15 - 17:00 Mini-Satellite Symposium Linköping
Identification and treatment of central sleep apnea in heart failure
Mini-Satellite Symposium organised by RESPICARDIA
Chairpersons: F. Ruschitzka (Zurich, CH); P. Ponikowski (Wroclaw, PL)
16:15 Introduction. 23
F. Ruschitzka (Zurich, CH)
16:20 Clinical problem and identification of central sleep apnea in heart failure patients. 24
S. Javaheri (Cincinnati, US)
16:35 Novel therapeutic approach and treatment of CSA. 25
P. Ponikowski (Wroclaw, PL)
16:50 Panel discussion.
15
SATURDAY

SATURDAY
SATURDAY 21 MAY 2011 - AFTERNOON
18:00 - 19:15 Special Session Gothenburg
OPENING CEREMONY
Chairpersons:
P. Ponikowski (Wroclaw, PL)
K. Swedberg (Gothenburg, SE)
Welcome to Heart Failure 2011 in Gothenburg
K. Swedberg (Gothenburg, SE)
Welcome by the President of the Heart Failure Association
P. Ponikowski (Wroclaw, PL)
Opening Lecture: Heart Failure and the European Society of Cardiology
M. Komajda (Paris, FR)
Introduction of the lifetime achievement in heart failure 2011 awardee
K. Swedberg (Gothenburg, SE)
Lifetime Achievement Award
J.K. Kjekshus (Haslum, NO)
Closing remarks
The Heart Failure Association of the ESC,
the Gothenburg Town Hall and the Västra
Götaland County are glad to invite you to
a Welcome Cocktail in the Exhibition
19:15 - 21:00
16

Delegate lounge
on level 1
For those of you who left their computer
at home, a business centre is also available
on the same level with free internet
connection and printers.
sit,
relax,
connect
SUNDAY

SUNDAY 22 MAY 2011 - MORNING
08:30 - 10:00 Main Session Gothenburg
Impact of the new atrial fibrillation guidelines on heart failure
management
Joint session with the European Heart Rhythm Association (EHRA)
Chairpersons: C. Linde (Stockholm, SE); M. Komajda (Paris, FR)
Devices and Technology for heart failure in 2011
08:30 What is new in the guidelines? 29
A.J. Camm (London, GB)
08:52 Atrial fibrillation in heart failure: how big is the problem? 30
F. Braunschweig (Stockholm, SE)
09:15 Ablation therapy in heart failure. 31
Z. Kalarus (Zabrze, PL)
09:37 ESC guidelines on heart failure. 32
K. Dickstein (Stavanger, NO)
08:30 - 10:00 Main Session Stockholm
Update on anticoagulation therapy in heart failure
Chairpersons: E.A. Jankowska (Wroclaw, PL); J.P. Ribeiro (Porto Alegre, BR)
Education and Guidelines
08:30 Pathophysiology of thrombosis in heart failure. 33
B.M. Massie (San Francisco, US)
08:52 Review of existing anticoagulation trials in heart failure. 34
J.G.F. Cleland (Kingston Upon Hull, GB)
09:15 Emerging anticoagulant therapies. 35
G.S. Filippatos (Athens, GR)
09:37 What will the WARCEF trial tell us about heart failure? 36
S.D. Anker (Berlin, DE)
08:30 - 10:00 Main Session Malmö
Elderly patients with heart failure - What is different?
Chairpersons: A.W. Hoes (Utrecht, NL); U.G. Dahlstrom (Linkoping, SE)
Co-morbidities and heart failure
08:30 Heart failure in the elderly - Is it only heart failure? 37
B.M. Pieske (Graz, AT)
08:52 Atrial fibrillation in heart failure, importance of age. 38
L. Kober (Gentofte, DK)
09:15 Treatment-guidelines and one step beyond. 39
H.P. Brunner-La Rocca (Maastricht, NL)
09:37 End-of-life decisions in elderly heart failure patients. 40
L. Warner Stevenson (Boston, US)
19
SUNDAY

SUNDAY
SUNDAY 22 MAY 2011 - MORNING
08:30 - 10:00 Main Session Uppsala
Patient-reported outcomes - What and how to measure?
Chairpersons: T. Jaarsma (Norrkoping, SE); J.K. Kjekshus (Haslum, NO)
Education and Guidelines
08:30 Health economy models - Too simplified. 41
M.R. Cowie (London, GB)
08:52 Are soft endpoints feasible? 42
I. Ekman (Gothenburg, SE)
09:15 Qol what instruments to use: generic or disease specific? 43
J. Riley (London, GB)
09:37 Too many questionnaires, how can we simplify? 44
B. Granger (Durham, US)
08:30 - 10:00 Main Session Örebro
The energy crisis of the failing heart
Chairpersons: Z. Papp (Debrecen, HU); M.P. Frenneaux (Aberdeen, GB)
Basic Science, Basic Science translated for the clinician
08:30 State-of-the-art: metabolic remodelling in heart failure. 45
H. Taegtmeyer (Houston, US)
08:52 Mitochondrial dysfunction in heart failure. 46
C. Maack (Homburg/Saar, DE)
09:15 Insulin resistance in chronic heart failure. 47
W. Doehner (Berlin, DE)
09:37 Targeting metabolism to treat heart failure. 48
M.P. Frenneaux (Aberdeen, GB)
08:30 - 10:00 Main Session Linköping
Pulmonary hypertension in heart failure
Chairpersons: R. Pacher (Vienna, AT); L. Tavazzi (Cotignola, IT)
Education and Guidelines
08:30 Is pulmonary hypertension important in heart failure? 49
G. Wikstrom (Uppsala, SE)
08:52 Pulmonary hypertension in heart failure. 50
P.J. Eriksson (Olofstorp, SE)
09:15 Assessing pulmonary circulation in clinical practice: are we focusing on the problem? 51
O. Bech-Hanssen (Gothenburg, SE)
09:37 Treating the pulmonary circulation: why, when and how. 52
M. Guazzi (Milan, IT)
20

SUNDAY 22 MAY 2011 - MORNING
11:00 - 12:30 Special Session Gothenburg
Update from the industry
Chairpersons: J.J. V. McMurray (Glasgow, GB); S.D. Anker (Berlin, DE)
Session objectives:
Industry representatives will present highlights of their current programme of research in heart
failure and their views about the field more generally.
They will inform the audience about projects in the pipeline and phase II/III trials.
Each presentation will be concluded by panel discussion.
Questions from the audience are encouraged.
11:00 - 12:30 Main Session Stockholm
What should you know about exercise training?
Chairpersons: To be announced; B. Andersson (Gothenburg, SE)
Education and Guidelines
11:00 What does exercise training do in heart failure? 60
A.J. S. Coats (Norwich, GB)
11:18 Results from randomized clinical trials. 61
C. O’Connor (Durham, US)
11:36 How to exercise? 62
A. Cider (Gothenburg, SE)
11:54 Electrical muscle stimulation. 63
A.L. Clark (Kingston-Upon-Hull, GB)
12:12 How to keep patients adherent to exercise training. 64
M.H.L. Van Der Wal (Groningen, NL)
11:00 - 12:30 Main Session Malmö
Drug therapy in heart failure: has the emphasis shifted?
Chairpersons: K. McDonald (Dublin, IE); D.J. van Veldhuisen (Groningen, NL)
Latest Updates
Visit the Exhibition - Coffee Break in the Exhibition Area
Morning Poster Session: Poster Viewing 08:30 - 12:30
& Moderated Posters Session 10:00 - 11:00 See Page 35
11:00 Is heart rate a treatment target? 65
M. Bohm (Homburg/Saar, DE)
11:22 Do all symptomatics patients need 5 drugs or more? 66
T.A. McDonagh (London, GB)
11:45 How should SHIFT and Emphasis influence guideline recommendations? 67
K. Dickstein (Stavanger, NO)
12:07 What are the implications for future trials in heart failure? 68
H. Krum (Melbourne, AU)
21
SUNDAY

SUNDAY
SUNDAY 22 MAY 2011 - MORNING
11:00 - 12:30 How-to Session Uppsala
Surgery and device intervention for the elderly with heart failure: assessing the need
Chairpersons: P. Hauptman (Saint Louis, US); P.J. Mohacsi (Bern, CH)
Devices and Technology for heart failure in 2011
11:00 Assessing cardiovascular function in the elderly: the cardiopulmonary exercise test. 69
L. Ingle (Leeds, GB)
11:18 Assessing cardiovascular function in the elderly: composite scores - Better than
VO2 alone. 70
L.H. Lund (Stockholm, SE)
11:36 ICD and CRT devices in the elderly: any special considerations? 71
A. Auricchio (Lugano, CH)
11:54 VADs in the elderly: too late? 72
M. Strueber (Hannover, DE)
12:12 Care of the elderly with devices. 73
B. Granger (Durham, US)
11:00 - 12:30 Main Session Örebro
MicroRNAs on their way to the clinic
Chairpersons: S. Janssens (Leuven, BE); J. Bauersachs (Hannover, DE)
Basic Science, Basic Science translated for the clinician
11:00 An introduction to MicroRNAs – The new magic bullet? 74
S. Engelhardt (Munich, DE)
11:18 MicroRNAs as biomarkers for heart failure. 75
Y. Pinto (Amsterdam, NL)
11:36 MicroRNAs to regulate cardiac growth and hypertrophy. 76
To be announced
11:54 A MicroRNA-based diagnostic signature for vascular dysfunction. 77
M. Mayr (London, GB)
12:12 MicroRNA-based regulation of angiogenesis. 78
T. Thum (Hannover, DE)
More Late Breaking Trials
and Research Clinical Trial Forum Posters
on Level 1
22

SUNDAY 22 MAY 2011 - MORNING
11:00 - 12:30 YIA Abstracts Linköping
Nursing Investigator Award
Chairperson: B. Riegel (Philadelphia, US)
Judges: M. Ryder (Perth, AU); A.W. Hoes (Utrecht, NL); M.C. Deaton (Manchester, GB)
11:00 The influence of heart failure on longitudinal changes in cognition among
individuals 80 years of age and older. 79
C. Hjelm, A. Dahl, A. Brostrom, J. Martensson, B. Johansson, A. Stromberg
(Linkoping, Jonkoping and Gothenburg, SE)
11:15 Factors associated with dementia in elderly-elderly patients with heart failure. 80
C. Hjelm, A. Brostrom, A. Dahl, M. Fredriksson, B. Johansson, A. Stromberg
(Linkoping, Jonkoping and Gothenburg, SE)
11:30 Effects of person-centered care in patients with chronic heart failure - the PCC-
HF study. 81
A. Wolf, L.-E. Olsson, K. Dudas, K. Swedberg, C. Taft, M. Schaufelberger, I. Ekman
(Gothenburg, SE)
11:45 Tailored telemonitoring in patients with heart failure: the tehaf-study. 82
J.J.J. Boyne, H.J.M. Vrijhoef, F.H.N. Nieman, R. De Wit, G.J. De Weerd, J.
Kragten, A.P.M. Gorgels (Maastricht, Sittard and Heerlen, NL)
12:00 Education and support needs of the older adult with congenital heart disease. 83
H. Habibi, J.P. Riley, W. Banya, A. Firouzi, M. Gatzoulis, M. Lau-Walker, M. Cowie
(London, GB)
12:15 In an elderly patient population, health-related quality of life is close to that of
a general population twelve months following surgery for aortic valve disease. 84
R. Szczecinska, J.P. Riley (London, GB)
23
SUNDAY

SUNDAY
SUNDAY 22 MAY 2011 - AFTERNOON
12:45 - 14:00 Satellite Symposium Gothenburg
Improving the lives of patients with chronic heart failure: iron matters
Satellite Symposium organised by Vifor Pharma
Chairpersons: K. Swedberg (Gothenburg, SE); T. Jaarsma (Norrkoping, SE)
12:45 Introduction. 85
K. Swedberg (Gothenburg, SE); T. Jaarsma (Norrkoping, SE)
13:00 Iron deficiency in CHF – A new piece of the puzzle? 86
P. Ponikowski (Wroclaw, PL)
13:15 Evidence for treating iron deficiency in chronic heart failure patients. 87
G.S. Filippatos (Athens, GR)
13:30 A practical guide for treating iron deficiency in cardiorenal patients. 88
T.A. Mc Donagh (London, GB)
13:45 Q&A.
12:45 - 14:00 Satellite Symposium Stockholm
The role of mineralocorticoid receptor (MR) antagonists throughout the heart
failure continuum: evidence from laboratory to clinical practice
Satellite Symposium organised by Pfizer, Inc.
Chairpersons: J.J.V. McMurray (Glasgow, GB); F. Zannad (Vandoeuvre Les Nancy, FR)
Welcome and introduction. 90
F. Zannad (Vandoeuvre Les Nancy, FR); J.J.V. McMurray (Glasgow, GB)
12:45 Opening lecture: key achievements and unmet needs across the heart failure
disease spectrum. 91
J.J.V. McMurray (Glasgow, GB)
12:55 New insights into the role of mineralocorticoid receptor activation for
myocardial remodelling and failure. 92
J. Bauersachs (Hannover, DE)
13:10 Clinical implications based on evidences from recent trials with aldosterone
receptor blockers. 93
D.J. van Veldhuisen (Groningen, NL)
13:25 Serum potassium and cardiorenal outcomes in cardiovascular clinical trials of
RAAS therapy. 94
F. Zannad (Vandoeuvre Les Nancy, FR)
13:40 Discussion. 95
J.J.V. McMurray (Glasgow, GB); F. Zannad (Vandoeuvre Les Nancy, FR)
24

SUNDAY 22 MAY 2011 - AFTERNOON
12:45 - 14:00 Satellite Symposium Malmö
Cardiac resynchronization therapy: from patient selection to patient management
Satellite Symposium organised by Medtronic
Chairpersons: M. Bohm (Homburg/Saar, DE); J.C. Daubert (Rennes, FR)
12:45 Introduction. 96
J.C. Daubert (Rennes, FR)
12:50 Which patients benefit from CRT: guidelines and clinical practice. 97
K. Dickstein (Stavanger, NO)
13:10 CRT: recent learnings and cost efficacy results. 98
R. Willems (Leuven, BE)
13:30 Device diagnostic information to improve management of HF patients. 99
M.R. Cowie (London, GB)
13:50 Conclusion. 100
M. Bohm (Homburg/Saar, DE)
12:45 - 14:00 Satellite Symposium Uppsala
Patient-physician touch points: sharing perspectives and unmet needs in heart failure
Satellite Symposium organised by Novartis Pharma AG
Chairpersons: S.D. Anker (Berlin, DE); H. Krum (Melbourne, AU)
12:45 Introduction. 101
H. Krum (Melbourne, AU)
12:50 Heart failure touch point: first contact - the challenges and importance of
initial patient-physician interactions. 102
F.D.R. Hobbs (Birmingham, GB)
13:00 Heart failure touch point: crisis - managing acute heart failure in the
emergency room. 103
S. Collins (Cincinnati, US)
13:10 No time to relax in the pursuit of new approaches in acute heart failure. 104
J.R. Teerlink (San Francisco, US)
13:25 Heart failure touch point: chronic care - planning heart failure care for the long-term. 105
H. Krum (Melbourne, AU)
13:35 Chronic heart failure: potential new treatment paradigms on the horizon. 106
I.B. Squire (Leicester, GB)
13:50 Q&A session and close. 107
S.D. Anker (Berlin, DE)
25
SUNDAY

SUNDAY
SUNDAY 22 MAY 2011 - AFTERNOON
12:45 - 14:00 Satellite Symposium Örebro
Are ventricular assist devices ready for the mainstream?
Satellite Symposium organised by Thoratec Corporation
Chairpersons: J.-N. Trochu (Nantes, FR); H.J. Dargie (Glasgow, GB)
12:45 Introduction. 108
H.J. Dargie (Glasgow, GB)
12:50 When does my patient become a VAD patient? 109
S. Russell (Baltimore, US)
13:05 EU MCS patient referral guidelines. 110
D. Logeart (Paris, FR)
13:20 MCS therapy: from case report to common practice. 111
F. Gustafsson (Copenhagen, DK)
13:35 How old is too old for MCS? 112
J.-N. Trochu (Nantes, FR)
13:50 Q&A.
13:55 Conclusion. 114
J.-N. Trochu (Nantes, FR)
26

SUNDAY 22 MAY 2011 - AFTERNOON
14:15 - 15:45 Clinical Interactive Educational Session Gothenburg
Acute heart failure: assessment and management of the difficult patient
Chairpersons: G.S. Filippatos (Athens, GR); M.S. Nieminen (Helsinki, FI)
Education and Guidelines
Panel. 115
P. Ponikowski (Wroclaw, PL); C. Mueller (Basel, CH)
14:15 Acute heart failure non-responsive to diuretics (hemofiltration). 116
A. Mebazaa (Paris, FR)
14:37 Acute heart failure with low cardiac output not responding to drug therapy (LVAD). 117
F. Ruschitzka (Zurich, CH)
15:00 Early management of severe pulmonary oedema (Non-invasive ventilation). 118
A.J.S. Coats (Norwich, GB)
14:15 - 15:45 Special Session Stockholm
14:15 - 15:45 Main Session Malmö
The value of the heart failure registries
Chairpersons: L. Tavazzi (Cotignola, IT); K. Sliwa-Hahnle (Cape Town, ZA)
Education and Guidelines
Late Breaking Trials - Session I
Consult Session details in the Addendum & on the Website
Latest Updates
This session will feature the latest breakthrough in Clinical Research.
Each trial presentation will be concluded by a discussant review.
14:15 Potential values of a registry in heart failure. 129
U.G. Dahlstrom (Linkoping, SE)
14:37 Advantages and disadvantages with a registry in heart failure. 130
J.-N. Trochu (Nantes, FR)
15:00 Should we collect patient focused variables? 131
J. Drozdz (Lodz, PL)
15:22 Presentation of a concept for a European heart failure registry. 132
A.P. Maggioni (Florence, IT)
27
SUNDAY

SUNDAY
SUNDAY 22 MAY 2011 - AFTERNOON
14:15 - 15:45 Main Session Uppsala
Do heart failure patients need guts?
Chairpersons: L. Gullestad (Oslo, NO); P.J. Mohacsi (Bern, CH)
Co-morbidities and heart failure
14:15 Caring for cachectic heart failure patients - What can be done in 2011? 133
M. Lainscak (Golnik, SI)
14:33 How to evaluate nutrition in patients with heart failure. 134
H. Philipson (Molnlycke, SE)
14:51 Weight gain or muscle gain - Exercise programmes for heart failure patients. 135
M.F. Piepoli (Piacenza, IT)
15:09 How to feed malnourished heart in heart failure. 136
M. Gheorghiade (Chicago, US)
15:27 Nutrient deficiencies - Are calories everything we need? 137
S. Von Haehling (Berlin, DE)
14:15 - 15:45 Main Session Örebro
New biological heart failure mechanisms or twists to old ones?
Chairpersons: A.M. Shah (London, GB); E. Hirsch (Turin, IT)
Basic Science, Basic Science translated for the clinician
14:15 Sarcolemmal microdomain signalling: not all calcium is the same. 138
F.R. Heinzel (Graz, AT)
14:33 Protective roles of reactive oxygen species: why antioxidant trials failed? 139
A.M. Shah (London, GB)
14:51 There’s more to beta-adrenoceptor regulation in heart failure: A tale of beta2. 140
S. Engelhardt (Munich, DE)
15:09 PDE inhibitors, but not for cAMP. 141
S. Janssens (Leuven, BE)
15:27 Targeting the non-myocytes. 142
J. Bauersachs (Hannover, DE)
28

SUNDAY 22 MAY 2011 - AFTERNOON
14:15 - 15:45 YIA Abstracts Linköping
Young Investigator Award for Clinical research
Chairpersons: H.J. Dargie (Glasgow, GB); P. Seferovic (Belgrade, RS)
Judges: H. Hillege (Groningen, NL); L. Neyses (Manchester, GB); V. Mareev (Moscow, RU)
14:15 Factors related to long-term compliance with non-pharmacological treatment
in heart failure patients 143
M.M.W. Nieuwenhuis, T. Jaarsma, D.J. Van Veldhuisen, M.H.L. Van Der Wal
(Groningen, NL; Norrkoping, SE)
14:30 Long-term growth hormone replacement therapy in chronic heart failure:
preliminary data 144
A.M. Marra, L. Saldamarco, M. Arcopinto, A. Salzano, E. Bobbio, S. Longobardi,
E. Bossone, G. Malizia, I. Isgaard, A. Cittadini (Naples, Rome and Palermo, IT;
Gothenburg, SE)
14:45 Reverse electrical remodeling after ventricular assist device may predict risk of
heart failure hospitalization 145
S. Hozayen, H. Roukoz, A. Rosenbaum, S. Duval, P. Eckman (Minneapolis, US)
15:00 Plasma renin activity and angiotensinogen M235T polymorphism are
determinants of aldosterone escape in patients with systolic heart failure 146
G. Vergaro, C. Fatini, E. Sticchi, C. Vassalle, C. Passino, M. Emdin, R. Abbate
(Pisa and Florence, IT)
15:15 Choosing Beta-blockers in treating patients with chronic heart failure in
combination with chronic obstructive pulmonary disease 147
P.A. Fedotov, M.Y. Sinikova, E.V. Shlyakhto, N.L. Shaporova (St Petersburg, RU)
15:30 Hypertensive cardiomyopathy. Is it a distinct phenotype of heart failure
syndrome? Preliminary results of a 10 years screening on patients with
hypertension and left ventricular dysfunction 148
A. Iorio, B. Pinamonti, M. Merlo, M. Bobbo, L. Massa, G. Faganello,
A. Di Lenarda, G. Sinagra (Trieste, IT)
Visit the Exhibition - Coffee Break in the Exhibition Area
Afternoon Poster Session: Poster Viewing 14:00 - 18:00
& Moderated Posters Session 15:45 - 16:30 See Page 54
29
SUNDAY

SUNDAY
SUNDAY 22 MAY 2011 - AFTERNOON
16:30 - 18:00 Clinical Interactive Educational Session Gothenburg
Difficult cases in heart failure with preserved ejection fraction
Chairpersons: B.M. Pieske (Graz, AT); L. Neyses (Manchester, GB)
Education and Guidelines
Panel. 149
M. Bohm (Homburg/Saar, DE); B.M. Massie (San Francisco, US)
16:30 A 75 year old female with uncontrolled diabetes and recurrent cardiac
decompensation. 150
M. Mamas (Manchester, GB)
16:52 A 80 year old male with rapid atrial fibrillation. 151
F.R. Heinzel (Graz, AT)
17:15 A 60 year old male with unexplained shortness of breath. 152
S. Solomon (Boston, US)
16:30 - 18:00 Main Session Stockholm
Novel device therapies for heart failure
Chairpersons: E. Omerovic (Gothenburg, SE); R. Pacher (Vienna, AT)
Devices and Technology for heart failure in 2011
16:30 Cardiac contractility modulation. 153
M. Borggrefe (Mannheim, DE)
16:48 New trends in CRT and ICD therapy. 154
A. Auricchio (Lugano, CH)
17:06 Artificial heart. 155
E.J. Birks (Louisville, GB)
17:24 Mitral clip. 156
M. Settergren (Stockholm, SE)
17:42 Ultrafiltration. 157
A. Mebazaa (Paris, FR)
16:30 - 18:00 Main Session Malmö
Chronic heart failure and chronic obstrutctive pulmonary disease: ignored common duel!
Chairpersons: B. Granger (Durham, US); A.L. Clark (Kingston-Upon-Hull, GB)
Co-morbidities and heart failure
16:30 Link between chronic obstructive pulmonary disease and chronic heart failure. 158
N.M. Hawkins (Warrington, GB)
16:52 Difficulty and challenge to diagnose chronic heart failure in chronic
obstrutctive pulmonary disease. 159
F.H. Rutten (Utrecht, NL)
17:15 Dyspnea - the common symptom. 160
A.L. Clark (Kingston-Upon-Hull, GB)
17:37 How to optimise therapy for both: drugs to be preferred and avoided. 161
J.T. Parissis (Athens, GR)
30

SUNDAY 22 MAY 2011 - AFTERNOON
16:30 - 18:00 How-to Session Uppsala
How to talk to your patients
Chairpersons: M.H.L. Van Der Wal (Groningen, NL); B. Riegel (Philadelphia, US)
Education and Guidelines
16:30 Strategies for motivating the elderly patients. 162
B. Riegel (Philadelphia, US)
16:52 Strategies to motivate young patients with heart failure. 163
J. Martensson (Jonkoping, SE)
17:15 Putting this into practice - General practitioner’s perspective. 164
A.W. Hoes (Utrecht, NL)
17:37 Heart failure; changing beliefs in the first six months. 165
S. Newman (London, GB)
16:30 - 18:00 Main Session Örebro
Inflammation in heart failure: biomarker, bystander or mediator
Chairpersons: M. Fu (Gothenburg, SE); H.P. Schultheiss (Berlin, DE)
Basic Science, Basic Science translated for the clinician
16:30 Inflammation: how does it occur and how do we measure it? 166
G.K. Hansson (Stockholm, SE)
16:48 Insight from clinical trials of anti-inflammatory therapy in chronic heart failure. 167
M. Fu (Gothenburg, SE)
17:06 Novel matricellular proteins to target. 168
J. Diez Martinez (Pamplona, ES)
17:24 Novel anti-inflammatories on the horizon: PI3K antagonists. 169
E. Hirsch (Turin, IT)
17:42 Immunoadsorption therapy in inflammatory heart disease. 170
S.B. Felix (Greifswald, DE)
31
SUNDAY

SUNDAY
SUNDAY 22 MAY 2011 - AFTERNOON
16:30 - 18:00 YIA Abstracts Linköping
Young Investigator Award for Basic Science
Chairpersons: S. Janssens (Leuven, BE); T. Eschenhagen (Hamburg, DE)
Judges: D.L. Brutsaert (Kontich, BE); C. Maack (Homburg/Saar, DE);
A.M. Shah (London, GB)
16:30 Absence of microRNA-155 protects against adverse cardiac inflammation and
hypertrophy during pressure overload and prevents heart failure 171
M.F. Corsten, B. Schroen, M. Van De Vrie, W. Verhesen, E. Creemers, Y. Pinto,
P. Carmeliet, M. De Winther, A. Papageorgiou, S. Heymans (Maastricht and
Amsterdam, NL; Leuven, BE)
16:45 The NLRP3-dependent inflammasome in relation to cardiac diseases 172
Ø. Sandanger, T. Ranheim, L.E. Vinge, M. Bliksoen, G. Valen, E. Lien,
K.A. Fitzgerald, T. Espevik, P. Aukrust, A. Yndestad (Oslo and Trondheim, NO;
Worcester, US)
17:00 Impact of different ARVC-related desmin mutations on filament assembly using
dual-color photoactivation localization microscopy in living cells 173
A. Brodehl, P.N. Hedde, S. Gayda, F. Gartner, A. Gaertner, I. Stork, B. Klauke,
J. Gummert, G.U. Nienhaus, H. Milting (Bad Oeynhausen and Karlsruhe, DE)
17:15 IQGAP1 regulates ERK1/2 and AKT signaling in the heart and sustains
functional remodeling upon pressure overload 174
M. Sbroggio’, D. Carnevale, A. Bertero, G. Cifelli, E. De Blasio, G. Mascio,
E. Hirsch, M. Brancaccio, G. Lembo, G. Tarone (Turin and Pozzilli, IT)
17:30 Decreased calcium-sensitivity of force production and posttranslational protein
modifications in murine cardiomyocytes following myocardial infarction 175
A. Balogh, E.T. Pasztor, D. Czuriga, D. Santer, B. Podesser, Z. Papp (Debrecen,
HU; Vienna, AT)
17:45 The BNP metabolite BNP1-30 is a more potent vasorelaxant peptide than the
mature BNP1-32 176
A. Schwiebs, Y. Wang, K. Pankow, X. Zhu, W.-E. Siems, T. Walther (Giessen and
Berlin, DE; Hull, GB)
32

SUNDAY 22 MAY 2011 - AFTERNOON
18:15 - 19:45 Satellite Symposium Gothenburg
Ivabradine: a SHIFT paradigm in heart failure management
Satellite Symposium organised by SERVIER
Chairpersons: K. Swedberg (Gothenburg, SE); L. Tavazzi (Cotignola, IT)
18:15 Introduction. 177
K. Swedberg (Gothenburg, SE)
18:22 New clinical data from the SHIFT trial: what’s new. 178
M. Komajda (Paris, FR)
18:47 Pivotal role of heart rate reduction with ivabradine. 179
M. Bohm (Homburg/Saar, DE)
19:12 Ivabradine: changing the way we manage heart failure. 180
P. Ponikowski (Wroclaw, PL)
19:37 Conclusion. 181
L. Tavazzi (Cotignola, IT)
18:15 - 19:00 Mini-Satellite Symposium Linköping
Solutions for heart failure management: the ever-growing role of device therapy
Mini-Satellite Symposium organised by Boston Scientific
Chairperson: M.R. Cowie (London, GB)
18:15 Introduction. 182
M.R. Cowie (London, GB)
18:20 Identifying the patients for device therapy and their follow-up: heart Failure
specialist perspective. 183
P. Jourdain (Pontoise, FR)
18:40 Optimizing the patient outcome: electrophysiologist perspective. 184
A. Auricchio (Lugano, CH)
33
SUNDAY

MORNING
SUNDAY
POSTER SESSIONS
Moderated Posters Session 1 (10:00 - 11:00)...........................................................Page 36
Poster Session 1 ..........................................................................................................................Pages 38 to 53
All Posters will be on display from 08:30 - 12:30
AFTERNOON
Moderated Posters Session 2 (15:45 - 16:30) ...........................................................Page 54
Poster Session 2 ...........................................................................................................................Pages 55 to 70
All Posters will be on display from 14:00 - 18:00
The Heart Failure Association and the Scientific Programme Committee have
developed a programme to support young researchers.
Senior members of faculty, HFA Board Members experts in the topic presented
will come to meet and discuss the research presented during the coffee break of
the poster sessions.
The poster will be easily identified with a HFA Young Researcher
logo - which should be collected at the Poster Assistance Desk.
Join us in supporting the future of research and advances in all related aspects of
heart failure Clinical research / treatment and Basic Science - come and interact
with the Cardiologists of tomorrow.
More Late Breaking Trials and Research
Clinical Trial Forum Posters
on Level 1
35
Y
SUNDAY
POSTERS

SUNDAY
POSTERS
SUNDAY 22 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Moderated Posters Moderated Poster Area
Moderated Posters Session 1
Chairpersons: V. Mareev (Moscow, RU); L. Grinfeld (Buenos Aires, AR)
Moderated posters must be set up between 08:00 - 08:30, removed between 12:30 - 13:00, to
be on display between 08:30 - 12:30 in the designated Moderated Poster Area.
These abstracts were chosen for their outstanding quality and will be presented during the
Moderated Poster Session between 10:00 and 11:00.
Long-term complications related to biventricular defibrillator implantation: rate
of surgical revisions and impact on survival. P185
F. Oliva, M. Landolina, M. Lunati, A. Pierantozzi, C. Bonanno, A. Vado,
F. Ammirati, S. Valsecchi, R.P. Ricci, M. Santini (Milan, Pavia, Pesaro, Vicenza,
Cuneo, Ostia Lido and Rome, IT)
Impact of chronic atrial fibrillation in patients with heart failure, ventricular
dyssynchrony and indication for CRT. Register data with 1721 patients 2001-2010. P186
M. Taborsky, D. Rihova, E. Vait, M. Lazarova (Olomouc and Prague, CZ)
Incidence and clinical relevance of uncontrolled ventricular rate during atrial
fibrillation in heart failure patients treated with cardiac resynchronization therapy. P187
F. Oliva, M. Gasparini, A. Proclemer, G.L. Botto, G. Lonardi, S. Iacopino,
G. Molon, C. D’agostino, P. Di Stefano, G. Boriani (Milan, Rozzano, Udine, Como,
Legnago, Catanzaro, Negrar-Verona, Bari, Rome and Bologna, IT)
Impact of heart failure on accelerated ventricular tachyarrhythmias in patients
with implantable cardioverter-defibrillator therapy. P188
C. Schukro, L. Leitner, J. Siebermair, T. Pezawas, G. Stix, J. Kastner, M. Wolzt,
H. Schmidinger (Vienna, AT)
Do angiotensin-converting enzyme inhibitors improve clinical outcomes in
patients with moderate to severe mitral regurgitation independent of left
ventricular systolic function? P189
M.A. Nadir, S. Rekhraj, D. Elder, M.W. Mccartney, S.D. Pringle, A.M. Choy,
J. George, A.D. Struthers, C.C. Lang (Dundee, GB)
Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis. P190
M.A. Nadir, S. Rekhraj, R. Libianto, D. Elder, T. Lim, S.D. Pringle, J. George,
A.M. Choy, A.D. Struthers, C.C. Lang (Dundee, GB)
Interaction between heart rate and effect of candesartan on mortality in a
broad spectrum of patients with chronic heart failure: results from the CHARM
programme. P191
D. Castagno, H. Skali, K. Swedberg, S. Yusuf, C.B. Granger, E.L. Michelson,
M.A. Pfeffer, S.D. Solomon, J.J.V. Mcmurray (Boston, MA, Durham, NC and
Wilmington, DE, US; Gothenburg, SE; Hamilton, ON, CA; Glasgow, GB)
The beta1-adrenoceptor Arg389Gly-polymorphism modulates heart-ratelowering
effects of carvedilol in heart failure patients with atrial fibrillation - a
CIBIS-ELD substudy. P192
T. Rau, H.D. Duengen, F. Edelmann, F. Waagstein, M. Lainscak, S. Dimkovic,
S. Apostolovic, A. Neskovic, G. Gelbrich, T. Eschenhagen (Hamburg, Berlin,
Gottingen and Leipzig, DE; Gothenburg, SE; Golnik, SI; Belgrade and Nis, RS)
36

SUNDAY 22 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Moderated Posters Moderated Poster Area
The relationship between reactive pulmonary hypertension and mortality in
patients with acute decompensated heart failure. P193
D. Aronson, A. Eitan, R. Dragu, A. Burger (Haifa, IL; Cincinnati, US)
What has changed in surgery of severe aortic stenosis with the advent of
percutaneous intervention? P194
E. Pereira, G. Silva, O. Sousa, D. Caeiro, R. Carvalho, A. Albuquerque, J. Primo,
L. Simoes, V. Gama (Porto, PT)
37
SUNDAY
POSTERS

SUNDAY
POSTERS
SUNDAY 22 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Poster Session 1
Posters must be set up between 08:00 - 08:30, removed between 12:30 - 13:00, to be on display
between 08:30 - 12:30.
The presenter should be available by the poster during the coffee break (10:00 to 11:00) in order
to discuss the research with the audience.
Acute heart failure (diagnosis, pathophysiology, other)
Differences in clinical profile and mortality among chagasic and non-chagasic patients
with acute decompensated heart failure. P195
L.F.B.C. Seguro, D.M. Gualandro, F.G. Marcondes Braga, O. Silvestre, R.L. Lage,
C.S. Rocha, M. Lensi, J. Fabri Jr, M.T. Oliveira Jr (Sao Paulo, BR)
Demographic, etiologic and histological pulmonary analysis in patients dead due to
Acute Respiratory Failure with post-mortem diagnosis of Acute Myocardial Infarction. P196
A.D.P. Ruppert, E.R. Parra, A.M. Soeiro, C.J.R. Serrano, V.L. Capelozzi (Sao Paulo, BR)
Abdominal Fluid Content (AFC): a new parameter for assessment of systemic venous
congestion in patients with acute heart failure. P197
T. Taniguchi, H. Miura, K. Miyazaki, H. Inui, G. Hamano, M. Koide, M. Yamato, N. Sasaki,
K. Hirooka, Y. Yasumura (Osaka, JP)
Clinical implications of thoracic fluid accumulation in patients with mild to moderate
chronic heart failure. P198
T. Taniguchi, H. Miura, K. Miyazaki, H. Inui, G. Hamano, M. Koide, M. Yamato, N. Sasaki,
K. Hirooka, Y. Yasumura (Osaka, JP)
Clinical characteristics and outcome of hospitalized patients with acute decompensated
heart failure in Korea. P199
S.H. Kim, S.W. Han, D.J. Choi, J.J. Kim, E.S. Jeon, M.C. Cho, K.H. Ryu (Seoul and
Cheongju, KR)
Predictors of 30- and 180-day mortality in 326 consecutive patients admitted due to
acute heart failure in one cardiology centre. P200
J. Biegus, R. Zymlinski, J. Szachniewicz, P. Siwolowski, S. Nawrocka, W. Banasiak,
E.A. Jankowska, P. Ponikowski (Wroclaw, PL)
Acid-base balance in the emergency setting can predict the prognosis of patients with
acute heart failure. P201
A. Shirakabe, N. Hata, S. Yokoyama, T. Shinada, N. Kobayashi, K. Tomita, M. Kitamura,
A. Nozaki, K. Asai, K. Mizuno (Tokyo, JP)
Worsening renal function in patients admitted with acute decompensated heart
failure: prevalence, clinical factors and long-term outcomes. P202
A. Dominguez Rodriguez, P. Jorge-Perez, E. Arroyo-Ucar, R. Juarez-Prera,
M. Carrillo-Perez Tome, C. Hernandez-Garcia, G. Blanco-Palacios, A. Lara-Padron,
P. Avanzas, P. Abreu-Gonzalez (Tenerife and Oviedo, ES)
Evaluation of the heart rate variability in patients hospitalized with heart failure. P203
V. Pelaez, G. Pena, C. Figueroa, B. Ramos, L. Alcocer, K. Lammers, F. Oropeza
(Mexico City, MX)
Epidemiologic, diagnostic and therapeutic profile of acute cardiac failure. P204
H. Benhalla, S. Abderazzak, F.Z. Waderrahmane, K.H. Chraibi, A. Bennis (Casablanca, MA)
38

SUNDAY 22 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Cardiac remodelling and functional class in heart failure patients with preserved and
reduced ejection fraction in Lagos. P205
O.E. Usim, J.N. Ajuluchukwu, D.A. Oke (Lagos, NG)
Acute heart failure (therapy)
Clinical and haemodynamic effects of ivabradine in patients with acute ischemic heart
failure. P206
F. Barilla’, I. Jacomelli, F. Giordano, M. Pellicano, T. Dominici, C. Torromeo, V. Paravati,
N. Petrini, C. Gaudio (Rome, IT)
Lung Impedance guided preemptive treatment of evolving acute heart failure in
course of acute myocardial infarction reduces use of furosemide. P207
M. Shochat, M. Kazatsker, V. Gurovich, Y. Levy, L. Vasilenko, A. Asif, D. Blondhaim,
P. Rabinovich, A. Shotan, S. Meisel (Hadera and Tel Aviv, IL)
Epidemiology, therapeutic and future of heart failure in Moroccan women. P208
F. Wadrahmane, N. Zoubir, A. Bennis (Casablanca, MA)
Animal models and experimentation
Echocardiographic area at risk assessment in mice. P209
B. Redfors, M. Scharin Tang, A. Miljanovic, E. Omerovic (Gothenburg, SE)
Adenosine attenuates catecholamine-induced left ventricular dysfunction and
myocardial lipid accumulation. P210
B. Redfors, M. Scharin Tang, Y. Shao, A. Miljanovic, T. Raamunddal, J. Boren, E. Omerovic
(Gothenburg, SE)
Urocortin 2 versus enalapril: Effects of longer-term administration on left ventricular
function and survival in rats with severe heart failure. P211
S. Meili-Butz, K. Buehler, D. John, W.W. Vale, K.L. Peterson, T. Dieterle (Basel, CH; La Jolla, US)
Coverage of a post-infarction scar using a pericardial-derived vascular adipose flap
reduces infarct size in a porcine model of chronic myocardial infarction. P212
C. Prat-Vidal, C. Galvez-Monton, S. Roura, C. Soler-Botija, A. Llucia-Valldeperas,
I. Diaz-Guemes, F.M. Sanchez-Margallo, A. Bayes-Genis (Badalona and Caceres, ES)
Arrhythmias and treatment
Adaptive servoventilation therapy reduces the risk of malignant arrhythmic events in
patients with congestive heart failure and Cheyne-Stokes respiration: results from the
MAAS observational study. P213
T. Bitter, N. Westerheide, G. Noelker, K.J. Gutleben, J. Vogt, J. Heintze, A. Schmidt,
C. Prinz, D. Horstkotte, O. Oldenburg (Bad Oeynhausen and Bielefeld, DE)
The role of endocardial biopsy in ventricular arrhythmias treatment. P214
R. Tatarsky, D.S. Lebedev, G.V. Michailov, L.B. Mitrofanova (St Petersburg, RU)
Atrial fibrillation
Importance of left ventricle dysfunction quantification for thromboembolic risk
prediction in patients with atrial fibrillation. P215
R.A. Providencia, A. Botelho, J. Trigo, A. Faustino, F. Caetano, J. Nascimento, N. Quintal,
P. Mota, A.M. Leitao-Marques (Coimbra, PT)
39
SUNDAY
POSTERS

SUNDAY
POSTERS
SUNDAY 22 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Evaluation of renal function and collagen matrix in patients with chronic heart failure
and permanent atrial fibrillation. P216
J. Nikonova, N. Koziolova, Y. Shilova (Perm, RU)
In patients with left ventricular dysfunction, conversion of atrial fibrillation in sinus rhythm
significantly changes the strain rate and the main echocardiography standard parameters. P217
S. Mazzetti, D. Poggio, M. Bonadies, I. Fracchioni, M. Chioffi, G. Scardina, M. Grillo,
G. Specchia, A. Mortara (Monza, IT)
Left atrial and ventricular dysfunction after treated lone atrial fibrillation. P218
E.-T. Siniorakis, S. Arvanitakis, D. Barlagiannis, N. Skandalakis, S. Pamouki, G. Psatheris,
E. Prokovas, N. Marinakis, I. Papadopoulos, N. Exadactylos (Athens, GR)
Beta blockers
Beta blockers and chronic heart failure: reasons of no-prescription in 1500 patients. P219
N. Zoubeir, H. Salih, F.Z. Wadrahmane, S. Abderazzak, A. Bennis (Casablanca, MA)
Redox status in patients with chronic heart failure: does the choice of the beta-blocker
matter? P220
M. Reina Couto, T. Sousa, M. Morato, J. Afonso, L. Morgado, M. Marques, M. Mota,
P. Bettencourt, A. Albino-Teixeira (Porto, PT)
Heart rate at rest in chronic heart failure under beta-blocker therapy. P221
G.C. Cardoso, C. Aguiar, A. Ventosa, F.M. Costa, J. Ferreira, M. Trabulo, M. Mendes
(Lisbon, PT)
Study of clinical efficacy of nebivolol, carvedilol and metoprolol succinate
administration in complex therapy of chronic heart failure due to coronary heart
disease combined with COPD. P222
V. Evdokimov, A. Radzevich, A. Evdokimova, E. Kovalenko, E. Zolotareva, N. Klevtzova
(Moscow and Balashikha, RU)
Use of beta blockers in chilean patients with heart failure. chilean registry of heart
failure: icaro. P223
L. Sepulveda Morales, R. Concepcion, J. Vukasovic, E. Garces, V. Rossel, P. Castro,
F. Lanas, P. Bilbao, R. Pacheco (Santiago, Valdivia and Temuco, CL)
Comparison efficacy of nebivolol end metoprolol tartrate on clinical status,
hemodynamics and serum concentration of the carboxi-terminal telopeptide of
collagen type I (CITP) in chronic heart failure. P224
V. Mareev, F. Ageev, Y.U. Lopatin, S. Nedogoda, M. Danielyan (Moscow and Volgograd, RU)
Cancer / Cardiotoxicity
Differences in cardiotoxicity induced by trastuzumab and cytotoxic anticancer agents. P225
M. Arao, Y. Kitahara, K. Setsuta (Tokyo, JP)
Parameters of systolic and diastolic left ventricle function during the first year of the
treatment in patients suffering from non-hemotologic tumors requiring complex
oncologic therapy containing an. P226
M. Kocik, A. Vecerova, M. Zahin, K. Gorican, M. Zimovjanova, L. Petruzelka, A. Zak
(Prague, CZ)
Cardiac imaging of trastuzumab-induced cardiomyopathy. P227
V. Kirthi, C. Schultz, S.W. Davies (London, GB; Rotterdam, NL)
40

SUNDAY 22 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Cardiac resynchronisation therapy
Response prediction of cardiac resynchronisation therapy. P228
S. Agosti, L. Casalino, G. Bertero, G. Zaccone, S. Morelloni, C. Brunelli (Novi Ligure and
Genoa, IT)
The mechanoenergetic efficiency of Cardiac Resynchronization Therapy and of
Atrioventricular delay optimization. P229
A. Kyriacou, P. Pabari, R. Cornellussen, R. Baruah, S. Sen, J. Mayet, N. Peters,
P. Kanagaratnam, Z. Whinnett, D. Francis (London, GB)
Does the etiology of heart failure influences the response to cardiac resynchronization
therapy? P230
C. Gomes, A. Meireles, D. Anjo, N. Antunes, L. Caiado, C. Roque, P. Vieira, V. Lagarto,
H. Reis, S. Torres (Porto, PT)
Use of cardiopulmonary exercise testing (CPET) as a prognostic tool to predict the
cardiac resynchronization therapy (CRT) outcome. P231
O. Biadi, F. Menichetti, R. Mariotti, G. Borelli, L. Gabriele, L. Rondinini, M.G. Bongiorni,
M. Marzilli (Pisa, IT)
Acute rise in systolic blood pressure following biventricular pacing is associated with
short-term improvement in renal function: a marker for clinical response to cardiac
resynchronisation therapy? P232
P.J. Cowburn, J.D. Parker (Southampton, GB; Toronto, CA)
The use of cardiac resynchronisation therapy may allow the the optimisation of beta
blocker therapy. P233
K. Guha, Z. Khalique, N. Pareek, B. Chandrasekaran, T. Mcdonagh, M.R. Cowie,
R. Sharma (London, GB)
Alternate Right Ventricular (RV) pacing site to improve the response to Cardiac
Resynchronization Therapy (CRT). P234
H. Alhous, B. Stegemann, A. Hannah, G. Small, G. Hillis, P. Broadhurst (Aberdeen, GB;
Maastricht, NL; Sydney, AU)
Cardiomyopathy
Regression of left ventricular remodeling in chronic heart failure: the effects of high
thoracic epidural sympathetic blockade for the treatment of severe chronic heart
failure due to dilated cardiomy. P235
C. Zhang, W. Guo, F. Liu, L. Fu, R. Qu, G. Wang (Harbin, CN)
Effects of serum from patients with stress-induced cardiomyopathy on HL-1
cardiomyocytes. P236
Y. Shao, A.Z.R.A. Miljanovic, J.A.N. Boren, E.L.M.I.R. Omerovic (Gothenburg, SE)
Myocardial acceleration during isovolumic contraction in assessment of systolic
function of left and right ventricles in patients with hypertrophic cardiomyopathy. P237
Z. Oko-Sarnowska, H. Wachowiak-Baszynska, A. Katarzynska-Szymanska, O. Trojnarska,
E. Straburzynska-Migaj, R. Ochotny, S. Grajek (Poznan, PL)
Clinical-hemodynamic efficacy of metabolic therapy with mildronat at patients with
dilated cardiomyopathy. P238
N.A. Kurbanov, U.A. Abdusattarov (Tashkent, UZ)
Comparison between Myocarditis and Tako-Tsubo Cardiomyopathy. P239
H. Dores, S. Leal, F. Costa, I. Rosario, J. Abecasis, J. Monge, M.J. Correia, I. Arroja,
A. Aleixo, M. Mendes (Lisbon, PT)
41
SUNDAY
POSTERS

SUNDAY
POSTERS
SUNDAY 22 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Endomyocardial biopsy in recently occured dilated cardiomyopathy. P240
J. Krejci, P. Hude, L. Spinarova, E. Ozabalova, T. Freiberger, A. Sirotkova, J. Vitovec (Brno, CZ)
Cardiac function and prognosis of patients with familial form of dilated cardiomyopathy. P241
N.A. Kurbanov, T.A. Abdullaev, B.U. Mardanov (Tashkent, UZ)
What are particularities in echocardiography and Doppler of diabetics with chronic
heart failure? P242
M.K. Benjelloun, S. Hajib, N. Yamoul, Z. El Honsali, A. Bennis (Casablanca, MA)
Clinical features and outcome of non-compaction cardiomyopathy. P243
M. Kubanek, R. Virtova, T. Marek, I. Malek, J. Kautzner (Prague, CZ)
Cardio-renal syndrome
Abnormalities in renal and liver function are of additive value in predicting prognosis
in chronic heart failure. P244
G. Poelzl, M. Ess, C. Koppelstaetter, M. Rudnicki, H. Ulmer, M. Frick (Innsbruck, AT)
Fibronectine and orosomucoid level in patients with congestive heart failure and renal
insufficiency. P245
O.V. Kuryata, O.V. Soya, A.O. Miroshnichenko (Dnipropetrovsk, UA)
The prevalence of cardiac dysfunction in the oldest old with a normal and a low eGFR:
results of the BELFRAIL study (BFC80+). P246
G. Van Pottelbergh, B. Vaes, A. Pasquet, P. Wallemacq, J. Degryse (Brussels, BE)
Worsening renal function in patients with heart failure: clinical predictors and
prognostic impact. P247
V. Larina, B. Bart, M. Michaylusova, M. Golovko (Moscow, RU)
Co-morbidities (inc COPD, anaemia, cachexia)
Prevalence and impact on prognosis of the euthyroid sick syndrome in patients with
systolic heart failure. P248
J.A. Ramirez-Martinez, G. Gonzalez Robledo, J. Comin-Colet, M. Cladellas, M. Rizzo,
S. Ruiz, C. Vilaplana, J.M. Verdu, R. Elosua, J. Bruguera (Barcelona, ES)
Short-term outcomes in heart failure patients with chronic obstructive pulmonary
disease in the community. P249
S. Ghosh, W.T.M. Robertson, C. Carroll-Hawkins, J. Dexter, J. Smith, N.I. Okelly (Leicester, GB)
Low relative count predicts risk of serious infections in patients with acute heart failure. P250
S. Madero, J. Nunez, G. Minana, P. Palau, P. Merlos, J. Sanchis, V. Bodi, M. Olivares,
E. Nunez, A. Llacer (Valencia, ES)
Thyroid disfunctions in severe systolic heart failure: prevalence and management. P251
G.E. Conceicao-Souza, V.S. Issa, S.M. Ayub-Ferreira, F. Bacal, P.R. Chizzola, E.A. Bocchi
(Sao Paulo, BR)
NT-proBNP and left ventricular function in patients with acute exacerbation of chronic
obstructive pulmonary disease. P252
R. Marcun, A. Sustic, P. Mesko Brguljan, S. Kadivec, J. Farkas Lainscak, M. Kosnik,
M. Lainscak (Golnik and Ljubljana, SI; Rijeka, HR)
Echocardiographic structural and functional alterations in patients with rheumatoid
arthritis. P253
J.I.A. Orea-Tejeda, R. Sanchez-Santillan, L. Castillo-Martinez, C. Murphy-Arteaga,
G. Sanchez-Vidal, O. Carrasco-Ortiz, A. Navarro-Navarro, E. Colin-Ramirez, K. Balderas-Diaz
(Mexico, MX)
42

SUNDAY 22 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Clinical profile, comorbidities and prognosis in a spanish cohort of elderly patients with
acute decompensated heart failure. P254
J.A. Satue, J.C. Belinchon, A. Perez Martin, J. Marrero, M. Luaces, A. Zapatero
(Fuenlabrada, ES)
Cytokines and inflammation
Inflammatory markers in systolic heart failure and heart failure with preserved ejection
fraction. P255
L. Martinez-Dolz, I.J. Sanchez Lazaro, L. Almenar-Bonet, V. Vila-Liante, V. Martinez-Salez,
E. Reganon-Salvador, A. Salvador-Sanz (Valencia, ES)
Serum sFAS-ligand level and metabolic status of patients with myocardial infarction. P256
A.S. Iakovleva, O. Mirolyubova, K.K. Holmatova, I.V. Dvoryashina (Arkhangelsk, RU)
Inflammatory and neurohormonal activation in children with repaired Coarctation of
Aorta. P257
A.C. Moutafi, T. Alissafi, S.N. Chryssanthakopoulos, V. Thanopoulos, D. Tousoulis,
C. Stefanadis, M.A. Gatzoulis, C.H. Davos (Athens, GR; London, GB)
ICD therapy
Impact of Immediate versus deferred defibrillation threshold testing in patients
undergoing Cardiac Resynchronization Therapy. P258
M.Y. Liu, G. Lin, D. Hodge, P.A. Friedman, Y.-M. Cha, S.J. Asirvatham, R. Rea, P. Brady
(Rochester, US)
Prediction of appropriate defibrillator therapy in patients with chronic heart failure. P259
N. Nyolczas, M. Dekany, B. Szabo, B. Ancsin, A. Sandor, A. Kovacs, T. Bauernfeind,
A. Szabo, R. Markus, R.G. Kiss (Budapest, HU)
Use of a wearable cardioverter defibrillator among pre-partum pregnant women:
An analysis of safety, characteristics and outcomes. P260
M. Saltzberg, S. Szymkiewicz, N. Bianco (Newark and Pittsburgh, US)
Primary prophylaxis of sudden cardiac death in patients with severe Chagas
cardiomyopathy: further studies. P261
R. Bestetti, A. Cardinalli-Neto, M.A. Nakazone, L. Grassi, B.A. Tavares (Sao Jose do Rio Preto, BR)
Diagnosis of heart failure and biomarkers
Blood genes expression profiles as markers for pre-heart failure detection. P262
F. Smih, F. Desmoulin, M. Berry, A. Turkieh, R. Harmancey, A. Pathak, O. Lairez,
J. Ferrieres, M. Galinier, P. Rouet (Toulouse, FR)
Asymptomatic left ventricular diastolic dysfunction in a high-risk population enrolled
in a primary care setting. prevalence and screening value of electrocardiography and
natriuretic peptides. P263
A. Iacovoni, M. Senni, M. Gori, A. Grosu, P. Ferrari, S. Guideri, A. Fontana, A. Filippi,
R. De Maria, A. Gavazzi (Bergamo and Milan, IT)
Serum neutrophil gelatinase-associated lipocalin (NGAL) in patients with systolic
chronic heart failure: clinical determinants and prognostic consequences. P264
E.A. Jankowska, J. Malyszko, J. Malyszko, A. Witkowska, E. Koc-Zorawska, S. Von Haehling,
W. Banasiak, S.D. Anker, I.C. Macdougall, P. Ponikowski (Wroclaw and Bialystok, PL;
Berlin, DE; London, GB)
43
SUNDAY
POSTERS

SUNDAY
POSTERS
SUNDAY 22 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Growth differentiation factor 15 and lipoprotein - associated phospholipase A2 in heart
failure patients. P265
E. Moldoveanu, D.S. Marta, M. Serban, G. Catalin, R. Huica, G. Dinca, I. Serban, T. Kosaka
(Bucharest, RO; Osaka, JP)
Osteopontin plasma level as a target in the assessment of severity heart failure and
cardiac remodelling. P266
A. Berezin, T. Panasenko, V. Seden (Zaporozhye and Kherson, UA)
Quantitative estimation of the endothelium damage and its practical application in
advance heart failure patients. P267
A.K. Kurlianskaya, T.L. Denisevich (Minsk, BY)
Parameters of cardio-pulmonary exercise test as prognostic factors in patients with
stable coronary disease and asymptomatic heart dysfunction during 2-years observation. P268
A. Skrzypek, J. Nessler, B. Nessler (Krakow, PL)
NT-proBNP value as a long term predictor of mortality after an Acute Coronary
Syndrome. P269
C. Fernandez-Vivancos Marquina, R. Calvo Jambrina, R.J. Hidalgo Urbano,
C. Sanchez-Tembleque, A. Castro Fernandez, A. Recio Mayoral, S. Rodriguez De Leiras,
J.M. Cruz Fernandez (Seville, ES)
Disease management and patient education
Impact of a nurse-led heart failure program on all cause mortality in Saudi Arabia. P270
M.B. Bdeir, T. Conboy, A. Mukhtar, H. Omer, R. Odeh, I. Farah, M. Al-Khateeb, A. Tayiem,
A. El Tayeeb, M. Al Mallah (Riyadh, SA)
Continuous monitoring of respiratory rate derived from an implantable right
ventricular pressure sensor in patients with heart failure. P271
F. Braunschweig, B. Kjellstrom, D. Ersgard, C. Linde, M. Erickson (Stockholm, SE;
Minneapolis, US)
Can be the home care of the heart failure patients a better economic alternative? P272
C.L. Andrei, C.J. Sinescu, R.M. Ianula, A.I. Popa, V.P. Chioncel, A.N. Mischie, F.C. Adam,
M. Dasoveanu, D.E. Mincu, V.T. Grigorean (Bucharest, RO)
A dedicated to heart failure outpatient clinic in salerno: our first two years of experience. P273
N. Tufano, A. Gigantino, S. De Angelis, G. Gigantino, T. Attisano, G. Sessa, S. Minichiello,
M. Mirra, R. Giudice, A. Battimelli (Salerno and Naples, IT)
Diuretics and fluid status management
Acute heart failure patients undergoing continuous renal replacement therapy:
predictors of in-hospital mortality. P274
M. Satendra, C. Santos De Sousa, L. Sargento, M.R. Marques, R. Marcal, J.L. Gouveia,
H. Bento, C. Franca (Lisbon, PT)
Tolvaptan improved cardiac function in rat with myocardial infarction; beyond to
diuretic action. P275
T. Yamazaki, Y. Nakamura, Y. Izumi, A. Hanatani, K. Shimada, T. Muro, H. Iwao,
M. Yoshiyama (Osaka, JP)
Peritoneal dialysis as an alternative approach to end stage refractory heart failure
contraindicated for heart transplantation: a retrospective controlled cohort study. P276
G.E. Conceica-Souza, E.A. Osawa, E.S. Oliveira, S.M. Ayub-Ferreira, V.S. Issa, F. Bacal,
P.R. Chizzola, E.A. Bocchi (Sao Paulo, BR)
44

SUNDAY 22 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Drug therapy, other
Statins in heart failure: the paradox between randomized clinical trials and real life. P277
M. De Antonio, J. Lupon, A. Urrutia, B. Gonzalez, L. Cano, R. Cabanes, C. Diez, R. Coll,
S. Altimir, A. Bayes-Genis (Badalona, ES)
Acetazolamide decreases obstructive sleep apnea severity in patients with chronic
heart failure. P278
E. Belyavskiy, V. Mareev (Moscow, RU)
Ivabradine improves diastolic function and physical performance in patients with
diastolic heart failure. P279
G. De Masi De Luca, L. Capulzini, M. Accogli, R. Mangia, A. De Masi De Luca,
K. Vaziri Farahani, C. Sacra, S. Longo, A. Galati (Tricase and Florence, IT; Brussels, BE)
Statins and response to carvedilol given to patients with chronic heart failure. P280
B. Nessler, R. Golebiewska, A. Gackowski, J. Nessler (Krakow, PL)
Levosimendan provides a better pulmonary hemodynamic profile than dobutamine in
reducing systolic pulmonary pressure in patients with systolic dysfunction presenting
with acute heart failure syndromes. P281
Y. Cavusoglu, E. Gencer, M. Tek, M. Bilgin, A. Nadiradze, A. Birdane, B. Gorenek, A. Unalir,
N. Ata (Eskisehir, TR)
Enhanced external counterpulsation in the treatment of chronic angina: a long-term
follow-up outcome from Turkish patients with chronic heart failure. P282
G. Kozdag, G. Ertas, Y. Akay, F. Aygun, E. Emre, A. Kirbas, G. Kahraman, D. Ural (Kocaeli, TR)
Clinical experience of treatment with ivabradine in patients with severe chronic heart
failure. P283
E. Tarlovskaya, N. Maksimchuk, M. Kazakovtseva, A. Tarlovsky, G. Kolevatova, N.
Smerdova, A. Isakov (Kirov, RU)
ACEi in combination with beta-blockers or spironolactone the cornerstone of mid- term
therapeutics in heart failure patients. P284
L. Sargento, C. Sousa, M. Satendra, N. Lousada, R. Palma Reis (Lisbon, PT)
Echocardiography
Selection of patients for percutaneous transvenous mitral balloon valvotomy: is there a
definitive limit for wilkins score? P285
A.S. Correia, M. Paiva, R. Lopes, A. Goncalves, R. Almeida, P.B. Almeida, C. Frutuoso,
F. Macedo, J.C. Silva, M.J. Maciel (Porto, PT)
Feasibility of domiciliary echocardiography in the oldest old: the Newcastle 85+ study. P286
F. Yousaf, J. Collerton, A. Kenny, A. Kingston, T. Kirkwood, B. Keavney (Newcastle upon
Tyne, GB)
Compression of tissue Doppler imaging (TDI ) and tissue strain imaging(TSI) in
evaluation of left ventricular dyssynchrony in heart failure patients and healthy
individuals. P287
M. Rezvanfard, H. Sadeghian, M. Lotfi_Tokaldany, A. Safir Mardanloo, M. Sheikh Fathollahi
(Tehran, IR)
The effect of levosimendan on tissue doppler parameters of right ventricle in heart failure. P288
F. Alibaz Oner, O.Z. Gurbuz, E. Oner, M. Erguney (Istanbul, TR)
45
SUNDAY
POSTERS

SUNDAY
POSTERS
SUNDAY 22 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Correlation between postinfarction remodelling process and development of
ventricular arrhythmia in ischaemic dilated cardiomyopathy. P289
T. Benedek, M. Chitu, I. Kovacs, I.A. Sarbu-Pop, Z. Suciu, B. Jako, I. Benedek Jr,
I.S. Benedek (Targu Mures, RO)
Diastolic functional reserve effect on stroke volume by leg elevation in hypertensive
patients. P290
S.N. Shin, S.J. Rhee, I.S. Shin, E.M. Lee, N.J. Yoo, K.H. Yun, N.H. Kim, S.K. Oh, J.W. Jeong
(Iksan, KR)
Can we predict the development of diastolic dysfunction in patients treated with
primary percutaneous coronary intervention. P291
I. Nedeljkovic, M. Ostojic, B. Vujisic-Tesic, M. Petrovic, B. Jakovljevic, D. Trifunovic,
M. Banovic, O. Petrovic, B. Beleslin, M. Nedeljkovic (Belgrade, RS)
Exercise testing & training
Cardiovascular effects of testosterone and exercise training in hypogonadal males with
chronic heart failure. P292
M. Stout, H. Doll, N. Woodroofe, G. Tew, K. Channer, J. Saxton (Manchester, Norwich and
Sheffield, GB)
Combined cardiopulmonary exercise stress echocardiography test: new test for
assessment of diastolic dysfunction in patients with hypertension. P293
I. Nedeljkovic, M. Ostojic, V. Giga, D. Trifunovic, B. Parapid, M. Nedeljkovic, J. Stepanovic,
S. Mazic, A. Djordjevic Dikic, B. Beleslin (Belgrade, RS)
The effect of long-term exercise training on endothelial function in chronic heart failure. P294
E. Besaga, I. Shkurat, L. Voronkov (Kyiv, UA)
Heart rate reserve is the most important determinant of exercise capacity in patients
with heart failure and preserved left ventricular function. P295
J. De Sutter, S. Pardaens, M. Vanderheyden, N. Van De Veire, J. Bartunek
(Ghent and Aalst, BE)
Chronotropic incompetence in men with heart failure regardless of left ventricular
ejection fraction. P296
B. Krakowiak, E.A. Jankowska, W. Banasiak, P. Ponikowski (Wroclaw, PL)
Effect of efonidipine therapy on exercise intolerance in patients with first myocardial
infarction. Efonidipine and myocardial infarction study. P297
T. Naka, C. Yoshida, T. Akagami, T. Doi, T. Sakoda, T. Masuyama, M. Ohyanagi
(Nishinomiya, JP)
Resting transthoracic impedance cardiography links with prognostic parameters of
cardiopulmonary exercise test in subjects with heart failure. P298
A. Gwizdala, E. Straburzynska-Migaj, A. Katarzynska, R. Ochotny, S. Grajek (Poznan, PL)
Effects of exercise training on functional capacity and quality of life in heart failure
patients. P299
D. Marinkovic, M. Deljanin-Ilic, S. Ilic, B. Ilic, V. Nikolic (Niska Banja and Nis, RS)
Haemodynamics / Coronary and peripheral circulation
Implantable hemodynamic monitoring: response of intracardiac pressures to small
changes in volume load. P300
F. Braunschweig, B. Kjellstrom, T. Fux, A.G. Arslan, E. Lofberg, C. Linde (Stockholm, SE)
46

SUNDAY 22 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
A simple mathematical model for capillary wedge pressure determination based on
parameters obtainable non-invasively. P301
C. Kapelios, G. Sainis, M. Bonios, S. Vakrou, N. Michelinakis, D. Anagnostou, Z. Margari,
A. Ntalianis, J. Terrovitis, J. Nanas (Athens, GR)
Impedance cardiography reliably identifies hemodynamic status of subjects with
chronic heart failure. P302
A. Gwizdala, E. Straburzynska-Migaj, A. Siniawski, A. Katarzynska, R. Ochotny, S. Grajek
(Poznan, PL)
Heart transplantation / Assist devices
Selecting patients for heart transplantation: comparison of the Heart Failure Survival
Score (HFSS) and the Seattle Heart Failure Model (SHFM). P303
L.H. Lund, A. Goda, D.M. Mancini (Stockholm, SE; Tokyo, JP; New York, US)
Is there a difference in organ recovery after full versus partial mechanical circulatory
support. P304
S.J. Jacobs, F. Rega, J. Geens, W. Droogne, K. Van Den Bossche, H. Bollen, B. Meyns
(Leuven, BE)
The effects of phosphodiesterase III inhibitor administration on end-organ function in
patients supported by left ventricular assist device. P305
T. Sugiyama Kato, K. Hashimura, I. Nakajima, S. Hashimoto, M. Kitakaze (New York, US;
Osaka, JP)
Advanced heart failure managed with new generation of non-pulsatile ventricular
assist device. P306
J. Garbade, E.M. Langenstroth, M.J. Barten, H.B. Bittner, A. Rastan, S. Lehmann,
M.A. Borger, F.W. Mohr (Leipzig, DE)
Effect of cardiac resynchronization therapy in systolic heart failure patients with
periodic breathing. P307
T. Lelyavina, T.A. Lelyavina, M.A. Sitnikova, A.V. Beresina, M.A. Trukshina, D.S. Lebedev,
E.V. Shlyakhto (Saint Petersburg, RU)
Impact in survival after change imunossupressive regimens in heart transplantation. P308
M. Avila Samuel, J.L. Vieira, S.M. Ayub-Ferreira, V.S. Issa, F. Bacal, F.G. Marcondes-Braga,
P.R. Chizolla, F. Cruz, E.A. Bocchi (Sao Paulo, BR)
Hormones / Neurohumoral regulation
Correlation of proBNP, proANP and novel biomarkers: copeptin and
proadrenomedullin with LVEF, NYHA and other parameters in patients with ischemic
CHF, non-ischemic CHF and arterial hypertension. P309
F. Malek, P. Ostadal, M. Schejbalova, J. Vranova, D. Vondrakova, M. Prucha, P. Neuzil
(Prague, CZ)
Influence of transforming growth factor-beta 1 on the processes of heart remodeling
in 2nd type diabetes mellitus patients associated with heart failure. P310
A. Berezin, A. Glavatskiy (Zaporozhye, UA)
Are IGF-1 levels really low in chronic heart failure? P311
M. Arcopinto, A. Salzano, E. Bobbio, G. Limongelli, O. Vriz, E. Bossone, C. De Vincentiis,
G. Malizia, M. Matarazzo, A. Cittadini (Naples, San Daniele del Friuli (Udine), Milan and
Palermo, IT)
47
SUNDAY
POSTERS

SUNDAY
POSTERS
SUNDAY 22 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Hypertension / LV hypertrophy
Chronic isoproterenol treatment enhances extracellular fibrosis and postischemic
diastolic dysfunction in male but not female rat heart. P312
M.B. Aljabri, S. Al-Said, J. Benjaminsen, T.V. Andreasen, T. Lund, K. Ytrehus (Tromso, NO)
Characteristics and outcome of patients with longstanding hypertension and acute
decompensated heart failure (data from the AHEAD registry). P313
M. Felsoci, J. Parenica, J. Jarkovsky, P. Widimsky, A. Linhart, F. Malek, M. Fedorco,
Z. Coufal, R. Miklik, J. Spinar (Brno, Prague, Olomouc and Zlin, CZ)
Raas in patients with abdominal obesity. P314
E. Bazhenova, O. Belyaeva, A. Berezina, T. Ivanova, T. Karonova, T. Lozovaya, C. Nifontov,
O. Berkovich, E. Baranova, E. Shlyakhto (St Petersburg, RU)
Left ventricular function
Rate of LV systolic function recovery in cardiomyopathy patients prescribed wearable
cardiac defibrillator. P315
D. Karia, N. Bianco, S. Szymkiewicz (Philadelphia and Pittsburgh, US)
Ratio E/Vp> 1,5 can predict an early stage of the left ventricular diastolic dysfunction
in asymptomatic hypertensives with microvascular coronary lesion. P316
A. Kisko, J. Kmec, M. Vereb, M. Vytykacova, M. Babcak, J. Cencarik, P. Gazdic, J. Stasko,
M. Mikulak (Presov, SK)
Benefit of coronary revascularization in patients with severe systolic heart failure
without angina. P317
L. Vandor, K. Heltai, B. Merkely (Budapest, HU)
Left ventricular function of premature infant. By use of new echocardiographic
3D imaging and tissue doppler imaging of strain and strain rate. P318
Y. Kikuchi (Tochigi, JP)
Metabolism / Diabetes mellitus
Long term metformin therapy results in improvement of exercise tolerance, left
ventricular ejection fraction and left ventricular remodelling in heart failure patients
with type 2 diabetes. P320
V. Mareev, O. Narusov, Y.U. Lapina, Y.U. Belenkov (Moscow, RU)
Reperfusion therapy characteristics in diabetic and non-diabetic patients with st
elevation myocardial infarction. P321
Y.A.B. Belenkova, O.L.B. Barbarash, V.V.K. Kashtalap, K.S.S. Shafranskaya (Kemerovo, RU)
Ischemia / Reperfusion / Preconditioning
Alterations in oxidant/antioxidant balance contribute to failing delayed
preconditioning in mouse models of the metabolic syndrome. P322
A. Vanderper, I. Vanhorebeek, T. Van Assche, A. Carpi, G. Van Den Berghe, J.L. Balligand,
P. Holvoet, P. Herijgers (Leuven and Sint-Stevens Woluwe, BE; Padova, IT)
Sex different in AMI. P323
H. Hashemizadeh (Quchan , IR)
48

SUNDAY 22 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Clear endothelial cell activation but absent platelet activation in early clinical
myocardial ischemia/reperfusion injury. P324
K.A. Kortekaas, M. Roest, R.J.M. Klautz, E.P. Van Der Veer, M.E.J. Reinders,
T.C. Van Holten, P.G. De Groot, J.H.N. Lindeman (Leiden and Utrecht, NL)
MRI, nuclear cardiology and CT (imaging)
Cardiac resynchronization therapy, pre implantation cardiac magnetic resonance
imaging and mortality at three years of follow up. P325
M.E. Tettamanti, A. Revilla Orodea, J. Lopez Diaz, R. Arnold, J.A. San Roman Calvar,
E. Garcia Moran, J. Rubio, L. De La Fuente Galan, I. Gomez Salvador, A. Recio Platero
(Valladolid, ES)
Echocardiographic response to cardiac resynchronization therapy in non ischemic
cardiomyopathy can be predicted by Ischemic and non ischemic patterns of late
gadolinium enhancement CMR. P326
A. Valle, J. Estornell, M. Corbi, J. Perez, O. Fabregat, M. Ferrando, J. Jimenez, V. Palanca,
A. Quesada, F. Ridocci Soriano (Albacete and Valencia, ES)
Characterization by high resolution 18F-Fluorodeoxyglucose Positron Emission
Tomography of the early stage of cardiac remodelling in the rat infarct model. P327
M. Bousquenaud, F. Maskali, P.Y. Marie, S. Poussier, H. Boutley, G. Karcher, D.R. Wagner,
Y. Devaux (Luxembourg, LU; Vandoeuvre les Nancy, FR)
Heart rate turbulence and MIBG in systolic advance heart failure. P328
L. Martinez-Dolz, I.J. Sanchez Lazaro, O. Cano-Perez, C. Ruiz-Llorca, L. Almenar-Bonet,
M.J. Sancho-Tello, M. Rivera-Otero, M. Portoles, A. Navarro-Mateo, A. Salvador-Sanz
(Valencia, ES)
Natriuretic peptides
Comparison of mass spectrometry and clinical assay measurements of circulating
fragments of B-type natriuretic peptide in patients with chronic heart failure. P329
W.L. Miller, M.A. Phelps, C.M. Wood, U. Schellenberger, A. Van Le, R. Perichon, A.S. Jaffe
(Rochester, MN, Hayward, CA and Raritan, NJ, US)
Attenuation of monocyte chemotaxis - a novel anti-inflammatory mechanism of action
for the cardioprotective hormone B-type Natriuretic Peptide. P330
N. Glezeva, P. Collier, C. Watson, M. Ledwidge, K. Mcdonald, J. Baugh (Dublin, IE)
Impact of glomerular and tubular kidney dysfunction on plasma and urinary NTproBNP
in acute heart failure. P331
A. Fernandez-Fernandez, S. Manzano Fernandez, D.A. Pascual-Figal, M. Boronat-Garcia,
J.C. Bonaque-Gonzalez, A. Mateo-Martinez, M. Sanchez-Martinez, J.M. Lopez-Ayala,
M.D. Albaladejo-Oton, M. Valdes (Murcia, ES)
Comparison of NT-proBNP measured with the old polyclonal and the new monoclonal
antibody assay in outpatients with systolic heart failure. P332
M. Schou, M. Egstrup, C.N. Kistorp, I. Gustafsson, J. Faber, P.R. Hildebrandt, C.D. Tuxen,
F. Gustafsson, J.P. Goetze (Hillerod, Frederiksberg, Herlev, Hellerup and Copenhagen, DK)
Nursing
The heart failure palliative care nurse: a single centre experience of this service innovation. P333
C. Griffiths, J.M. Beattie (Birmingham, GB)
49
SUNDAY
POSTERS

SUNDAY
POSTERS
SUNDAY 22 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Health-related quality of life after long-term right ventricular pacing in young adults
with congenital atrioventricular block. P334
K.R. Silva, R. Costa, R.M. Oliveira Jr, M. Martinelli Filho, M. Sobral, M. Bertelli, A. Huang,
W.T. Tamaki, E.S. Crevelari, N.A.G. Stolf (Sao Paulo, BR)
Other
Resource use and costs in heart failure - economic evaluation by severity of disease. P335
J. Biermann, A. Neumann, R. Erbel, T. Mueller-Tasch, S. Pankuweit, S. Stoerk, R. Wachter,
G. Gelbrich, J. Wasem, T. Neumann (Essen, Heidelberg, Marburg, Wurzburg, Goettingen
and Leipzig, DE)
Acute pulmonary embolism is a predictor of unfavorable evolution in severe
decompensated heart failure patients. P336
M. Dasoveanu, R.M. Ianula, C.J. Sinescu, A.I. Popa, C.L. Andrei, V.P. Chioncel, F.C. Adam,
L.N. Axente, A.N. Mischie, M. Anastasiu (Bucharest, RO)
Gender features heart rate variability in patients with chronic heart failure. P337
A. Ibatov (Moscow, RU)
Low Temperature and High Atmospheric Pressure may Contribute to Increase
Incidence of Acute Heart Failure. P338
M. Hirai, Y. Kinugasa, S. Sugihara, K. Yanagihara, K. Ishida, M. Kato, S. Chiaki (Yonago, JP)
Impact of optimization of chronic heart failure treatment in improvement of erectile
function. P339
N. Zoubeir, F.Z. Wadrahmane, S. Abderazzak, H. Najih, A. Bennis (Casablanca, MA)
Echocardiography versus clinical examination in detection of congenital heart diseases. P340
Z.M. Amirimoghadam (Tehran, IR)
Population studies / Epidemiology
Serum cotinine levels in patients with chronic heart failure, discordance between
subjec-tive and objective smoking habits. P341
N. Ebner, G. Foeldes, T. Szabo, A. Sandek, W. Doehner, S.D. Anker, S. Von Haehling
(Berlin, DE; London, GB)
Clinical characteristics and prevelance of hyponatremia in a hospitalized heart failure
population. P342
L. Bettari, M. Fiuzat, L. Shaw, S. Shirolkar, M. Felker, C. O’connor (Durham, US)
Heart failure in Berlin: rationale, design and baseline data of the TOP40 (therapy
outcome and prevention) pilot-registry. P343
R. Stern, H.D. Duengen, V. Tscholl, S. Inkrot, E. Tahirovic, A. Mielke, I. Siegel, R. Berthel,
J. Eberhard, G. Gelbrich (Berlin and Leipzig, DE)
Clinical characteristics of very elderly patients hospitalized for heart failure. P344
D. Bartos, E. Badila, S.A. Frunza, S. Ghiorghe, C.M. Tirziu, M. Dorobantu (Bucharest, RO)
Heart failure in very elderly patients admitted to a cardiology ward. P345
P. Carrilho-Ferreira, N. Cortez-Dias, C. Jorge, D. Silva, A. Magalhaes, J. Silva Marques,
A. Nunes Diogo, D. Brito (Lisbon, PT)
The prevalence of cardiac dysfunction in the oldest old: the BELFRAIL (BFC80+) study. P346
B. Vaes, N. Rezzoug, A. Pasquet, P. Wallemacq, G. Van Pottelbergh, C. Mathei,
J.L. Vanoverschelde, J. Degryse (Brussels, BE)
50

SUNDAY 22 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Prognosis (other)
The impact of functional mitral valve regurgitation in patients with chronic heart failure. P347
S. Mard, F. Nielsen (Herlev, DK)
Impact of tricuspid regurgitation on survival in patients with chronic heart failure - a
long-term observational study. P348
S. Neuhold, M. Huelsmann, D. Bondermann, E. Pernicka, C. Adlbrecht, T. Binder, A. Fast,
G. Maurer, R. Pacher, J. Mascherbauer (Vienna, AT)
Etiology-specific assessment of predictors of long-term survival in chronic systolic heart
failure. P349
J. Franke, A. Hack, M. Hochadel, L. Frankenstein, P. Ehlermann, M. Nelles, R. Zahn,
H.A. Katus, J. Senges, C. Zugck (Heidelberg and Ludwigshafen am Rhein, DE)
Prognostic impact of sleep disordered breathing and their treatment. P350
S. Guendouz, L. Hittinger, A. Noroc, L. Boyer, X. Drouot, A. Paulino, S. Adnot, L. Margarit,
M.P. D’ortho, T. Damy (Creteil, FR)
Prognostic value of right ventricle dysfunction assessed by 2d strain in chronic heart failure. P351
S. Guendouz, S. Rappeneau, C. Verdonq, J. Nahum, J.L. Dubois-Rande, P. Gueret, P. Lim,
S. Adnot, L. Hittinger, T. Damy (Creteil, FR)
The relationship between variation in body mass index and prognosis in patients with
heart failure. P352
E. Stoica, O. Chioncel, A. Carp, R. Stanescu Cioranu, I. Tepes Piser, I. Kulcsar, C.E. Macarie
(Bucuresti, RO)
Evaluation of ventricular remodeling as prognostic predictor in advanced heart failure:
comparison of chagasic and non-chagasic aetiology. P353
G.E. Conceicao-Souza, L.M. Pessoa De Melo, V. Batistela, E. Gorobets, E.A. Bocchi,
J.A.F. Ramires (Sao Paulo, BR)
Distribution of cardiac disorders causing recovery of left ventricular systolic function. P354
S. Lee, W. Kim, Y. Park, L. Jung, M. Song, H. Yoon, S. Lee, K. Rhee, J. Chae, J. Ko (Jeonju, KR)
Does the physical examination still have a role in patients with potential chronic heart
failure? P355
T. Damy, A. Kallvikbacka-Bennet, K. Goode, L. Buga, C. Lewinter, J. Hobkirk,
J.L. Dubois-Rande, L. Hittinger, J.C.G. Cleland, A.L. Clark (Creteil, FR; Hull, GB)
Charlson Comorbidity Index adequately predicts survival in geriatric patients with slow
onset heart failure. P356
I. Oudejans, A. Mosterd, N.P.A. Zuithoff, A.W. Hoes (Helmond, Amersfoort and Utrecht, NL)
The impact of mean blood pressure at admission, in-hospital prognosis and three
months after in a population with heart failure. (Results from RICA- Acute heart failure
registry). P357
B. Rodrigues, D. Moreira, L.F. Santos, E. Correia, R. Faria, P. Gama, P. Ferreira, J. Pipa,
O. Santos (Viseu, PT)
Coronary artery bypass surgery and percutaneous coronary artery intervention in
chronic heart failure patients: does a revascularization intervention have a greater
impact on clinical outcome than t. P358
G. Kozdag, G. Ertas, M. Yaymaci, E. Emre, Y. Akay, G. Kahraman, U. Celikyurt, T. Kilic,
D. Ural (Kocaeli, TR)
51
SUNDAY
POSTERS

SUNDAY
POSTERS
SUNDAY 22 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Heart rate and outcomes in a broad spectrum of patients with chronic heart failure:
results from the CHARM programme. P359
D. Castagno, H. Skali, K. Swedberg, S. Yusuf, C.B. Granger, E.L. Michelson, M.A. Pfeffer,
J.J.V. Mcmurray, S.D. Solomon (Boston, Durham and Wilmington, US; Gothenburg, SE;
Hamilton, CA; Glasgow, GB)
Prognosis (using biomarkers)
The role of anemia in early left ventricular remodeling and in-hospital mortality after
an acute myocardial infarction. P360
A. Ntalianis, E. Konstantakis, C. Kapelios, G. Sainis, V. Sousonis, E. Kaldara, E. Tsagalou,
J. Kanakakis, J. Terrovitis, J. Nanas (Athens, GR)
Prognostic value of variations of red cell distribution width in patients hospitalized for
acute heart failure. P361
N. Pezzali, M. Metra, C. Lombardi, E. Vizzardi, L. Lupi, B. Piovanelli, C. Ciccarese,
F. Quinzani, L. Dei Cas (Brescia, IT)
Cystatin C associates with unfavorable outcome after acute coronary syndrome in
patients with high level of BNP-fragment of brain natriuretic peptide and normal renal
function. P362
E.N. Dankovtseva, M.A. Evdokimova, N.E. Reznichenko, V.G. Barinov, D.A. Zateyshchikov
(Moscow, RU)
Impact of serotoninergic system on heart failure prognosis in initially stable patients
with atrial fibrillation: results of one-year follow-up. P363
M.S. Deshko, V.A. Snezhitsky, E.M. Doroshenko (Grodno, BY)
Long-term prognostic value of hsCRP and NtproBNP on all-cause mortality in elderly
with suspected heart failure. P364
M. Olofsson, K. Boman (Skellefteå, SE)
The Nt-proBNP variation during clinical stability is a long-term survival predictor in
heart failure patients followed in a heart failure outpatients clinic. P365
M. Satendra, C. Santos De Sousa, L. Sargento, N. Lousada, R. Palma Dos Reis (Lisbon, PT)
Elevated Mid-region Pro-Adrenomedullin is associated with increased mortality in
patients with diastolic dysfunction. P366
Y. Xue, P. Taub, A. Fard, N. Iqbal, H. Nguyen, P. Clopton, A. Maisel (San Diego, US)
Psychosocial / Ethical concepts / Education
Group therapy of IV-CHF NYHA patients during medical treatment. P367
A. Rosenthal (Tel Aviv, IL)
Single living is associated with increased risk of death in patients with heart failure. P368
S. Mard, F.E. Nielsen (Herlev, DK)
Mobility assessment in patients with heart failure P369
E.G. Malev, E.V. Zemtsovsky, A.L. Hama-Murad (St Petersburg, RU)
Pulmonary hypertension
Levosimendan attenuates hypoxia induced pulmonary hypertension in a porcine model. P370
A. Wiklund, D. Kylhammar, G. Radegran (Lund, SE)
Adrenomedullin: a new clinical and structural marker in pulmonary arterial hypertension. P371
C. Jorge, J. Silva Marques, S. Robalo Martins, P. Carrilho-Ferreira, C. Calisto, I. Barrigoto,
S. Ribeiro, S. Pires, M. Mieiro, A. Nunes Diogo (Lisbon, PT)
52

SUNDAY 22 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
History, six-minute walk test and heart failure serum biomarkers in patients with
Eisenmenger’s syndrome. P372
N.S. Goncharova, O.M. Moiseeva (St Petersburg, RU)
Analysis of beta-blocker treatment of patients with post-infarction cardiosclerosis,
pulmonary hypertension subject to systolic dysfunction. P373
O. Pashuk, E. Atroshtchenko (Minsk, BY)
Surgery (CABG, valvular, artificial heart, other)
Left sympathetic surgical blockade in systolic heart failure patients with optimal
medical therapy. P374
G.E. Conceicao-Souza, P.M. Pego-Fernandes, L.F. Moreira, F. Bacal, C.J. Grupi,
M.L.C. Vieira, G.V. Guimaraes, F.D. Cruz, C.E. Negrao, E.A. Bocchi (Sao Paulo, BR)
Postoperative left ventricular remodeling in patients with ischemic cardiomyopathy. P375
N. Maroz-Vadalazhskaya, I. Vodolazhskiy, I. Ostrovskiy (Minsk, BY)
Risk factors for heart failure after coronary artery bypass surgery. P376
B. Ivanovic, M.T. Tadic, N.Z. Zivkovic (Belgrade, RS)
Telemedecine and E-Health
Remote monitoring of ICD patients by carelink system. P377
E. Zambon, D. Miani, M. Narciso, J. Comisso, S. Indrigo, D. Facchin, L. Rebellato,
A. Proclemer (Udine and Milan, IT)
Integrating remote monitoring to heart failure management. P378
A. Acosta, J.P. Riley, M.R. Cowie (London, GB)
Are virtual reality applications feasible to increase physical activity in heart failure
patients? A systematic review. P379
L.S.M. Verheijden Klompstra, A. Stromberg, A. Turolla, T. Jaarsma (Norrkoping and
Linkoping, SE; Venice, IT)
Effects of timing of drug therapy, salt intake and exercise on non-invasive
haemodynamics as measured by volume clamp technology-HeartCycle (FP7-216695)
European Union 7th Framework Programme. P380
R. Antony, A. Torabi, J. Weston, J. Zhang, J. Hobkirk, P. Costanzo, O. Khaleva, P. Pellicori,
A.L. Clark, J.G.F. Cleland (Hull, GB)
Poster Presenters can request their Poster Presentation Certificate
at the Poster Assistance Desk
53
SUNDAY
POSTERS

SUNDAY
POSTERS
SUNDAY 22 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Moderated Posters Moderated Poster Area
Moderated Posters Session 2
Posters must be set up between 13:30 - 14:00 and removed between 18:00 - 18:30.
These abstracts were chosen for their outstanding quality and will be presented during the
Moderated Poster Session between 15:45 and 16:30.
Chairperson: A.J.S. Coats (Norwich, GB)
Comparison of traditional and novel definitions of acute kidney injury for the
prediction of outcomes in acute decompensated heart failure. P381
A. Roy, C. Mc Gorrian, C. Tracey, E. Kavanaugh, A. Brennan, N.G. Mahon,
P.T. Murray (Dublin, IE)
Prognosis of patients with heart failure and cardiorenal syndrome treated
with ultrafiltration. P382
E. Grapsa, E. Repasos, N. Mpakirtzi, N. Papaioannou, A. Ntalianis, E. Kaldara,
N. Michelinakis, P. Siskas, J. Terrovitis, J. Nanas (Athens, GR)
Worsening renal function in heart failure patients post myocardial infarction.
Determinants, outcome and effects of Eplerenone. Insights from EPHESUS. P383
P. Rossignol, J.G. Cleland, S. Bandhari, S. Tala, F. Gustaffson, B. Pitt, F. Zannad
(Vandoeuvre Les Nancy, FR; Hull, GB; Copenhagen, DK; Ann Arbor, US)
Role of renal function on development of cardiotoxicity associated with
trastuzumab-based adjuvant chemotherapy for early breast cancer. P384
G. Russo, S. Oliva, S. Frattini, S. Gori, C. Lestuzzi, N. Maurea, L. Boccardi, G. Cioffi,
A. Di Lenarda, L. Tarantini (Trieste, Bari, Brescia, Perugia, Aviano, Naples, Rome, Trento and Belluno, IT)
Autonomic dysfunction, neuroendocrine activation and impaired exercise
capacity: A comparison of patients with chronic heart failure and advanced cancer. P385
T. Kung, L. Cramer, K. Wichmann, U. Pelzer, D. Binder, B. Hildebrandt,
W. Doehner, S.D. Anker, M. Rauchhaus, S. Von Haehling (Berlin, DE)
Sarcopenia in patients with chronic Heart Failure: Results from the SICA-HF Study. P386
S. Fuelster, T. Kung, A. Sandek, M. Tacke, M. Valentova, S. Lokau, W. Doehner,
S.D. Anker, S. Von Haehling (Berlin, DE)
Do gradual weight changes impact 5-year mortality in patients with chronic
systolic heart failure? P387
J. Franke, J.S. Wolter, L. Frankenstein, A. Schneeweiss, A. Hack, P. Ehlermann,
M. Nelles, H.A. Katus, C. Zugck (Heidelberg, DE)
Neurohormonal activation in patients with chronic heart failure and
preserved left ventricular fraction. P388
G. Gonzalez-Robledo, J.A. Ramirez-Martinez, J. Comin-Colet, S. Ruiz, M. Rizzo,
J.M. Verdu, M. Cladellas, R. Elosua, C. Vilaplana, J. Bruguera (Barcelona, ES)
The fibroblast as an inflammatory supporter cell : increased chemotaxis
and activation of inflammatory cells due to paracrine action of cardiac
myofibroblasts in patients with heart failure. P389
D. Westermann, D. Lindner, H.P. Schultheiss, C. Tschoepe (Berlin, DE)
Depressive symptoms, antidepressants, and long-term mortality in heart
failure: a prospective follow-up study. P390
C. Diez, J. Lupon, B. Gonzalez, A. Urrutia, L. Cano, R. Cabanes, M. De Antonio,
S. Altimir, R. Coll, A. Bayes-Genis (Badalona, ES)
54

SUNDAY 22 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Poster Session 2
Posters must be set up between 13:30 - 14:00, removed between 18:00 - 18:30, to be on display
between 14:00 - 18:00.
The presenter should be available by the poster during the coffee break (15:45 to 16:30) in order
to discuss the research with the audience.
Acute heart failure (diagnosis, pathophysiology, other)
Acute myocarditis: Development of diastolic heart failure in patients in a six-year
follow-up study. P391
F. Escher, D. Westermann, U. Kuehl, D. Lassner, H.P. Schultheiss, C. Tschoepe (Berlin, DE)
Monitoring of daily body weight and intra-thoracic impedance in patients with
decompensated heart failure. P392
K. Gudmundsson, P. Lynga, H. Karlsson, C. Linde, M. Rosenqvist, F. Braunschweig
(Stockholm, SE.D.dimer levels following acute heart failure in patients with different type
of blood
flow patterns. P393
L. Malinova, G. Simonenko, P. Dolotovskaya, N. Furman, T. Denisova, V. Tuchin (Saratov, RU)
Body mass index and prognosis in patients with acute heart failure - the paradox
remains at short-term follow-up? P394
R.M. Duarte Faria, E. Correia, B. Rodrigues, D. Moreira, J.L. Pipa, O. Dionisio, O. Santos (Viseu, PT)
Inferior vena cava diameter is associated with renal dysfunction in patients with
acutely decompensated heart failure. P395
I. Papadakis, J. Parissis, K. Koniari, C. Varounis, P. Psarogiannakopoulos, V. Stasinos,
K. Papadopoulos, I. Paraskevaidis, G. Filippatos, M. Anastasiou-Nana (Athens, GR)
Changes in laboratory and clinical parameters during 48h of hospitalization as
predictors of 30- and 180-day mortality in 326 consecutive patients admitted due to
acute heart failure. P396
M. Sokolski, J. Biegus, R. Zymlinski, P. Siwolowski, S. Nawrocka, W. Banasiak,
E.A. Jankowska, P. Ponikowski (Wroclaw, PL)
Predictors of intrahospitalar and three months outcomes in patients with acute heart
failure: which is the role of admissional, predischarge and diferencial BNP?
(Results from RICA- Acute HF registry). P397
B. Rodrigues, L.F. Santos, R. Faria, D. Moreira, E. Correia, P. Gama, C. Nascimento,
J. Pipa, O. Santos (Viseu, PT)
Articularities of Heart failure in Asian people. P398
C. Pons, S. Pacreu, E. Frigola, L. Paredes, O. Londono Sanchez (Barcelona, ES)
Acute heart failure with preserved left ventricular ejection fraction after myocardial
infarction: persistence and predictors of long-term prognosis. P399
S. Kozhukhov, A. Parkhomenko, Y. Lutay, A. Stepura (Kiev, UA)
Epidemiological, etiological and prognostic feature of acute heart failure in an
intensive care unit in Ivory Coast. P400
K.A. Adoubi, J. Kouame, J.B. Anzouan-Kacou, A.M. Adoh (Abidjan, CI)
Predicting factors of mortality among patients hospitalized for acute heart failure in an
intensive care unit in Subsaharan Africa. P401
K.A. Adoubi, D. Koffi, C. Konin, J. Kouame, M. Diomande, A.M. Adoh, K.F. Diby (Abidjan, CI)
55
SUNDAY
POSTERS

SUNDAY
POSTERS
SUNDAY 22 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Acute heart failure (therapy)
Heart rate and ivabradin influence on post-infarction remodeling in the patients with
acute coronary syndrome. P402
O.V. Laba, V.I. Tseluyko (Kharkiv, UA)
Low systolic blood pressure at admission as poor prognostic factor in acute heart
failure: Data from KorHF registry. P403
S.W. Han, K.H. Ryu, M.M. Lee, M.C. Cho, J.J. Kim, E.S. Jeon, D.J. Choi, S.C. Chae
(Seoul, Ilsan, Cheongju and Daegu, KR)
A novel method to reduce preload mechanically in patients with congestive heart
failure, the dynamic restriction of flow in the Inferior Vena Cava. P404
J.E. Herrera, J.A. Herrera, J.E. Marques, I. Mendoza (Porlamar and Caracas, VE)
Animal models and experimentation
The induction of mild hypothermia does not potentiate sympathetic activation after
cardiac arrest in pigs. P405
M. Schwarzl, P. Steendijk, S. Huber, H. Maechler, B. Obermayer-Pietsch, B. Pieske,
H. Post (Graz, AT; Leiden, NL)
Lumican-null mice are susceptible isoproterenol-induced myocardial fibrosis. P406
P.-H. Chu (Taipei, TW)
A cavopulmonary shunt effectively reduces right sided filling pressures in ischaemic
right heart failure in pig. P407
P. Schiller, J. Johansson, L. Hellgren (Uppsala, SE)
Arrhythmias and treatment
Heart rate reduction and electrocardiography changes in heart transplant recipients
with long-term ivabradine treatment. P408
R. Zhang, D. Bobylev, P. Stiefel, A. Haverich, C. Bara (Hannover, DE)
Predictors of in-hospital mortality in the setting of temporary cardiac pacing. P409
I. Rangel, C. Sousa, A. Goncalves, R. Mota-Garcia, C. Frutuoso, J. Campos, S. Oliveira,
A. Lebreiro, A. Sousa, M.J. Maciel (Porto, PT)
Atrial fibrillation
Heart rate control in atrial fibrillation during pregnancy. P410
M. Sebastian, S. Pacreu, E. Frigola, O. Londono Sanchez (Barcelona, ES)
Anticoagulation for atrial fibrillation following admission with heart failure - findings
from a contemporary, elderly cohort. P411
P.M. Haydock, H.F. Mcintyre (London and Hastings, GB)
Peculiarities of structure and function of arterial wall in patients with ischemic chronic
heart failure and permanent atrial fibrillation. P412
Y. Shilova, N. Koziolova, J. Nikonova (Perm, RU)
Assesment of thromboembolic complications risk in patients with atrial fibrillation. P413
R.D. Kurbanov, N.U. Zakirov, D. Irisov, S.H.S. Khusanov (Tashkent, UZ)
Heart failure functional class and risk of thromboembolic complications in patients with
atrial fibrillation. P414
R.D. Kurbanov, N.U. Zakirov, S.H.S. Khusanov, D. Irisov (Tashkent, UZ)
56

SUNDAY 22 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Cancer / Cardiotoxicity
Incidence of cardiotoxicity of Trastuzumab in Her2Neu positive breast cancer patients:
a retrospective cohort study. P415
C. Liesting, J.J. Brugts, M.-D. Levin, M.J.M. Kofflard (Dordrecht, NL)
Regulation of kinase cascade activation and heat shock protein expression by poly
(ADP-ribose) polymerase inhibition in doxorubicin-induced heart failure. P416
R. Halmosi, E. Bartha, I. Solti, G. Olah, K. Magyar, T. Kalai, D. Gero, C.S. Szabo, B. Sumegi,
K. Toth (Pecs, Hungary and Pecs, HU; Galveston, US)
Early Trastuzumab-induced cardiotoxicity in breast cancer patients. P417
H. Dores, F. Gandara, M.J. Correia, J. Abecasis, I. Rosario, C. Fonseca, I. Arroja, A. Aleixo,
A. Martins, M. Mendes (Lisbon, PT)
Cardiac resynchronisation therapy
Cardiac resynchronisation in the real world: an outcome study of ‘National Institute for
Clinical Excellence’ compliant and ‘off label’ implants. P418
S. Russell, I. Rees, P. O’callaghan, Z.R. Yousef (Cardiff, GB)
Cardiac dyssynchrony do not affect quality of life and physical capacity of patients
with isolated congenital heart block and chronic right ventricular pacing. P419
R.M. Oliveira Jr, R. Costa, M. Martinelli Filho, K.R. Silva, L.M. Martins, E.S. Crevelari,
W.T. Tamaki, S.A.D. Nishioka, N.A.G. Stolf (Sao Paulo, BR)
Effect of cardiac resynchronization therapy on left ventricular diastolic function in
patients with advanced heart failure: a single-center trial. P420
M.Z. Petrovic, M.T. Petrovic, G. Milasinovic, B. Vujisic-Tesic, I. Nedeljkovic, D. Trifunovic,
D. Popovic, M. Boricic, I. Petrovic, M. Banovic (Belgrade, RS)
Cardiac resynchronization therapy in heart failure patients NYHA function class I/II. P421
M. Sasov, B. Liska, M. Svetlosak, P. Margitfalvi, T. Malacky, R. Hatala, E. Goncalvesova
(Bratislava, SK)
Usefulness of the 6-minute walk test in the evaluation of the functional response in
patients receiving cardiac resynchronization therapy. P422
M. Valente, N. Cotez-Dias, S. Sobral, D. Silva, C. Bogalho, S. Goncalves, J. Silva-Marques,
P. Carrilho-Ferreira, J. Sousa, A. Nunes Diogo (Lisbon, PT)
Reduction of mitral regurgitation post cardiac resynchronization therapy predicts
favourable long term clinical outcome. P423
Y.F. M. Nosir (Cairo, EG)
Cardiomyopathy
Calcium and vitamin D status in Iranian patients with congestive heart failure. P424
S. Mahjoub, M.T. Salehi Omran, P. Karimi (Babol, IR)
Validation of the Heart Failure Survival Score in the era of beta-blockers and cardiac devices. P425
S.M. R. Amorim, M. Paiva, P. Viana, B. Moura, M. Campelo, E. Martins, J. Silva-Cardoso,
M.J. Maciel (Porto, PT)
Can we describe diastolic function separately in hypertrophic cardiomyopathy or
systole has a finger in the pie? P426
L. Halmai, A. Kardos, R. Sepp, M. Csanady, T. Forster (Szeged, HU; Milton Keynes, GB)
57
SUNDAY
POSTERS

SUNDAY
POSTERS
SUNDAY 22 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
TNF and its soluble receptor as prognostic factors in dilated cardiomyopathy. P427
C.A. Wojciechowska, W. Jachec, E. Romuk, B. Skrzep-Poloczek, A. Gala, E. Birkner,
E. Nowalany-Kozielska (Zabrze, PL)
Heart rate in patients with heart failure. P428
D. Ghellab, H. Saleh, R. Kongo, A. Drighil, A. Bennis (Casablanca, MA)
Myocardial fibrosis detected by cardiac MR is predictive of ventricular structural
changes while elevated BNP predicts both structural and functional changes in
ischemic cardiomyopathy. P429
D. Henkel, W. Miller, J. Glockner (Rochester, US)
Iinsertional-deletional polymorphism of ACE-gene at patients with dilated
cardiomyopathy and its relationships with cardiac function. P430
N.A. Kurbanov, T.A. Abdullaev, B.U. Mardanov (Tashkent, UZ)
Some differences of peripartum and idiopathic dilated cardiomyopathy. P431
N.A. Kurbanov, S.T. Mirzarakhimova, B.U. Mardanov, Y.K. Rakhimova (Tashkent, UZ)
Cardio-renal syndrome
Independent role of left and right ventricular filling pressure in predicting renal
function worsening in chronic hart failure patients. P432
A. Puzzovivo, M. Iacoviello, P. Guida, C. Forleo, F. Monitillo, S. Lattarulo, D. Saulle,
M.M. Ciccone, S. Favale (Bari, IT)
Biomarkers predicting cardiovascular events and mortality in patients with chronic
kidney disease: a systematic review. P433
J. Kerschbaum, G. Poelzl, G. Mayer, M. Rudnicki (Innsbruck, AT)
Clinical value of uric acid in chronic heart failure elderly patients without advanced
renal impairment. P434
Y. Mitsuke, A. Nakano, H. Uzui, T. Geshi, T. Satoh, T. Morishita, J.D. Lee (Fukui, JP)
In chronic heart failure setting the potential for renal toxicity by ACE-inhibitors mostly
requires the concurrent use of high doses of loop diuretics and rarely develops in the
presence of diabetes. P435
R. De Vecchis, G. Di Biase, C. Ariano, C. Cioppa, A. Giasi, A. Ciccarelli, A. Pucciarelli,
S. Cantatrione (Naples and Somma Vesuviana(Naples), IT)
Co-morbidities (inc COPD, anaemia, cachexia)
Lipopolysaccharide responsiveness is an independent predictor of death in chronic
heart failure. P436
N. Ebner, T. Kung, G. Foeldes, A. Sandek, J. Springer, E. Jankowska, S. Genth-Zotz,
W. Doehner, S.D. Anker, S. Von Haehling (Berlin, DE; London, GB)
The correlation of cardiac dysfunction with poor functioning in the oldest old:
the BELFRAIL (BFC80+) study. P437
B. Vaes, N. Rezzoug, A. Pasquet, P. Wallemacq, G. Van Pottelbergh, C. Mathei,
J.L. Vanoverschelde, J. Degryse (Brussels, BE)
Severe Central Sleep Apnea / Cheyne-Stokes respiration is associated with elevated
C-reactive protein in heart failure patients. P438
H. Schmalgemeier, T. Bitter, Z. Dimitriadis, K. Bullert, D. Horstkotte, O. Oldenburg
(Bad Oeynhausen, DE)
58

SUNDAY 22 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
The effect of diuretics, with or without ACE-I or ARBs on all-cause mortality in patients
with diabetes and heart failure. P439
F.H. Rutten, Y. Van Mourik, L.J.M. Boonman-Winter, M. Hollander, A.W. Hoes (Utrecht, NL)
Undiagnosed heart failure in patients with stable chronic obstructive pulmonary disease. P440
C. Diaconu (Bucharest, RO)
The prevalence of comorbidities in a cohort of chronic heart failure outpatients. P441
W.A. Martins, L.B. Oliveira, L.N. Barros, R.F.S. Abreu, G.A.M. Pereira, M.A.R. Manhaes,
P.J.P. Camandaroba, S.F. Sgaraglia, E.T. Mesquita, E.P. Campos (Niteroi and Teresópolis, RJ, BR)
Selective beta-1 blockers therapy in chronic heart failure patients with concomitant
chronic obstructive pulmonary disease complicated by pulmonary hypertension. P442
M. Gertsen, A.N. Zuiko (Minsk, BY)
Cytokines and inflammation
Abnormal monocyte subsets in ischemic heart failure. P443
B.J. Wrigley, L.D. Tapp, B. Pamukcu, E. Shantsila, G.Y.H. Lip (Birmingham, GB)
Circulating endothelial cells in heart failure. P444
L. Martinez-Dolz, I.J. Sanchez Lazaro, L. Almenar-Bonet, V. Martinez-Sales, V. Vila Liante,
E. Reganon-Salvador, A. Salvador-Sanz (Valencia, ES)
Clinical value of interleukin-12p40 in patients with chronic Heart Failure. P445
T. Satoh, Y. Mitsuke, A. Nakano, H. Uzui, T. Geshi, J.D. Lee (Fukui, JP)
ICD therapy
Prognosis of heart failure patients undergoing implantation of biventricular pacemaker
therapy with or without a defibrillator. P446
A. Porter, S. Mostov, R. Nevzorov, H. Kusnies, G. Golovciner, Z. Iakobishvilli, D. Hasdai,
B. Strasberg, M. Haim (Petah Tikva and Jerusalem, IL)
Heart failure and elderly patients: experience of the cardiology department at IBN
ROCHD Hospital. P447
S. Abderazzak, Z. Honsali, H. Najih, N. Zoubeir, A. Bennis (Casablanca, MA)
Is defibrillation threshold testing necessary at the time of Cardiac Resynchronization
Therapy upgrade in patients with a chronic right ventricular shocking lead? P448
M.Y. Liu, G. Lin, D. Hodge, P.A. Friedman, Y.-M. Cha, S.J. Asirvatham, R. Rea, P. Brady
(Rochester, US)
Remote control of implanted cardioverter defibrillator devices in heart failure patients: A
safe, efficient and cost-saving method to reduce routine device follow ups (The SAVE-Trial). P449
S. Perl, P. Stiegler, B. Rotman, G. Prenner, P. Lercher, M. Anelli-Monti, V. Riegelnik,
F.R. Heinzel, K.H. Tscheliessnigg, B.M. Pieske (Graz, AT)
Diagnosis of heart failure and biomarkers
Prevalence and prognosis of heart failure with preserved ejection fraction confirmed
by elevated NT-proBNP: a 10 year retrospective analysis from the Copenhagen Hospital
Heart Failure Study (CHHF). P450
C.M. Carlsen, M. Bay, V. Kirk, L. Kober, O.W. Nielsen (Copenhagen and Frederiksberg, DK)
Results of NT-proBNP-guided preemptive treatment of outpatients with chronic heart
failure followed in a out hospital clinic. P451
M. Shochat, A. Shotan, M. Kazatsker, V. Gurovich, Y. Levy, L. Vasilenko, E. Noiman, A. Asif,
D. Blondhaim, S. Meisel (Hadera, IL)
59
SUNDAY
POSTERS

SUNDAY
POSTERS
SUNDAY 22 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Association between hyperuricemia and prognosis in Moroccan patients with heart failure. P452
Z. Elhonsali, A.B. Bennis (Casablanca, MA)
Impact of left ventricular diastolic dysfunction on screening for left ventricular systolic
dysfunction using b-type natriuretic peptide : a report from the STOP - HF study. P453
G. Murtagh, I.R. Dawkins, M.T. Ledwidge, E. Tallon, R. O’ Hanlon, K.M. Mc Donald (Dublin, IE)
High sensitive troponin T and heart fatty acid binding protein: novel biomarker in
heart failure with normal ejection fraction. P454
W. Dinh, W. Nickl, M. Coll Barroso, G. Hess, D. Zdunek, R. Fueth, M. Lankisch,
T.H. Scheffold, K. Tiroch, M. Seyfarth (Witten-Herdecke, Wuppertal, Mainz and
Ludwigshafen, DE; Rotkreuz, CH)
Predictors of anemia emergence in patients with chronic heart failure. P455
A. Martinez-Ruiz, P.L. Tornel-Osorio, M.C. Asensio-Lopez, A. Lax, N. Sancho-Rodriguez,
F. Pastor-Perez, I.P. Garrido-Bravo, M.T. Perez-Martinez, P. Martinez-Hernandez,
D.A. Pascual-Figal (Murcia, ES)
Determinants of functional class in systolic heart failure. P456
J. Silva Marques, C. Jorge, C. David, S. Robalo Martins, H. Luz Rodrigues,
A.G.A,A. Nunes Diogo (Lisbon, PT)
It is enough to measure brain natriuretic peptide to detect heart failure after
myocardial infarction? P457
A.S. Galyavich, A. Shaidullina, R. Minnetdinov, R. Galyavi, I. Yakupov (Kazan, RU)
Unexplained dyspnoea and suspected diastolic dysfunction. A study involving treated
hypertensive patients undergoing exercise testing. P458
E. Saeed, J. Davidson, A. Cunnigham, N. Daly, S. Leonard, P. Marsden, P. Shiels (Tullamore, IE)
Disease management and patient education
Multidisciplinary heart failure management program in Japanese patients with heart failure. P459
Y. Kinugasa, M. Kato, S. Sugihara, M. Hirai, K. Yanagihara, K. Ishida, K. Ogino, I. Hisatome,
C. Shigemasa (Yonago, JP)
Psychophysiological stress effects in the health of patients with heart failure. P460
V. Pelaez, G. Pena, C. Figueroa, B. Ramos, L. Alcocer, K. Lammers, F. Oropeza
(Mexico City, MX)
Epidemiological profile, management and outcome of 1578 patients with chronic
heart failure. P461
H. Salih, D. Ghellab, R. Kongo, R. Habbal, L. Azzouzi, A. Bennis (Casablanca, MA)
Relationship between self - rated depression and parameters of impaired cardiac
function in chronic heart failure. P462
K.D. Vitlianova, T.I. Donova, K.N. Ramshev (Sofia, BG)
Diuretics and fluid status management
Plasma copeptin levels predict mortality and hospitalization independently of plasma
sodium and loop diuretics in outpatients with heart failure. P463
L. Balling, M. Schou, C. Kistorp, M. Egstrup, I. Gustafsson, J.P. Goetze, P. Hildebrandt,
F. Gustafsson (Copenhagen, Hillerod, Herlev, Frederiksberg and Gentofte, DK)
Biological variability of bioelectrical impedence testing in a cardiac inpatient setting. P464
G. Mak, G. Murtagh, I. Dawkins, R. O’connell, R. O’hanlon, M. Ledwidge, K. Mcdonald
(Dublin, IE)
60

SUNDAY 22 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
In right or biventricular chronic heart failure addition of thiazides to loop diuretics
to achieve a sequential blockade of the nephron is associated with increased risk of
hemodilution hyponatremia. P465
R. De Vecchis, G. Di Biase, C. Ariano, A. Ciccarelli, A. Giasi, C. Cioppa, A. Fusco,
S. Cantatrione (Naples and Somma Vesuviana(Naples), IT)
Drug therapy, other
Quinapril in treatment of ambulatory patients with arterial hypertension and
congestive heart failure and preserved systolic left ventricular function
(Results from the SNEGOVIK Study). P466
V. Mareev, A. Skvortsov, M. Danielyan, Y.U. Belenkov (Moscow, RU)
Time until the occurrence of the first treatment by implantable cardioverterdefibrillator:
implications for the optimization of pharmacological therapy. P467
G.C. Cardoso, C. Aguiar, A. Ventosa, F.M. Costa, J. Ferreira, M. Trabulo, M. Mendes
(Lisbon, PT)
Has Trimetazidine an extracardiac effects in patients after myocardial infarction? P468
A.S. Galyavich, R. Minnetdinov, R. Galyavi, L. Galimzyanova, E. Safina, T. Ishmetova
(Kazan, RU)
Normal haemoglobin level and low Mean Corpuscular Volume in patients suffering
Chronic Heart Failure, does it matter? P469
E. Saeed, I.R. Dawkins, R. O’ Hanlon, M. Ledwidge, K. Mcdonald (Dublin, IE)
Changes in brachial-ankle pulse wave velocity and endothelium-dependent
vasodilatation in congestive heart failure with subclinical hypothyroidism : beneficial
effect of levothyroxine therapy. P470
E. Seredenina, O. Svirida, Z. Blankova, J. Zhitnyaya, E. Zhoubrina, B. Koulev, O. Ryabceva,
F. Ageev (Moscow, RU)
Evolution of therapeutic profile during five years in heart failure patients. P471
D.T. Zdrenghea, O. Penciu, G. Gusetu, A. Sitar Taut, D. Pop (Cluj-Napoca, RO)
Krill oil attenuates cardiac remodelling after myocardial infarction in rats. P472
L.E. Fosshaug, J.O. Beitnes, R.K. Berge, K. Berge, H. Vik, P. Aukrust, L. Gullestad,
L.E. Vinge, E. Oie (Oslo and Bergen, NO)
Multi-disciplinary heart failure team (HF-MDT) approach to improve medical therapy of
hospitalised patients. P473
A. Al-Mohammad, N. Buckley, D. Barnett, A. Birchall, M. Warriner, S.H. Song,
F.M. Creagh, A. Scott, R. Gandhi, L. O’toole (Sheffield, GB)
Echocardiography
Does open-access echocardiography change the management of patients suspected
of heart failure or valvular disease by general practitioners? P474
E.E. S. Van Riet, F.H. Rutten, R.M. Van Tooren, A.W. Hoes (Utrecht and Nieuwegein, NL)
Chronic moderate aortic regurgitation: can a single transthoracic echocardiogram
predict risk of decompensated heart failure? P475
S. Barra, F. Caetano, P. Gomes, C. Faustino, R. Providencia, A. Leitao Marques (Coimbra, PT)
Prognostic value of a novel Tissue Doppler index in patients with non-revascularized
coronary artery disease. P476
C. Mornos, D. Cozma, R. Dan, A. Ionac, D. Dragulescu, A. Mornos, L. Petrescu (Timisoara, RO)
61
SUNDAY
POSTERS

SUNDAY
POSTERS
SUNDAY 22 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
The impact of the right atrium volume on the right ventricular diastolic function in
coronary artery disease patients with heart failure. P477
L. Agoston-Coldea, S. Lupu, T. Mocan (Cluj-Napoca, RO)
Pulmonary artery blood flow and global function of the right ventricle in patients with
pulmonary hypertension. P478
C.I. Santos De Sousa, M. Satendra, L. Sargento, M. Teixeira, I. Almeida, F. Salazar,
N. Lousada, R. Palma Reis (Lisbon, PT)
The variants of myocardial remodeling in patients with arterial hypertension and type
2 diabetes mellitus or impaired tolerance of glucose. P479
E. Tarlovskaya, I. Sapozhnikova, K. Tarlovsky, Y. Balandina, N. Maksimchuk (Kirov, RU)
Exercise tissue doppler echocardiography in prognostic stratification of patients with
congestive heart failure. P480
O. Ludka, Z. Pozdisek, V. Musil, J. Spinar (Brno, CZ)
Exercise testing & training
Actual daily physical activity in heart failure patients. The HEART*BEAT study. P481
M.L. Dontje, M.H.L. Van Der Wal, T. Jaarsma, C.P. Van Der Schans, M.H.G. De Greef
(Groningen, NL; Norrkoping, SE)
Physical training in patients with chronic heart failure decreases serum ability to induce
endothelial cell death. P482
C. Mammi, A. La Sala, L. Gatta, A. Antelmi, A. Feraco, G. Caminiti, C. Vitale, M. Caprio,
M. Volterrani, G.M.C. Rosano (Rome, IT)
Has cardiopulmonary exercise test prognostic implications in an unselected heart
disease population? An Italian multi-centre study. P483
L.E. Pastormerlo, M. Piepoli, E. Berton, C. Vigorito, F. Cecaro, A.B. Scardovi, R. Raimondo,
P.G. Agostoni (Pisa, Piacenza, Trieste, Naples, Ferrara, Rome, Tradate and Milan, IT)
Influence of body mass index in O2 uptake efficiency slope. P484
A. Toste, R. Soares, J. Feliciano, B. Valente, S. Silva, A. Abreu, L. Ferreira, R.C. Ferreira (Lisbon, PT)
Does red blood cell width affect functional capacity recovery in patients attending
cardiac rehabilitation after ACS? P485
C. Sousa, A. Rocha, A. Sousa, A. Goncalves, I. Rangel, M. Paiva, A.S. Correia, V. Araujo,
F.P. Pereira, M.J. Maciel (Porto, PT)
Are there any indicators prognosticating the effectiveness of home-based
tele-rehabilitation of heart failure patients? P486
E. Piotrowicz, R. Baranowski, M. Bilinska, M. Piotrowska, R. Piotrowicz (Warsaw, PL)
Effects of 12 - week Nordic Walking training on physical fitness and quality of life in
patients with chronic systolic heart failure. P487
A. Lejczak, J. Wilczynski, R. Jasinski, E. Rudzinska, K. Wegrzynowska-Teodorczyk, K. Josiak,
E.A. Jankowska, W. Banasiak, P. Ponikowski, M. Wozniewski (Wroclaw, PL)
Relationship between exercise intolerance and plasma insulin and leptin levels in
hypertensives with postinfarction cardiosclerosis. P488
M.A. Orynchak, I.I. Vakalyuk, I.P. Vakalyuk (Ivano-Frankivsk, UA)
62

SUNDAY 22 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Haemodynamics / Coronary and peripheral circulation
Elderly patients submitted to PCI in the ACS Setting: what can we rely on to predict survival? P489
S.M. Oliveira, V. Ribeiro, F. Melao, R. Lopes, A. Goncalves, J.C. Silva, R. Rodrigues,
D. Magalhaes, P. Dias, M.J. Maciel (Porto, PT)
Global outcomes of elderly patients submitted to percutaneous coronary intervention. P490
S.M. Oliveira, F. Melao, V. Ribeiro, R. Lopes, A. Goncalves, J.C. Silva, D. Magalhaes,
R. Rodrigues, P. Dias, M.J. Maciel (Porto, PT)
Arterial stiffness is related to heart structure and function in subjects with diastolic
heart failure. P491
I. Goncharov, R. Akhmetov, A. Safarova, L. Alexandria, Y. Kotovskaya, Z. Kobalava (Moscow, RU)
Palliative evacuation of pleural transudates and haemodynamic consequences. P492
E.-T. Siniorakis, S. Arvanitakis, D. Barlagiannis, S. Pamouki, N. Skandalakis, G. Psatheris,
E. Prokovas, N. Marinakis, I. Papadopoulos, N. Exadactylos (Athens, GR)
Arterial stiffness and wave reflections in patients with heart failure with preserved
systolic function. P493
O.V. Ilyukhin, T.H. Termisultanova, V.V. Ivanenko, Y.M. Lopatin (Volgograd, RU)
Heart transplantation / Assist devices
The development of right ventricular failure after ventricular assist device implantation
is associated with persistently increased serum levels of extracellular matrix markers
TIMP1 and osteopontin. P494
T. Sugiyama Kato, T. Khawaja, A. Chokshi, P. Singh, H. Akashi, H. Takayama, Y. Naka,
M. Farr, D. Mancini, P.C. Schulze (New York, US)
APACHE II, SAPS II and SOFA score are of limited value to predict the outcome of
patients undergoing heart transplantation. P495
G.M. Froehlich, G.R. Rizzi, X.S. Startseva, M.W. Wolfrum, F.R. Ruschitzka, G.N. Noll,
I.S. Sudano, T.F.L. Luescher, F.E. Enseleit (Zurich, CH)
Intra-aortic balloon counterpulsation as a bridge to heart transplantation: results on
short and long-term outcomes. P496
A. Fontana, N. Gorislavets, A. Iacovoni, F. Taddei, U. Veritti, R. Sebastiani, R. Fiocchi,
A. Terzi, P. Ferrazzi, A. Gavazzi (Bergamo, IT)
Arterial conduit function assessment in chronic congestive heart failure: predictors of
true circulatory decompensation for optimal timing of mechanical circulatory support. P497
H. Siniawski, H.B. Lehmkuhl, N. Hiemann, M. Dandel, D. Kemper, R. Hetzer (Berlin, DE)
Efficacy of oral Valganciclovir prophylaxis for cytomegalovirus infection in heart
transplant patients. P498
A. Doesch, J. Repp, S. Mueller, L. Frankenstein, S. Celik, A. Ruhparwar, T.J. Dengler,
C. Zugck, P.H. Ehlermann, H.A. Katus (Heidelberg, DE)
Relationship between pericardial cavity size and post transplant pericardial effusion. P499
M.R. Brown, V. Wijesekera, D. Platts, G. Javorsky (Brisbane, AU)
Hormones / Neurohumoral regulation
Relative influence of changes in renal function on prognostic role of B-TYPE natriuretic
peptide trend from admission to discharge in patients hospitalized for acute heart failure. P500
A. Buiatti, M. Merlo, E. Stenner, G. Barbati, B. Biasioli, G. Sinagra (Trieste and Padova, IT)
63
SUNDAY
POSTERS

SUNDAY
POSTERS
SUNDAY 22 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Incidence of thyroid disorders during chronic stable heart failure patients. P501
O. Carrasco-Ortiz, A. Orea-Tejeda, L. Castillo-Martinez, A. Navarro-Navarro,
R. Sanchez-Santillan, J.A. Pineda-Juarez, A. Sanchez-Ramirez, E. Colin-Ramirez,
P. Montano-Hernandez (Mexico, MX)
Thyroid hormone replacement therapy impact on left ventricular diastolic function in
patients with subclinical hypothyroidism. P502
O. Makar, I. Shatynska-Mytsyk, Y.U. Kyyak (Lviv, UA)
Hypertension / LV hypertrophy
Increased enddiastolic wall stress leads to left ventricular hypertrophy in dilative
heart failure. P503
P. Alter, H. Rupp, F. Stoll, P. Adams, M.B. Rominger, B. Maisch (Marburg, DE)
Plasma lipids display increased mean carboxyl chain length in Human Hypertensive
Heart Disease. P504
M. Berry, F. Desmoulin, F. Smih, A. Turkieh, B. Chamontin, P. Rouet, M. Galinier
(Toulouse, FR)
Does left ventricular geometry affects the B-type natriuretic peptide level in treated
population? P505
A. Pajak, A. Szyszka, M. Wierzchowiecki, M. Michalski, K. Szymanowska, A. Nowicka,
R. Dankowski, L. Religa (Poznan, PL)
Left ventricular function
Does left ventricular dysfunction affect the response to cardiac rehabilitation after an
acute coronary syndrome? P506
C. Sousa, A. Rocha, I. Rangel, A. Goncalves, S. Oliveira, A. Lebreiro, A. Sousa, V. Araujo,
F.P. Pereira, M.J. Maciel (Porto, PT)
Does endothelial function correlate with left ventricular myocardium damage in young
patients after acute myocardial infarction? P507
A. Ledakowicz-Polak, L. Polak, M. Zielinska (Lodz, PL)
Levels of n-3 PUFAs correlate with echo parameters of left ventricular size and function
in heart failure patients. P508
S. Nodari, U. Campia, M. Triggiani, A. Manerba, G. Milesi, B. Cesana, M. Gheorghiade,
L. Dei Cas (Brescia, IT; Chicago, US)
Left ventricular myocardial performance indexes and optical properties of red blood
cells along heart failure continuum. P509
K. Mikhaliev, O. Ushenko, M. Kolomoiets, T. Chursina, M. Ginguliak, L. Suprun,
Y. Logvinov (Chernivtsi and Kyiv, UA)
Metabolism / Diabetes mellitus
Hyperuricemia and increased risk of cardiac events. P510
V. Larina, B. Bart (Moscow, RU)
The metabolic profile and global cardiovascular risk in a cohort of chronic heart failure
outpatients. P511
W.A. Martins, L.B. Oliveira, L.N. Barros, R.F.S. Abreu, G.A.M. Pereira, M.A.R. Manhaes,
P.J.P. Camandaroba, S.F. Sgaraglia, M.G. Oliveira, E.T. Mesquita (Niteroi and Teresópolis, RJ, BR)
64

SUNDAY 22 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Ischemia / Reperfusion / Preconditioning
The impact of heart failure at admission on 1-year mortality and major adverse
cardiovascular events in patients successfuly treated with primary percutaneous
coronary intervention. P512
L. Savic, I. Mrdovic, G. Krljanac, J. Perunicic, L. Lasica, M. Asanin, M. Matic, Z. Vasiljevic,
M. Ostojic (Belgrade, RS)
Ischemic myocardial injuries after cardiac malformation repair in infants may be
associated with oxidative stress mechanisms. P513
S.G. Ramos, M.S. Oliveira, W.V.A. Vicente, E.Z. Martinez, S.C. Mazin, E.M. Floriano,
M.A. Rossi, L.C. Peres (Ribeirao Preto, BR; Sheffield, GB)
The role of systolic dysfunction in recovery of patients with myocardial infarction in
early postinfarction period. P514
V. Shumakov, I. Malynovska, L. Tereshkevych, L. Prohna, L. Kisilevich (Kiev, UA)
MRI, nuclear cardiology and CT (imaging)
Impact of early revascularization for myocardial infarction on relationship between
infarct tissue characteristics and left ventricular remodeling as assessed with contrastenhanced
CMR. P515
M. Olimulder, M.A. Galjee, L.J. Wagenaar, J. Van Es, J. Van Der Palen, C. Von Birgelen
(Enschede, NL)
Volumetric evaluation of epicardial tissue after acute myocardial infarction and during
recovery. P516
M. Scharin Tang, L. Grip, E. Omerovic (Gothenburg, SE)
Comparative evaluation of systolic/diastolic functional parameters of left ventricle in
patients with CHF with preserved and reduced its ejection fraction by radionuclide
4D-tomoventriculography. P517
D. Satlykova, V.Y.U. Mareev, V.B. Sergienko (Moscow, RU)
Natriuretic peptides
Factors that contribute to reduced exercise capacity in diastolic dysfunction and
diastolic heart failure: role of neurohormonal activation. P518
F. Edelmann, A. Duvinage, R. Stahrenberg, G. Gelbrich, H.-D. Duengen, G. Hasenfuss,
R. Wachter, B. Pieske (Gottingen, Leipzig and Berlin, DE; Graz, AT)
Designed natriuretic peptide ACNP stimulating NPRA and NPRB, is a new promising
tool for the treatment of cardiovascular diseases. P519
X. Zhu, Y. Wang, A. Schwiebs, T. Walther (Hull, GB; Giessen, DE)
Impact of glomerular filtration rate on urinary BNP and NT-proBNP concentrations in
heart failure. P520
M. Rivera, E. Rosello, P. Orosa, T. Lozano, F. Garcia De Burgos, L. Martinez Dolz,
C. Lauwers, I. Sanchez, P. Morillas, A. Salvador (Valencia, Gandia, Villajoyosa, Elche and
Alicante, ES)
Nt Pro-BNP screening for silent cardiac dysfunction in acute elderly care admissions? P521
S.B. L. Claridge, G.S. Kanaganayagam, P. Vamadevan, S. Duckett, G. Carr-White (London, GB)
65
SUNDAY
POSTERS

SUNDAY
POSTERS
SUNDAY 22 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Nursing
Contributing factors for hospital re-admission in patients with heart failure. P522
A. Heydari, E. Ziaee (Mashhad, IR)
Usefulness of a nurse counselling in congestive heart failure patients. P523
M. Feola, M. Mozzone, A. Sbardellini, M. Parola, P. Pirra, E. Lombardo, C. Taglieri, S. Piccolo
(Fossano, IT)
Other
Influence of chronic heart failure on the risk of deep vein thrombosis recurrence,
hemorrhagic complications and D-dimer level during anticoagulant therapy in patients
with venous thromboembolism. P524
N.M. Vorobyeva, A.B. Dobrovolsky, E.V. Titaeva, O.V. Ermolina, T.V. Balakhonova,
A.I. Kirienko, E.P. Panchenko (Moscow, RU)
Gender difference in the alteration of cardiac structure and function in obese adults. P525
M.-S. Shin, B.R. Kim, K.H. Lee, W.-J. Chung, W.C. Kang, T.H. Ahn, I.S. Choi, E.K. Shin
(Incheon and Seoul, KR)
Healthcare encounters among heart failure (HF) patients with preserved ejection
fraction (HF-PEF) and reduced ejection fraction (HF-REF) in Sweden. P526
G. Wikstrom, J. Stalhammar, R. Ariely, R. Linder, A. Ogbonnaya, L. Stern
(Uppsala and Stockholm, SE; East Hanover and New York, US)
Head-up tilt table test in neurocardiogenic syncope: can we predict the need to a
nitrate-challenge phase? P527
A.S. Correia, A. Lebreiro, A. Sousa, A. Goncalves, M. Paiva, S.M. Oliveira, C. Sousa,
I. Ranjel, J. Freitas, J.M. Maciel (Porto, PT)
Major depressive disorder in patients with chronic heart failure: Does silent cerebral
infarction cause major depressive disorder in this patient population. P528
G. Kozdag, I. Yalug, N. Inan, M. Selekler, G. Ertas, E. Emre, Y. Akay, D. Ural (Kocaeli, TR)
An exploratory study of health related quality of life following transcatheter aortic
valve implantation (TAVI). P529
K. Davies, J. Riley (London, GB)
Pathophysiology
Role of PKG and actin-myosin interaction in the adaptive diastolic response to an acute
hemodynamic overload in the normal and ischemic heart. P530
R. Ladeiras-Lopes, R. Castro-Ferreira, J.S. Neves, R. Fontes-Carvalho, P. Castro-Chaves,
A. Leite-Moreira (Porto, PT)
Collagen deposition in heart failure with reduced and preserved ejection fraction. P531
N. Solomakhina, Y.N. Belenkov (Moscow, RU)
New therapeutic targets in pulmonary hypertension: a study of neurohormonal
activation and left ventricular dyssynchrony. P532
J. Silva Marques, S. Robalo Martins, S. Ribeiro, C. Calisto, L. Santos, J. Carvalho De Sousa,
A.G. Almeida, A. Nunes Diogo (Lisbon, PT)
66

SUNDAY 22 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Population studies / Epidemiology
The obesity paradox in heart failure: aetiology is key? P533
E. Zamora, J. Lupon, M. De Antonio, A. Urrutia, R. Cabanes, B. Gonzalez, L. Cano,
T. Pascual, C. Diez, A. Bayes-Genis (Badalona, ES)
Life-time risk of heart failure among normal weight, overweight and obese men. P534
L. Bjorck, M. Schaufelberger, M. Rosengren (Gothenburg, SE)
Recruiting minority ethnic groups to the Ethnic-Echocardiographic Heart of England
Screening study (E-ECHOES): challenges and solutions. P535
P.S. Gill, M. Calvert, H. Duffy, R. Davis, N. Freemantle, G.Y.H. Lip (Birmingham, GB)
The prevalence of extra-cranial carotid artery disease in patients with chronic heart
failure. P536
N. Sherwi, J. Zhang, J. Bryce, A. Yassin, P. Pellicori, O. Khaleva, A. Torabi, A. Bennett,
A.L. Clark, J.G.F. Cleland (Hull, GB)
Characteristics and outcomes of acute heart failure patients in a referral university
hospital. P537
M.L. Talavera, F.L. Favaloro, M.D. Diez, M.P. Peradejordis, C.H. Huerta, F.R. Favaloro
(Buenos Aires, AR)
Heart failure mortality has more than halved in young adults: a Swedish registry study
from 1987 to 2006. P538
A. Barasa, A. Rosengren, K. Swedberg, M. Schaufelberger (Gothenburg, SE)
Prognosis (other)
Five-year survival and predictors of mortality after hospitalization for acute heart failure. P539
J.P.E. Lassus, K. Siirila-Waris, J. Melin, K. Peuhkurinen, M.S. Nieminen, V.-P. Harjola
(Helsinki, Jyvaskyla and Oulu, FI)
Determinants and temporal developments of heart failure treatment and outcome
in a secondary and tertiary hospital setting. P540
J. Franke, J.S. Wolter, M. Hochadel, L. Frankenstein, R. Winkler, P. Ehlermann, R. Zahn,
H.A. Katus, J. Senges, C. Zugck (Heidelberg and Ludwigshafen am Rhein, DE)
Hyponatremia and long-term outcomes in heart failure. P541
L. Bettari, M. Fiuzat, L. Shaw, S. Shirolkar, M. Felker, C. O’connor (Durham, US)
Predictors of early period mortality in hospitalized patients for heart failure. P542
B.S. Yoo, J.W. Lee, J.Y. Kim, S.H. Lee, D.J. Choi, M.C. Cho, E.S. Jeon, S.C. Chae, M.M. Lee,
K.H. Ryu (Wonju, Seoul, Chungbuk, Daegu and Ilsan, KR)
Could E/(E’xS’) predict cardiac death in patients with heart failure? P543
C. Mornos, A. Ionac, R. Dan, D. Cozma, A. Mornos, L. Petrescu (Timisoara, RO)
Prehospital thrombolytic therapy influence upon chronic heart failure development
and subsequent clinical course in patients with an ST-segment elevation myocardial
infarction. P544
Y. Dovgalevskiy, N. Furman, I. Schetinkina, L. Malinova, P. Dolotovskaya (Saratov, RU)
Clinical and echocardiographical features correlated with spatial QRS-T angle in
patients with chronic heart failure. P545
F. Boncagni, F. Guerra, A. Capucci (Ancona, IT)
67
SUNDAY
POSTERS

SUNDAY
POSTERS
SUNDAY 22 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Basic laboratory data and echocardiographic parameters as predictors of in-hospital
death in patients with heart failure. P546
M. Wiktorowicz, M. Romaszkiewicz, I. Stopczynska, I. Pisowodzka, J. Bellwon, B. Zieba,
W. Puchalski, M. Gruchala, A. Rynkiewicz (Gdansk, PL)
Prognostic value of serial clinical, laboratory and ecocardiographic tests in ambulatory
patients with chronic heart failure. P547
C. Lombardi, A. Manerba, E. Vizzardi, C. Maiandi, G. Milesi, N. Berlinghieri, V. Carubelli,
S. Nodari, M. Metra, L. Dei Cas (Brescia, IT)
LDL- Cholesterol level and other predictors of recurrent hospitalization in chronic heart
failure patients. P548
G. Kozdag, G. Ertas, M. Yaymaci, E. Emre, Y. Akay, H. Ekren, U. Celikyurt, T. Sahin,
G. Kahraman, D. Ural (Kocaeli, TR)
Clinical score for assessment of long-term mortality in acute coronary syndrome. P549
H. Dores, S. Leal, I. Rosario, J. Abecasis, J. Monge, L. Bronze, C. Fonseca, I. Arroja,
A. Aleixo, M. Mendes (Lisbon, PT)
Glycoprotein IIb/IIIa inhibitor use and chronic heart failure development after myocardial. P550
A. Galyavich, E. Makhiyanova, R. Galyavi, R. Minnetdinov (Kazan, RU)
Prognosis (using biomarkers)
B-type natriuretic peptide in patients with non-ST-elevation acute coronary syndromespredictor
of heart failure or mortality at 6 months? P551
P. Sousa, N. Marques, W. Santos, J. Mimoso, S. Pereira, I. Jesus (Faro, PT)
Prognostic value of highly sensitive troponin T in acute dypnea. P552
S. Van Wijk, L.H. Jacobs, L.W. Eurlings, R. Lemmers, P. Broos, M. Prins, H.J.G.M. Crijns,
Y.M. Pinto, M.P. Dieijen-Visser, H.P. Brunner-La Rocca (Maastricht, Limburg and
Amsterdam, NL)
Does extremely high red blood cell distribution width (RDW) indicate worse outcome
in chronic heart failure? P553
R. Sigurjonsdottir, A. Holmstrom, O. Hammarsten, M. Fu (Gothenburg, SE)
Incremental change in plasma level of cystatin is a powerful prognostic biomarker for
5 years mortality in patients with infective endocarditis. P554
C. Bjurman, U. Snygg-Martin, O. Hammarsten, L. Olaison, M. Fu (Gothenburg, SE)
The correlation between endothelial dysfunction, platelets hyperactivity, oxidative
stress, heart failure readmission and left ventricular systolic dysfunction in acute
coronary syndromes. P555
E. Bobescu, M. Radoi, G. Datcu, D. Dobreanu, L. Rogozea, B.F. Doka, C. Gavris,
G. Ifteni, G.I. Catanescu, O. Neagu (Brasov, Iasi and Targu Mures, RO)
Is Pro-BNP alteration during exercise in patients with a diagnosis of CHF a potential
surrogate prognostic marker for valvular heart disease? P556
E. Saeed, E. Saeed, J. Davidson, A. Cunningham, N. Daly, S. Leonard, P. Marsden,
P. Shiels (Tullamore, IE)
Creactive protein in acute exacerbation of heart failure and its impact in short-term
prognosis. P557
D.A. Moreira, B.F. Rodrigues, C.E. Correia, L.F. Santos, L.M. Nunes, J.O. Santos (Viseu, PT)
68

SUNDAY 22 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Red blood cell distribution width predicts mortality in elderly patients with acute
dyspnea : Data from YONDER (YONsei Dyspnea on Emergency department Registry). P558
J. Oh, S.M. Kang, S.Y. Kim, N. Hong, H. Won, S. Park, C.O. Kim, Y. Jang, N. Chung
(Seoul, KR)
Psychosocial / Ethical concepts / Education
Do doctors and nurses follow the guidelines for cardiovascular prevention and do they
practice sports? P559
R. Glowczynska, K.J. Filipiak, G. Opolski (Warsaw, PL)
Differences in emotional status of men and women with chronic heart failure P560
A. Ibatov (Moscow, RU)
Impact of a home health monitoring and care programme provided by a heart failure
unit in the assistance of patients with heart failure. P561
M. Satendra, C. Santos De Sousa, L. Sargento, M. Teixeira, F. Salazar, I. Almeida,
N. Lousada, R. Palma Dos Reis (Lisbon, PT)
Pulmonary hypertension
Pulmonary artery circulation after transjugular portosystemic shunting. P562
R. Pudil, V. Safka, T. Fejfar, P. Hulek, J. Vojacek (Hradec Kralove, CZ)
The contribution of systolic and diastolic disorders into the level of systolic pulmonary
artery pressure level in patients with chronic heart failure, complicated secondary
pulmonary hypertension. P563
O. Pashuk, E. Atroshtchenko (Minsk, BY)
Prognostic value of pulmonary hypertension in heart failure. P564
G. Borelli, L. Rondinini, N. Scelza, F. Donati, F. De Caro, T. Cellamaro, R. Mariotti (Pisa, IT)
Which factors impact the right ventricle in systemic sclerosis? P565
M. Tadic, B.I. Ivanovic, M.Z. Zlatanovic, N.D. Damjanov (Belgrade, RS)
Surgery (CABG, valvular, artificial heart, other)
Predictors of mortality in aortic valve replacement surgery in patients with severe aortic
stenosis. P566
G. Silva, E. Pereira, G. Morais, D. Caeiro, R. Carvalho, A. Albuquerque, J. Primo, L. Simoes,
V. Gama (Porto, PT)
Severe aortic stenosis in octogenarians: how to treat? P567
G. Silva, E. Pereira, G. Pires De Morais, D. Caeiro, R. Fontes De Carvalho, A. Albuquerque,
L. Simoes, V. Gama (Vila Nova de Gaia, PT)
Risk factors for postoperative pulmonary complications in coronary artery bypass graft
surgery patients. P568
H. Hashemizadeh (Quchan , IR)
Telemedecine and E-Health
The remote monitoring by implantable cardioverter defibrillator of chronic heart failure
outpatients: our experience. P569
V.E. Santobuono, M. Iacoviello, F. Nacci, M. Anaclerio, A. Puzzovivo, F. Quadrini,
R. Memeo, G. Luzzi, S. Favale (Bari, IT)
69
SUNDAY
POSTERS

SUNDAY
POSTERS
SUNDAY 22 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
A remote monitoring experience in heart failure patients implanted with ICD and
CRT-D devices. P570
P. Neri, V. Giudici, A. Locatelli, B. Casiraghi, P. Rocca, L. Viscardi (Seriate, IT)
Assessment of ECG during home-based tele-monitored cardiac rehabilitation in heart
failure patients. P571
E. Piotrowicz, A. Jasionowska, M. Banaszak-Bednarczyk, J. Gwilkowska, R. Piotrowicz
(Warsaw, PL)
Results of a randomized clinical study evaluating nurse-driven telemedicine
interventions for high risk chronic heart failure patients with frequent rehospitalizations. P572
H. Persson, J. Lofsjogard, M. Melin, D. Jaraj, A. Fjellner, E. Straat (Stockholm, SE)
70

Update
your Journal Delivery Address
www.escardio.org/address
Pe r p c d r l m o a i l n r d r n P C I
p i a g f o t r e
i n n S E I
r m r o a t i y d p s
o a n o r y p ve
C 1 o y s
a d va s u r o c m e
E u r o p e a n
H e a t r t o u r J n o a u l r n a l
EASY - FAST - IMMEDIATE
Manage your journal subscriptions and update
your details online 24 hours a day,
any time of year
Bookmark www.escardio.org/address
for quick future access
Questions? “Contact us“ on www.escardio.org
w w w u e r o g
o u n l o t h e E u o ea n o i t y f C r i l g y
d t r Di d i k E Gr bb
MONDAY

MONDAY 23 MAY 2011 - MORNING
08:30 - 10:00 Clinical Interactive Educational Session Gothenburg
The unstable patient who needs neurohormonal blockade
Case based interactive session
Chairpersons: K. Swedberg (Gothenburg, SE); K. Dickstein (Stavanger, NO)
Co-morbidities and heart failure
Panel. 573
J.J.V. McMurray (Glasgow, GB); B. Andersson (Gothenburg), SE)
08:30 The hypotensive patient. 574
L.H. Lund (Stockholm, SE)
09:00 Patient with chronic obstructive pulmonary disease. 575
N.M. Hawkins (Warrington, GB)
09:30 Patient with renal dysfunction. 576
C. Tschoepe (Berlin, DE)
08:30 - 10:00 Main Session Stockholm
Anemia and iron deficiency
Chairpersons: J.K. Kjekshus (Haslum, NO); J. Nanas (Athens, GR)
Co-morbidities and heart failure
08:30 Cause of impaired erythropoiesis. 577
A.A. Voors (Groningen, NL)
08:52 Trigger of compromised tissue energetics and poor outcomes. 578
E.A. Jankowska (Wroclaw, PL)
09:15 Which therapeutic role for Erythropoetin stimulating agents (ESA). 579
J.R. Teerlink (San Francisco, US)
09:37 Iron, combination therapies and new drugs on horizon. 580
P. Ponikowski (Wroclaw, PL)
08:30 - 10:00 Main Session Malmö
Palliative care for patients with end-stage heart failure
Chairpersons: B. Riegel (Philadelphia, US); K.O.A. Boman (Skelleftea, SE)
Education and Guidelines
08:30 Palliative care in heart failure - An overview. 581
T. Jaarsma (Norrkoping, SE)
08:52 Severe chronic heart failure in palliative advanced home care. 582
M. Brannstrom (Skelleftea, SE)
09:15 Palliative care in patients with heart failure and cancer. 583
M. Ryder (Perth, AU)
09:37 Ethics in palliative care of patients in end-stage heart failure. 584
J.M. Beattie (Birmingham, GB)
73
MONDAY

MONDAY
MONDAY 23 MAY 2011 - MORNING
08:30 - 10:00 Main Session Uppsala
TeleMonitoring for heart failure - Latest evidence
Chairpersons: S.D. Anker (Berlin, DE); L. Warner Stevenson (Boston, US)
Devices and Technology for heart failure in 2011
08:30 Update on the North American experience. 585
L. Warner Stevenson (Boston, US)
08:52 The TIM-HF experience. 586
F. Koehler (Berlin, DE)
09:15 Decision making from a distance – A case for biomarkers?! 587
A. Maisel (Solana Beach, US)
09:37 Overview and meta-analysis update. 588
J.G.F. Cleland (Kingston Upon Hull, GB)
08:30 - 10:00 Main Session Örebro
New drugs on the horizon for heart failure
Chairpersons: T. Thum (Hannover, DE); G. Hasenfuss (Goettingen, DE)
Basic Science, Basic Science translated for the clinician
08:30 HDAC inhibitors. 589
L.J. De Windt (Maastricht, NL)
08:48 Myofilament-targeted agents. 590
Z. Papp (Debrecen, HU)
09:06 Cam K antagonists. 591
L.S. Maier (Gottingen, DE)
09:24 Iron and Epo - Treating anemia in heart failure. 592
I. Macdougall (London, GB)
09:42 Adenosine antagonists and the cardiorenal syndrome. 593
C. Gaillard (Bilthoven, NL)
08:30 - 10:00 Main Session Linköping
Preventing heart failure in women pre and post partum
Chairpersons: M. Schaufelberger (Gothenburg, SE); V. Regitz-Zagrosek (Berlin, DE)
Education and Guidelines
08:30 Oxidative stress and heart failure peripartum - A fine balance. 594
D. Hilfiker-Kleiner (Hannover, DE)
08:52 Preexisting cardiovascular disease aggravated by pregnancy. 595
V. Regitz-Zagrosek (Berlin, DE)
09:15 Managing heart failure in pregnancy and peripartum. 596
K. Sliwa-Hahnle (Cape Town, ZA)
09:37 Adult congenital heart disease and pregnancy. 597
J.W. Roos-Hesselink (Rotterdam, NL)
74

MONDAY 23 MAY 2011 - MORNING
11:00 - 12:30 Clinical Interactive Educational Session Gothenburg
Management of difficult cardiac patients in the emergency room
Chairpersons: A. Mebazaa (Paris, FR); A. Maisel (Solana Beach, US)
Education and Guidelines
Panel. 598
M. Metra (Brescia, IT); D.J. van Veldhuisen (Groningen, NL)
11:00 Acute dyspnea and chest pain in the emergency room. 599
C. Mueller (Basel, CH)
11:22 Myocarditis presenting as acute heart failure. 600
H.P. Schultheiss (Berlin, DE)
11:45 Acute myocardial infarction and congestion. 601
J.T. Parissis (Athens, GR)
11:00 - 12:30 Main Session Stockholm
Update on the treatment of chronic heart failure 2011
Chairpersons: To be announced; A.P. Maggioni (Florence, IT)
Education and Guidelines
11:00 Interaction with the renin-angiotensin system. 602
J.J.V. McMurray (Glasgow, GB)
11:22 Heart rate modulation. 603
K. Swedberg (Gothenburg, SE)
11:45 Mineralocorticoid-antagonists and potassium. 604
F. Zannad (Vandoeuvre Les Nancy, FR)
12:07 Anticoagulation in heart failure. 605
G.Y.H. Lip (Birmingham, GB)
11:00 - 12:30 How-to Session Malmö
Implantable cardioverter-defibrillator (ICD) therapy: risks and complications.
Chairpersons: P. Adamson (Oklahoma City, US); J.G.F. Cleland (Kingston Upon Hull, GB)
Devices and Technology for heart failure in 2011
11:00 The impact of ICD shocks on morbidity and mortality. 606
A.J. Camm (London, GB)
11:22 How to avoid inappropriate shocks in heart failure patients. 607
F. Ruschitzka (Zurich, CH)
11:45 Importance of psychosocial support for the ICD patient. 608
S. Kikkenborg Berg (Copenhagen, DK)
12:07 Information to the potential ICD patient: how to be accurate. 609
B. Riegel (Philadelphia, US)
75
MONDAY

MONDAY
MONDAY 23 MAY 2011 - MORNING
11:00 - 12:30 Main Session Uppsala
Systemic problems in cancer patients
Chairpersons: S.D. Anker (Berlin, DE); G.S. Filippatos (Athens, GR)
Co-morbidities and heart failure
Visit the Exhibition - Coffee Break in the Exhibition Area
Morning Poster Session: Poster Viewing 08:30 - 12:30
& Moderated Posters Session 10:00 - 11:00 See Page 87
11:00 Chemotherapy and cardiac dysfunction – From molecular biology to symptoms. 610
L. Force (Philadelphia, US)
11:22 Cardiac problems in oncology patients beyond cardiotoxicity: a road to cachexia. 611
S. Von Haehling (Berlin, DE)
11:45 Body wasting, cachexia, and nutritional support. 612
M. Lainscak (Golnik, SI)
12:07 Glucose and lipid metabolism. 613
W. Doehner (Berlin, DE)
11:00 - 12:30 Oral Abstracts Örebro
Judges choice: Basic Science
Chairpersons: B.M. Pieske (Graz, AT); Z. Papp (Debrecen, HU)
11:00 Myoscape (muscle specific calcium-channel associated protein) is a novel
striated muscle enriched gene regulating calcium cycling and contractile function. 614
M. Eden, B. Meder, M. Voelkers, R. Will, S. Wiemann, P. Most, W. Rottbauer,
H.A. Katus, N. Frey (Kiel, Heidelberg and Ulm, DE)
11:15 Genetics of dilated cardiomyopathy: novel mutations in the RNA-binding
motif protein 20 gene (RBM20). 615
A. Perrot, B. Kherad, M.G. Posch, W. Haverkamp, C. Oezcelik (Berlin, DE)
11:30 T-type Ca2+ channel antagonists attenuated aldosterone induces
endothelin-1-Rho/Rho-kinase-interleukin-18 pathway in cardiomyocytes. 616
T. Doi, T. Sakoda, T. Akagami, T. Naka, T. Tsujino, T. Masuyama, M. Ohyanagi
(Nishinomiya, JP)
11:45 Istaroxime mechanism of action in heart failure. 617
P. Ferrari, B.P. Barassi, F.M. Ferrandi, F.M. Florio, T.G. Tripodi, R.C. Reina,
M.I. Molinari, B.G. Bianchi (Settimo Milanese, IT)
12:00 Metformin protects cardiomyocyte against doxorubicin-induced stress
oxidative via adiponectin receptors. 618
M.C. Asensio-Lopez, J. Sanchez-Mas, D.A. Pascual-Figal, S. Abenza,
M.T. Perez-Martinez, F. Pastor-Perez, M. Valdes, A. Lax (Murcia, ES)
12:15 SOCS1 gene transfer accelerates the transition to heart failure through the
inhibition of the gp130/JAK/STAT pathway in a chronic pressure-overload rat model. 619
A. Cittadini, M.G. Monti, M. Chiacchio, A. Salzano, E. Bobbio, S. Longobardi,
L. Saldamarco, A. Baldi, V. Petrillo, G. Condorelli (Naples, Rome and Milan, IT)
76

MONDAY 23 MAY 2011 - MORNING
11:00 - 12:30 Symposium Linköping
Controversies in the optimal management of ischaemic
heart failure
Joint Session with the Argentinian and Brazilian Working Groups on
Heart Failure
Chairpersons: P. Seferovic (Belgrade, RS); L. Grinfeld (Buenos Aires, AR)
Co-morbidities and heart failure
More Late Breaking Trials
and Research Clinical Trial Forum Posters
on Level 1
11:00 From myocardial infarction to heart failure – How do we prevent this? 620
To be announced
11:22 Perspectives of pharmacological therapy. 621
J.P. Ribeiro (Porto Alegre, BR)
11:45 Optimal candidate for coronary intervention. 622
M. Petrie (Glasgow, GB)
12:07 When surgical help is needed. 623
To be announced
Heart Failure
General Assembly
Room Linköping (Level 1)
10:00 - 11:00
77
MONDAY

MONDAY
MONDAY 23 MAY 2011 - AFTERNOON
12:45 - 14:00 Satellite Symposium Stockholm
Stroke prevention in atrial fibrillation: challenges and opportunities
Satellite Symposium organised by Bristol-Myers Squibb/Pfizer
Chairpersons: K. Swedberg (Gothenburg, SE); A.J. Camm (London, GB)
12:45 Introduction and welcome. 624
A.J. Camm (London, GB)
12:50 Setting the scene: the burden of atrial fibrillation. 625
K. Swedberg (Gothenburg, SE)
13:10 Stroke prevention in atrial fibrillation: the unmet need. 626
D. Atar (Oslo, NO)
13:30 Is there still a role for aspirin in stroke prevention in atrial fibrillation? 627
J. Eikelboom (Hamilton, CA)
13:55 Closing remarks. 628
K. Swedberg (Gothenburg, SE)
12:45 - 14:00 Satellite Symposium Malmö
Remote disease management in the HF patient
Satellite Symposium organised by St. Jude Medical
Chairperson: To be announced
12:45 Introduction comments. 629
12:50 Role and limitation of diagnostics & therapies in HF patients. 630
13:05 Advanced CRT-D technologies in HF patients. 631
13:20 The CHAMPION trial update. 632
13:35 The future of devices technologies in HF management: challenges & opportunities. 633
13:50 Round table discussion. 634
78

MONDAY 23 MAY 2011 - AFTERNOON
12:45 - 14:00 Satellite Symposium Uppsala
Point-of-care biomarkers in the real world of practice: managing the patients
from the hospital to home
Satellite Symposium organised by ALERE
Chairpersons: K. McDonald (Dublin, IE); H.J. Dargie (Glasgow, GB)
12:45 Introduction. 635
H.J. Dargie (Glasgow, GB)
12:50 Applications of B-Type Natriuretic Peptide (BNP) in the early differential
diagnosis of patients with acute dyspnea in the emergency departmentt. 636
C. Mueller (Basel, CH)
13:05 The clinical challenges of acute kidney injury and cardio-renal syndrome:
neutrophil gelatinase associated lipocalin (NGAL) as a vital biomarker in the
emergency department and intensive care unit. 637
C. Ronco (Vicenza, IT)
13:20 Telemonitoring: a promising strategy for a comprehensive and integrated
approach to chronic care management of heart failure patients. 638
F.X. Kleber (Potsdam, DE)
13:35 The clinical spectrum of heart failure in the community: the key role of BNP in
the assessment and confirmation of heart failure patients. 639
H.J. Dargie (Glasgow, GB)
13:50 Faculty discussion and concluding comments. 640
K. McDonald (Dublin, IE)
12:45 - 14:00 Satellite Symposium Örebro
Improving heart failure risk assessment
Satellite Symposium organised by GE Healthcare
12:45 Introduction. 641
13:00 Heart failure challenges in 2011: is LVEF the only answer? 642
13:15 Cardiac sympathetic innervation imaging. 643
13:30 Impact of new clinical studies with ADMIRE-HF. 644
13:45 Conclusion. 645
79
MONDAY

MONDAY
MONDAY 23 MAY 2011 - AFTERNOON
12:45 - 13:30 Mini-Satellite Symposium Linköping
Transcatheter mitral valve repair therapy, a novel approach for heart failure
patients suffering from mitral regurgitation
Mini-Satellite Symposium organised by Crossroads, the Abbott Vascular education network
Chairpersons: P. Ponikowski (Wroclaw, PL); M. Senni (Bergamo, IT)
12:45 Introduction. 646
P. Ponikowski (Wroclaw, PL)
12:50 Clinical data on transcatheter mitral valve repair therapy - The EVEREST II study. 647
K.H. Kuck (Hamburg, DE)
13:00 European experience with transcatheter mitral valve repair therapy in heart
failure patients. 648
O.W. Franzen (Hamburg, DE)
13:15 How to select suitable patients: the clinical decision tree. 649
A. Vahanian (Paris, FR)
13:25 Take home message. 650
M. Senni (Bergamo, IT)
80

MONDAY 23 MAY 2011 - AFTERNOON
14:15 - 15:45 Main Session Gothenburg
New medical treatment in acute heart failure
Chairpersons: C. Mueller (Basel, CH); G.S. Filippatos (Athens, GR)
Latest Updates
14:15 New natriuretic peptides. 651
F. Ruschitzka (Zurich, CH)
14:33 Guanylate cyclase activators. 652
M. Gheorghiade (Chicago, US)
14:51 Cardiac myosin activators. 653
J.J.V. McMurray (Glasgow, GB)
15:09 Calcium modulators. 654
B.M. Massie (San Francisco, US)
15:27 Relaxin. 655
A.A. Voors (Groningen, NL)
14:15 - 15:45 Debate Stockholm
Award Ceremony followed by a Symposium
Chairpersons: K. Swedberg (Gothenburg, SE); P. Ponikowski (Wroclaw, PL)
Latest Updates
14:15 Young Investigator Award Presentation: Clinical. 656
S.D. Anker (Berlin, DE)
14:20 Young Investigator Award Presentation: Basic Science. 657
B.M. Pieske (Graz, AT)
14:25 HFA Research Grant Presentation. 658
P. Ponikowski (Wroclaw, PL)
14:30 Nursing Investigator Award Presentation. 659
I. Ekman (Gothenburg, SE)
Revascularization and remodelling surgery in heart failure: when, how and why
14:35 Revascularisation in heart failure – Can we improve above drug therapy? 660
M. Petrie (Glasgow, GB)
14:43 Ventricular remodelling in heart failure: implications and opportunities. 661
S. Solomon (Boston, US)
15:11 The importance of left ventricular volumes in chronic heart failure - A place for
active reduction? 662
U. Landmesser (Zurich, CH)
15:28 Update on the Surgical Treatment for Ischemic Heart Failure (STICH) Trial. 663
C. O’Connor (Durham, US)
81
MONDAY

MONDAY
MONDAY 23 MAY 2011 - AFTERNOON
14:15 - 15:45 How-to Session Malmö
Therapeutic controversies in patients with diabetes
Chairpersons: P. Seferovic (Belgrade, RS); K.O.A. Boman (Skelleftea, SE)
Co-morbidities and heart failure
14:15 How would I treat diabetes in my heart failure patient: a comprehensive view. 664
L. Ryden (Stockholm, SE)
14:37 How would I treat diabetes in my heart failure patient: a cardiologist view. 665
V. Mareev (Moscow, RU)
15:00 How would I treat heart failure in my diabetic patient: a cardiologist view. 666
P. Seferovic (Belgrade, RS)
15:22 How would I treat heart failure in my diabetic patient: a diabetologist view. 667
O. Schnell (Baierbrunn, DE)
14:15 - 15:45 Read with the Experts Uppsala
Diuretics in heart failure, friend or foe?
Chairpersons: M. Schaufelberger (Gothenburg, SE); M. Metra (Brescia, IT)
Education and Guidelines
14:15 Metabolic reactions to diuretics. 668
J.R. Teerlink (San Francisco, US)
14:45 Spironolactone in heart failure. 669
F. Zannad (Vandoeuvre Les Nancy, FR)
15:15 Renal function in heart failure related to diuretics. 670
H. Hillege (Groningen, NL)
14:15 - 15:45 Main Session Örebro
Systems medicine approaches in translational heart failure research
Chairpersons: L. Neyses (Manchester, GB); G. Hasenfuss (Goettingen, DE)
Basic Science, Basic Science translated for the clinician
14:15 Systems genomics and genetics. 671
N. Huebner (Berlin, DE)
14:33 Clinical metabolomics from bench to bedside. 672
M. Mamas (Manchester, GB)
14:51 Proteomics combined with other ‘omics. 673
M. Mayr (London, GB)
15:09 Integrating and analyzing the data tsunami. 674
N. Samani (Leicester, GB)
15:27 How to introduce systems medicine in heart failure trials. 675
D.L. Brutsaert (Kontich, BE)
82

MONDAY 23 MAY 2011 - AFTERNOON
14:15 - 15:45 Oral Abstracts Linköping
Judges choice: Clinical treatment research
Chairpersons: L. Grinfeld (Buenos Aires, AR); Z. Papp (Debrecen, HU)
14:15 Effects of adding ivabradine to optimal medical therapy in symptomatic
patients with left ventricular systolic dysfunction secondary to ischemic or
idiopathic dilated cardiomyopathy. 676
Y.A. Abdel Hady (Beni-Suef, EG)
14:30 Ventricular rate profiles during atrial fibrillation in heart failure patients. 677
F. Oliva, M. Gasparini, M. Landolina, A. Proclemer, G. Zanotto, L. Padeletti,
M. Santini, D. Catanzariti, A. Grammatico, G. Boriani (Milan, Rozzano, Pavia,
Udine, Legnago, Firenze, Rome, Rovereto and Bologna, IT)
14:45 Medication profile on admission and discharge in diabetic and non-diabetic
patients with acute heart failure in ALARM-HF survey. 678
J.T. Parissis, P. Rafouli-Stergiou, V. Bistola, A. Mebazaa, I. Ikonomidis, M. Nikolaou,
J. Delgado, F. Vilas-Boas, M. Anastasiou-Nana, F. Follath (Athens, GR; Paris, FR;
Madrid, ES; Bahia, BR; Zurich, CH)
15:00 Risk score and antithrombotic treatment in an unselected population of non
valvular atrial fibrillation patients: the ATA-AF Survey. 679
G.M. T. Fabbri, S. Baldasseroni, A.P. Maggioni, C. Nozzoli, F. Chiarella,
F. Colombo, D. Lucci, M. De Biasio, G. Di Pasquale, G. Mathieu (Florence,
Genoa, Milan, Udine, Bologna and Pinerolo, IT)
15:15 Genetic variants associated to reverse remodelling after cardiac
resynchronization therapy. 680
R. De Maria, M. Lunati, M. Landolina, M. Gasparini, B. Schmitz, J. Campolo,
M. Parolini, S.M. Brand, O. Parodi (Milan, Pavia and Rozzano-Milano, IT; Munster, DE)
15:30 Normobaric intermittent hypoxia training as a method of preoperative
preparation for coronary bypass surgery of the patients with ischemic
cardiomyopathy and chronic heart failure. 681
T. Dubovik, L. Rachok, I. Sidorenko, E. Zhujko (Minsk, BY)
Visit the Exhibition - Coffee Break in the Exhibition Area
Afternoon Poster Session: Poster Viewing 14:00 - 18:00
& Moderated Posters Session 15:45 - 16:30 See Page 104
HFA Forum
Join the HFA Committees on Level 1
from 15:45 to 16:30
Come share and learn with your peers
and colleagues
83
MONDAY

MONDAY
MONDAY 23 MAY 2011 - AFTERNOON
16:30 - 18:00 Clinical Interactive Educational Session Gothenburg
Managing patients with hyperkalaemia during RAAS-blockade
Case based interactive session
Chairpersons: F. Zannad (Vandoeuvre Les Nancy, FR);
D.J. van Veldhuisen (Groningen, NL)
Co-morbidities and heart failure
Panel. 682
M. Metra (Brescia, IT); S.D. Anker (Berlin, DE)
16:30 Patient with hyperkalaemia during initiation of ACE-inhibitor therapy. 683
L. Gullestad (Oslo, NO)
17:00 Patient on ACE-inhibitor who develops hyperkalaemia during spironolactone. 684
G. Hasenfuss (Goettingen, DE)
17:30 Elderly patient on spironolactone who develops heart failure and needs an
ACE-inhibitor. 685
E. Omerovic (Gothenburg, SE)
16:30 - 18:00 Special Session Stockholm
Late Breaking Trials - Session II
Consult Session details in the Addendum & on the Website
This session will feature the latest breakthrough in Clinical Research.
Each trial presentation will be concluded by a discussant review.
16:30 - 18:00 Main Session Malmö
Management of heart failure patients guided by implantable sensors
Chairpersons: I. Ekman (Gothenburg, SE); M.R. Cowie (London, GB)
Devices and Technology for heart failure in 2011
16:30 Why do we need implantable monitoring solutions for the heart failure patient? 696
L. Warner Stevenson (Boston, US)
16:52 Remote heart failure monitoring in CRT and ICD patients in daily practice. 697
F. Braunschweig (Stockholm, SE)
17:15 Implantable hemodynamic sensors. 698
P. Adamson (Oklahoma City, US)
17:37 How to integrate monitoring into routine clinical work-flow. 699
P. Hauptman (Saint Louis, US)
84

MONDAY 23 MAY 2011 - AFTERNOON
16:30 - 18:00 Main Session Uppsala
The failing right heart
Chairpersons: G. Wikstrom (Uppsala, SE); M. Ryder (Perth, AU)
Education and Guidelines
16:30 Pathophysiology of right heart failure. 700
T.A. McDonagh (London, GB)
16:52 Assessment of the right heart: why and how? 701
S. Solomon (Boston, US)
17:15 Medical therapy for the failing right ventricle. 702
P.J. Mohacsi (Bern, CH)
17:37 Non pharmacological approaches. 703
B. Granger (Durham, US)
16:30 - 18:00 Main Session Örebro
New drug targets in heart failure – from EUGeneHeart
Chairpersons: T. Eschenhagen (Hamburg, DE); P.A.F.M. Doevendans (Utrecht, NL)
Basic Science, Basic Science translated for the clinician
16:30 Next generation beta-blocking by I-1 inhibition. 704
A. El-Armouche (Goettingen, DE)
16:52 PDE5 inhibition. 705
S. Janssens (Leuven, BE)
17:15 Beta3 agonists: beyond and above beta-blockade in heart failure. 706
J.L. Balligand (Brussels, BE)
17:37 PI3K inhibition to prevent maladaptive hypertrophy. 707
E. Hirsch (Turin, IT)
85
MONDAY

MONDAY
MONDAY 23 MAY 2011 - AFTERNOON
16:30 - 18:00 Oral Abstracts Linköping
Judges choice: Clinical research
Chairperson: V. Mareev (Moscow, RU)
16:30 Atrial fibrillation is associated with worse outcome compared with sinus
rhythm among patients with heart failure with preserved or reduced LV
ejection fraction: results from the MAGGIC meta-analysis. 708
R. Doughty, A.P. Maggioni, K. Poppe, J. Dobson, N. Earle, G.A. Whalley,
S. Pocock, J.J.V. Mcmurray, K. Swedberg, L. Kober (Auckland, NZ; Florence, IT;
London and Glasgow, GB; Gothenburg, SE; Copenhagen, DK)
16:45 NT-proBNP: strong prognostic marker in hypertrophic cardiomyopathy. 709
D. Brito, N. Cortez-Dias, D. Silva, H. Madeira (Lisbon, PT)
17:00 Heart failure as a strong predictor of left atrial thrombosis prior to
cardioversion in anti-coagulated patients with persistent atrial fibrillation. 710
A. Ciro, E. Piazzi, A. Vincenzi, G. Trocino, G. De Vito, P. Neri, C. Giannattasio,
A. Grieco (Monza and Seriate, IT)
17:15 Atrial dyssynchrony syndrome : an overlooked cause of heart failure with
normal ejection fraction. 711
J.-C. Eicher, G. Laurent, O. Barthez, A. Mathe, G. Bertaux, J.-E. Wolf (Dijon, FR)
17:30 Communication between primary and secondary care at hospital discharge; a
retrospective audit on heart failure patients. 712
S.A. O Driscoll, C.M. Chapman, J.P. Riley (London, GB)
17:45 Low levels of vascular endothelial growth factor B predict late remodelling
after myocardial infarction. 713
Y. Devaux, I.B. Squire, M. Vausort, F. Azuaje, M.L. Lair, E. Gayat, J. Lassus, L.L. Ng,
D. Kelly, D.R. Wagner (Luxembourg, LU; Leicester, GB; Paris, FR; Helsinki, FI)
86

MORNING
MONDAY
POSTER SESSIONS
Moderated Posters Session 3 (10:00 - 11:00)...........................................................Page 88
Poster Session 3 .......................................................................................................................Pages 89 to 103
All Posters will be on display from 08:30 - 12:30
AFTERNOON
Moderated Posters Session 4 (15:45 - 16:30) .......................................................Page 104
Poster Session 4 ....................................................................................................................Pages 105 to 119
All Posters will be on display from 14:00 - 18:00
The Heart Failure Association and the Scientific Programme Committee have
developed a programme to support young researchers.
Senior members of faculty, HFA Board Members experts in the topic presented
will come to meet and discuss the research presented during the coffee break of
the poster sessions.
The poster will be easily identified with a HFA Young Researcher
logo - which should be collected at the Poster Assistance Desk.
Join us in supporting the future of research and advances in all related aspects of
heart failure Clinical research / treatment and Basic Science - come and interact
with the Cardiologists of tomorrow.
More Late Breaking Trials and Research
Clinical Trial Forum Posters
on Level 1
87
Y
MONDAY
POSTERS

MONDAY
POSTERS
MONDAY 23 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Moderated Posters Moderated Poster Area
Moderated Posters Session 3
Chairpersons: J. Nanas (Athens, GR); M.F. Piepoli (Piacenza, IT)
Posters must be set up between 08:00 and 08:30 and removed between 12:30 and 13:00
These abstracts were chosen for their outstanding quality and will be presented during the
Moderated Poster Session between 10:00 and 11:00
Preliminary report on the effects of ultrafiltration in severe HF refractory to
conventional diuretic therapy: the Continuous Ultrafiltration for cOngestive
heaRt failurE (CUORE) trial. P714
E.R. Cosentino, E.R. Rinaldi, D. Degli Esposti, F. Santi, E. Ferramosca,
G. Colombo, P. Agostoni, G. Marenzi, A. Santoro, C. Borghi (Bologna and Milan, IT)
The novel marker Ltbp2 powerfully predicts all-cause and pulmonary death in
patients with acute dyspnea. P715
T. Breidthardt, M. Potocki, G. Vanpoucke, T. Gregoire, W. Laroy, K. Verleysen,
B. Drexler, A. Mebazaa, K. Kas, C.H. Mueller (Basel, CH; Ghent, BE; Paris, FR)
Sildenafil as treatment for heart failure in women. The difference in treament in men. P716
L. Torres, E. Frigola, S. Pacreu, O. Londono Sanchez (Barcelona, ES)
Intracardiac gradient of mast cell mediators (tryptase, transforming growth
factor beta 1) and myocardial remodeling in patients with heart failure with
versus without recent decompensation. P717
A. Kopec, E.A. Jankowska, D. Kustrzycka-Kratochwil, A. Fal, K. Reczuch,
K. Gomulka, W. Banasiak, B. Panaszek, P. Ponikowski (Wroclaw, PL)
The important role of lung impedance monitoring in the outpatient clinic for
predicting and preventing of hospitalizations of patients with chronic heart failure. P718
M. Shochat, A. Shotan, M. Kazatsker, V. Gurovich, Y. Levy, L. Vasilenko, A. Asif,
D. Blondhaim, P. Rabinovich, S. Meisel (Hadera and Tel Aviv, IL)
Gender-related differences in clinical phenotype and in-hospital management
in patients with acute heart failure : an ALARM-HF survey sub-analysis. P719
J.T. Parissis, N. Kaldoglou, I. Ikonomidis, M. Nikolaou, K. Nikolopoulou,
A. Mebazaa, J. Delgado, F. Vilas-Boas, M. Anastasiou-Nana, F. Follath
(Athens, GR; Paris, FR; Madrid, ES; Bahia, BR; Zurich, CH)
Prevalence and prognostic significance of elevated serum phosphate levels in
chronic heart failure. P720
M. Ess, K. Heitmair-Wietzorrek, H. Ulmer, M. Frick, G. Poelzl (Innsbruck, AT)
Especially moderate QRS prolongation is an independent risk for all-cause
mortality in heart failure patients. Data from a heart failure registry with
29 000 patients. P721
M. Edner, U. Dahlstrom, U. Alehagen (Danderyd and Linkoping, SE)
Usefulness of peritoneal dialysis in patients with congestive heart failure and
renal dysfunction. Effect on quality of life and biochemical prognostic markers. P722
G. Minana Escriva, J. Nunez, M. Gonzalez, J. Sanchis, R. Garcia-Ramon, P. Palau,
C. Gomez, F.J. Chorro, A. Llacer, A. Miguel (Valencia, ES)
Relation of loop diuretic dose to morbimortality in patients with heart failure
and left ventricular systolic dysfunction: insights from EPHESUS. P723
S. Tala, P. Rossignol, R. Fay, B. Pitt, F. Zannad (Vandoeuvre-les-Nancy
and Vandoeuvre-Les-Nancy, FR; Ann Arbor, US)
88

MONDAY 23 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Poster Session 3
Posters must be set up between 08:00 - 08:30, removed between 12:30 - 13:00, to be on display
between 08:30 - 12:30.
The presenter should be available by the poster during the coffee break (10:00 to 11:00) in order
to discuss the research with the audience.
Acute heart failure (diagnosis, pathophysiology, other)
Exhaled breath condensate parameters in decompensated and stable heart failure:
potential new insight in the role of the alveolar capillary barrier. P724
L. Pappas, G. Giannopoulos, S. Loukides, G. Gavrielatos, E. Athanasopoulou, I. Alexanian,
D. Farmakis, V. Pyrgakis, D. Kremastinos, G. Filippatos (Athens, GR)
Clinical Characteristics of acute decompensated heart failure in patients with nighttime onset. P725
M. Fujino, H. Yokoyama, H. Kanzaki, Y. Goto, M. Kitakaze, H. Nonogi (Suita, JP)
Diminished utility of ejection fraction in older heart failure patients (SUSSEX HF). P726
H.F. Mcintyre, A. Riding, A. Smith, P. Haydock (Hastings, Brighton and London, GB)
Preliminary results of the heart function assessment registry trial in saudi arabia in
patients with acute decompensated heart failure (HEARTS-AHF). P727
K.F. Alhabib, A.A. Elasfar, H. Albackr, H. Alfaleh, A. Hersi, T. Kashour, K. Alnemer,
G.A. Hussein, L. Mimish (Riyadh, Tabuk and Jeddah, SA)
Are there any Gender Differences in Patients Presenting with Acute Heart Failure? P728
H. Benhalla, F.Z. Waderrahmane, K.H. Chraibi, A. Bennis (Casablanca, MA)
A new radiological score for the verification of evolving acute heart failure in the
course of acute myocardial infarction. P729
M. Shochat, A. Shotan, M. Kazatsker, V. Gurovich, Y. Levy, L. Vasilenko, A. Asif,
D. Blondhaim, P. Rabinovich, S. Meisel (Hadera and Tel Aviv, IL)
Improving decompensated heart failure evaluation through the physician-hospital
aligned co-management model. P730
G.F. Dawson, M. Aboudan, P. Ramachandran, S. Smith, H. Yarlagadda, J. Walter (Grand Blanc, US)
ADHERE study NCVC Jakarta Indonesia. P731
B.B. Siswanto, S.H. Soeriasaputra, P.S. Roebiono, B. Radi, H. Kalim, M. Kasim (Jakarta, ID)
How does heart failure impact the quality of life in patients? P732
T. Bibi (Nottingham, GB)
Matrix metalloproteinase: investigation from gene to protein as effective factor in
myocardial infarction. P733
S.M. H. Ghaderian, R. Akbarzadeh Najar, A.S. Tabatabaei Panah, G. Rezaie,
A. Rezaei Farimani, A. Beigi Harchegani, E. Azargashb (Tehran, IR)
Acute heart failure (therapy)
Use of nt-proBNP for risk stratification in the early follow-up of acute heart fail-ure patients. P734
J. Tolonen, J.P.E. Lassus, K. Siirila-Waris, K. Pulkki, R. Sund, K. Peuhkurinen, M.S. Nieminen,
V.-P. Harjola (Helsinki, Kuopio and Oulu, FI)
Levosimendan to withdraw dobutamine in patients with advanced decompesated
heart failure. P735
A.C. Pereira Barretto, M.E. Ochiai, J.N. Cardoso, C.H. Del Carlo, P.C. Morgado,
R.T. Munhoz, A.R. Scipioni, J.A.F. Ramires (Sao Paulo, BR)
89
MONDAY
POSTERS

MONDAY
POSTERS
MONDAY 23 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Thermal vasodilation by portable infrared thermal blanket in decompensated heart failure. P736
M.V. Lima, M.E. Ochiai, J.N. Cardoso, E.C.O. Brancalhao, R. Puig, K.R. Novaes,
A.C. Pereira-Barretto (Sao Paulo, BR)
Animal models and experimentation
Electrophysiological consequence of autologous skeletal myoblast sheet
transplantation in infracted myocardium. P737
Y. Terajima, T. Shimizu, S. Tsuruyama, H. Ishii, H. Sekine, K. Yamazaki, N. Hagiwara,
T. Okano (Tokyo, JP)
Changes in cardiac function and systolic/diastolic reserve at early and advanced stage
of chronic heart failure in transgenic mice. P738
U. Tyrankiewicz, M. Jablonska, T. Skorka, S. Chlopicki (Krakow, PL)
Reduced expression of nicotinic receptor N alpha7 in medulla oblongata in male pigs
with tachycardia induced cardiomyopathy. P739
A. Tomaszek, M.W. Zacharski, J. Bania, U. Paslawska, A. Janiszewski, L. Kiczak, T. Stefaniak,
A. Noszczyk-Nowak, E.A. Jankowska, P. Ponikowski (Wroclaw, PL)
Galectin-3 is a potential mediator of aldosterone effects in vascular remodeling. P740
L. Calvier, B. Martin-Fernandez, V. Lahera, F. Zannad, V. Cachofeiro, P. Lacolley,
P. Rossignol, N. Lopez-Andres (Vandoeuvre-les-Nancy, FR; Madrid, ES)
Arrhythmias and treatment
Patients receiving standard pacemaker generator replacems frequently have impaired
left ventricular function and exercise intolerance, related to the percentage of right
ventricular pacing. P741
G.A. Begg, Z.L. Waldron, J. Gierula, K. Witte (Leeds, GB)
The role of premature ventricular contraction burden and ventricular coupling interval
to the initial mechanism of heart failure progression. P742
D.C. Cozma, L. Petrescu, C. Mornos, D. Lighezan, C. Tutuianu, S.I. Dragulescu (Timisoara, RO)
Symptoms recurrence in patients with postural orthostatic tachycardia syndrome. P743
A. Sousa, A. Lebreiro, C. Sousa, S. Oliveira, A.S. Correia, M. Paiva, I. Rangel, V. Ribeiro,
J. Freitas, M.J. Maciel (Porto, PT)
Atrial fibrillation
Longterm effects of aspirin and vitamin K antagonists on mortality in patients with
atrial fibrillation and heart failure. An observational study. P744
F.H. Rutten, E.E.S. Van Riet, M. Hollander, A.W. Hoes (Utrecht, NL)
Can values of NT-proBNP accurately predict left ventricular systolic dysfunction in
patients with atrial fibrilation? P745
A.-M. Vintila, D. Munteanu, D. Isacoff, M. Muraru, I. Bruckner (Bucharest, RO)
Features of emotional status of patient with ischemic heart disease and paroxysmal
atrial fibrillation. P746
A. Ibatov (Moscow, RU)
Cardiac resynchronisation therapy
Markers of satisfactory versus in satisfactory response to CRT. P747
S. Hozayen, H. Roukoz, S. Duval, A. Rosenbaum, P. Eckman (Minneapolis, US)
90

MONDAY 23 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Is cardiac resynchronization therapy useful in patients with end-stage heart failure
patients inotrope-supported? P748
S. Pescariu, D. Brie, A. Dumitrescu, R. Sosdean, A. Ionac, C. Mornos, S.T. Dragulescu
(Timisoara, RO)
The impact of a specialist heart failure pacing clinic upon the management of patients
treated with cardiac resynchronization therapy. P749
K. Guha, A. Mantziari, Z. Khalique, M.R. Cowie, T. Mcdonagh, R. Sharma (London, GB)
Systolic dyssynchrony index at real-time three-dimensional echocardiography correlates
with LVEF improvement and reverse remodeling after cardiac resynchronization therapy. P750
E. De Marco, A. Colucci, G. Comerci, F.A. Gabrielli, R. Natali, M. Savino, M. Lotrionte,
B. Garramone, F.A. Loperfido (Rome, IT)
Impact of right ventricular function in the response to cardiac resynchronization therapy. P751
D. Silva, N. Cortez-Dias, S. Goncalves, L. Sargento, J. Silva-Marqes, C. Jorge, C. Bogalho,
S. Sobral, M. Valente, J. Sousa (Lisbon, PT)
Clinical responder rate and survival of patients receiving cardiac resynchronization
therapy and followup at a heart failure clinic. P752
M. Dekany, B. Szabo, N. Nyolczas, G.Z. Duray, A. Szabo, B. Ancsin, T. Borsanyi, A. Molnar,
G. Zoltan, R.G. Kiss (Budapest, HU)
Correction of dyssynchrony, as assessed using TUS but not TP-SD of circumferential
strains, is associated with acute contractile recovery in HF patients during CRT vs AAI
pacing mode. P753
P.N. Marino, C. Cavallino, F. De Vecchi, M. Santagostino, P. Devecchi, E. Occhetta,
A. Magnani (Novara, IT)
Cardiomyopathy
New onset left bundle branch block independently predicts long-term mortality in
patients with Idiopathic Dilated Cardiomyopathy. data from Trieste heart muscle
disease registry. P754
A. Aleksova, C. Carriere, R. Belfiore, G. Barbati, G. Vitrella, M. Zecchin, R. Gerloni,
A. Di Lenarda, G. Sinagra (Trieste, IT)
Effects of protein A immunoadsorption on methylglyoxal levels in patients with chronic
dilated cardiomyopathy and diabetes mellitus. P755
A. Doesch, S. Mueller, M. Konstandin, S. Celik, L. Frankenstein, T.J. Dengler, C. Zugck,
A. Bierhaus, H.A. Katus (Heidelberg, DE)
The prognostic role of echocardiography during follow-up in cardiac amyloidosis. P756
G. Finocchiaro, M. Merlo, B. Pinamonti, G. Barbati, A. Dilenarda, R. Bussani, G. Sinagra
(Trieste and Padova, IT)
Prognostic role of pulmonary hypertension at echo-Doppler evaluation in cardiac
amyloidosis. P757
G. Finocchiaro, M. Merlo, B. Pinamonti, G. Barbati, A. Dilenarda, R. Bussani, G. Sinagra
(Trieste and Padova, IT)
Doxorubicin suppresses myocardial synthesis of cardioprotective apoB lipoproteins - a
novel pharmacologic target for treatment of cytostatics-induced heart failure? P758
E. Omerovic, T. Ramunddal, M. Lindbom, Y. Shao, J. Boren (Gothenburg, SE)
Comparative study of circulating endothelial progenitor cells in patients with ischemic
heart disease and dilated cardiomyopathy. P759
E. Karelkina, O. Moiseeva, V. Moroshkin, E. Shlyakhto (St Petersburg, RU)
91
MONDAY
POSTERS

MONDAY
POSTERS
MONDAY 23 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Characterization of a population with hypertrophic cardiomyopathy: from genetics to
longitudinal strain. P760
D.A. Moreira, C.E. Correia, B.F. Rodrigues, L.F. Santos, L.M. Nunes, J.O. Santos (Viseu, PT)
The features of electrocardiographic changes at dilated cardiomyopathy patients. P761
N.A. Kurbanov, T.A. Abdullaev, B.U. Mardanov (Tashkent, UZ)
Cardio-renal syndrome
Spectrophotometric analysis in estimation of 24-h sodium excretion from a spot urine
sample for early detection of renal tubulointersticial tissue lesion in patients with
chronic heart failure. P762
L.G. Oganezova, G.P. Arutyunov (Moscow, RU)
Renal dysfunction in 1367 patients with chronic heart failure : incidence and predictors
of worsening renal function. P763
H. Salih, D. Ghellab, R. Kongo, A. Bennis (Casablanca, MA)
When the three «A» come together: acute coronary syndrome, acute heart failure and
acute kidney injury. P764
F. Simoes Marques Assuncao Caetano, I. Almeida, J. Silva, L. Seca, P. Mota, A. Botelho,
A. Leitao Marques (Coimbra, PT)
Is NGAL a biomarker of dehydration in elderly patients with Heart Failure. P765
M. Escande, M. Mordarska, L. Marsoubian, N. Escande Beillard, E. Beillard (Allauch, FR;
Singapour, SG)
Deterioration of renal function in pts regularly followed in a heart failure outpatient
clinics and long term prognosis. P766
C.I. Santos De Sousa, M. Satendra, L. Sargento, I. Almeida, M. Teixeira, F. Salazar,
N. Lousada, R. Palma Reis (Lisbon, PT)
Cellular biology
Adenosine stimulates angiogenesis through increased production of thrombospondin-1. P767
I. Ernens, B. Lenoir, A. Noel, Y. Devaux, D.R. Wagner (Luxembourg, LU; Liège, BE)
KLF15 regulates cardiac progenitor cell fate via inhibition of beta-catenin. P768
M.W. Bergmann, C. Noack, L.J. Zelarayan (Hamburg and Berlin, DE)
atorvastatin improves effects of transplanted mesenchymal stem cells through
AMP-activated protein kinase in post-infarcted porcine hearts. P769
Q.-T. Dong, Y.J. Yang, L. Song, H.Y. Qian, H.S. Guan (Beijing, CN)
Adenosine modifies the balance between membrane and soluble forms of Flt-1. P770
F. Leonard, Y. Devaux, M. Vausort, I. Ernens, C. Nicolas, E. Lieffrig, M. Rolland-Turner,
D.R. Wagner (Luxembourg, LU)
Cell Signalling
Interleukin-18 (IL-18), endothline-1 and aldosterone induce smooth muscle senescence
via Rho/Rho-kinase-, PPAR-, and p53-dependent pathways. P771
T. Akagami, T. Sakoda, T. Doi, T. Naka, M. Ohyanagi (Nishinomiya, JP)
Co-morbidities (inc COPD, anaemia, cachexia)
3-year mortality of anemic and non-anemic patients with acute heart failure. Data
from the AHEAD registry. P772
R. Miklik, M. Felsoci, J. Parenica, J. Jarkovsky, K. Horakova, J. Spinar (Brno, CZ)
92

MONDAY 23 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Resting spirometry and exercise intolerance in patients with systolic heart failure
without known lung disease. P773
B. Krakowiak, K. Ludwikowska, E.A. Jankowska, W. Banasiak, P. Ponikowski (Wroclaw, PL)
Gender difference in the relationship between obesity and heart failure with preserved
ejection fraction. P774
M.-S. Shin, B.R. Kim, D.-J. Choi, E.S. Jeon, J.-J. Kim, M.-C. Cho, S.C. Chae, K.-H. Ryu,
B.-H. Oh, M.M. Lee (Incheon, Seoul, Seongnam, Cheongju, Daegu and Goyang, KR)
Depression in older heart failure patients and its effect on family caregivers. P775
L. Loftus, A.D.M. Davies, D. King, E.W. Thornton (Liverpool and Wirral, GB)
High prevalence of unrecognized COPD in stable ambulant patients with heart failure. P776
M.J.M. Valk, F.H. Rutten, A. Mosterd, A.M. Hilligehekken, S. Hillebrand, A.W. Hoes
(Utrecht, NL)
Risk factors for ventricular dysfunction in patients with rheumatoid arthritis. P777
R. Sanchez-Santillan, L. Castillo-Martinez, J.I. A. Orea-Tejeda, C. Murphy-Arteaga,
G. Sanchez-Vidal, O. Carrasco-Ortiz, A. Navarro-Navarro, E. Colin-Ramirez,
M. Utreras-Lagunas M. Utreras-Lagunas, K. Balderas-Diaz (Mexico, MX)
Heart failure can reduce pulmonary forced expiratory volumes and may distort severity
grading in comorbid COPD. P778
G. Guder, S. Brenner, F.H. Rutten, A.W. Hoes, B. Jany, D. Berliner, G. Ertl,
C.E. Angermann, S. Stork (Wurzburg, DE; Utrecht, NL)
Cytokines and inflammation
Clostridial infection without pseuomemranouse colitis in patients with chronic heart failure. P779
N. Bylova, G.P. Arutyunov, L.I. Kafarskaya, Z.A. Chernaya, U.A. Pokrovskiy (Moscow, RU)
Increased expression of chemokine receptor CCR2 and lipopolysaccharide receptor
CD14 on monocyte subsets in heart failure. P780
B.J. Wrigley, L.D. Tapp, B. Pamukcu, E. Shantsila, G.Y.H. Lip (Birmingham, GB)
Matrix metalloproteinase-9, plasminogen activator inhibitor-1, myeloperoxidase, and
circulating adhesion molecules in coronary artery disease patients with stable and
unstable angina. P781
P. Tretjakovs, A. Jurka, I. Bormane, I. Mikelsone, K. Elksne, G. Krievina, D. Reihmane,
J. Verbovenko, G. Bahs (Riga, LV)
Diagnosis of heart failure and biomarkers
Diagnostic value of D-dimer as a marker of decompensation of chronic heart failure. P782
N.M. Vorobyeva, A.B. Dobrovolsky, E.V. Titaeva, E.P. Panchenko (Moscow, RU)
Red blood cell distribution width (RDW) is correlated with both LVEF and NTpro BNP in
a prospective hospital cohort study. P783
A. Holmstrom, R. Sigurjonsdottir, O. Hammarsten, D. Gustafsson, M. Fu (Gothenburg, SE)
Prognostic impact of echocardiographically assessed diastolic versus systolic heart
failure in a mixed patient population. P784
P. Jung, M. Mueller, T. Huber, J. Rieber, A. Koenig, F. Kroetz, V. Klauss, H.-Y. Sohn (Munich, DE)
Correlation of ST2 with IL6 and B-type natriuretic peptide in asymptomatic heart failure
patients. P785
E. Omer, N. Murphy, M. Ledwidge, I. Dawkins, C. Watson, K. Mcdonald (Dublin, IE)
Clinical role of tinnutis in patients with heart failure. P786
E.R. Cosentino, E.R. Rinaldi, A. Dormi, D. Degli Esposti, F. Campomori, G. Colombo,
C. Borghi (Bologna, IT)
93
MONDAY
POSTERS

MONDAY
POSTERS
MONDAY 23 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Circulating stromelysin-1 as a possible marker of severity of cardiovascular remodeling
in obesity patients after acute myocardial infarction. P787
A. Berezin, T. Panasenko (Zaporozhye, UA)
Response to cardiac resynchronization therapy, serum biomarkers and long term survival. P788
M.E. Tettamanti, J. Lopez Diaz, A. Revilla Orodea, R. Arnold, E. Garcia Moran, M.L. Nieto,
R.M. Montana, J.A. San Roman Calvar, I. Gomez Salvador, A. Recio Platero (Valladolid, ES)
Disease management and patient education
Self-reported versus true compliance in heart failure patients; a study using the MEMS. P789
M.M.W. Nieuwenhuis, T. Jaarsma, D.J. Van Veldhuisen, M.H. L. Van Der Wal
(Groningen, NL; Linkoping, SE)
Clinical outcome of patients with chronic heart failure followed in a specialized heart
failure center. P790
I. Gotsman, D. Zwas, Z. Zemora, D. Admon, R. Jabara, C. Lotan, A. Keren (Jerusalem, IL)
Differences between diabetic and non-diabetic outpatients with systolic heart failure in
the implementation of European guidelines in Poland. P791
E.A. Jankowska, C. Zajaczkowski, Z. Bentkowski, W. Banasiak, P. Ponikowski
(Wroclaw and Warsaw, PL)
Epidemiological profile of infective endocarditis: regarding 206 cases. P792
S. Fadili, S. Fadili, N. Baaddy, A. Bennis (Casablanca, MA)
Acquired heart disease in Nigerian children: an illustration of the influence of
socio-economic factors on disease pattern. P793
A.O. Adeniran (lagos, NG)
Adherence of patients with chronic heart failure to medicamentous recommendations. P794
T. Murataliev, Y.N. Nekljudova, V.K. Zventsova (Bishkek, KG)
Diuretics and fluid status management
Furosemide-mannitol infusion, another potential diuretic option in hospitalized
patients with heart failure: a retrospective single-center cohort study of 122 patients. P795
M. Turagam, P. Velagapudi, A. Kalra, V. Ramalingam, R. Sinnakirouchenan, J. Holley
(Milwaukee and Urbana, US)
Drug therapy, other
Clinical and hemodynamic effects of using sildenafil in patients with heart failure due
to left ventricular systolic dysfunction. P796
Y.A. Abdel Hady, Y.M. B. Baghdady, M.O. E. Elmokadem (Beni-Suef and Cairo, EG)
Cardiac Safety of Selective Heart Rate Reduction with Ivabradine in Chronic Heart
Failure: Insights from the SHIFT ECG-Holter Sub-study. P797
J. Camm, M. Talajic, M. Komajda, M. Bohm, J.S. Borer, I. Ford, L. Tavazzi, K. Swedberg
On Behalf Of The Shift Investigators (London and Glasgow, GB; Montreal, CA; Paris, FR;
Homburg/Saar, DE; Brooklyn and New York, US; Cotignola, IT; Gothenburg, SE)
Do pulmonary drugs increase mortality in patients with heart failure? Data from a
primary care registry. P798
F.H. Rutten, M.J. Warnier, Y. Van Mourik, L. Bertens, A.W. Hoes (Utrecht, NL)
Amino acids supplementation in patients with heart failure. P799
C. Lombardi, M. Metra, E. Vizzardi, N. Pezzali, C. Maiandi, S. Bugatti, A. D’aloia, S. Nodari,
M. Gheorghiade, L. Dei Cas (Brescia, IT; Chicago, US)
94

MONDAY 23 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Heart failure in rheumatoid arthritis and the effect of biological therapy. P800
V. Tyrenko, A. Koltsov (Saint Petersburg, RU)
Metabolic effects of aliskiren, fosinopril, telmisartan in patients with arterial
hypertension and diastolic dysfunction. P801
O. Rekovets, Y. Sirenko, K. Mikheeva, S. Savitsky, G. Primak, S. Kushnir, A. Vaschylko,
G. Ponomariova (Kiev, UA)
Importance of adherence to therapy in patients with heart failure. P802
E.R. Cosentino, E.R. Rinaldi, D. Degli Esposti, F. Campomori, F. Santi, G. Colombo,
S. Bacchelli, C. Borghi (Bologna, IT)
Effects purine (adenosine) receptors activator on heart rate vari-ability and oxidative
stress in patients with heart failure. P803
I. Knyazkova, A.N. Bilovol, V. Kozlovskiy (Kharkov, UA)
Combined therapy with enalapril and rasilez in nephroprotection of hypertensive patients. P804
V. Tyrenko, V. Kachnov, A. Nikitin, A. Koltsov (Saint Petersburg, RU)
Echocardiography
Right heart function in pulmonary embolism: diagnosis and follow-up with threedimensional
echocardiography and speckle tracking echocardiography. P805
A. Vitarelli, S. D’orazio, L. Capotosto, O. Dettori, G. Continanza, V. De Cicco, M. De Maio,
P. Bruno, M. D’ascanio, L. Alessandroni (Rome, IT)
Isovolumic Myocardial Acceleration, New Index Of Right Ventricular Function After
Percutaneous Mitral Valvuloplasty. P806
E.A. Khalifa, W. El Naggar, Z. Ashour (cairo and Cairo, EG)
Determinants of reduced tricuspid annular plane systolic excursion in patients with
severe systolic left ventricular dysfunction. P807
M. Bieseviciene, E. Ereminiene, J. Vaskelyte, N. Stoskute, A. Kavoliuniene, R. Ordiene,
I. Nedzelskiene (Kaunas, LT)
Ejection fraction of the left atrium and left ventricle global function in patients with
heart failure and left ventricle systolic impairment. A 2D strain study. P808
C.I. Santos De Sousa, M. Satendra, L. Sargento, I. Almeida, M. Teixeira, F. Salazar,
N. Lousada, R. Palma Reis (Lisbon, PT)
Three-dimensional assesment of left ventricular remodelling and ischemia in ischaemic
dilated cardiomyopathy using 3D echocardiography and angio CT multislice 64. P809
T. Benedek, M. Chitu, O. Bucur, I. Kovacs, I.A. Sarbu-Pop, Z. Suciu, B. Jako, I. Benedek Jr,
I.S. Benedek (Targu Mures, RO)
Prognostic value of increased aortic stiffness index in acromegaly - Results from a
4-year follow-up. P810
A. Nemes, E. Csajbok, A. Kalapos, H. Gavaller, T. Wittmann, M. Csanady, T. Forster
(Szeged, HU)
Stroke volume augmentation is related with diastolic functional reserve at volume
loading status by leg elevation. P811
S.J. Kim, S.J. Rhee, C.O. Choi, J.J. Choi, N.J. Yoo, K.H. Yun, N.H. Kim, S.K. Oh, J.W. Jeong,
S.N. Shin (Iksan, KR)
Exercise testing & training
Does cardiopulmonary exercise test still hold prognostic value in the BNP era? P812
L.E. Pastormerlo, C. Passino, C. Mammini, M. Fontana, R. Poletti, G. Mirizzi, G. Nassi,
M. Emdin (Pisa, IT)
95
MONDAY
POSTERS

MONDAY
POSTERS
MONDAY 23 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Heart failure and exercise adherence: a systematic review of controlled studies. P813
S. Tierney, M. Mamas, M.K. Rutter, M. Gibson, L. Neyses, C. Deaton (Manchester, GB)
Acute metabolic effects of endurance training in patients with chronic heart failure are
enhanced by the association of whole body vibration. P814
G. Caminiti, M. Volterrani, F. Iellamo, A. Cerrito, G. Marazzi, A. Franchini, A. Carluccio,
G. Rosano (Rome, IT)
Autonomic imbalance and heart rate reduction during recovery in men with systolic
heart failure. P815
B. Krakowiak, E.A. Jankowska, W. Banasiak, P. Ponikowski (Wroclaw, PL)
Lung function and cardiac rehabilitation program: maximum volume ventilation as
a marker for effort perception and functional capacity? P816
A.S. Correia, A. Rocha, M. Paiva, S.M. Oliveira, A. Lebreiro, I. Rangel, A. Sousa, V. Araujo,
F.P. Pereira, M.J. Maciel (Porto, PT)
Does cardiac rehabilitation improve functional capacity and cardiovascular risk profile
in patients with coronary artery disease and metabolic syndrome? P817
A. Sousa, A. Rocha, C. Sousa, A. Lebreiro, M. Paiva, S. Oliveira, A.S. Correia, V. Araujo,
F. Parada-Pereira, M.J. Maciel (Porto, PT)
Relationship between body mass index and cardiopulmonary exercise test parameters
in patients with chronic heart failure. P818
A. Toste, R. Soares, J. Feliciano, B. Valente, S. Silva, A. Abreu, L. Ferreira, R.C. Ferreira (Lisbon, PT)
Gene and cell therapy
The reverse remodelling effect of bone-marrow-derived stem cells is independent from
the site of epimyocardial cell transplantation. P819
M. Arsalan, J. Garbade, H. Aupperle, S. Dhein, T. Walther, F.W. Mohr (Bad Nauheim and
Leipzig, DE)
Optimization of isolation of bone marrow-derived very small embryonic-like stem cells. P820
H. Xu, Y.J. Yang, H.Y. Qian (Beijing, CN)
Haemodynamics / Coronary and peripheral circulation
Serial troponin-I measurement after elective percutaneous coronary intervention: is it worth? P821
A. Sousa, A. Lebreiro, C. Sousa, I. Rangel, R. Lopes, S. Amorim, E. Martins, M. Campelo,
J.C. Silva, M.J. Maciel (Porto, PT)
Evaluation of effective pulmonary arterial elastance in patients with systolic heart failure. P822
A. Amin, S. Taghavi, M. Esmaelzade, H. Bakhshande, N. Naderi, M. Maleki (Tehran, IR)
Clinical correlates of endothelial function in chronic heart failure. P823
M. Iacoviello, M.M. Ciccone, A. Puzzovivo, P. Scicchitano, V. Caragnano, F. Monitillo,
S. Favale (Bari, IT)
Blood velocity in the distal segment of lad artery in patients with ischemic and dilated
cardiomyopathy. P824
E.N. Pavlyukova, E.V. Trubina, R.S. Karpov (Tomsk and Barnaul, RU)
Heart transplantation / Assist devices
The % BNP change before and after Left Ventricular Assist Device surgery predicts
prognosis. P825
H. Akashi, T. Sugiyama Kato, K. Shahzad, M. Deng, D. Mancini, T. Yamamoto, A. Amano,
H. Takayama, Y. Naka (New York, US; Tokyo, JP)
96

MONDAY 23 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Effect of plasmapheresis for acute antibody-mediated rejection after heart
transplantation. P826
J.L. Vieira, M.S. Avila, S.M. Ayub-Ferreira, V.S. Issa, G.E. Conceicao-Souza, P.R. Chizzola,
G.V. Guimaraes, A.I. Fiorelli, F. Bacal, E.A. Bocchi (Sao Paulo, BR)
Role of implantable cardioverter-defibrillators in patients with left ventricular assist
devices P827
A. Gkouziouta, S. Adamopoulos, A. Manginas, A. Kostopoulou, T.H. Maounis, E. Livanis,
G. Pavlides, V. Voudris (Athens, GR)
Metabolic syndrome and long-term prognostic in heart transplant patients. P828
L. Martinez-Dolz, I.J. Sanchez Lazaro, L. Almenar-Bonet, J.M. Sanchez-Gomez,
M. Portoles, B. Munoz-Giner, E. Rosello-Lleti, R. Cortes, M. Rivera-Otero, A. Salvador-Sanz
(Valencia, ES)
Heart transplantation in patients with pozitive cross-match. P829
I. Malek, L. Voska, L. Hoskova, M. Hegarova, M. Podzimkova, T. Gazdic (Prague, CZ)
Oxidative stress and inflammatory activation in end-stage heart failure do not
ameliorate during early phase (1 month) of left ventricular mechanical assistance. P830
R. Caruso, A. Verde, C. Boroni, J. Campolo, M. Parolini, L. Cozzi, A. Corno, M. Frigerio,
O. Parodi (Milan, IT)
Early clinical experience with the minimally invasive HeartWare ventricular assist system
in the only transplant centre in Greece. P831
A. Gouziouta, L. Louca, S. Adamopoulos, A. Manginas, E. Leontiades, L. Tsourelis,
G. Pavlides, P. Sfirakis, V. Voudris (Athens, GR)
Hypertension / LV hypertrophy
Low systolic blood pressure at admission predicts long-term mortality in heart failure
with preserved ejection fraction. P832
D. Rusinaru, O. Buiciuc, F. Levy, M. Peltier, M. Slama, L. Leborgne, C. Tribouilloy (Amiens, FR)
High-sensitivity cTnT in essential hypertension. P833
T. Sawa, Y. Sato, S. Koyama, M. Kawashima, E. Yamamoto, Y. Tanada, R. Taniguchi,
T. Miyamoto, H. Fujiwara, Y. Takatsu (Amagasaki, JP)
The enduring association of plasma renin activity to cardiovascular and all-cause
mortality. P834
M.C. Gonzalez, H.W. Cohen, J.E. Sealey-Laragh, J.H. Laragh, M.H. Alderman (New York, US)
NT-proBNP and left ventricular mass are independent predictors of diastolic
dysfunction in patients with essential hypertension. P835
M. Rivera, R. Cortes, A. Salvador, J.L. Perez Bosca, J.R. Gonzalez Juanatey, P. Orosa,
A. Jordan, P. Morillas, M. Portoles, V. Bertomeu (Valencia, Santiago de Compostela, Gandia
and Alicante, ES)
Left ventricular function
Effect of thyroid function normalization on clinical, haemodinamic and neurohormonal
statement in patients with congestive heart failure and subclinical hypothyroidism. P836
Z. Blankova, E. Seredenina, B. Koulev, J. Zhitnyaya, O. Svirida, E. Zhoubrina, O. Ryabceva,
F. Ageev (Moscow, RU)
Left ventricular function after long term apical pacing in a group of patients with sick
sinus syndrome. P837
E. Belu, R. Musetescu, R. Mustafa, D.-D. Ionescu, M. Cosulschi, N. Florescu, C. Bataiosu
(Craiova, RO)
97
MONDAY
POSTERS

MONDAY
POSTERS
MONDAY 23 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Left ventricular diastolic dysfuntion in pre-diabetic and diabetic outpatient population. P838
L.C. Danzmann, M.R. Pontes, C.F. Saldanha, L.H. Canani (Porto Alegre, BR)
Predictors of left ventricular dysfunction after acute myocardial infarction treated by
primary coronary angioplasty. P839
J. Abroug, S. Hamdi, M. Mosrati, H. Hriz, T. Trimech, L. Chaker, K. Ben Hamda,
F. Maatouk (Monastir, TN)
Metabolism / Diabetes mellitus
A low glycemic and insulinemic diet improves cardiac function and metabolic syndrome
more than the traditional low-fat diet in overweight patients with type 2 diabetes. P319
H. Von Bibra, G. Wulf, T. Schuster, A. Pfuetzner, P. Heilmeyer (Munich, Isny and Mainz, DE)
Distribution of QTc interval and QT dispersion in disglycemic patients and theirs
correlation with diabetic damage markers. P840
C.F. Saldanha, L.C. Danzmann, M.R.N. Pontes, L.H.S. Canani (Porto Alegre, BR)
Relation between NTproBNP and metabolic/inflammatory parameters in patients with
acute myocardial infarction treated with primary PCI. P841
D. Trifunovic, S. Stankovic, M. Ostojic, B. Vujisic-Tesic, M. Petrovic, I. Nedeljkovic,
M. Banovic, M. Boricic, G. Draganic, M. Tesic (Belgrade, RS)
Ischemia / Reperfusion / Preconditioning
Predictive value of b-type natriuretic peptide in patients with non-ST-elevation acute
coronary syndromes. P842
P. Sousa, N. Marques, W. Santos, J. Mimoso, S. Pereira, I. Jesus (Faro, PT)
The prognostic significance of combined left ventricular systolic dysfunction and
chronic kidney disease in patients treated with primary percutaneous coronary
intervention. P843
L. Savic, I. Mrdovic, G. Krljanac, J. Perunicic, R. Lasica, M. Asanin, M. Matic, Z. Vasiljevic,
M. Ostojic (Belgrade, RS)
Title: Role of tirofiban in acute ST-elevation myocardial infarction in combination with
reduced dose of streptokinase. P844
A. Alradhi, D.R. Eletribi, D.R. Gomah (Sanaa, YE; Cairo, EG)
Molecular biology / Genetics
Glycogen synthase kinase-3 interacts with and phosphorylates IKKgamma/NEMO and
is involved in the regulation of NF-kappaB activity. P845
S. Medunjanin, W. Zuschratter, A. Schmeisser, C. Fiegehenn, V. Thonn, S. Weinert,
J. Herold, R. Braun-Dullaeus (Magdeburg, DE)
Nitric oxide induces differentiation of murine embryonic stem cells to cardiomyocytes. P846
A.S. Walravens, S. Vandenwijngeart, P. Pokreisz, H. Gillijns, K.D. Bloch, J.U. Voight,
S. Janssens (Leuven, BE; Boston, US)
Eya4/Six1, a signalling cascade crucial in acquired heart disease. P847
T. Williams, J. Schoenberger, M. Hundertmark, M. Czolbe, F. Panther, O. Ritter (Wurzburg, DE)
Hypelipidemia combined with hyperglycemia induces altered endothelial cell senescence. P848
E.V. Shlyakhto, I.A. Meln, P.A. Butylin, O.A. Freilikhman, D.A. Zhebrun, A.A. Kostareva,
S.V. Anisimov, A.Y. Zaritskey (St Petersburg, RU)
98

MONDAY 23 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
MRI, nuclear cardiology and CT (imaging)
Measurement of trabeculated left ventricular mass using cardiac magnetic resonance
imaging: a new diagnostic criteria for left ventricular non-compaction? P849
O. Sousa, N. Bettencourt, R. Fontes-Carvalho, N. Dias Ferreira, G. Silva, E. Pereira,
D. Caeiro, J. Ribeiro, C. Fonseca, V. Gama (Vila Nova de Gaia, PT)
PET with [11C]PIB and [11C]acetate is able to diagnose myocardial amyloidosis without
invasive approach. P850
O. Vedin, G. Antoni, K. Carlsson, S. Estrada, B. Langstrom, S. Rosengren, J. Sorensen,
P. Westermark, G. Wikstrom (Uppsala, SE)
Effects of PCI on the clinical status and physical capacity in patients with systolic and
diastolic heart failure. P851
N. Shashkova, Y.U. Osmolovskaya, M. Nepoklonov, A. Skvortsov, L. Samoylenko,
S. Tereshenko, V. Sergienko (Moscow, RU)
Natriuretic peptides
Induction of biomarkers in a thrombus-induced model of congestive heart failure. P852
S. Parthasarathy, A.N. Chandrakala, P. Kwiatkowski, C. Sai-Sudhakar, B. Sun (Columbus, US)
Predictors of progression in diastolic dysfunction in an at risk population. P853
P. Collier, D.F. Waterhouse, I.R. Dawkins, A.K. Patel, C.J. Watson, S. Horgan, J.A. Baugh,
R. O’ Hanlon, M.T. Ledwidge, K.M. Mc Donald (Dublin, IE)
Relation between coronary flow velocity and lesion complexity on N-terminal proBNP
level dynamics in patients with acute coronary syndromes treated with primary
percutaneous intervention. P854
M. Stachura, P.J. Kwasiborski, G.J. Horszczaruk, E. Komar, A. Cwetsch (Warsaw, PL)
The role of B-type natriuretic peptide with peak exercise and symptom reproduction
in determining heart failure diagnosis in a new diagnostic heart failure clinic - initial
experience analysis. P855
K.J. Voon, G. Murtagh, M. Badabhagni, A. Patle, M.T. Ledwidge, R. O’ Hanlon,
K.M. Mc Donald (Dublin, IE)
Nursing
Effects of an integrated educational and psychosocial intervention in patient-partner
dyads affected by chronic heart failure. P856
K. Arestedt, S. Agren, A. Stromberg (Kalmar and Linkoping, SE)
Impact of cardiac resynchronization therapy on the quality of life of patients with heart
failure. P857
M. Albernaz, N. Cortez-Dias, C. Bogalho, C. Coelho, P. Martins, S. Sobral, M. Valente,
D. Silva, J. Sousa, A. Nunes Diogo (Lisbon, PT)
Self-assessed needs of education and support in patient-partner dyads affected by
heart failure. P858
M. Liljeroos, S. Agren, T. Jaarsma, A. Stromberg (Linkoping, SE)
Other
Pro-thrombotic and pro-inflamatory factors in advanced chagas cardiomyopathy in
comparison to systolic heart failure of other etiologies. P859
G.E. Souza, L.M. Pessoa De Melo, G.E. Conceicao-Souza, E.A. D Amico, C.M.C. Strunz,
A.C.P. Barretto, E.A. Bocchi, J.A.F. Ramires (Sao Paulo, BR)
99
MONDAY
POSTERS

MONDAY
POSTERS
MONDAY 23 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Duke Activity Status Index is correlated with subpulmonary ventricular function in
patients with congenital heart disease. P860
A. Frogoudaki, C. Andreou, J. Parissis, M. Nikolaou, V. Bistola, H. Triantafyllidi,
J. Paraskevaidis, J. Rizos, G. Filippatos, M. Anastasiou-Nana (Athens, GR)
High Geneva score: a new independent predictor of adverse prognosis in pulmonary
embolism. P861
L.V. Paiva, R. Providencia, S. Barra, P. Gomes, C. Faustino, A. Leitao-Marques (Coimbra, PT)
Prevalence of renal dysfunction and its influence on functional capacity in elderly
patients with stable chronic heart failure. P862
S. Apostolovic, D. Stanojevic, R. Jankovic Tomasevic, M. Pavlovic, I. Stojanovic, S. Salinger
Martinovic, D. Djordjevic Radojkovic, D. Kutlesic Kurtovic, G. Koracevic, I. Ilic (Nis, RS)
Heart failure with preserved ejection fraction. P863
S. Mettini, I. Villanueva, L. Latronico, A. Bunay, M. Urdapilleta, F. Pianciola, A. Zambrano,
N. Gambazza, R. Tuda, J.J. Herrera Paz (Buenos Aires, AR)
Short-term reproducibility of heart rate turbulence parameters in chronic heart failure. P864
A. Fernandez-Fernandez, S. Manzano Fernandez, F.J. Pastor-Perez, O. Barquero-Perez,
R. Goya-Esteban, D.A. Pascual-Figal, J.L. Rojo-Alvarez, M.D. Martinez Martinez-Espejo,
M. Valdes, A. Garcia-Alberola (Murcia and Madrid, ES)
Congnitive-behavioral therapy for patients with heart failure. P865
M. Yari (Torbat Jaam, IR)
Pathophysiology
Tissue characterization by integrated backscatter and its relationship with longitudinal
deformation and diastolic filling properties in heart failure with normal ejection fraction. P866
E. Carluccio, P. Biagioli, G. Alunni, A. Murrone, E. Biscottini, C. Zuchi, B. Guarascio, E. Rossi,
G. Ambrosio (Perugia, IT)
The relationship between uric acid, oxidativ stress and inflamation in chronic heart failure. P867
A. Campeanu, A. Iliesiu, D. Dusceac, E. Moldoveanu, G. Uscoiu, B. Strajean, D. Marta
(Bucharest, RO)
Population studies / Epidemiology
In-hospital and one-year mortality of AHF: The OFICA study. P868
D. Logeart, P. Degroote, R. Isnard, J.J. Dujardin, M.F. Seronde, E. Donal, M. Galinier,
P. Jourdain, G. Jondeau, J.N. Trochu (Paris, Lille, Douai, Besancon, Rennes, Toulouse,
Pontoise and Nantes, FR)
Future hospital admissions of patients with cardiovascular diseases as result of
demographic changes in germany. P869
J. Biermann, A. Neumann, A. Goehler, G. Goerge, A. Hewer, M.G. Gottwik, F. De Haan,
J. Wasem, S.N. Willich, T. Neumann (Essen, Saarbruecken, Berlin, Duesseldorf and
Munich, DE; Boston, US)
Differences in the management of patients with heart failure in university and nonuniversity
hospitals in Berlin: the TOP40 (therapy outcome and prevention) pilot-registry. P870
V. Tscholl, H.D. Duengen, G. Gelbrich, S. Inkrot, E. Tahirovic, A. Mielke, I. Siegel,
R. Berthel, J. Eberhard, R. Stern (Berlin and Leipzig, DE)
Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD:
impact on clinical outcome. A 6-month follow-up study. P871
L. San Vicente, N. Galofre, J. Oriol, S. Fernandez, J.A. Gonzalez-Ares, E. Kaplinsky,
E. Galvez, L. Ortega, M. Altimira, G. Beltran (Badalona, ES)
100

MONDAY 23 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Congestive heart failure and systolic dysfunction: predictors of low cardiac output
syndrome at admission in emergency room. P872
M.L. Talavera, M.D. Diez, L.F. Favaloro, M.P. Peradejordis, R.R. Ratto, C.H. Huerta,
R.F. Favaloro (Buenos Aires, AR)
Prognosis (other)
Hypo- and hyperglycaemia predict adverse outcomes in patients with heart failure
after acute myocardial infarction: Data from EPHESUS. P873
C. Ukena, D. Dobre, F. Mahfoud, Z. Lamiral, S. Tala, P. Rossignol, B. Pitt, F. Zannad,
M. Bohm (Homburg, DE; Vandœuvre-lès-Nancy, FR; Ann Arbor, US)
Hyperuricemia in heart failure: Associated with increased E/A ratio and predictor of
increased risk for adverse outcome. P874
I. Gotsman, D. Zwas, D. Admon, C. Lotan, A. Keren (Jerusalem, IL)
Right ventricular end systolic pressure as a predictor of outcome after acute myocardial
ST- elevation infarction. P875
C. Hohmann, M. Bock, T. Rauwolf, K. Haacke, S. Katzke, R.H. Strasser (Dresden, DE)
Beck depression score as the predictor of 12 months survival in chronic heart failure P876
L. Voronkov, O. Lutsak, P. Babich (Kyiv, UA)
Does a high Boston score predict early mortality following liver transplantation,
a retrospective hospital cohort study. P877
A. Josefsson, M. Fu, E. Bjornsson, M. Castedal, M. Olausson, E. Kalaitzakis
(Gothenburg, SE; Reykjavik, IS)
Clinical outcomes and predictors of late mortality after transcatheter aortic valve
implantation of severe symptomatic aortic stenosis with the CoreValve prosthesis. P878
A.J. Munoz Garcia, A.J. Dominguez Franco, M.J. Molina Mora, M.F. Jimenez Navarro,
J.H. Alonso Briales, M. Such Martinez, P. Hernandez, I. Rodriguez Bailon, J.M. Hernandez
Garcia, E. De Teresa Galvan (Malaga, ES)
Manchester triage system in acute pulmonary embolism - can it unmask the great simulator? P879
L.V. Paiva, R. Providencia, C. Faustino, L. Seca, S. Barra, A. Botelho, A. Leitao-Marques (Coimbra, PT)
Hyponatremia as bad prognostic factor in elderly patients with congestive heart failure. P880
T. Burkard, O. Pfister, L. Joerg, M. Studer, M. Peter, D. Hack, D. Studer, M. Neuhaus,
M. Pfisterer, H.P. Brunner-La Rocca (Basel, Lucerne, Wolhusen, St. Gallen and Baden, CH;
Maastricht, NL)
Abnormalities in spirometry (PFT) name chronic heart failure (CHF) patients with a
higher risk of death than a cardiopulmonary exercise test (CPET) result suggests. P881
M.K. Lizak, M. Zakliczynski, A. Jarosz, M. Zembala, Z. Kalarus (Zabrze, PL)
Prognostic impact of variability of heart rhythm in Patients with Chronic Heart Failure. P882
N.A. Kosheleva, A.P. Rebrov (Saratov, RU)
Influence of reduced left ventricle ejection fraction and microalbuminuria on 6-month
prognosis after acute myocardial infarction. P883
S. Apostolovic, D. Stanojevic, R. Jankovic Tomasevic, V. Djordjevic, M. Pavlovic,
I. Stojanovic, S. Salinger Martinovic, G. Koracevic, D. Kutlesic Kurtovic, I. Ilic (Nis, RS)
Determinants of poor left ventricular function in patients with acute myocardial
infarction referred for primary percutaneous coronary intervention. P884
I. Nedeljkovic, M. Ostojic, B. Vujisic-Tesic, M. Petrovic, D. Trifunovic, B. Jakovljevic,
M. Banovic, A. Djordjevic-Dikic, J. Stepanovic, B. Beleslin (Belgrade, RS)
101
MONDAY
POSTERS

MONDAY
POSTERS
MONDAY 23 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Effect of outpatient care on the survival of acute myocardial infarction patients with
left ventricular systolic dysfunction. P885
B. Szabo, M. Dekany, N. Nyolczas, B. Ancsin, E. Marosi, T. Borsanyi, B. Muk, Z.S. Puspoki,
R.G. Kiss (Budapest, HU)
Prognosis (using biomarkers)
Quality of life and mortality in patients with suspected heart failure. P886
J. Zhang, J. Hobkirk, S. Carroll, A. Torabi, K.M. Goode, A.L. Clark, J.G.F. Cleland (Hull, GB)
Low serum apolipoprotein AI and high plasma NT-proBNP predict poor outcome in
diabetic patients with coronary artery disease, irrespectively of coexisting heart failure. P887
S. Powierza, B. Ponikowska, L. Borodulin-Nadzieja, W. Banasiak, E.A. Jankowska,
P. Ponikowski (Wroclaw, PL)
Use of an extracellular matrix metabolism marker may identify a sub-group of postmyocardial
infarction patients with preserved left ventricular systolic function that may
benefit from eplerenone. P888
N. Kampouridis, D.N. Tziakas, G. Chalikias, D. Papazoglou, D. Stakos, S. Apostolakis,
A. Thomaidi, S. Konstantinides (Kavala and Alexandroupolis, GR)
Copeptin is an independent predictor of mortality in systolic heart failure. P889
J. Silva Marques, D. Silva, C. David, S. Robalo Martins, A.G. Almeida, H. Luz Rodrigues,
A. Nunes Diogo (Lisbon, PT)
Body mass index and NT-pro-BNP level inluence on the prognosis in heart failure. P890
E. Nikolaychuk, N.A. Dykman, E.A. Bazhenova, O.A. Berkovich (St Petersburg, RU)
Role of interleukin-12 in assessing st elevation myocardial infarction severity and
prognosing its complications within 12-month follow-up. P891
M.V.Z. Zykov, V.V.K. Kashtalap, K.S.S. Shafranskaya, O.L.B. Barbarash (Kemerovo, RU)
High cardiac troponin I concentrations are associated with worse outcome in stable
heart failure patients. P892
A. Navarro-Navarro, L. Castillo-Martinez, J.I. A. Orea-Tejeda, O. Carrasco-Ortiz,
R. Sanchez-Santillan, G. Sanchez-Vidal, J. Pineda-Juarez, M. Vazquez-Duran,
A. Gutierrez-Rodriguez, E. Gaspariano-Flores (Mexico, MX)
Prognostic value of high sensitivity troponin T serum levels in ambulatory patients with
heart failure. P893
M. De Antonio, J. Lupon, A. Galan, A. Urrutia, L. Cano, B. Gonzalez, R. Cabanes,
S. Altimir, R. Coll, A. Bayes-Genis (Badalona, ES)
Pulmonary hypertension
Prognostic value of heart failure hospitalization in pulmonary hypertension. P894
M.L. Talavera, L.F. Favaloro, M.D. Diez, M.P. Peradejordis, C.H. Huerta, R.F. Favaloro
(Buenos Aires, AR)
Importance of challenging right side ventriculo-arterial interactions in advanced heart
failure patients. P895
N. Piriou, F. Valleix, J. Roy-Giocosa, F. Floch, J.P. Gueffet, J.N. Trochu (Nantes, FR)
Widening of coronary sinus in CT pulmonary angiography indicates right ventricular
dysfunction in patients with acute pulmonary embolism. P896
B. Rodrigues, H. Correia, L.F. Santos, E. Correia, D. Moreira, A. Figueiredo, J. Pipa,
I. Beirao, O. Santos (Viseu, PT)
102

MONDAY 23 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Clinical and hemodynamic picture of Eisenmenger syndrome patients followed-up
with a multidisiplinary approach in a tertiary referral center at the time of first admission. P897
H. Gungor, S. Ertugay, M.F. Ayik, E. Demir, C. Engin, T. Yagdi, M. Ozbaran, Y. Atay,
S. Nalbantgil (Izmir, TR)
Renin-angiotensin-aldosterone antagonists
Assessment of the effect of perindopril, telmisartan and combination of both on
endothelial dysfunction, oxidative stress in patients with congestive heart failure
and diabetes mellitus type 2. P898
E.V. Privalova, I. Chekneva, J.A. Danilogorskaya, E.A. Zheleznykh, U.N. Belenkov (Moscow, RU)
Pathophysiological mechanisms involved in the evolution of hemoglobin in patients
with heart failure. P899
A. Martinez-Ruiz, P.L. Tornel-Osorio, J. Sanchez-Mas, A. Lax, N. Sancho-Rodriguez,
F. Pastor-Perez, I.P. Garrido-Bravo, M.T. Perez-Martinez, P. Martinez-Hernandez,
D.A. Pascual-Figal (Murcia, ES)
The preoperative estimation of glomerular filtration rate as a predictor of patients’
outcome after coronary artery bypass grafting. P900
A. Ledakowicz-Polak, S. Jander, R. Jaszewski, M. Zielinska (Lodz, PL)
Percutaneous mitral commissurotomy. P901
F. Wadrahmane, S. Hajib, K. Benjelloun (Casablanca, MA)
Long waiting a cardiosurgery of patients with heat failure and heart valves diseases. P902
E. Averin, Y. Lopatin (Volgograd, RU)
Efficacy of combination therapy of spironolactone and telmisartan in diabetes induced
cardiovascular complications. P903
B.R. Goyal, R.K. Goyal, A.A. Mehta (Ahmedabad and Vadodara, IN)
Vascular biology, other
Endothelial function in children suffering with sleep respiratory disorders. P904
L. Brunetti, M.M. Ciccone, V. Miniello, F. Fornarelli, F. Monitillo, G. Ricci, S. Carbonara,
M. Gesualdo, M. Iacoviello (Bari, IT)
Microvascular effects of myeloperoxidase. P905
V. Csato, E.T. Pasztor, A. Toth, Z. Papp (Debrecen, HU)
Increase in free radical production mediated by xantine oxidase and oxidative lipid
and protein damage in heart failure patients: relation between oxidant stress and
endothelial dysfunction. P906
S. Radovanovic, B. Todic, R. Pokrajac, S. Hinic, S. Banicevic, N. Ninkovic, J. Saric,
M. Zdravkovic, A. Djokovic, M. Krotin (Belgrade, RS)
Poster Presenters can request their Poster Presentation Certificate
at the Poster Assistance Desk
103
MONDAY
POSTERS

MONDAY
POSTERS
MONDAY 23 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Moderated Posters Moderated Poster Area
Moderated Posters Session 4
Chairpersons: J. Drozdz (Lodz, PL); A. Stromberg (Linkoping, SE)
Posters must be set up between 13:30 and 14:00 and removed between 18:00 and 18:30
These abstracts were chosen for their outstanding quality and will be presented during the
Moderated Poster Session between 15:45 and 16:30
High prevalence of undiagnosed cardiac dysfunction in the oldest old: findings
from the NEWCASTLE 85+ STUDY. P907
F. Yousaf, J. Collerton, A. Kenny, A. Kingston, T. Kirkwood, B. Keavney
(Newcastle upon Tyne, GB)
Changes in symptom and quality-of-life assessments correlate strongly and
consistently with changes in functional capacity in patients with heart failure. P908
T.J. Cooper, K. Dickstein, N. Hasselberg, J. Comin-Colet, G. Filippatos,
M. Lainscak, T.F. Luscher, P. Ponikowski, R. Willenheimer, S. Anker (Stavanger, NO;
Barcelona, ES; Athens, GR; Golnik, SI; Zurich, CH; Wroclaw, PL; Malmo, SE; Berlin, DE)
Guideline adjusted telemonitoring improves mortality and morbidity of
patients with chronic heart disease: a specific approach for underserved regions. P909
F. Zucca, C. Novakovic, Y. Haver, W. Ricken, H. Palisch, K. Pethig, M. Rauchhaus
(Dusseldorf, Krefeld, Bad Nauheim, Dresden, Hamm and Berlin, DE)
Indicators of efficacy of a home based telesurveillance program (PTS) in
chronic heart failure: the experience of the lombardy region with new health care
networks. P910
A. Giordano, S. Scalvini, M. Marzegalli, V. Antonazzo, G. Borghi, S. Baraldo,
M. Frigerio, S. Lombroso, C. Tridico (Lumezzane, Milan and Busto Arsizio (Varese, IT)
Depressive symptoms and inflammation in patients hospitalised for heart failure P911
P. Johansson, G.A.T. Lesman - Leegte, E. Svensson, A.A.:. Voors,
D.J. Van Veldhuisen, T. Jaarsma (Linkoping, SE; Groningen, NL)
Treatment strategy in patients with non-valvular atrial fibrillation and
congestive heart failure. P912
V.B. Barauskiene Vilija, J.J. Janenaite Jurate, J.L. Laukaitiene Jolanta (Kaunas, LT)
Accuracy of non invasive methods to diagnose chronic myocarditis in patients
with dilated cardiomyophaty. P913
M.W. Montera, E.E. Silva, C. Takiya, A.C. Oliveira, C.E. Rochitte, E.T. Mesquita
(Rio de Janeiro, BR)
Comprehensive assessment of endomyocardial biopsy specimens in patiens
with recent-onset dilated cardiomyopathy. P914
M. Kubanek, J. Maluskova, D. Hulinska, M. Sramko, I. Malek, J. Kautzner (Prague, CZ)
Differences in clinical manifestation of two types of stress-related left ventricular
dysfunction: neurogenic stress cardiomyopathy and Tako-tsubo cardiomyopathy. P915
R. Agladze, Z. Pagava, R. Shakarishvili, N. Sharashidze, L. Gujejiani, I. Bochorishvili,
N. Jakhutashvili (Tbilisi, GE)
Role of left ventricular systolic function evaluated by 2-dimensional strain in
predicting heart failure worsening. P916
M. Iacoviello, R. Catanzaro, A. Puzzovivo, F. Monitillo, S. Lattarulo, D. Saulle,
V. Marangelli, C. Forleo, S. Favale (Bari, IT)
104

MONDAY 23 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Poster Session 4
Posters must be set up between 13:30 - 14:00, removed between 18:00 - 18:30, to be on display
between 14:00 - 18:00.
The presenter should be present by the poster during the coffee break (15:45 to 16:30) in order to
discuss the poster.
Acute heart failure (diagnosis, pathophysiology, other)
Prognostic role of cardiac index in patients with acute heart failure: an analysis from
the ESCAPE trial. P917
C. Lombardi, M. Fiuzat, L. Swan, C. O’connor, J. Rogers (Brescia, IT; Durham, US)
Patterns of acute heart failure in nonagenarians. P918
H. Dossi, F. Tournoux, D. Logeart, F. Beauvais, A. Cohen-Solal (Paris, FR)
Heart failure readmission rates to a regional university health sciences center
1992-2006: clinical variables and risk of readmission. P919
J.M.O. Arnold, G.E. Marchiori, L.W. Stitt (London, CA)
The association of Chagas disease and elevation of troponin t levels predicts poor
outcome in patients with acute decompensated heart failure compared with other
dilated cardiomyopathies. P920
M.C. Moreira, M.D.C. Oliveira (Belo Horizonte, BR)
Right bundle branch block is a prognostic marker for cardiovascular events in patients
hospitalized with acute heart failure: Data from KorHFR (Korean acute Heart Failure
Registry). P921
J. Oh, S.M. Kang, H. Won, N. Hong, S.Y. Kim, S. Park, Y. Jang, N. Chung (Seoul, KR)
Noninvasive simultaneous measurement of both systemic vascular resistance and cardiac
power would provide optimal drug selection in acute decompensated heart failure. P922
K. Hashimura, M. Watanabe, T.S. Kato, Y. Yasumura, M. Kitakaze (Yao, Osaka,JP;
Melbourne, AU; New York, US)
Gender differences in cholesterol levels in patients with acute heart failure. P923
L. Spinarova, J. Spinar, J. Vitovec, A. Linhart, P. Widimsky, J. Parenica, D. Tomcikova,
L. Dusek, K. Zidova, J. Jarkovsky (Brno and Prague, CZ)
Troponin level and outcome in acute heart failure. P924
V.P. Chioncel, C.L. Andrei, A.I. Popa, D. Mincu, R.M. Ianula, M. Anastasiu, M. Dasoveanu,
A.N. Mischie, F.C. Adam, C.J. Sinescu (Bucharest, RO)
Stress-induced cardiomyopathy in Sweden - evidence for different ethnic predisposition
and altered sympathetic nervous system function. P925
E. Omerovic, T. Schultz, Y. Bergmann Sverrisdottir, T. Ramunddal, P. Albertsson,
G. Matejka (Gothenburg, SE)
Experimental no-reflow-infarction by coronary microembolisation causes peracute
diastolic heart failure in pigs. P926
M. Schwarzl, P. Steendijk, S. Huber, H. Maechler, M. Truschnig-Wilders, B. Pieske, H. Post
(Graz, AT; Leiden, NL)
Acute heart failure (therapy)
The induction of mild hypothermia improves systemic oxygen supply-demand-balance
during acute ischemic heart failure in pigs. P927
M. Schwarzl, P. Steendijk, S. Huber, H. Maechler, M. Truschnig-Wilders, B. Pieske, H. Post
(Graz, AT; Leiden, NL)
105
MONDAY
POSTERS

MONDAY
POSTERS
MONDAY 23 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Effects of statin therapy according to plama antigen carbohydrate 125 following an
admission for acute heart failure. P928
P. Palau Sampio, J. Nunez, G. Minana, J. Sanchis, V. Bodi, C. Bonanad, M. Olivares,
E. Nunez, F.J. Chorro, A. Llacer (Valencia, ES)
The efficacy of tolvaptan depends on eGFR in acute heart failure patients-QUEST
substudy. P929
M. Fukunami, M. Matsuzaki, M. Hori, T. Izumi (Osaka, Ube and Sagamihara, JP)
Importance lung impedance-guided treatment of the patients with acute myocardial
infarction for preventing acute heart failure and reducing long-term mortality. P930
M. Shochat, A. Shotan, M. Kazatsker, V. Gurovich, Y. Levy, A. Asif, D. Blondhaim,
P. Rabinovich, L. Vasilenko, S. Meisel (Hadera and Tel Aviv, IL)
Animal models and experimentation
Sex- and age -based differences in cardiac tolerance to ischemia-reperfusion injury. P931
M. Foadoddini, M. Bliksoen, G. Valen (Birjand, IR; Oslo, NO)
Angiotensin II-induced diastolic dysfunction with preserved ejection in conscious pigs:
is there any evidence for systolic alteration? P932
M. Rienzo, D. Pongas, A. Bize, H. Chan, L. Sambin, L. Hittinger, A. Berdeaux, B. Ghaleh
(Creteil, FR)
TNF-alpha contributes to the increased activation of brain angiotensin AT-1 receptors
in rats with the post-infact heart failure. P933
T. Zera, M. Ufnal, E. Szczepanska-Sadowska (Warsaw, PL)
A mock circulatory system to assess the performance of continuous flow left-ventricular
assist devices: Does axial flow unload better than centrifugal LVAD? P934
T. Senage, J.C. Roussel, O. Baron, D. Duveau, S. Tsui (Nantes, FR; Cambridge, GB)
Arrhythmias and treatment
The correlation between the late potentials on Holter ECG monitoring and the occurence
of severe ventricular arrhythmias in an unselected population with heart failure. P935
G. Gheorghe, A. Cristea, I.T. Nanea, A. Hodorogea, S. Almarichi, M. Nanea (Bucharest, RO)
Anti-arrhythmic effects of very low density lipoproteins. P936
Y. Shao, J.A.N. Boren, E.L.M.I.R. Omerovic, A.Z.R.A. Mijatovic (Gothenburg, SE)
Assessment of dyssynchrony in patients with selective septum pacing: 2 year results. P937
A.E. Komlev, O.V. Sapelnikov, M.A. Saidova, V.N. Shitov, R.S. Latypov, R.S. Akchurin
(Moscow, RU)
Atrial fibrillation
Left atrium and left atrial appendage deformation in patients with AF: Role and
meaning in heart failure patients. P938
R.A. Providencia, A. Botelho, J. Trigo, A. Faustino, F. Caetano, J. Nascimento, N. Quintal,
A.M. Leitao-Marques (Coimbra, PT)
Estimation of diastolic functions and global contractility of left ventricle at patients with
atrial fibrillation. P939
B.Z. Jalolov (Tashkent, UZ)
Association between inflammation markers, recurrence of atrial fibrillation after
successful cardioversion and outcome of advanced heart failure. P940
S. Grigoryan, K.G. Adamyan, L.G. Hazarapetyan, A.A. Stepanyan (Yerevan, AM)
106

MONDAY 23 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
The parameters, those define deduction of sinus rhythm during one year after
electrical cardioversion. P941
T. Motylevska, V.I. Tseluyko, Z.S. Vashakidze (Kharkiv, UA)
Beta blockers
Bisoprolol effect on the right ventricular function in chronic heart failure. P942
M.R. Kongo, A. Salih, N. Jardi, F. Belmourida, L. Azzouzi, A. Bennis (Casablanca, MA)
The impact of the rapid use of beta blockers on ventricular mortality and remodeling
in and-stage heart failure. P943
D.S.B. Melo, A.C.P. Barretto, A.I. Oliveira, A.H. Uchida, M.E. Ochiai, J.N. Cardoso,
P.C. Morgado, J.A.F. Ramires (Sao Paulo, BR)
Are BNP and collagen peptide predicting the presence of LV remodeling in patients
with newly developed hypertension? P944
B.S. Yoo, J.W. Lee, J.Y. Kim, M.S. Ahn, S.H. Lee, K.H. Choe (Wonju, KR)
Assessment of the use of beta-receptor antagonists among patients followed at
a heart failure outpatient clinic. P945
B. Muk, M. Dekany, N. Nyolczas, B. Szabo, B. Ancsin, B. Polgar, T. Borsanyi, R.G. Kiss
(Budapest, HU)
Intervention plan to improve prescription and dosage of betablockers in heart failure
patients with heart rate more than 70 bpm. P946
G. Russo, A. Cherubini, G. Faganello, L. Massa, M. Merlo, M. Dal Ferro, A. Di Chiara,
M. Bonin, G. Sinagra, A. Di Lenarda (Trieste and Tolmezzo, IT)
Cardiac resynchronisation therapy
Gender differences in utilization of Cardiac Resynchronization Therapy with Defibrillator. P947
M. Liu, G. Lin, D. Hodge, P.A. Friedman, Y.-M. Cha, S.J. Asirvatham, R. Rea, P. Brady
(Rochester, US)
Echocardiographic evaluation of right ventricular dysfunction in patients undergoing
cardiac resynchronization therapy. P948
S. Salinger, Z. Perisic, T. Kostic, M. Pavlovic, T. Stanojlovic, S. Apostolovic, N. Krstic,
M. Zivkovic, N. Bozinovic, D. Stanojevic (Nis, RS)
Dosing of angiotensin converting enzyme inhibitors and angiotensin receptor blockers
in patients receiving cardiac resynchronization therapy and its impact on long term
outcomes. P949
A. Mantziari, K. Guha, R. Sharma (London, GB)
Echocardiographic optimization of peak LVOT velocity using sequential VV and AV
pacing significantly improves dyssynchrony and functional response to CRT at sixmonth
follow-up. P950
M.J. Daly, R. Doherty, K. Ashfield, R. Kirkpatrick, B. Smith, J. Buchanan, L. Hill, L.J. Dixon
(Belfast, GB)
Effects of cardiac resynchronization therapy on left ventricular contraction
performance as quantified by echo color kinesis. P951
C. Lu, F. Lu, V. Di Bello, M. Marzilli, A. Balbarini (Pisa, IT)
Institutional review of cardiac resynchronization therapy utilization in peripartum
cardiomyopathy. P952
S. Emani, C. O’keefe, N.A. Patel, A.K. Hasan (Columbus, US)
107
MONDAY
POSTERS

MONDAY
POSTERS
MONDAY 23 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Cardiomyopathy
Surgical treatment of HOCM in patients with severe hypertrophy and septal
myocardial fibrosis. P953
K.V. Borisov (Moscow, RU)
Left ventricle shape and trabeculations in idiopathic dilated cardiomyopathy assessed
by cardiac magnetic resonance imaging. P954
P. Marchal, O. Lairez, M. Galinier, J. Roncalli, M. Elbaz, H. Rousseau, P. Barrier,
M.A. Marachet, V. Chabbert, D. Carrie (Toulouse, FR)
Are there any differences between diabetics and non diabetics in chronic Heart Failure? P955
M.K. Benjelloun, H. Salih, S. Laraibi, S. Hellab, A. Bennis (Casablanca, MA)
Clinical predictors of DCM recovery. P956
A. Rieth, J. Sperzel, C. Liebetrau, A. Rolf, V. Mitrovic, C.W. Hamm (Bad Nauheim, DE)
Combination of immune and myocardial structural markers can help in detection
of hypertrohic cardiomyopathy. P957
R. Pudil, M. Tichy, M. Vasatova, J. Vojacek (Hradec Kralove, CZ)
Body temperature circadian rhythm variability in dilated cardiomyopathic hamsters. P958
A. Ahmed, S. Gondi, C. Cox, A. Mohammed, I. Stupin, A. Brewer, S. Wang, L.M. Buja,
S.W. Casscells, J.M. Wilson (Houston, US)
Structural polymorphism of ACE-gene at Uzbek patients with dilated cadiomyopathy. P959
N.A. Kurbanov, T.A. Abdullaev, B.U. Mardanov, U. Abdusattarov (Tashkent, UZ)
Hemodynamic characteristics of patients with right ventricular dilated cardiomyopathy. P960
N.A. Kurbanov, Y.A.R. Ahmatov, U.A. Abdusattarov (Tashkent, UZ)
Cardio-renal syndrome
Beneficial role of magnesium valproate on type-1 diabetes induced cardiac and
renal complications in rats. P961
S. Rabadiya, S.V. Bhadada, B.M. Patel (Ahmedabad, IN)
Hypertonic saline solution for prevention of renal dysfunction in patients with
decompensated heart failure - prospective, double blind, randomized,
placebo-controlled trial. P962
V.S. Issa, S.M. Ayub-Ferreira, F. Bacal, G.V. Guimaraes, L. Andrade, A.C. De Braganca,
G.E. Conceicao-Souza, P.R. Chizzola, I.T. Velasco, E.A. Bocchi (Sao Paulo, BR)
Peculiarities of changes in collagen matrix and arteries function in patients with
chronic heart failure depending on glomerular filtration rate. P963
N. Koziolova, A. Chernyavina, M. Surovtseva (Perm, RU)
Functional cardiac capacity, renal insufficiency and prognosis: is there a correlation? P964
R. Raimondo, R. Lagioia, D. Santoro, P. Guida, P. Caldarola, D. Scrutinio, F. Monitillo,
M. Gesualdo, A. Zito, R. Pedretti (Tradate, Cassano Murge and Bari, IT)
Severity of anemia and renal impairment set the chronic heart failure outcome. P965
G. Borelli, L. Rondinini, A. Iannielli, S. Mosa, T. Cellamaro, F. De Caro, F. Donati, R. Mariotti
(Pisa, IT)
Cellular biology
Human umbilical cord blood-derived mesenchymal stem cells demonstrate promising
angiogenic and vasculogenic potential for heart function recovery. P966
S. Roura Ferrer, J. Rodriguez Bago, C. Galvez-Monton, C. Prat-Vidal, C. Soler-Botija,
A. Llucia Valldeperas, J. Blanco, A. Bayes-Genis (Badalona and Barcelona, ES)
108

MONDAY 23 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Increased monocyte-platelet aggregates in ischemic heart failure. P967
B.J. Wrigley, L.D. Tapp, B. Pamukcu, E. Shantsila, G.Y.H. Lip (Birmingham, GB)
Electrical stimulation of adipose tissue-derived progenitor cells (ATDPCs) of
subcutaneous and cardiac origin for cardiac regeneration purposes. P968
A. Llucia-Valldeperas, B. Sanchez, C. Soler-Botija, S. Roura, C. Prat-Vidal,
C. Galvez-Monton, R. Bragos, A. Bayes-Genis (Badalona and Barcelona, ES)
Cell Signalling
Protein level of apelin-13 is reduced but level of apelin receptor is unchanged in left
ventricular myocardium of dogs with advanced heart failure. P969
R.C. Gupta, M. Wang, S. Rastogi, H.N. Sabbah (Detroit, US)
Co-morbidities (inc COPD, anaemia, cachexia)
Iron deficiency predisposes to depression in men with stable systolic heart failure. P970
E.A. Jankowska, A. Witkowska, S. Von Haehling, W. Doehner, J. Majda, W. Banasiak,
S.D. Anker, P. Ponikowski (Wroclaw, PL; Berlin, DE)
The impact of comorbidities on quality of life and long term prognosis in patients
with heart failure. Comorbidities or comortalities? P971
M. Nikolaou, J. Parissis, T. Katsoulas, P. Rafouli-Stergiou, S. Gaitani, F. Kolokathis,
D. Karatzas, D.T. Kremastinos, M. Anastasiou Nana, G. Filippatos (Athens, GR)
Chronic transvenous monitoring of ventilation using transthoracic impedance and
a novel lead placement. P972
K. James, A. Panteleon, A.R. Shaw, R.E. Germany, R.W. Westlund (Minnetonka, US)
Immunoinflammatory aspects in co-morbide conditions in patients with chronic heart
failure P973
G. Tytova, O. Liepieieva (Kharkiv, UA)
Effects of adaptive servo ventilation in patients with heart failure and central sleep
apnoea on breathing abnormalities and sympathetic tone. P974
E. D’elia, E. Vanoli, P. Delfino, M. Bonadies, V. Casali, Y. Fracchioni, A. Maggioni,
A. Mortara, G. Specchia (Monza and Pavia, IT)
Bioimpedance analysis f body composition in patients with heart failure. P975
N. Bylova, C.B. Shavgulidze, G.P. Arutyunov, U.V. Loshkarev, A.S. Tuhtina (Moscow, RU)
The influence of depression and anti-depressant medication on long-term mortality
in a sample of Portuguese heart failure patients. P976
M.M. Fontelonga Bento, C. Fonseca, I. Araujo, F. Marques, A. Leitao, F. Ceia (Lisbon, PT)
Cytokines and inflammation
Decreased parasympathetic drive is accompanied by increased expression of nicotinic
receptor Na7 and proinflammatory cytokines in peripheral blood mononuclear cells in
patients with heart failure. P977
A. Tomaszek, A. Rydlewska, L. Kiczak, J. Bania, A. Lejczak, W. Banasiak, E.A. Jankowska,
P. Ponikowski (Wroclaw, PL)
Cellular and humoral inflammation in acute myocarditis. P978
J. Silva Marques, A. Oliveira, M. Gato Varela, S. Robalo Martins, M. Pedro, M.E. Silva,
A.G. Almeida, A. Nunes Diogo (Lisbon, PT)
Cognitive impairment in patients with heart failure The role of the inflammatory
cytokines. P979
F. Fouad (Cairo, EG)
109
MONDAY
POSTERS

MONDAY
POSTERS
MONDAY 23 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Diagnosis of heart failure and biomarkers
Predictors of outcome in 369 patients with heart failure with preserved ejection fraction. P980
H. Salih, R. Kongo, D. Ghellab, R. Habbal, L. Azzouzi, A. Bennis (Casablanca, MA)
Characterization and prognostic value of sodium levels in Moroccans patients with
chronic heart failure. P981
Z. Elhonsali, A.B. Bennis (Casablanca, MA)
Noninvasive diagnosis of acute decompensated heart failure by analysis of exhaled
breath. P982
F.G. Marcondes-Braga, F. Bacal, G.L. Batista, P. Saldiva, S.M. Ayub-Ferreira, V.S. Issa,
S. Mangini, E.A. Bocchi, I.G.R. Gutz (Sao Paulo, BR)
Diastolic Dysfunction in Primary Care: potential role for hepatic biomarker measurement? P983
C.M. Conlon, C. Kelleher, H. Ulmer, I. Dawkins, A. Patle, C. O’ Louglin, M. Ledwidge,
K. Mc Donald (Dublin, IE; Innsbruck, AT)
Arterial stiffness parameters determining the accidence of diastolic and systolic heart
failure. P984
Y. Osmolovskaya, V.Y. Mareev, T.V. Balakhonova, A. Glechan (Moscow, RU)
Prognostic value of QRS duration to predict mortality in patients with heart failure. P985
V. Chioncel, C. Andrei, D. Mincu, M. Anastasiu, R. Ianula, C. Sinescu (Bucharest, RO)
Heart failure, new serum biomarkers and long term survival in a cohort of patients. P986
M.E. Tettamanti, M.L. Nieto, J. Lopez Diaz, L. De La Fuente Galan, R.M. Montana,
R. Arnold, A. Revilla Orodea, P. Mota Gomez, I. Gomez Salvador, J.A. San Roman Calvar
(Valladolid, ES)
NtProBNP as a marker of right ventricular systolic function in patients with pulmonary
hypertension. P987
C.I. Santos De Sousa, M. Satendra, L. Sargento, M. Teixeira, I. Almeida, F. Salazar,
N. Lousada, R. Palma Reis (Lisbon, PT)
Disease management and patient education
Clinical impact of a critical pathway for heart failure patients. P988
N. Garin, A. Zawodnik, S. Carballo, P. Meyer, E. Gerstel, A. Perrier (Geneva, CH)
Medical home model in the management of heart failure. P989
L. Houston-Feenstra, I. Pina (Loma Linda and Cleveland, US)
A simple rule for predicting outcome in heart failure patients managed in
a community-based disease management program. P990
H. Alhosaini, D. Torres, J. Brinkley, W.E. Cascio (Greenville, NC and Tarboro, NC, US)
Therapy in patients with heart failure: long term prognosis. P991
C.I. Santos De Sousa, M. Satendra, L. Sargento, I. Almeida, M. Teixeira, F. Salazar,
N. Lousada, R. Palma Reis (Lisbon, PT)
The T.O.S.CA project: research, education and care. P992
E. Bossone, F. Ferrara, E. Bobbio, A. Salzano, A. Frigiola, R. Citro, O. Vriz, A. Ballotta,
L. Caliendo, A. Cittadini (Naples, Milan, Salerno and Udine, IT)
Diuretics and fluid status management
Chronic effects of oral vasopressin type 2 receptor blocker, tolvaptan during the
transition to heart failure in rat experimental model with high salt diet. P993
H. Morooka, Y. Iwanaga, T. Takase, Y. Tamaki, H. Fujiki, S. Miyazaki (Osakasayama, Kyoto
and Tokushima, JP)
110

MONDAY 23 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
In patients with elevated lv filling pressure loop diuretics improve severity of heart
failure and diastolic dysfunction, but torasemide does it somewhat better than
furosemide. P994
A.G. Azizova, A.G. Ovchinnikov, Z. Blankova, F.T. Ageev (Moscow, RU)
Drug therapy, other
First baseline results from Aldo-DHF, the largest prospective international multicenter
trial on diastolic heart failure. P995
E. Kraigher-Krainer, B. Pieske, A. Schmidt, C. Colantonio, A. Duvinage, R. Wachter,
M. Halle, F. Edelmann (Graz, AT; Göttingen and Munich, DE)
Asymptomatic left ventricular systolic dysfunction is prevalent and undertreated prior
to diagnosis : a report from the STOP _ HF study. P996
G. Murtagh, I.R. Dawkins, M.T. Ledwidge, E. Tallon, R. O’ Hanlon, K.M. Mc Donald
(Dublin, IE)
Optimal medical therapy in heart failure: is there space for additional heart rate control? P997
S. Russell, M. Oliver, H. Llewellyn-Griffiths, A. Raybould, V. Sim, Z.R. Yousef (Cardiff and
Camarthen, GB)
The benefits of the use of chronic phosphodiesterase 5 inhibitors (PDE5) in patients
with heart failure with reduced ejection fraction and secondary hypertension:
A single center study. P998
M. Al Qaseer, C. Raleigh, S. Egan, B. Mcadam (Dublin, IE)
Positive impact of ACE inhibitor therapy on cognitive function in patients with systolic
heart failure though tendency to increase arterial hypotension. P999
Y. Krylova, M. Sitnikova, E. Shlyakhto, V. Krasnov, V. Sorocoumov, A. Velikanov
(Saint Petersburg, RU)
Short term infusion of levosimendan increases QT dispersion in patients with
congestive heart failure. P1000
S. Cay, G. Cagirci, A. Yildiz, Y. Guray, S. Korkmaz (Istanbul, Antalya, Sanliurfa and
Ankara, TR)
Prohibition of the nuclear translocation of calcineurin: a new approach in the therapy
of myocardial hypertrophy. P1001
M. Czolbe, M. Hallhuber, N. Burkard, C. Gebhardt, T. Williams, F. Panther, J. Strasen,
O. Ritter (Wurzburg, DE)
The dynamics of heart parametrs according to the polymorhizm of ACE-gene at
patients with myocardial infarction. P1002
G.U. Mullabayeva (Tashkent, UZ)
Echocardiography
Diastolic right ventricular adaptational changes in wrestlers and water polo athletes:
a pulsed tissue Doppler study. P1003
D. Popovic, M. Ostojic, M. Petrovic, B. Vujisic-Tesic, A. Kocijancic, I. Nedejkovic,
A. Arandjelovic, V. Stojanov, S. Damjanovic (Belgrade, RS)
Myocardial isovolumic acceleration as an index of right ventricular contractile function
in heart failure patients. P1004
A. Mantziari, V. Kamperidis, E. Damvopoulou, I. Ventoulis, G. Giannakoulas,
S. Paraskevaidis, V. Vassilikos, H. Karvounis, I.H. Styliadis (Thessaloniki, GR)
111
MONDAY
POSTERS

MONDAY
POSTERS
MONDAY 23 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
value of IV iron therapy in non-anemic iron deficient chronic heart failure patients:
tissue Doppler study. P1005
R. Gaber, N. Kotb (Tanta, EG)
Systolic left ventricular adaptation in wrestlers and water polo players: a pulsed tissue
Doppler study. P1006
D. Popovic, M. Ostojic, M. Petrovic, B. Vujisic-Tesic, A. Kocijancic, I. Nedeljkovic,
A. Arandjelovic, V. Stojanov, S. Damjanovic (Belgrade, RS)
Usefulness of tricuspid annular displacement (TAD) to identify right ventricular
dysfunction in normotensive patients with acute pulmonary embolism. P1007
T. Hugues, K. Yaici, N. Saoudi, P. Gibelin (Monaco, MC; Nice, FR)
Echocardiographic assessment in 1578 patients with chronic heart failure. P1008
H. Salih, R. Kongo, D. Ghellab, A. Bennis (Casablanca, MA)
RV function evaluated by 2-dimensional speckle tracking is not volume independent. P1009
C.S. Park, Y.K. Kim, Y.D. Kim, M.J. Kim, E.J. Cho, S.H. Ihm, H.O. Jung, H.K. Jeon, H.Y. Kim,
H.J. Youn (Seoul, KR)
Exercise testing & training
Resistance training in heart failure patients: systematic review and meta-analysis. P1010
L. Zanolla, C. Chiari, C. Vassanelli (Verona, IT)
Predictors of compliance to a cardiac rehabilitation program. P1011
I. Rangel, A. Rocha, C. Sousa, S. Oliveira, A. Lebreiro, A. Sousa, A.S. Correia, M. Paiva,
F. Parada, M.J. Maciel (Porto, PT)
Effect of aging in the aerobic capacity and aerobic function in patients with heart failure. P1012
G. Guimaraes, J.A. Neder, V.O. Carvalho, J.F.C. Belli, V.S. Issa, S.A. Ferreira, J.R. Marcelo,
G.C. Sousa, E.A. Bocchi (Sao Paulo, BR)
Prognostic value of the new variables of the cardiopulmonary stress test in dilated
cardiomyopathy. P1013
S.M. R. Amorim, M. Paiva, P. Viana, B. Moura, M. Campelo, E. Martins, F. Ribeiro Santos,
J. Silva-Cardoso, M.J. Maciel (Porto, PT)
Correlation between six-minute walk test with treadmill exercise testing in heart failure
outpatients. P1014
W.A. Martins, G.A.M.C. Pereira, L.S.N. Barros, M.M.P. Quintao, L. Mello, A.F. Bastos,
L.B. Oliveira, R.F.S. Abreu, E.T. Mesquita, S.S.M.C. Chermont (Niteroi and Teresópolis, RJ, BR)
The effect of exercise training on parameters of cardiopulmonary exercise testing
(CPET) and left ventricular systolic function in patients with chronic heart failure. P1015
N. Santos, R.M. Soares, A. Abreu, S. Silva, S. Alves, T. Alves, E. Oliveira, R. Ferreira (Lisbon, PT)
Design of a study using a virtual reality application to improve physical activity in heart
failure patients. P1016
L.S.M. Verheijden Klompstra, A. Stromberg, T. Jaarsma (Norrkoping and Linkoping, SE)
Gene and cell therapy
Improved Cardiomyogenesis of Genetically Engineered Human ESC and iPSC for
cardiomyocyte enrichment and in vivo Monitoring. P1017
R. Zweigerdt, K. Schwanke, S. Mueller, S. Merkert, S. Rojas Hernandez, A. Martens,
I. Kutschka, C. Templin, U. Landmesser, U. Martin (Hannover, DE; Zurich, CH)
Effect of intramyocardial transplantation of autologous 5-azacytidine-cultured
bone-marrow stem cells in patients with heart failure. P1018
T.M. Belyavskaya, E.A. Scridlevskaya, A.G. Konoplyannikov, L.E. Samoilenko,
R.S. Akchurin (Moscow and Obninsk, RU)
112

MONDAY 23 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Administration of minimally fractionned bone marrow inpatients with coronary artery
disease and severe heart failure. P1019
V.I. Lukashenko, S.N. Burnos (Saint Petersburg, RU)
Haemodynamics / Coronary and peripheral circulation
The effect of long-term exercise training on lower limbs arterial blood flow in chronic
heart failure patients. P1020
L. Voronkov, E. Besaga, I. Shkurat (Kyiv, UA)
Relation between left ventricle wall stress estimated by Ntprobnp and microvascular
coronary function in patients with moderate or severe aortic stenosis and
nonobstructive coronary arteries. P1021
M.B. Banovic Marko, B.V. Bosiljka Vujisic-Tesic, M.C. Callahan Mark, V.K. Kujacic Vuk,
I.N. Nedeljkovic Ivana, D.T. Trifunovic Danijela, M.P. Petrovic Milan, M.B. Boricic Marija,
G.D. Draganic Gordana, M.O. Ostojic Miodrag (Belgrade, RS; Rochester, Minnesota, US;
Gothenburg, SE)
Correlation between hemodynamic parameters and high-sensitivity cardiac troponin T. P1022
T. Sawa, Y. Sato, S. Koyama, M. Kawashima, Y. Tanada, E. Yamamoto, R. Taniguchi,
T. Miyamoto, H. Fujiwara, Y. Takatsu (Amagasaki, JP)
Heart transplantation / Assist devices
Single-center experience in Heart Transplantation of Cardiac Sarcoidosis. P1023
H. Akashi, T. Sugiyama Kato, M. Farr, K. Shahzad, M. Deng, H. Takayama, Y. Naka,
P. Schulze, D. Mancini (New York, US)
What is the impact of donor age or vasopressors utlilization in heart transplant in the
real world? P1024
G.E. Conceicao-Souza, J.L. Vieira, A.I. Fiorelli, S.M. Ayub-Ferreira, V.S. Issa, P.R. Chizzola,
F. Bacal, A. Benicio, P.A.M. Pomerantzeff, E.A. Bocchi (Sao Paulo, BR)
Hyperimmunity in children undergoing ventricle assist device as a bridge to heart
transplantation. P1025
G. Grutter, A. Amodeo, L. Mantione, G. Del Principe, G. Brancaccio, G. Michielon,
F. Parisi, G. Pongiglione (Rome, IT)
Immune monitoring in pediatric heart transplantation: correlation with infection and
rejection. P1026
T. Ben Gal, N. Zucker, M. Israeli, V. Yaari, A. Valdman, I. Matz, B. Medalion, E. Birk, T. Klein,
A. Battler (Petah Tikva, IL)
Renal failure and metabolic syndrome in heart transplants patients. P1027
L. Martinez-Dolz, I.J. Sanchez Lazaro, L. Almenar-Bonet, J.M. Sanchez-Gomez, M. Portoles,
B. Munoz-Giner, E. Rosello-Lleti, R. Cortes, M. Rivera-Otero, A. Salvador-Sanz (Valencia, ES)
Impact of an antialcohol abuse law in cardiac transplant indicators: 12 months follow up. P1028
G.E. Conceicao-Souza, V.S. Issa, S.M. Ayub-Ferreira, F. Bacal, G.V. Guimaraes,
P.R. Chizzola, F.D. Cruz, P.M. Pomerantzeff, N.A.G. Stolf, E.A. Bocchi (Sao Paulo, BR)
Left Ventricular Assist Device for destination therapy in patients older than 65 years:
Monocentric experience. P1029
J.C. Roussel, M. Michel, T. Senage, J.P. Gueffet, S. Pattier, M. Treilhauld, O. Baron,
D. Duveau, J.N. Trochu (Nantes, FR)
113
MONDAY
POSTERS

MONDAY
POSTERS
MONDAY 23 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Hypertension / LV hypertrophy
Doppler tissue myocardial performance index in estimation of left ventricular
remodeling process in hypertensive patients. P1030
A. Stevanovic, M. Krotin, M. Dekleva, S. Trajic, A. Simic (Belgrade, RS)
Interstitial collagen, apoptosis and diastolic function in essential hypertension. P1031
M. Rivera, R. Cortes, E. Rosello, N. Carpena, J.R. Calabuig, V. Miro, J.R. Gonzalez Juanatey,
A. Jordan, M. Portoles, V. Bertomeu (Valencia, Santiago de Compostela and Alicante, ES)
Left ventricular function
Type of desmin expression as a good predictor of remodeling of left ventricle. P1032
A. Pawlak, M. Pronicki, E. Czarnowska, R.J. Gil (Warsaw, PL)
Ejection fraction and hospital mortality in a large cohort of diabetic patients
undergoing elective percutaneous coronary intervention. P1033
A. Dominguez Rodriguez, P. Jorge-Perez, E. Arroyo-Ucar, C. Hernandez-Garcia,
M. Carrillo-Perez Tome, R. Juarez-Prera, G. Blanco-Palacios, A. Lara-Padron, P. Avanzas,
P. Abreu-Gonzalez (Tenerife and Oviedo, ES)
Left ventricular diastolic dysfunction in patients with abdominal obesity. P1034
E. Bazhenova, O. Belyaeva, A. Berezina, E. Nikolaychuk, T. Lozovaya, D. Kolodina,
E. Nifontov, O. Berkovich, E. Baranova, E. Shlyakhto (St Petersburg, RU)
Global longitudinal and circumferential strain/strain rate in ischemic heart disease
patients with three types of left ventricle shape abnormalities. P1035
E. Pavlyukova, V.M. Shipulin, R.S. Karpov (Tomsk, RU)
Metabolism / Diabetes mellitus
Impact of diabetes on left ventricular function heart rate variability, QT dispersion
and in patients after myocardial infarction. P1036
V. Stoickov, S. Ilic, M. Deljanin Ilic (Niska Banja, RS)
Elevated extracellular glucose concentration imparts a marked protection from
simulated ischaemia to isolated rat ventricular myocytes. P1037
M.W. Sims, I.B. Squire, R.D. Rainbow (Leicester, GB)
Diabetes mellitus and its influence in cardiac rehabilitation program for coronary
patients. P1038
M. Paiva, A. Rocha, A. Sousa, A. Lebreiro, C. Sousa, S. Correia, I. Rangel, V. Araujo,
F. Parada, M.J. Maciel (Porto, PT)
Ischemia / Reperfusion / Preconditioning
Reversible myeloperoxidase-induced contractile dysfunction in isolated human
cardiomyocytes. P1039
J. Kalasz, A. Balogh, E.T. Pasztor, M. Fagyas, A. Toth, I. Edes, Z. Papp, A. Borbely
(Debrecen, HU)
Cardiac function at baseline in a revascularized coronary artery disease cohort with
obstructive sleep apnea in the RICCADSA trial. P1040
H. Glantz, E. Thunstrom, B. Cederin, A. Kallryd, J. Ejdeback, J. Herlitz, Y. Peker
(Skövde and Gothenburg, SE)
Molecular biology / Genetics
Genes polymorphisms ACE, AGT, beta-2AR and survival in patients with HF of ischemic
etiology. P1041
E.V. Shlyakhto, M.Y.U. Sitnikova, S.G. Ivanov, O.A. Krasnova, V.I. Larionova (St Petersburg, RU)
114

MONDAY 23 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
GSTT1 null genotype in smokers is associated with higher risk of chronic heart failure. P1042
N. Jankovic, D. Simic, S. Radovanovic, M. Matic, S. Suvakov, T. Djukic, A. Djokovic,
V. Coric, T. Simic (Belgrade, RS)
Comparative analysis of key properties of bone marrow and fat tissue mesenchymal
stem cells isolated from the same heart failure patients. P1043
E.V. Shlyakhto, R.I. Dmitrieva, I.R. Minullina, O.V. Tarasova, A.A. Bilibina, A.Y. Gudkova,
S.V. Anisimov, A.Y. Zaritskey (St Petersburg, RU)
Circulating microRNA 155 as potential biomarker of heart failure. P1044
M. Anton, A. Botezatu, I.V. Iancu, M. Muraru, D. Isacoff, I. Bruckner, G. Anton (Bucharest, RO)
Recent bioinformatics and ultrastructure-based gene-identification responsible for
complicated familial cardiomyopathies with the ethnicity. P1045
T. Toyo-Oka, M. Kobayashi, L. Toyo-Oka, T. Nakajima, T. Izumi, M. Richter, S. Kostin,
J. Schaper, K. Tokunaga (Tokyo and Sagamihara, JP; Bad Nauheim, DE)
MRI, nuclear cardiology and CT (imaging)
Infarct tissue characterization in ICD recipients for primary versus secondary prevention
following myocardial infarction as assessed with contrast-enhanced CMR. P1046
M. Olimulder, K. Kraaier, M.A. Galjee, M.F. Scholten, J. Van Es, L.J. Wagenaar,
J. Van Der Palen, C. Von Birgelen (Enschede, NL)
Myocarditis as a precipitating factor for heart failure. Evaluation and one year
follow-up using cardiovascular magnetic resonance and endomyocardial biopsy. P1047
S. Mavrogeni, C. Spargias, C. Bratis, G. Kolovou, E. Papadopoulou, P. Constadoulakis,
M. Papadimitropoulos, M. Douskou, G. Pavlides, D.V. Cokkinos (Athens, GR)
Effects of PCI with stenting on the left and right ventricular performance in patients
with ischemic chronic heart failure, decreased and preserved EF LV. P1048
N. Shashkova, M. Nepoklonov, Y.U. Osmolovskaya, S. Tereshenko, L. Samoylenko,
A. Skvortsov (Moscow, RU)
Natriuretic peptides
Long-term outcome of NT-proBNP-guided versus symptom-guided therapy: results
from the TIME-CHF study. P1049
S. Van Wijk, M.T. Maeder, F. Nietlispach, H. Rickli, W. Estlinbaum, P. Erne, P. Rickenbacher,
M. Peter, M. Pfisterer, H-P. Brunner-La Rocca (Maastricht, NL; St Gallen, Basel, Liestal,
Lucerne, Bruderholz and Wolhusen, CH)
Induction of BNP and MCP-1 gene expressions by oxidized low-density lipoprotein. P1050
S. Parthasarathy, A.N. Chandrakala (Columbus, US)
NT-proBNP variations during hospitalization predicts mortality in heart failure patients. P1051
F.J. Carrasco Sanchez, L. Galisteo Almeda, M.I. Paez Rubio, J.I. Perez Calvo, R. Lopez
Aguilar, E. Ortiz Lopez, I. Vazquez Garcia, E. Pujol De La Llave (Huelva and Zaragoza, ES)
N.Terminal Pro-B-Type Natriuretic Peptide and some inflammation markers as part of
complex approach to prognosing course of postinfarction period. P1052
E.N.U. Usoltseva, O.L.B. Barbarash, V.V.K. Kashtalap, K.S.S. Shafranskaya, L.S.B. Barbarash
(Kemerovo, RU)
Brain-natriuretic peptide and time interval difference of isovolumic relaxation in typ 2
diabetic patients. P1053
A. Stevanovic, L.J. Sevic, V. Andric, G. Podnar, N. Paunovic, J. Elez, V. Vojinovic-Culafic,
J. Canic, I. Milincic, R. Cvjetan (Belgrade, RS)
115
MONDAY
POSTERS

MONDAY
POSTERS
MONDAY 23 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Nursing
Psychometric properties of the Swedish version of the Control Attitudes Scale for
patients with cardiac disease and their family members. P1054
K. Arestedt, S. Agren, I. Flemme, D. Moser, A. Stromberg (Kalmar, Linkoping and Halmstad,
SE; Lexington, US)
Factors influencing nutritional status in chronic heart failure. P1055
C. Andreae, A. Stromberg, C. Hjelm, K. Arestedt (Linkoping, SE)
Quality of life of patients with heart failure. P1056
A.C. Cavalcanti, G.C.A. Vieira, J.M.V. Pereira, W.A. Martins, K.M. Cassiano (Niteroi, BR)
Other
The impact of cardiac dyssynchrony on speckle tracking parameters in heart failure
complicating ischemic cardiomyopathy. P1057
C. Mornos, L. Petrescu, A. Ionac, R. Dan, A. Mornos, S. Pescariu (Timisoara, RO)
Existence of masked obstructive sleep apnea after adaptive servo ventilation therapy
in heart failure patient of central sleep apnea. P1058
Y. Matsuo, N. Takama, T. Sasaki, N. Kanesawa, M. Kurabayashi (Takasaki, Isesaki and
Maebashi, JP)
Regional Cooperation Network of Patient Education as a tool in development of heart
failure patients health education. P1059
V. Kemppainen, M. Kiema, K. Haatainen (Kuopio, FI)
Salt and water restriction is effective in patients with chronic heart failure. P1060
H. Philipson, S.E.H.S.E Hagelind, K.S. Swedberg, I.E. Ekman, M.S. Schaufelberger
(Gothenburg, SE)
Hospital admissions for pulmonary embolism: Discriminative capacity of the scales for
diagnosis. P1061
L. Costa, M. Germano, D. Portelinha (Coimbra, PT)
Hospital admissions for pulmonary embolism: a descriptive study in a central hospital. P1062
M. Germano, L. Costa, D. Portelinha (Coimbra, PT)
Pathophysiology
Heart failure with normal ejection fraction : central arterial stiffness and impaired
ventricular-arterial coupling play a key role in symptoms at exercise. P1063
F. Vallet, D. Coisne, B. Lequeux, P. Sosner, C. Diakov, C. Bobier, L. Christiaens (Poitiers, FR)
Sleep/wake fluctuations and Cheyne-Stokes respiration in heart failure patients:
insights from daytime laboratory recordings. P1064
G.D. Pinna, M.T. La Rovere, E. Robbi, R. Maestri (Montescano, IT)
Levels of n-3 PUFAs and functional capacity in heart failure patients. P1065
S. Nodari, U. Campia, M. Triggiani, G. Milesi, A. Manerba, B. Cesana, M. Gheorghiade,
L. Dei Cas (Brescia, IT; Chicago, US)
Population studies / Epidemiology
Quality of care in unselected patients admitted with acute heart failure. P1066
S.K. Bhagra, M. Barlow, S. Mckee, H. Bilkhu, M.C. Petrie, H.J. Dargie
(Newcastle upon Tyne, Glasgow and Stirling, GB)
116

MONDAY 23 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Heart rate in ambulatory heart failure ouptatients followed in multidisciplinary heart
failure clinics. P1067
J.M.O. Arnold, J. Howlett, P. Liu, H. Haddad, M.-H. Leblanc, A. Ignaszewski, M. Rajda,
M. Chan, G. Marchiori, L. Stitt (London, Calgary, Toronto, Ottawa, Quebec City,
Vancouver, Halifax and Edmonton, CA)
High prevalence of diastolic dysfunction in patients with type 2 diabetes. P1068
L.J.M. Boonman-De Winter, F.H. Rutten, M.J.M. Cramer, M.J. Landman, A.H. Liem,
A.W. Hoes (Etten-Leur, Utrecht, Leusden and Goes, NL)
Gender-based differences in the trends of heart failure and their implication on
outcome and prognosis: a middle-eastern perspective. P1069
M. Alqaseer, Y. Mussayab, H. Khudhair, A. Jamsheer (Manama, BH)
Determining the prevalence and management of heart failure in Dutch nursing
homes using a structured heart failure assessment: a study protocol. P1070
M. Daamen, J.P.H. Hamers, A.P.M. Gorgels, H.P. Brunner-La Rocca, J.M.G.A. Schols
(Maastricht, NL)
Prognosis (other)
Mode of death in patients with heart failure: comparison between Chagas’ disease
and other etiologies. P1071
S.M. Ayub Ferreira, S. Mangini, F.D. Cruz, V.S. Issa, F. Bacal, P.R. Chizzola,
G.E. Conceicao-Souza, G.V. Guimaraes, F.G. Marcondes-Braga, E.A. Bocchi
(Sao Paulo, BR)
Negative impact of protein-energy malnutrition on in-hospital mortality in acute
decompensated heart failure. P1072
M. Fujino, H. Yokoyama, K. Sekiguchi, H. Kanzaki, Y. Goto, M. Kitakaze, H. Nonogi
(Suita, JP)
Duration of prognostic capability of cardiopulmonary exercise testing in patients with
heart failure. P1073
B. Valente, R.M. Soares, A. Toste, J. Feliciano, F. Frreira, H. Hamad, A. Lousinha,
J.P. Lopes, A. Abreu, R.C. Ferreira (Lisbon, PT)
Red cell distribution width relates to exercise capacity in chronic heart failure but
provides prognostic information incremental to peak oxygen consumption. P1074
N. Zaman, A. Barron, M. Thomas, S. Woldman, J. Mayet, D. Francis, D.O. Okonko
(London, GB)
Left atrial strain by speckle tracking echocardiography is a new noninvasive predictor
of cardiac death or need of heart transplantation in patients with moderate to severe
heart failure. P1075
T. Helle-Valle, K. Broch, A. Opdahl, E. Gude, A. Andreassen, O.A. Smiseth, L. Gullestad
(Oslo, NO)
Patient-reported effort dyspnea in suspected coronary artery disease. P1076
I.P. Clements, D.O. Hodge, C.G. Scott (Rochester, US)
Long-term follow-up of patients with positive head-up tilt test: does the type of
response influences prognosis? P1077
A. Lebreiro, A. Sousa, A.S. Correia, P. Lourenco, S. Oliveira, M. Paiva, I. Rangel, C. Sousa,
J. Freitas, M.J. Maciel (Porto, PT)
117
MONDAY
POSTERS

MONDAY
POSTERS
MONDAY 23 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Microalbuminuria is a better prognostic marker than creatinine or glomerular filtration
rate in patients with established heart failure. P1078
H. Villacorta, P. Ferradaes, E.T. Mesquita (Rio de Janeiro, BR)
Statin induced low cholesterol does not associated with poor outcome in chronic
heart failure. P1079
S.M. Silva, P. Lourenco, C. Paulo, E. Ferreira, A. Lebreiro, A. Sousa, J. Mascaranhas,
M. Patacho, J.P. Araujo, P. Bettencourt (Porto, PT)
Prognostic impact of occult renal failure on acute coronary syndromes. P1080
F. Moscoso Costa, R. Cale, P. Sousa, J. Brito, P.G. Santos, C. Aguiar, M. Trabulo, R. Teles,
F. Jorge, M. Mendes (Lisbon, PT)
Influence of pre-existing chronic heart failure (CHF) on in-hospital mortality of patients
with acute coronary syndrome (ACS). P1081
J. Gilis-Januszewski, K.-P. Mellwig, F. Van Buuren, M. Wiemer, T. Gilis-Januszewski,
G. Koenig, M. Moellenberg, B. Brockmeyer, A. Schmidt, D. Horstkotte (Bad Oeynhausen, DE)
Is myocardial viability assessment useful in predicting prognosis after coronary artery
bypasss graft among ischemic cardiomyopathy patients in real world? P1082
G.E. Conceicao-Souza, E. Roque, J.L. Vieira, V.S. Issa, S.M. Ayub-Ferreira, F. Bacal,
P.R. Chizzola, L. Watanabe, E.A. Bocchi (Sao Paulo, BR)
Prognosis (using biomarkers)
Oxidative stress in chronic heart failure patients considering presence of diabetes mellitus. P1083
S. Radovanovic, M. Krotin, I. Zivanovic, M. Zdravkovic, A. Djokovic, N. Ninkovic, J. Saric,
S. Jelic, V.D. Simic, T. Simic (Belgrade, RS)
Red blood cell distribution width: a severity marker in acute heart failure. P1084
C. Galvao Braga, M. Fonseca, V. Ramos, C. Vieira, S. Ribeiro, A. Gaspar, S. Rocha,
J. Cerqueira, S. Magalhaes, A. Correia (Braga, PT)
Prognostic values of NTpro BNP/BNP ratio in comparison with NTpro BNP or BNP
alone in elderly patients with chronic heart failure in a 2-year follow up. P1085
J. Jensen, L. Ma, C. Bjurman, O. Hammarsten, M.F.X. Fu (Gothenburg, SE; Shanghai, CN)
Prognostic value of changes in NT-proBNP levels and echocardiographic parameters
in patients admitted for acutely decompensated heart failure. P1086
K. Salah, M. Koomen, W.E.M. Kok, M. Metra, L. Bettari, Y.M. Pinto, P.G. Meregalli
(Amsterdam, NL; Brescia, IT)
Hypoalbuminemia as a predictor of poor prognosis in acute coronary syndrome. P1087
C. Sousa, I. Rangel, A. Goncalves, R. Lopes, A.P. Lourenco, S. Oliveira, A. Lebreiro,
A. Sousa, E. Martins, M.J. Maciel (Porto, PT)
relation between NT-proBNP and blood urea nitrogen plasma levels in patients with
acutely decompensated heart failure. P1088
F.A. Gabrielli, E. De Marco, M. Savino, R. Natali, G. Bencardino, M. Lotrionte,
B. Garramone, G. Comerci, F. Loperfido (Rome, IT)
Prognostic value of troponin I in patients with heart failure who suffered acute
coronary syndrome. P1089
N. Koziolova, E.A. Polyanskaya (Perm, RU)
Combined assessment of a novel virtual analyte NT-proXNP and pro-inflammatory
cytokines in the prognostic evaluation of patients with acute heart failure. P1090
K. Miettinen, J. Magga, O. Vuolteenaho, J. Lassus, V.P. Harjola, K. Siirila-Waris,
K.R. Punnonen, M.S. Nieminen, K.J. Peuhkurinen (Kuopio, Oulu and Helsinki, FI)
118

MONDAY 23 MAY 2011 - AFTERNOON POSTERS
14:00 - 18:00 Poster Session Poster Area
Pulmonary hypertension
Increased concentrations of circulating platelet derived microparticles and plateletmonocyte
aggregates in patients with pulmonary arterial hypertension. P1091
C. Christersson, A. Siegbahn, G. Wikstrom (Uppsala, SE)
Endothelin in pulmonary arterial hypertension: measure to treat. P1092
J. Silva Marques, S. Robalo Martins, C. Jorge, A. Sousa, S. Pires, C. Calisto, A.G. Almeida,
J. Carvalho De Sousa, A. Nunes Diogo (Lisbon, PT)
Diastolic dysfunction of the right ventricle in patients with scleroderma and normal
pulmonary arterial pressure. P1093
I.P. Alexanian, A. Kalogirou, E. Tsougos, K. Letsas, N. Flessas, A. Sideris (Athens, GR)
Comparative analysis of eprosartan and enapril treatment combining with bisoprolol
in patients with pulmonary hypertension due to systolic dysfunction. P1094
O. Pashuk, E. Atroshtchenko (Minsk, BY)
Surgery (CABG, valvular, artificial heart, other)
Fondaparinux vs enoxaparin used postoperatively in patients undergoing CABG
surgery-institutional experience and review of literature. P1095
D. Kosevic, C.B. Calija, V.F. Vuk, L.J.V. Lausevic Vuk, I.P. Petrovic, P.D. Dabic, T.P. Spasic,
Z.V. Vukajlovic, L.J.T. Djokovic, P.G. Gajin (Belgrade, RS)
Off-pump coronary surgery in patients with ventricular dysfunction and multiple
coronary artery disease: safety, efficacy and outcome. P1096
Y. Vechersky, S.L. Andreev, A.G. Miroshnichenko, Y.A. Arsenjeva (Tomsk, RU)
Association between sinus of Valsalva aneurysm and bicuspid aortic valve in a patient
presented with right heart failure simptoms. P1097
D. Toader, M. Cocora, C. Bataiosu, I. Marinas, E. Belu, R. Musetescu, D.-D. Ionescu
(Craiova and Timisoara, RO)
Vascular biology, other
Decreased Proximal Aortic Diameter is Associated with the Mortality of Patients with
Congestive Heart Failure. P1098
D. Kamimura, K. Uchino, H. Ogawa, T. Shigemasa, M. Shimizu, Y. Morita, K. Kimura,
S. Umemura (Yokohama, Atami and Sagamihara, JP)
Ethnic differences in endothelial function in chronic heart failure. P1099
E. Shantsila, P.S. Gill, G.Y.H. Lip (Birmingham, GB)
Risk score for estimation the evolution of the patients with acute decompensation of
heart failure. P1100
M. Andor, M. Tomescu, D. Lighezan, R. Christodorescu, A. Thanaraj (Timisoara, RO)
119
MONDAY
POSTERS

HIGHLIGHTS FROM
He a R T Fa I L u R e 2011
Highlights from the Heart Failure Association winter and summer meetings
and the European Journal of Heart Failure
Chairpersons:
K. Swedberg (Gothenburg, SE) & T. Eschenhagen (Hamburg, DE)
08:30
Basic and translational science
B.M. Pieske (Graz, AT)
08:52
Update on diagnosis and prognostic
assessment
S.D. Anker (Berlin, DE)
Wednesday, 31 August 2011
08:30 - 10:00 - Stockholm - Zone A
09:15
Therapeutic news
M. Metra (Brescia, IT)
09:37
My top ten papers from the
European Journal of Heart Failure
2009-2010
W.H. van Gilst (Groningen,NL)
TUESDAY

TUESDAY 24 MAY 2011 - MORNING
08:30 - 10:00 How-to Session Gothenburg
How to interpret the recent trials with expert statisticians
Chairpersons: C. O’Connor (Durham, US); L. Kober (Gentofte, DK)
Latest Updates
Panelists. 1101
M. Gheorghiade (Chicago, US)
08:30 Drug trials. 1102
K. Swedberg (Gothenburg, SE)
09:00 Device and telemedecine trials. 1103
I. Ford (Glasgow, GB)
09:30 Biomarker trials. 1104
H. Wedel (Gothenburg, SE)
08:30 - 10:00 Main Session Stockholm
Using biomarkers to sort out the complex patient
Chairpersons: A.A. Voors (Groningen, NL); J.T. Parissis (Athens, GR)
Education and Guidelines
08:30 The dyspneic patient in the emergency department - Which biomarkers
should we use and how? 1105
A. Maisel (Solana Beach, US)
08:52 How to use new sensitive troponins in the era of the complex patient. 1106
C. Mueller (Basel, CH)
09:15 Using biomarkers in the cardiorenal syndrome. 1107
C. Ronco (Vicenza, IT)
09:37 Using biomarkers to guide therapy. 1108
H.P. Brunner-La Rocca (Maastricht, NL)
08:30 - 10:00 Main Session Malmö
Personalised medicine and person-centered care – What is the difference?
Chairpersons: M. Ryder (Perth, AU); B. Granger (Durham, US)
Education and Guidelines
08:30 Personalised medicine - How far from implementation? 1109
T. Eschenhagen (Hamburg, DE)
08:52 Person-centered care - What is it? 1110
I. Ekman (Gothenburg, SE)
09:15 How to measure what the patient wants. 1111
A.L. Clark (Kingston-Upon-Hull, GB)
09:37 Utilisation of personalised medicine and person-centered care - Hurdles and
possibilities. 1112
F. Zannad (Vandoeuvre Les Nancy, FR)
123
TUESDAY

TUESDAY
TUESDAY 24 MAY 2011 - MORNING
08:30 - 10:00 Main Session Uppsala
Sleep apnea - the need to synchronize the heart, the lung and the brain
Chairpersons: Z. Papp (Debrecen, HU); G.M. De Ferrari (Pavia, IT)
Co-morbidities and heart failure
08:30 Novel pathophysiological concepts for the development and impact of sleep
apnea in chronic heart failure. 1113
O. Oldenburg (Bad Oeynhausen, DE)
08:52 When heart, lung and brain are desynchronized - Should we be more focused
on sleep apnea in chronic heart failure? 1114
M.R. Cowie (London, GB)
09:15 How to assess symptoms in sleep apnea. 1115
A. Brostrom (Linkoping, SE)
09:37 Future possibilities in treatment of sleep apnea. 1116
Y. Peker (Skovde, SE)
08:30 - 10:00 Special Session Örebro
Highlights of the congress: Basic Science translated for the clinician
Chairpersons: B.M. Pieske (Graz, AT); C. Maack (Homburg/Saar, DE)
08:30 Subcellular determinants of diastolic stiffness. 1117
To be announced
08:45 Late Breaking Research Presentation 1. 1118
To be announced
09:00 Energy and heart failure. 1119
H. Taegtmeyer (Houston, US)
09:15 Late Breaking Research Presentation 2. 1120
To be announced
09:30 Phosphodiesterases in hypertrophy and failure. 1121
S. Janssens (Leuven, BE)
09:45 Late Breaking Research Presentation 3. 1122
To be announced
Visit the Exhibition - Coffee Break in the Exhibition Area
Morning Poster Session: Poster Viewing 08:30 - 12:30
& Moderated Posters Session 10:00 - 11:00 See Page 127
124

TUESDAY 24 MAY 2011 - MORNING
11:00 - 12:30 Main Session Gothenburg
New biomarkers for diagnosis and prognosis in heart failure
Chairpersons: F. Ruschitzka (Zurich, CH); D. Logeart (Paris, FR)
Latest Updates
11:00 Markers of renal function. 1123
A.A. Voors (Groningen, NL)
11:18 Oxidative stress and inflammatory markers in heart failure. 1124
D. Tousoulis (Athens, GR)
11:36 Copeptin in heart failure. 1125
C. Mueller (Basel, CH)
11:54 Fibrosis and metalloproteinase. 1126
J. Diez Martinez (Pamplona, ES)
12:12 Biomarkers as treatment targets. 1127
A. Maisel (Solana Beach, US)
11:00 - 12:30 Special Session Stockholm
Highlights of the congress
Chairpersons: S.D. Anker (Berlin, DE); K. Swedberg (Gothenburg, SE)
11:00 Basic Science. 1128
T. Thum (Hannover, DE)
11:15 Patient care. 1129
J. Riley (London, GB)
11:30 Diagnosis, imaging, pathophysiology. 1130
A.L. Clark (Kingston-Upon-Hull, GB)
11:45 HFPEF: heart failure with preserved ejection fraction. 1131
B.M. Pieske (Graz, AT)
12:00 Drug treatment. 1132
A.P. Maggioni (Florence, IT)
12:15 Devices. 1133
F. Braunschweig (Stockholm, SE)
125
TUESDAY

TUESDAY
TUESDAY 24 MAY 2011 - MORNING
11:00 - 12:30 Main Session Malmö
Mortality or morbidity as target in acute heart failure trials
Chairpersons: To be announced; L. Force (Philadelphia, US)
Latest Updates
11:00 How to define the target population? 1134
M. Metra (Brescia, IT)
11:22 What is a clinically meaningful benefit? Symptoms vs. outcome. 1135
M. Gheorghiade (Chicago, US)
11:45 Mortality: an efficacy or a safety endoint? 1136
C. O’Connor (Durham, US)
12:07 Potential future targets. 1137
A. Mebazaa (Paris, FR)
11:00 - 12:30 How-to Session Uppsala
The dynamic social media wave: Twitter, Facebook, Internet etc.
Chairpersons: M.C. Deaton (Manchester, GB); To be announced
Education and Guidelines
11:00 Keep in touch with your patients: Communication via the internet and Facebook. 1138
A. Stromberg (Linkoping, SE)
11:22 The potential of Massive Multiplayer Online Role-playing Game («MMORG»). 1139
A. Wolf (Gothenburg, SE)
11:45 Communicating with patients using the media. 1140
T. Jaarsma (Norrkoping, SE)
12:07 Providing information to patients via a website: heartfailurematters.org. 1141
K. Dickstein (Stavanger, NO)
11:00 - 12:30 Main Session Örebro
Cardiac regeneration and repair – What’s new
Chairpersons: T. Eschenhagen (Hamburg, DE); U. Landmesser (Zurich, CH)
Basic Science, Basic Science translated for the clinician
11:00 Modelling cardiac disease with iPS cells. 1142
K.-L. Laugwitz (Munich, DE)
11:18 Human spermatogonial cells. 1143
K. Guan (Goettingen, DE)
11:36 Endogenous cardiac stem cell recruitment. 1144
M.J. Goumans (Leiden, NL)
11:54 Cardiac valve culture. 1145
A. Hilfiker (Hannover, DE)
12:12 Direct reprogramming of fibroblasts into cardiomyocytes. 1146
G. Hasenfuss (Goettingen, DE)
126

MORNING
TUESDAY
POSTER SESSIONS
Moderated Posters Session 5 (10:00 - 11:00)....................................................... Page 129
Poster Session 5 ...................................................................................................................Pages 130 to 144
All Posters will be on display from 08:30 - 12:30
The Heart Failure Association and the Scientific Programme Committee have
developed a programme to support young researchers.
Senior members of faculty, HFA Board Members experts in the topic presented
will come to meet and discuss the research presented during the coffee break of
the poster sessions.
The poster will be easily identified with a HFA Young Researcher
logo - which should be collected at the Poster Assistance Desk.
Join us in supporting the future of research and advances in all related aspects of
heart failure Clinical research / treatment and Basic Science - come and interact
with the Cardiologists of tomorrow.
More Late Breaking Trials and Research
Clinical Trial Forum Posters
on Level 1
127
Y
TUESDAY
POSTERS

TUESDAY 24 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Moderated Posters Moderated Poster Area
Moderated Posters Session 5
Chairpersons: L. Neyses (Manchester, GB); L.S. Maier (Gottingen, DE)
Posters must be set up between 08:00 and 08:30 and removed between 12:30 and 13:00
These abstracts were chosen for their outstanding quality and will be presented during the
Moderated Poster Session between 10:00 and 11:00
Molecular signature analysis reveals a set of genes that can be involved in
balance between concentric and eccentric cardiac growth. P1147
M. Torrado, R. Iglesias, A. Centeno, A. Mikhailov (La Coruna, ES)
In vivo non-invasive bioluminescence imaging monitoring of cTnI gene
expression in cardiac adipose tissue-derived progenitor cells (ATDPCs)
implanted in a mouse model of myocardial infarction. P1148
C. Soler-Botija, J.R. Bago, A. Llucia-Valldeperas, C. Galvez-Monton, N. Rubio,
C. Prat-Vidal, S. Roura Ferrer, J. Blanco, A. Bayes-Genis (Badalona, ES)
Adenosine inhibits autophagy in murine cardiomyocytes. P1149
M. Saric, E. Hamad, Y. Devaux, T. Chan, A. Feldman, D.R. Wagner
(Luxembourg, LU; Philadelphia, US)
Hunting for the genetic cause in a case with familial peripartum/dilated
cardiomyopathy using haplotype sharing analysis and exome sequencing. P1150
K.Y. Van Spaendonck-Zwarts, J.D. H. Jongbloed, P.A. Van Der Zwaag,
A. Posafalvi, W. Koetsier, I.M. Van Langen, D.J. Van Veldhuisen, R.J. Sinke,
M.P. Van Den Berg, J.P. Van Tintelen (Groningen, NL)
Dysregulation of mitochondria fission and fusion proteins in explanted failing
human hearts. P1151
H.N. Sabbah, R.C. Gupta, S. Rastogi, M.M. Wang (Detroit, US)
Adenosine reduces cell-surface expression of Toll-like receptor 4 in response
to lipopolysaccharide and matrix degradation products. P1152
B. Haas, F. Leonard, I. Ernens, S. Rodius, M. Vausort, M. Rolland-Turner,
Y. Devaux, D.R. Wagner (Luxembourg, LU)
MicroRNA-16 down regulates cyclin expression in endothelial progenitor cells. P1153
M. Rolland-Turner, E. Goretti, F. Leonard, L. Zhang, C. Nicolas, B. Leners,
C. Jeanty, F. Azuaje, D.R. Wagner, Y. Devaux (Luxembourg, LU)
Sustained inhibition of phosphodiesterase 5 improves left ventricular function
and attenuates adverse remodeling one year after myocardial infarction in mice. P1154
P. Pokreisz, A. Lux, S. Vandenwijngaert, J. D hooge, T. Dresselaers,
U. Himmelreich, K.D. Bloch, S. Janssens (Leuven, BE; Budapest, HU; Boston, US)
Plasmonic nanophotothermal atherodestruction and stem cell therapy for the
management of heart failure. P1155
A.N. Kharlamov, J. Gabinsky, V. Veselova (Yekaterinburg, RU)
Characterizing the role of spinophilin in ryanodine receptor 2 phosphorylation
in cardiac myocytes. P1156
P. Wakula, S. Sedej, E.M. Gutschi, F.R. Heinzel, B. Pieske (Graz, AT)
129
TUESDAY
POSTERS

TUESDAY
POSTERS
TUESDAY 24 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Poster Session 5
Posters must be set up between 08:00 - 08:30, removed between 12:30 - 13:00, to be on display
between 08:30 - 12:30.
The presenter should be available by the poster during the coffee break (10:00 to 11:00) in order to
discuss the research with the audience
Acute heart failure (diagnosis, pathophysiology, other)
The frequency and serial changes of cardiac troponin release in patients with acute
heart failure syndrome who were treated with levosimendan or dobutamine. P1157
Y. Cavusoglu, E. Gencer, F. Mutlu, M. Tek, A. Nadiradze, A. Birdane, B. Gorenek, A. Unalir,
N. Ata (Eskisehir, TR)
The prognosis of patient hospitalised with acute heart failure on departments with
24 hour cath lab service - Acute HEArt Database (AHEAD) main registry. P1158
J. Spinar, J. Parenica, J. Vitovec, L. Spinarova, R. Miklik, P. Widimsky, A. Linhart,
J. Jarkovsky, L. Dusek (Brno and Prague, CZ)
Carbohydrate antigen 125 serial measurements after an admission for acute heart
failure and early readmission. P1159
G. Minana Escriva, J. Nunez, J. Sanchis, V. Bodi, P. Palau, M. Olivares, C. Bonanad,
S. Ventura, F.J. Chorro, A. Llacer (Valencia, ES)
Profile of the acute decompensated heart failure in children and adolescents:
opportunities to improve care of this critically ill population. P1160
M.C. Moreira, N.N. Diamantino, T.C. Diamantino, A. Costa, F. Araujo, L. Costa
(Belo Horizonte and Montes Claros, BR)
Clinical characteristics and the outcome of acute heart failure with severe LV systolic
dysfunction at the time of diagnosis: from KorHF Registry. P1161
S.H. Kim, S.W. Han, M.S. Shin, D.J. Choi, J.J. Kim, E.S. Jeon, M.S. Cho, C.C. Chae,
H. Ryu (Seoul, Incheon, Cheongju and Daegu, KR)
BNP levels, markers on inflammation and their interrelationship with aortic stenosis. P1162
I. Burazor, M. Burazor, V. Atanaskovic, J. Glasnovic, S. Stamenko (Nis and Novi Sad, RS)
Endothelial dysfunction in patients with chronic heart failure and myocardial infarction. P1163
N. Bylova, G.P. Arutyunov, I.M. Plieva, E.A. Kokin, I.I. Daiter (Moscow, RU)
Prognosis of heart failure (series of 1500 patients). P1164
F. Wadrahmane, N. Zoubir, A. Bennis (Casablanca, MA)
Effect of afterload alterations on left ventricular diastolic function and mechanical
dyssynchrony during ischemia and reperfusion; experimental study. P1165
N. Diakos, I. Pozios, L. Katsaros, E. Tseliou, M. Bonios, M. Tsamatsoulis, A. Ntalianis,
A. Papalois, J. Terrovitis, J. Nanas (Athens and Patras, GR)
Acute heart failure (therapy)
Treatment at discharge of AHF-related hospitalisation: The OFICA study. P1166
D. Logeart, J.N. Trochu, R. Isnard, P. Degroote, M. Galinier, T. Damy, J.C. Eicher, P. Gibelin,
F. Delahaye, Y. Neuder (Paris, Nantes, Lille, Toulouse, Creteil, Dijon, Nice, Lyon and Grenoble, FR)
Incidence and Predictors of Hyperkalemia in Patients With Heart Failure in Morocco. P1167
S. Fadili, N. Jardi, N. Baaddy, A. Bennis (Casablanca, MA)
Prediction of acute effect of tolvaptan on urine output in decompensated heart failure
patients -a substudy of QUEST trial. P1168
M. Fukunami, M. Matsuzaki, M. Hori, T. Izumi (Osaka, Ube and Sagamihara, JP)
130

TUESDAY 24 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Impact of atrial fibrillation on mortality, morbidity, and quality of life of heart failure
patients. P1169
F.D.C. Cruz, F.D. Cruz, V.S. Issa, S.F. Ayub, J. Vieira, J.R. Lanz, F.G. Baptista, E.A. Bocchi
(Sao Paulo, BR)
Animal models and experimentation
Alteration in systolic and diastolic cardiac function in murine model of atherosclerosis
(ApoE/LDLR-/- mice). P1170
U. Tyrankiewicz, T. Skorka, M. Jablonska, S. Chlopicki (Krakow, PL)
Myocardial expression of steroid 5-alpha-reductase and androgen receptor along with
testosterone and dihydrotestosterone concentrations in male pigs with tachycardiainduced
cardiomyopathy. P1171
M.W. Zacharski, A. Tomaszek, L. Kiczak, J. Bania, U. Paslawska, A. Janiszewski,
A. Noszczyk-Nowak, D. Zysko, E.A. Jankowska, P. Ponikowski (Wroclaw, PL)
MMP9-NGAL-TIMP1 complexes constitute myocardial pool of inactive MMP9 in male
pigs with tachycardia-induced cardiomyopathy. P1172
L. Kiczak, A. Tomaszek, J. Bania, M.W. Zacharski, U. Paslawska, A. Janiszewski, I. Rybinska,
J. Gajek, E.A. Jankowska, P. Ponikowski (Wroclaw, PL)
A natural p300-specific histone acetyltransferase inhibitor, curcumin, in addition to ACE
Inhibitor exerts beneficial effects on left ventricular systolic function after myocardial
infarction in rats. P1173
T. Morimoto, S. Sunagawa, H. Wada, T. Takaya, A. Shimatsu, T. Kimura, M. Fujita,
K. Hasegawa (Shizuoka and Kyoto, JP)
Arrhythmias and treatment
Significance of time to symptoms during head-up tilt test in patients with recurrent
syncope. P1174
A. Sousa, A.S. Correia, A. Lebreiro, C. Sousa, S. Oliveira, M. Paiva, I. Rangel, V. Ribeiro,
J. Freitas, M.J. Maciel (Porto, PT)
An in vitro method for studies of arrhythmogenesis in the heart. P1175
Y. Shao, A.Z.R.A. Mijatovic, E.L.M.I.R. Omerovic (Gothenburg, SE)
Atrial fibrillation
Implication of AGE-RAGE axis in atrial fibrillation in patients with heart failure. P1176
S. Raposeiras Roubin, B.K. Rodino Janeiro, L. Grigorian Shamagian, A. Seoane Blanco,
M. Moure Gonzalez, A. Varela Roman, E. Alvarez, J.R. Gonzalez Juanatey (Santiago de
Compostela and Vigo, ES)
The value of atrial fibrillation on exercise capacity and haemodynamic parameters at
dilated cardiomyopathy patients. P1177
T.A. Abdullaev, B.U. Mardanov, A.S. Eshpulatov, S.T. Mirzamukhamedova (Tashkent, UZ)
Inflammatory syndrome and missing tooth in Romanian patients with cardiovascular
disease and atrial fibrillation; possible role in atrial fibrillation pathogenesis. P1178
I.A. Gutiu, L.I. Gutiu, F.S. Radulescu, L. Dumitrescu (Bucharest and Chiajna, Ilfov, RO)
Beta blockers
Does beta-blockers intolerance in systolic heart failure really exists? P1179
G.E. Conceicao-Souza, P.R. Chizzola, V.S. Issa, F. Bacal, S.M. Ayub-Ferreira, F.D. Cruz,
G.V. Guimaraes, E.A. Bocchi (Sao Paulo, BR)
131
TUESDAY
POSTERS

TUESDAY
POSTERS
TUESDAY 24 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Comparison of the outcome in men and women who were on beta blocker and RAS
blocker treatment with chronic heart failure. P1180
G. Kozdag, G. Ertas, M. Yaymaci, U. Celikyurt, Y. Akay, H. Ekren, T. Sahin, T. Kilic,
G. Kahraman, D. Ural (Kocaeli, TR)
Cancer / Cardiotoxicity
A new index to predict heart failure in patients receiving trastuzumab. P1181
M. Arao, Y. Kitahara, K. Setsuta (Tokyo, JP)
The anti-neoplastic ErbB2-antibody 2C4 produces left ventricular dysfunction in
murine hearts. P1182
C.G. Tocchetti, C. Coppola, A. Barbieri, D. Rea, G. Ragone, G. Palma, C. Arra,
C. De Lorenzo, R.V. Iaffaioli, N. Maurea (Naples, IT)
Cardiac resynchronisation therapy
Analysis of mortality events in ischemic heart failure patients after coronary artery
bypass grafting and concomitant cardiac resynchronization therapy: results from
multicenter study. P1183
A. Romanov, E. Pokushalov, V. Shabanov, D. Prokhorova, I. Stenin, D. Elesin (Novosibirsk, RU)
Outcomes of cardiac resynchronization therapy in chronic chagasic cardiomyopaty. P1184
M. Martinelli, S. Martins, R. Molina, S. Siqueira, S.A.D. Nishioka, R. Alkmim-Teixeira,
A.A.A. Pedrosa, G.L. Peixoto, R. Costa, J.A.F. Ramires (Sao Paulo, BR)
Development of a clinical and late gadolinium enhancement CMR index to predict
cardiac events after cardiac resynchronization therapy. P1185
A. Valle, J. Estornell, M. Corbi, E. Lucas, P. Garcia, O. Fabregat, A. Pirola, A. Quesada,
R. Paya, F. Ridocci Soriano (Albacete and Valencia, ES)
The role of stress myocardial perfusion to predict left ventricular reverse remodeling in
patients with ischemic cardiomyopathy treated by resynchronisation therapy. P1186
M.-A. Morales, A. Gimelli, U. Startari, L. Panchetti, A. Rossi, P. Marzullo, M. Piacenti (Pisa, IT)
Cardiac resynchronization therapy - prognosis of patients with upgrade from
conventional pacing. P1187
H. Dores, J.M. Santos, J. Abecasis, S. Leal, M.J. Correia, S. Fartouce, C. Aguiar,
F.B. Morgado, A. Aleixo, M. Mendes (Lisbon, PT)
Diastolic function in patients with cardiac resynchronization therapy. P1188
O. Londono Sanchez, J. Perez, S. Pacreu, E. Frigola (Barcelona, ES)
Outcomes of biventricular pacemaker upgrade. P1189
J.D. Brito, P. Carmo, D. Cavaco, K. Reis Santos, F. Morgado, F. Costa, M. Santos,
P. Adragao, M. Mendes (Carnaxide, PT)
The effect of cardiac resynchronization therapy in patients with atrial fibrillation and
non-left bundle branch block morphology: the role of atrioventricular node ablation. P1190
A.D. Demir, S. Cay, O. Ozeke, R. Atak (Eskisehir, Istanbul and Ankara, TR)
Heart failure and cardiac resynchronization therapy: clinical characteristics and long
term mortality. P1191
M.E. Tettamanti, J. Lopez Diaz, J.A. San Roman Calvar, L. De La Fuente Galan, R. Arnold,
E. Garcia Moran, C. Tapia Ballesteros, I. Gomez Salvador, A. Recio Platero, A. Puerto Sanz
(Valladolid, ES)
Short-term CRT effects on patients implanted according to guidelines. P1192
M. Brambatti, S. Molini, F. Guerra, M. Morelli, S. Guardiani, A. Romandini, A. Giovagnoli,
M.V. Matassini, M. Marchesini, A. Capucci (Ancona, IT)
132

TUESDAY 24 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Cardiomyopathy
Desmin expression in cardiomyocytes and mitochondrial alteration in idiopathic dilated
cardiomyopathy. P1193
A. Pawlak, J. Rzezak, A. Nasierowska-Guttmejer, E. Czarnowska, K. Gil, K. Byczkowska,
R.J. Gil (Warsaw, PL)
The value of global myocardial index to detect cardiac dyssynchrony in patients with
non-ischemic dilated cardiomyopathy. P1194
C. Mornos, M. Nicolin, A. Ionac, A. Mornos, S. Pescariu, S.I. Dragulescu (Timisoara, RO)
Congestive heart failure in patients with hypertrophic cardiomyopathy. P1195
N.S. Krylova, E.V. Avdeeva, N.G. Poteshkina (Moscow, RU)
Evaluation of hemodynamic, echocardiographic and laboratory parameters as
prognostic factors in non-ischemic dilated cardiomyopathy in 2.5-years follow-up. P1196
W. Jachec, C.A. Wojciechowska, A. Gala, K. Krzemien-Wolska, E. Nowalany-Kozielska (Zabrze, PL)
Echocardiography, ECG and holter monitoring indices and c-reactive protein values in the
hypertrophic cardiomyopathy patients with heart failure of different functional classes. P1197
O.O. Bilostotska, K.Y.U. Kinoshenko, V.I. Tseluyko (Kharkiv, UA)
Peripartum Cardiomyopathy in pregnant women positive to Chagas disease. P1198
O. Londono Sanchez, S. Pacreu, C. Muntaner, E. Frigola (Barcelona, ES)
Peripartum cardiomyopathy. P1199
N.A.J. Yamoul, K. Chraibi, R. Habbal, L. Azzouzi, A. Bennis (Casablanca, MA)
Cardio-renal syndrome
NGAL for the prediction of acute kidney injury in acute heart failure. P1200
T. Breidthardt, T. Socrates, B. Dexler, T. Klima, M. Potocki, M. Noveanu, T. Reichlin,
J. Steiger, C.H. Mueller (Basel, CH)
Blood urea nitrogen: the best renal predictor for mortality in patients with
decompensated heart failure. P1201
S. Barra, F. Caetano, L. Paiva, C. Faustino, P. Gomes, R. Providencia, I. Almeida,
A. Leitao Marques (Coimbra, PT)
NGAL as a new biomarker of renal dysfunction in acute heart failure. Methodological
implications. P1202
M. Bonadies, S. Mazzetti, P. Delfino, I. Fracchioni, E. D’elia, V. Casali, G. Specchia,
A. Mortara (Monza, IT)
Risk factors for heart failure decompensation in patients who undergo creation of an
arterio-venous fistula for chronic intermittent ultrafiltration therapy. P1203
E. Repasos, J. Terrovitis, A. Ntalianis, E. Kaldara, C. Pantsios, S. Vakrou, S. Sventzouri,
G. Alexopoulos, J. Kanakakis, J. Nanas (Athens, GR)
Cardiac functional capacity and kidney failure: is there a correlation? P1204
R. Lagioia, R. Raimondo, G. Farinola, M. Iacoviello, F. Monitillo, M. Gesualdo, A. Zito,
S. Favale, R. Pedretti, D. Scrutinio (Cassano Murge, Tradate and Bari, IT)
Cellular biology
EPA protects the cultured cardiac myocytes against oxidative stress via autophagy. P1205
C.H. Chiang, H.C. Hsu, M.F. Chen, C.Y. Chen (Taipei, TW)
Gene expression profile of atherosclerotic coronary artery disease of in patients of
different ethnicity in Malaysia. P1206
M.H. Ngoo Abdullah, Z. Othman, H. Mohd Noor, R. Jamal, A.K. Mohd Yusof,
A.R. Abdul Rahman (Cyberjaya and Kuala Lumpur, MY)
133
TUESDAY
POSTERS

TUESDAY
POSTERS
TUESDAY 24 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Co-morbidities (inc COPD, anaemia, cachexia)
Reduced bone mineral density is associated with cachexia in heart failure and can
identify patients at risk of adverse prognosis. P1207
P. Zotos, J. Terrovitis, E. Kaldara, A. Ntalianis, S. Vakrou, L. Katsaros, S. Sventzouri,
A. Chalazonitis, D. Kontoyannis, J. Nanas (Athens, GR)
Heart failure plus common co-morbidites and their outcomes in a multi-ethnic Asian
cohort in Singapore. P1208
K.T. G. Leong, Y. Cao, M. Tan, S. Buhari, S. Lim, Y. Yeo, K. Poh, P.P. Goh (Singapore, SG)
The relation between malnutrition evaluated by the Mini-Nutritional Assessment (MNA)
in ambulatory patients with heart failure, quality of life (QoL) assessed by the MLHFQ
test and NtProBNP. P1209
M. Satendra, C. Santos De Sousa, L. Sargento, I. Almeida, M. Teixeira, F. Salazar,
N. Lousada, R. Palma Dos Reis (Lisbon, PT)
Cardiac remodeling in elderly patients with heart failure: obesity influence. P1210
L. Malinova, T. Denisova, T. Silina (Saratov, RU)
Chronic obstructive pulmonary disease diagnosed based on the lower limit of normal
does not worsen survival in chronic heart failure patients. P1211
M.K. Lizak, M. Zakliczynski, A. Jarosz, M. Zembala, Z. Kalarus (Zabrze, PL)
A retrospective study of systematic research of chronic obstructive pulmonary disease
in a systolic heart failure population. P1212
B. Arnaudis, O. Lairez, J. Roncalli, A. Pathak, R. Escamilla, M. Galinier (Toulouse, FR)
Cardiac and non-cardiac comorbidity in elderly patients with HFREF and HFPEF P1213
N. Solomakhina, Y.N. Belenkov (Moscow, RU)
Vulnerability and protective factors of non-resilience in a sample of Portuguese
patients with heart failure. P1214
M.M. Fontelonga Bento, C. Fonseca, F. Marques, I. Araujo, A. Leitao, F. Ceia (Lisbon, PT)
Comparison of functional and laboratory indicators at patients with CHF and anemia,
depending on aetiology of disease. P1215
T.A. Abdullaev, I.A. Tsoi, B.U. Mardanov (Tashkent, UZ)
Cytokines and inflammation
Short term effects of reperfusion therapy on biomarkers of apoptosis and inflammation
in patients with acute myocardial infarction. P1216
A. Iakovleva, O. Mirolyubova, K. Holmatova, I. Dvoryashina (Arkhangelsk, RU)
Effectiveness of the relative lymphocyte count to predict one-year mortality in patients
with acute heart failure. P1217
M. Olivares, J. Nunez, G. Minana, J. Sanchis, V. Bodi, P. Palau, E. Nunez, F.J. Chorro,
A. Llacer (Valencia, ES)
ICD therapy
Efficacy of Ivabradine in patients with chronic heart failure after myocardial infarction. P1218
V. Moiseev, A. Potapenko, O. Abdulasisov, L. Dyatchuk, I. Meray, G. Kiyakbaev,
Z.H. Kobalava (Moscow, RU)
Laboratory results and death rate in patients with decompensated chronic heart
failure and hyperurikemia. P1219
E. Sinyutina, L. Aleksandriya, V. Moiseev (Moscow, RU)
134

TUESDAY 24 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Diagnosis of heart failure and biomarkers
Rapid point-of-care NT-proBNP optimal cut-off point for heart failure diagnosis in a
primary health care center. P1220
J.M. Verdu, J. Comin-Colet, M. Domingo, J. Lupon, L. Molina, M. Gomez, A. Mena,
M.A. Munoz, J.M. Casacuberta, J. Bruguera (Barcelona and Badalona, ES)
Usefulness of Framingham clinical criteria, ECG and NT-proBNP in patients with
suspected heart failure in a primary health care center. P1221
J.M. Verdu, J. Comin-Colet, M. Domingo, J. Lupon, S. Fuentes, A. Mena, J.M. Baena,
M.A. Munoz, J.M. Casacuberta, J. Bruguera (Barcelona, Badalona and
Santa Coloma de Gramanet, ES)
Endothelial and platelet -derived circulating microparticles - correlations with
lipoprotein-associated phospholipase A2, paraoxonase and myeloperoxidase in heart
failure. P1222
D.S. Marta, R. Huica, I. Serban, I. Serban, G. Catalin, S. Huica, E. Moldoveanu (Bucharest, RO)
Left ventricular diastolic dysfunction in patients at high risk for the development of
heart failure: gender differences. P1223
R. Dankowski, M. Wierzchowiecki, M. Michalski, A. Nowicka, K. Szymanowska, A. Pajak,
A. Szyszka (Poznan, PL)
Evolution of ferrokinetics and inflammatory parameters in patients with chronic heart
failure. P1224
A. Martinez-Ruiz, P.L. Tornel-Osorio, J. Sanchez-Mas, M.C. Asensio-Lopez, J.A. Vilchez,
F. Pastor-Perez, I.P. Garrido-Bravo, A. Lax, P. Martinez-Hernandez, D.A. Pascual-Figal
(Murcia, ES)
Combining electrocardiography and a B-type natriuretic peptide cutoff of 50 pg/mL
provides an effective screen for asymptomatic left ventricular dysfunction : a report
from the STOP - HF STUDY. P1225
G. Murtagh, R. O’ Connell, I.R. Dawkins, M.T. Ledwidge, E. Tallon, R. O’ Hanlon,
K.M. Mc Donald (Dublin, IE)
Relationship between end-tidal carbon dioxide tension and severity of heart failure
with reduced systolic function. P1226
T. Lelyavina, T.A. Lelyavina, M.Y.U. Sitnikova, A.V. Beresina, E.V. Shlyakhto
(Saint Petersburg, RU)
Persistent myocardial necrosis and prognosis of patients with chronic heart failure. P1227
E.N. Golovenko, D.A. Napalkov, V.A. Sulimov (Moscow, RU)
Disease management and patient education
ESC guidelines implementation in the management of outpatients with systolic heart
failure by cardiologists and general practitioners in Poland. P1228
E.A. Jankowska, B. Kurian, C. Zajaczkowski, W. Banasiak, P. Ponikowski (Wroclaw and
Warsaw, PL)
Heart failure integrated care management programs are the key to reduce
rehospitalizations. P1229
G. Borelli, L. Rondinini, S. Mosa, F. Bellini, P. Rossi, M. Polselli, B. Gavini, A. Balbarini,
R. Mariotti (Pisa and Massa, IT)
A french heart failure management program :a comparative study. P1230
F. Dany, P. Virot, C. Daragon, F. Dalmay, P.M. Preux, M. Icarlim Network Members
(Limoges, FR)
135
TUESDAY
POSTERS

TUESDAY
POSTERS
TUESDAY 24 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Effect of a patient education programme on quality of life among patients with
chronic heart failure. P1231
M.-F. Seronde, R. Chopard, S. Janin, Y. Bernard, N. Meneveau, F. Schiele (Besancon, FR)
Drug therapy, other
Is aspirin use associated with mortality risk in heart failure? Results from a large
community based cohort. P1232
M. Bermingham, M.K. Shanahan, S. Miwa, I. Dawkins, R. O hanlon, K. Mcdonald,
M. Ledwidge (Dublin, IE)
Dynamics of collagen matrix and renal dysfunction parameters in patients with
chronic heart failure treated with ivabradine. P1233
N. Koziolova, M. Surovtseva, A. Chernyavina (Perm, RU)
The effect of 5-lipoxygenase inhibitor on ventricular repolarization variability in
patient with mild-to-moderate chronic heart failure (NYHA II-IV). P1234
S. Kozhukhov, A. Parkhomenko, T. Sosnitska, A. Shumakov, A. Stepura (Kiev, UA)
Potential market for ivabradine in an outpatient-based heart failure unit in a large
university hospital. P1235
M.-F. Seronde, R. Chopard, S. Janin, Y. Bernard, N. Meneveau, F. Briand, F. Schiele
(Besancon, FR)
Marked reverse remodelling with medical therapy of heart failure. P1236
A. Ventosa, C. Aguiar, F.M. Costa, G. Cardoso, M. Trabulo, J. Ferreira, J. Aniceto Silva,
M. Mendes (Carnaxide, PT)
Impact of recent clinical trials on management of heart failure patients. P1237
R. Noad, N. Mckeag, L. Hill, J. Davidson, L. Dixon (Belfast, GB)
Short term evaluation of prostaglandin infusion in severe heart failure with
pulmonary hypertension. P1238
W. Serra, M.L. Musiari, A.M. Montanari, A.D. Ardissino, L.B. Boeti, A.C. Cattabiani,
T.G. Gherli (Parma, IT)
Levosimendan improves hemodynamics and renal function and reduces NT-proBNP
in stable patients with advanced heart failure. P1239
M. Stahlberg, I. Lofman, E. Ottenblad, I. Hagerman, L.H. Lund (Stockholm, SE)
Echocardiography
Percutaneous mitral commissurotomy in the pregnant woman. P1240
F. Wadrahmane, R.G. Kongo, H.S. Hajib (Casablanca, MA)
Diagnostic accuracy of Doppler diastolic parameters in revealing of moderate-severe
chronic heart failure in patients with elevated LV filling pressures. P1241
A.G. Ovchinnikov, A.G. Azizova, Z. Blankova, F.T. Ageev (Moscow, RU)
Three-dimensional assesment of left atrial mechanical and structural remodelling in
patients with heart failure and atrial fibrillation. P1242
I.S. Benedek, I. Kovacs, Z. Suciu, B. Jako, M. Chitu, I.A. Sarbu-Pop, I. Benedek Jr,
T. Benedek (Targu Mures, RO)
Preejection velocity spikes of the left ventricular wall in patients with heart failure. P1243
F.Q. Huang, R.S. Tan (Singapore, SG)
NtProBNP and systodiastolic left ventricular function in patients with heart failure
secondary to left ventricular impairment. A 2D Strain study. P1244
C.I. Santos De Sousa, M. Satendra, L. Sargento, I. Almeida, M. Teixeira, F. Salazar,
N. Lousada, R. Palma Reis (Lisbon, PT)
136

TUESDAY 24 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Impact of common echocardiographic measures in the progression of mitral
regurgitation in assintomatic patients. P1245
P. Gomes, S. Barra, R. Providencia, A.M. Leitao Marques (Coimbra, PT)
Exercise testing & training
Red cell distribution width (RDW) is better prognostic marker in heart failure patients
than cardiopulmonary exercise test parameters. P1246
E. Straburzynska-Migaj, A. Gwizdala, S. Grajek (Poznan, PL)
Psychological distress in cardiac rehabilitation: a dual relationship. P1247
S.M. Oliveira, A. Rocha, A.S. Correia, C. De Sousa, A. Lebreiro, A. Sousa, V. Araujo,
J.D. Sousa, F. Pereira-Parada, M.J. Maciel (Porto, PT)
Cognitive impairment affects physical recovery of patients with heart failure
undergoing exercise training. P1248
F. Ranghi, S. De Benedetti, M. Volterrani, G. Caminiti, D. Battaglia, A. Franchini,
B. Sposato, G. Rosano (Rome, IT)
Impact of ageing in peak VO2 and VE/VCO2 slope in heart failure patients. P1249
G. Guimaraes, J.A. Neder, L.N. Pascoalino, V.O. Carvalho, S. Ayub-Ferreira, V.S. Issa,
J.M. Roque, G.C. Sousa, J.F.C. Belli, E.A. Bocchi (Sao Paulo, BR)
Functional capacity and quality of life improvement among women and elderly
patients referenced to a cardiac rehabilitation program. P1250
A. Lebreiro, A. Rocha, M. Paiva, A. Sousa, P. Lourenco, S. Oliveira, A.S. Correia, V. Araujo,
F. Parada, M.J. Maciel (Porto, PT)
Cardiac vulnerability decrease by reduction of catecholaminergic response and
haemodinamic overload during maximal effort. The role of aerobic traning. P1251
L.E. Pastormerlo, A. Giannoni, F. Bramanti, C. Mammini, G. Mirizzi, C. Passino,
M. Emdin (Pisa, IT)
Rehabilitation patients after myocardial infarction with systolic dysfunction and
concomitant arterial hypertension. P1252
I. Malynovska, V. Shumakov, I. Gotenko, L. Kisilevich, L. Prohna, L. Tereshkevysh,
O. Yanus (Kiev, UA)
Haemodynamics / Coronary and peripheral circulation
The «paradox» of cardiac output reduction following surgical ventricular
reconstruction not associated with clinical worsening. P1253
M. Di Donato, F. Fantini, V. Dor, L.A.M. Menicanti (Florence and San Donato Milanese, IT;
Monaco, MC)
Characteristics of arterial stiffness in patients with systolic heart failure. P1254
R. Akhmetov, I. Goncharov, S. Villevalde, Y. Kotovskaya, L. Alexandria, A. Safarova,
V. Moiseev (Moscow, RU)
Left ventricle diastolic function after myocardial infarction in patients treated with
primary angioplasty (pPCI). P1255
M. Misztal, A. Gackowski, K. Zmudka, W. Piwowarska, J. Nessler (Krakow, PL)
Heart transplantation / Assist devices
Factors predicting successful prednisolone cessation in heart transplant recipients. P1256
S.C. Mckenzie, M.R. Brown, D.G. Platts, J. Maddicks-Law, G. Javorsky (Brisbane, AU)
Noninvasive criteria of acute cellular rejection transplanted heart. P1257
T. Vaikhanskaya, I. Sidorenko, Y. Ostrovskiy (Minsk, BY)
137
TUESDAY
POSTERS

TUESDAY
POSTERS
TUESDAY 24 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Driveline infections in patients supported with a continuous flow LVAD: incidence,
microbiology, biomarkers and outcome. P1258
T. Bomholt, C. Moser, S. Boesgaard, L. Kober, K. Sander, P.S. Olsen, P.B. Hansen,
S.A. Mortensen, F. Gustafsson (Copenhagen, DK)
Histology of the donor heart and graft dysfunction in heart transplantation. P1259
S. Mangini, M.L. Higuchi, S. Palomino, M.M. Reis, A.I. Fiorelli, A. Benicio,
P.M.A. Pomerantzeff, N.G. Stolf, F. Bacal, E.A. Bocchi (Sao Paulo, BR)
The «hub & spoke» model for long-distance bridging of patients on Mechanical
Circulatory Support (MCS). P1260
G. Guzzi, M. Maiani, V. Tursi, I. Vendramin, C. Daffarra, L. Vetrugno, D. Miani, U. Livi (Udine, IT)
Fontan like circulation as a criterion for heart transplantation in right ventricular
cardiomyopathies. A single center experience. P1261
J. Altenberger, G. Poelzl, B. Strohmer, R. Steinacher, C. Schernthaner, M. Pichler (Salzburg, AT)
Hormones / Neurohumoral regulation
fT3 to fT4 ratio predicts 5 year survival in heart failure patients. P1262
M. Nikolaou, J. Parissis, F. Kolokathis, C. Michalakeas, S. Gaitani, P. Rafouli-Stergiou,
K. Tsitlakidis, D.T. Kremastinos, M. Anastasiou Nana, G. Filippatos (Athens, GR)
Euthyroid sick syndrome management in congestive heart failure. P1263
I. Shatynska-Mytsyk, Y.U. Kyyak, O. Makar (Lviv, UA)
Hypertension / LV hypertrophy
Blood pressure variability increased is associated with heart rate turbulence in
hypertensive patients. P1264
E. Silva, E. Sierra, J.J. Villasmil, A. Gonzalez, M. Bracho, C. Esis, G. Calmon, S. Briceno
(Maracaibo, VE)
Atherosclerotic process and immunological factors in essential hypertension. P1265
M. Rivera, J.R. Calabuig, E. Rosello, N. Carpena, L. Almenar, V. Miro, L. Grigorian,
P. Morillas, M. Portoles, V. Bertomeu (Valencia, Santiago de Compostela and Alicante, ES)
Acute heart failure post myocardial infarction: arterial hypertension, an important risk
factor. P1266
F.C. Adam, R.M. Ianula, A.I. Popa, M. Dasoveanu, C.L. Andrei, V.P. Chioncel, L.N. Axente,
M. Anastasiu, D.E. Mincu, C.J. Sinescu (Bucharest, RO)
Tissue-type plasminogen activator plasma levels are related with systolic and pulse
pressure and left ventricular mass in patients with essential hypertension. P1267
M. Rivera, E. Rosello, J.R. Calabuig, J.R. Gonzalez Juanatey, P. Morillas, V. Miro, T. Lozano,
P. Orosa, M. Portoles, V. Bertomeu (Valencia, Santiago de Compostela, Alicante, Villajoyosa
and Gandia, ES)
Left ventricular function
Early signs of global left ventricular dyssynchrony at real-time 3-dimensional
echocardiography in high-risk type 2 diabetes patients correlate with higher coronary
calcium score and predict IMT. P1268
E. De Marco, A. Colucci, G. Savino, F.A. Gabrielli, R. Natali, G. Comerci, M. Savino,
B. Garramone, M. Lotrionte, F. Loperfido (Rome, IT)
Are there different profiles of patients with type 2 diabetes and diastolic dysfunction? P1269
L.J.M. Boonman-De Winter, F.H. Rutten, M.J. Landman, A.H. Liem, M.J.M. Cramer,
A.W. Hoes (Etten-Leur, Utrecht, Leusden and Goes, NL)
138

TUESDAY 24 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Global left ventricular function is related to coronary artery calcification score in
patients with chronic ischemic heart disease. P1270
I. Burazor, Z. Radovanovic, M. Burazor, P. Bosnjakovic, V. Erakovic (Nis, RS)
Metabolism / Diabetes mellitus
Clinical and biochemical predictors of carotid intima media thickness in adolescents
with type 2 diabetes. P1271
R. Gaber, N.E.S.R.E.N. Kotb (Tanta, EG)
Body mass index or nutritional status to stratify prognosis in heart failure? P1272
P. Gastelurrutia, J. Lupon, M. Domingo, N. Ribas, M. Noguero, A. Bayes-Genis
(Badalona and Barcelona, ES)
Decrease of glycated hemoglobin more than 1% is associated with increase of
exercise capacity in heart failure patients with type 2. P1273
V. Mareev, O. Narusov, Y.U. Lapina, N. Baklanova, Y.U. Belenkov (Moscow, RU)
Metabolic therapy of chronic heart failure in patients with alcoholic cardiomyopathy. P1274
A. Vertkin, A. Skotnikov (Moscow, RU)
Ischemia / Reperfusion / Preconditioning
Myocardial structural changes in human severe sepsis/septic shock in pediatric
patients undergoing surgery for congenital heart repair. P1275
S.G. Ramos, M.S. Oliveira, W.V.A. Vicente, E.Z. Martinez, E.M. Floriano (Ribeirao Preto, BR)
Predictors of heart failure at 6 month follow up after Acute coronary syndrome. P1276
R. Faria, N. Marques, J. Mimoso, I.L.I.D.I.O. Jesus (Faro, PT)
Molecular biology / Genetics
A potential role for DNA methylation in hypoxia induced cardiac fibrosis. P1277
C.J. Watson, C. Robinson, M. Xu, P. Collier, M. Ledwidge, K. Mcdonald, J. Baugh (Dublin, IE)
TIMP-4 single nucleotide polymorphism influences systolic dysfunction in patients
with heart failure. P1278
A. Alaves, Y. Rivlin, U. Rosenschein, J.A. Duarte, M. Sagiv, J. Oliveira, E. Goldhammer
(Porto, PT; Haifa and Netanya, IL)
MRI, nuclear cardiology and CT (imaging)
Detection of left ventricular thrombus in patients with decreased systolic function:
Magnetic resonance imaging or echocardiography? P1279
A. Musschoot, F. Mouquet, C. Goeminne, G. Goyault, M. Fertin, N. Lamblin, J.P. Beregi,
P. De Groote (Lille, FR)
Pericardial fat, a new marker of impaired left ventricle diastolic dysfunction. P1280
A. Faustino, R. Providencia, L. Paiva, P. Mota, M. Costa, A. Leitao-Marques (Coimbra, PT)
Natriuretic peptides
Valve replacement and NT pro-BNP level: influence of atrial fibrillation presence and
class of heart failure. P1281
A. Zhadan, V. Tseluyko, O. Romanenko (Kharkiv, UA)
An emerging risk factor for diabetic cardiomyopathy:Is B-type natriuretic peptide
associated with persistent nondipping nocturnal blood pressure over 1 year in patients
with hypertension and diabetes?. P1282
K.J. Voon, U. Bhutta, D. Phelan, C.J. Watson, O. Elrasheed, N. Murphy, R. O’ Hanlon,
M.T. Ledwidge, D. O’ Shea, K.M. Mc Donald (Dublin, IE)
139
TUESDAY
POSTERS

TUESDAY
POSTERS
TUESDAY 24 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Prognostic factors of mid-term clinical outcome in congestive heart failure patients. P1283
M. Feola, E. Lombardo, C. Taglieri, S. Piccolo, A. Vado (Fossano and Cuneo, IT)
Single centre observational study examines the diagnostic value of natriuretic peptides
in the assessment of de-compensating heart failure in patients with preserved left
ventricular function. P1284
C.C. Lewis, K. Morgan, J. O’farrell, B. Mcadam (Dublin, IE)
Nursing
Optimisation of medical therapy after cardiac resynchronisation: a nursing
opportunity not to be missed. P1285
S. Russell, J. Bell, J. Davies, H. Rose, L. Edmunds, Z.R. Yousef (Cardiff, GB)
Implementation and testing of the digital pen to support patients with heart failure
and their health care providers in detecting early signs of deterioration and monitor
adherence - a pilot study. P1286
L. Lind, L. Klompstra, T. Jaarsma, A. Stromberg (Linkoping, SE)
Educational level and self-care behaviour in heart failure patients. P1287
B. Gonzalez, J. Lupon, L. Cano, R. Cabanes, M. De Antonio, M. Arenas, E. Crespo,
M. Rodriguez, A. Urrutia, A. Bayes-Genis (Badalona, ES)
Other
Osteoporosis in chronic heart failure is associated with severity of clinical symptomatic,
impaired renal function, secondary hyperparathyroidism and vitamin D deficiency. P1288
E. Reznik, G. Gendlin, V. Guschina, I. Ganieva, G. Storozhakov (Moscow, RU)
Mortality and admission rates among heart failure (HF) patients with preserved
ejection fraction (HF-PEF) and reduced ejection fraction (HF-REF) in Sweden. P1289
G. Wikstrom, J. Stalhammar, R. Ariely, R. Linder, A. Ogbonnaya, L. Stern
(Uppsala and Stockholm, SE; East Hanover and New York, US)
Preliminary results of the heart function assessment registry trial in Saudi Arabia in
patients followed at the heart failure clinic (HEARTS-HFC). P1290
A. Elasfar, K. Alhabib, H. Albackr, F. Alshaer, H. Alfaleh, A. Hersi, T. Kashour, A. Qasim,
M. Youssef (Riyadh, SA)
Erectile dysfunction and chronic heart failure: correlation between ed and the severity
of symptoms at the 6 minutes walk test. P1291
N. Zoubeir, H. Najih, F.Z. Wadrahmane, S. Abderrazak, A. Bennis (Casablanca, MA)
Markers of oxidative stress in STEMI patients with acute heart failure. P1292
M. Tomandlova, J. Tomandl, J. Parenica, P. Kala, M. Poloczek, E. Taborska, J. Spinar (Brno, CZ)
Survival and prognosis of patients with chronic heart failure and left venticular
dysfunction. P1293
B. Kanazirev, K. Domuschiev, N. Konjarova, L. Shipchanova (Varna, Burgas and Pleven, BG)
Pathophysiology
Vitamin D deficiency In heart failure with normal ejection fraction. P1294
A.J. Lagoeiro Jorge, M.L. Ribeiro, L.C. M. Fernandes, P.G. Lanzieir, B.A. L. Jorge,
F.V. Licio, E.T. Mesquita (Niterói and Rio De Janeiro, BR)
Age features of cellular membranes in patients with chronic heart failure in carvedilol
therapy. P1295
T. Rebrova, S. Afanasiev, O. Putrova, V. Perchatkin, A. Repin (Tomsk, RU)
140

TUESDAY 24 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Population studies / Epidemiology
Prevalence of diastolic left ventricular dysfunction in European populations based on
cross-validated diagnostic thresholds. P1296
T. Kuznetsova, M. Kloch-Badelek, W. Sakiewicz, V. Tikhonoff, A. Ryabikov, S. Malyutina,
K. Stolarz-Skrzypek, K. Narkiewicz, K. Kawecka-Jaszcz, J. Staessen
(Leuven, BE; Krakow and Gdansk, PL; Padova, IT; Novosibirsk, RU)
Ethnic differences in patient characteristics at time of first referral to specialized heart
failure clinics. P1297
J.M.O. Arnold, J. Howlett, P. Liu, H. Haddad, M.-H. Leblanc, A. Ignaszewski, S. Zieroth,
S. Baker, D. Murthy, G. Marchiori (London, Calgary, Toronto, Ottawa, Quebec City,
Vancouver, Winnipeg, Penticton and Regina, CA)
Epidemiology of heart failure in the Hungarian patient population using administrative
health data. P1298
P. Soos, E. Belicza, D. Becker, A. Apor, L. Geller, B. Merkely (Budapest, HU)
The comparative heart failure profile at five years interval in a romanian general
hospital. P1299
D. Pop, G. Gusetu, O. Penciu, A. Sitar Taut, D.T. Zdrenghea (Cluj-Napoca, RO)
Comparison of elderly heart failure patients with younger based on Swedish
National Heart Failure Registry. P1300
A. Holmstrom, L. Ma, R. Sigurjonsdottir, M. Edner, Å. Jonsson, U. Dahlstrom, M. Fu
(Gothenburg, SE)
Prognosis (other)
Effect of Arterial Stiffness on Development of Cardio - Vascular Complications of
patients with Chronic Heart Failure. P1301
N.A. Kosheleva, A.P. Rebrov (Saratov, RU)
Hyponatremia - available and reliable predictor in acute heart failure patients. P1302
I. Varga, P. Lesny, P. Solik, M. Luknar, B. Liska, E. Goncalvesova (Bratislava, SK)
Absence of restrictive pattern in lung function tests predicts better survival in chronic
heart failure patients with peak oxygen consumption below the cut-off point for heart
transplantation listing. P1303
M.K. Lizak, M. Zakliczynski, A. Jarosz, M. Zembala, Z. Kalarus (Zabrze, PL)
Prognostic value of 24h Blood Pressure variability in Chronic Heart Failure. P1304
M. Berry, J. Fourcade, O. Lairez, A. Pathak, B. Chamontin, J. Roncalli, D. Carrie, M. Galinier
(Toulouse, FR)
Red cell distribution width, anemia and mortality in heart failure patients. P1305
J. Diez Manglano (Zaragoza, ES)
Impact of hyponatremia in short-term prognosis of heart failure, data from an heart
failure registry. P1306
D.A. Moreira, B.F. Rodrigues, C.E. Correia, L.F. Santos, L.M. Nunes, J.O. Santos (Viseu, PT)
Do risk scores for silent atherosclerosis underestimate disease risk? P1307
F. Moscoso Costa, J. Ferreira, P.E.D.R.O. Goncalves, S.A.L.O.M.E. Carvalho, G. Cardoso,
P. Santos, M. Santos, C. Aguiar, M. Trabulo, M. Mendes (Lisbon, PT)
Endothelial dysfunction in chronic heart failure is associated with increased mortality
risk and predicts long-term cardiovascular-related events. P1308
S. Radovanovic, M. Krotin, D.V. Simic, A. Djokovic, M. Zdravkovic, A. Savic-Radojevic,
M. Pljesa-Ercegovac, M. Matic, M. Zaja-Simic, T. Simic (Belgrade, RS)
141
TUESDAY
POSTERS

TUESDAY
POSTERS
TUESDAY 24 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Impact of fibrinogen, protein C and apolipoprotein B genes on prognosis in patients
with chronic heart failure who suffered troponin-positive acute coronary syndrome. P1309
N. Koziolova, E. Polyanskaya (Perm, RU)
Cardiac resynchronization therapy: is there background to use age as a criterion? P1310
C. Gomes, D. Anjo, A. Meireles, M. Vieira, M. Santos, C. Roque, P. Vieira, V. Lagarto,
H. Reis, S. Torres (Porto, PT)
Ventricular Late Potential Detected by Signal Averaged Electrogram was Predicted
Heart Failure Death in Patients With Chronic Heart Failure. P1311
Y. Furukawa, T. Yamada, T. Morita, K. Tanaka, Y. Iwasaki, M. Kawasaki, Y. Kuramoto,
T. Naito, T. Fujimoto, M. Fukunami (Osaka, JP)
Mitral Regurgitation after an acute myocardial infarction: predictors and prognosis
impact at a 2-year follow-up. P1312
L.V. Paiva, S. Barra, R. Providencia, P. Gomes, A. Botelho, A. Leitao-Marques (Coimbra, PT)
Peak vO2 and predicted vO2 in patients under beta blocker therapy - lower cut-off
for heart transplantation. P1313
M. Paiva, S. Amorim, P. Viana, E. Martins, M. Campelo, B. Moura, J. Silva Cardoso,
M.J. Maciel (Porto, PT)
Prognosis (using biomarkers)
N-terminal pro-B-type natriuretic peptide is a marker of reversible myocardial
dysfunction after non-ST-elevation acute coronary syndrome. P1314
K. Broch, C. Eek, R. Wergeland, T. Ueland, R. Skaardal, P. Aukrust, H. Skulstad,
L. Gullestad (Oslo, NO)
Prognostic role of red cell distribution width (RDW) variations among patients with
chronic heart failure. P1315
N. Pezzali, M. Metra, E. Vizzardi, C. Lombardi, L. Lupi, C. Ciccarese, B. Piovanelli,
L. Dei Cas (Brescia, IT)
Quality of life predictors in stable chronic heart failure. P1316
L. Voronkov, 0. Lutsak, P. Babich, A. Lyashenko (Kyiv, UA)
High sensitivity ST2 and prognosis in ambulatory heart failure patients. P1317
A. Bayes-Genis, M. De Antonio, A. Galan, A. Urrutia, R. Cabanes, L. Cano, B. Gonzalez,
C. Diez, T. Pascual, J. Lupon (Badalona, ES)
Early measurement of sP-selectin in patients with ST elevation acute coronary
syndrome undergone coronary stenting. P1318
E.A.S. Shmidt, S.A. Berns, O.L. Barbarash, A.V. Osokina (Kemerovo, RU)
Analytical parameters and long-term prognosis of heart failure patients regularly
followed on a home health care programme provided by a heart failure unit.
24 months of follow-up. P1319
M. Satendra, C. Santos De Sousa, L. Sargento, N. Lousada, R. Palma Dos Reis (Lisbon, PT)
Which measure of renal function provides most prognostic information in patients
with heart failure? P1320
J. Zhang, R. Antony, A. Yassin, N. Sherwi, L. Buga, P. Pellicori, O. Khaleva, A.L. Clark,
K.M. Goode, J.G.F. Cleland (Hull, GB)
142

TUESDAY 24 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Pulmonary hypertension
Exercise hemodynamics as a distinction tool between pre-capillary and post-capillary
pulmonary hypertension. P1321
P. Lesny, M. Luknar, I. Varga, P. Solik, E. Goncalvesova (Bratislava, SK)
Right ventricular dysfunction in acute pulmonary embolism: direct correlation
between troponin and AngioCT. P1322
B. Rodrigues, H. Correia, E. Correia, L.F. Santos, D. Moreira, A. Figueiredo, J. Pipa,
I. Beirao, O. Santos (Viseu, PT)
Bisoprolol efficacy in patients with chronic heart failure and pulmonary hypertension
due to diastolic dysfunction. P1323
O. Pashuk, E. Atroshtchenko (Minsk, BY)
Surgery (CABG, valvular, artificial heart, other)
Prognosis following coronary artery bypass grafting in patients with polyvascular
atherosclerosis. P1324
K.S.S. Shafranskaya, O.L.B. Barbarash, V.V.K. Kashtalap, L.S.B. Barbarash (Kemerovo, RU)
Coronary surgery with arterial grafts in patients with chronic heart failure: the use of
calcium antagonists to reduce the risk of postoperative complications and improve
long-term prognosis. P1325
M. Dyakova, Y. Vechersky, V. Zatolokin, K. Eremenko (Tomsk, RU)
Morbidity and mortality prediction in aortic valve surgery: comparison of two risk
stratification models. P1326
E. Pereira, G. Silva, M. Ponte, O. Sousa, D. Caeiro, R. Carvalho, A. Albuquerque, L. Simoes,
J. Primo, V. Gama (Porto, PT)
Cases
Pneumonia versus cardiogenic pulmonary edema: serious management implications. P1327
F. Simoes Marques Assuncao Caetano, J. Silva, P. Mota, P. Coutinho, A. Botelho,
M. Antunes, A. Leitao Marques (Coimbra, PT)
Fatal low cardiac output syndrome in a young male patient with celiac sprue and
accompanying cytomegalovirus infection. P1328
L. Toth, Z.S. Surinya, G. Szalai, J. Sipos (Sopron, HU)
Hypocalcemia as a reversible cause of heart failure. P1329
I. Rangel, G. Barbosa, C. Sousa, S. Oliveira, A. Lebreiro, A. Sousa, P.B. Almeida,
M. Campelo, T. Pinho, M.J. Maciel (Porto and Penafiel, PT)
Lethal outcome of a takotsubo cardiomyopathy due to cardiogenic shock in
a 83 y old lady. P1330
A. Fleig, K. Seitz (Sigmaringen, DE)
Acute heart failure: an unexpected etiology. P1331
F. Simoes Marques Assuncao Caetano, L. Paiva, P. Mota, J. Trigo, S. Basso, L. Araujo,
A. Leitao Marques (Coimbra, PT)
Arrythmogenic right ventricular dysplasia as a cause of heart failure. Case report. P1332
I. Rilo Miranda, J.R. Beramendi Calero, A. Izaguirre-Yarza, M. Castillo-Judez, S. Bianco,
R. Garcia-Martin, T. Echeverria Garcia, E. Uribe-Echeverria (San Sebastian, ES)
The possible role of the new neurohormonal system in chronic heart failure. P1333
O. Katerenchuk (Poltava, Ukraine, UA)
143
TUESDAY
POSTERS

TUESDAY
POSTERS
TUESDAY 24 MAY 2011 - MORNING POSTERS
08:30 - 12:30 Poster Session Poster Area
Dengue myocarditis simulating acute myocardial infarction - a case report. P1334
E.L. Figueiredo, M.S. Carneiro, A.S. Randt, M.H. Siqueira, G.F. Werner, B.E. Quirino,
K.A. Maia, R.D. Melo (Belo Horizonte, BR)
Satisfactory clinical response of autologous stem cells implant in one severe idiopathic
dilated myocardiopathy patient, by magnetic resonance imaging Case Report. P1335
O.T. Greco, A. Souza, J.L.B. Jacob, M.A. Ruiz, M.R. Lago, A.C. Abreu (Sao Jose do Rio Preto, BR)
The iron heart; the story of a refractory heart failure in a 37 years old man with
idiopathic hemochromatosis. P1336
D. Bartos, A.M. Daraban, E. Badila (Bucharest, RO)
Left ventricular non-compaction with diaphragmatic hernia and heart displacement
to the right side of the thorax (functional dextroversion). P1337
P. Rubis, T. Miszalski-Jamka, J. Podolec, M. Kostkiewicz, A. Lesniak-Sobelga, E. Suchon,
T. Senderek, M. Szuksztul, P. Podolec (Krakow, PL)
Heart failure with normal ejection fraction in a patient with unclassifiable multiple
endocrine neoplasya. P1338
A.I. Popa, C.L. Andrei, V.P. Chioncel, R.M. Ianula, D.E. Mincu, F.C. Adam, L.N. Axente,
M. Dasoveanu, M. Anastasiu, C.J. Sinescu (Bucharest, RO)
144

MODERATED
POSTER
AREA
POSTER
ASSISTANCE
Publishers' Row
C01:11
C01:10
To Mix Restaurant
C01:06
C01:05
C01:03
C01:02
C01:01
To Registration
Area
6 th Asia Pacific Congress
of Heart Failure C04:05
Alere C04:10
BG Medicine, Inc. C03:06
Boston Scientific C01:06
BRAHMS GmbH C03:05
European Society of Cardiology C03:01
GE Healthcare C03:08
POSTER AREA
To Level 1
Exhibition Floor Plan
To Registration
Area
To Level 1
C02:10 C03:11 C03:12 C04:15
C02:02
C02:01
C03:10
C03:05 C03:07
C03:01
C03:06
HeartWare, Inc. C04:11
Medtronic C02:01
Novartis Pharma AG C04:08
Orion Pharma C01:01
Oxford University Press C01:10
Pfizer Ltd C03:10
Pfizer Ltd/BMS C04:15
Philips Healthcare C03:12
C04:11 C04:12
C04:10
C03:08 C04:08
C04:05
C04:01
To Registration
Area
C04:07
Snack
Bar
COFFEE BREAK AREA COFFEE BREAK AREA
ResMed Europe C04:01
RespiCardia, Inc. C03:07
Robert Bosch Healthcare GmbH C01:05
SERVIER C02:10
Thoratec Corporation C01:02
Vifor Pharma Ltd. C02:02
Wisepress Medical Bookshop C01:11
ZOLL CMS GmbH C03:11
EXHIBITORS
& INDEX

EXHIBITORS
Exhibitors at Heart Failure 2011:
These descriptions were supplied by exhibitors, they have not been evaluated or endorsed by the
HFA of the ESC
6th Asia Pacific Congress of Heart Failure C04:05
1/70-71 Phahonyotin Soi 40
Senanikom
Jatuchak Bangkok
10900 Bangkok
Thailand
Tel: +66 294 024 83
Fax: +66 294 024 84
Email: info@apchf2012.com
Web Site: www.apchf2012.com
Related conferences: promoting APCHF2012 & APSAVD 2012.
Alere C04:10
Rue des Vignerons 1A
1110 Morges
Switzerland
Tel: +41 804 7140
Fax: +41 218 020 933
Email: carine.isenegger@alere.com
Web Site: www.alere.com
Alere enables individuals to take charge of improving their health and quality of life at home by
developing new capabilities in near-patient diagnosis, monitoring and health management. Our
global leading products and services, and new product development efforts, focus on cardiology,
women’s health, infectious disease, oncology and drugs of abuse.
BG Medicine, Inc. C03:06
610N Lincoln St.
Waltham, MA 02451
United States of America
Tel: +1 781 890 1199
Fax: +1 781 895 1119
Email: communications@bg-medicine.com
Web Site: www.bgmgalectin-3.com
BG Medicine (NASDAQ:BGMD) is a life sciences company focused on the discovery, development,
and commercialization of novel diagnostics to improve patient outcomes and contain healthcare
costs. BG Medicine’s Galectin-3 blood test identifies patients with an inherently progressive form of
heart failure resulting from fibrogenesis.
147
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
148
EXHIBITORS
Boston Scientific C01:06
Le Capitole
55 avenue des Champs Pierreux
TSA 51101
92729 Nanterre Cedex
France
Tel: +33 1 57 66 81 79
Fax: +33 1 57 66 81 72
Email: hadjmims@bsci.com
Web Site: www.bostonscientific.com
Boston Scientific (NYSE: BSX) is a worldwide developer, manufacturer and marketer of medical
devices with approximately 25,000 employees and revenue of $7.806 billion in 2010. For more than
30 years, Boston Scientific has advanced the practice of less-invasive medicine by providing a broad
and deep portfolio of innovative products, technologies and services across a wide range of medical
specialties. The Company’s products help physicians and other medical professionals improve their
patients’ quality of life by providing alternatives to surgery. For more information, please visit www.
bostonscientific.com.
BRAHMS GmbH C03:05
Neuendorfstrasse 25
16761 Hennigsdorf
Germany
Email: info.brahms@thermofisher.com
Web Site: www.thermofisher.com/brahms
BRAHMS GmbH, Part of Thermo Fisher Scientific, specialises in innovative products which facilitate
earlier diagnosis and better control of therapy, thus enabling doctors to provide more efficient and
economic patient care.
Major fields of activity are diagnosis of infectious and thyroid diseases, cardiology and pneumology
as well as sepsis, tumors, and Down’s syndrome.

EXHIBITORS
EUROPEAN SOCIETY OF CARDIOLOGY C03:01
2035 Route Des Colles
Les Templiers - BP 179
06903 Sophia Antipolis
France
Tel: +33 4 92 94 76 00
Fax: +33 4 92 94 86 69
Email: communications@escardio.org
Web Site: www.escardio.org
The European Society of Cardiology (ESC) represents more than 68,000 cardiology professionals
from across Europe and the Mediterranean. The ESC comprises 53 National Cardiac Societies, 19
Working Groups, 5 Associations and 5 Councils. It also includes the distinguished community of ESC
Fellows and Nurse Fellows. Its mission is «To reduce the burden of cardiovascular disease in Europe».
The ESC achieves this through a series of scientific and educational activities and the ESC Congress,
the largest medical meeting in Europe, held this year from 27-31 August 2011 in Paris Nord Villepinte,
France.
GE Healthcare C03:08
Pollards Wood
Nightingales Lane
Chalfont, St Giles
HP8 4SP Buckinghamshire
United Kingdom
Tel: +44 149 454 4000
Fax: +44 149 449 8234
Email: contactus@ge.com
Web Site: www.gehealthcare.com
GE Healthcare is dedicated to helping you transform healthcare delivery by driving critical
breakthroughs in biology and technology. Our expertise in medical imaging is enabling healthcare
professionals around the world discover new ways to diagnose and treat disease earlier. Our goal is
more targeted treatments, so they can help their patients live their lives to the fullest. Please visit our
stand while at ESC Heart Failure to learn more about our offerings in cardiology.
149
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
150
EXHIBITORS
HeartWare, Inc. C04:11
205 Newbury Street
Framingham, Massachusetts 01701
United States of America
Tel: +1 508 739 0950
Email: l_kryn@yahoo.com
Web Site: www.heartware.com
HeartWare, Inc. is developing a family of implantable mechanical circulatory support systems for
the treatment of advanced heart failure. HeartWare’s lead device, the HeartWare® Ventricular Assist
System, incorporates state-of-the-art peripherals and features the only full-output pump designed
to be implanted less invasively in the pericardial space. The HeartWare® System is commercially
available in Europe and is the subject of a 150-patient US IDE trial.
Medtronic C02:01
Route du Molliau 31
Case postale
1131 Tolochenaz
Switzerland
Tel: +41 218 027 000
Fax: +41 218 027 918
Email: christine.dettwiler@medtronic.com
Web Site: www.medtronic.eu
At Medtronic, we are committed to «Innovating for life» by pushing the boundaries of medical
technology and changing the way the world treats chronic disease.
Join our symposium on May 22, 12:45-14:00 (Malmö), and visit the Medtronic booth (C02:01) to
discover how CRT therapy is reducing mortality and preventing disease progression for HF patients.

EXHIBITORS
Novartis Pharma AG C04:08
Forum 1
Novartis Campus
4056 Basel
Switzerland
Tel: +41 613 241 111
Email: marco.arnold@novartis.com
Web Site: www.novartis.com
Novartis provides healthcare solutions that address the evolving needs of patients and societies.
Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative
medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer
health products. Novartis is the only company with leading positions in these areas. In 2010, the Group’s
continuing operations achieved net sales of USD 50.6 billion, while approximately USD 9.1 billion (USD
8.1 billion excluding impairment and amortization charges) was invested in R&D throughout the Group.
Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 119,000 fulltime-equivalent
associates (including 16,700 Alcon associates) and operate in more than 140 countries
around the world. For more information, please visit http://www.novartis.com.
Orion Pharma C01:01
Orionintie 1A
02200 Espoo
Finland
Tel: +35 810 4261
Fax: +35 810 426 3815
Email: firstname.lastname@orionpharma.com
Web Site: http://www.orion.fi/en/
Orion is an innovative European R&D-based pharmaceuticals and diagnostics company.
Orion Pharma’s critical care product portfolio includes two own proprietary molecules, levosimendan
(Simdax®) for acute heart failure and dexmedetomidine for sedation in intensive care.
Simdax®, a cardioprotective inodilator, gives rapid and sustained hemodynamic improvement,
normalizes neurohormone levels, and relieves symptoms in patients with acute heart failure.
Oxford University Press C01:10
Great Clarendon Street
OX2 6DP Oxford
United Kingdom
Email: jnls.mkt@oxfordjournals.org
Web Site: www.oup.com
Oxford University Press publishes some of the most respected medical books and journals in the
world including The ESC Textbook of Cardiovascular Medicine, and on behalf of the ESC, European
Journal of Heart Failure and European Heart Journal. Visit our stand to browse books and pick up
free copies of the journals.
151
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
152
EXHIBITORS
Pfizer Ltd C03:10
Pfizer Ltd/BMS C04:15
Walton Oaks
Dorking Road, Tadworth, Surrey
KT20 7NS Tadworth
United Kingdom
Tel: +44 130 461 6161
Email: virginia.hayward@pfizer.com
Web Site: www.pfizer.co.uk / http://www.bms.com
Pfizer Inc.: Working together for a healthier world.
At Pfizer, we apply science and our global resources to improve health and well-being at every stage
of life. We strive to set the standard for quality, safety and value in the discovery, development and
manufacturing of medicines for people and animals. Our diversified global health care portfolio
includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional
products and many of the world’s best-known consumer products. Every day, Pfizer colleagues work
across developed and emerging markets to advance wellness, prevention, treatments and cures
that challenge the most feared diseases of our time. Consistent with our responsibility as the world’s
leading biopharmaceutical company, we also collaborate with health care providers, governments
and local communities to support and expand access to reliable, affordable health care around the
world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and
deliver innovative medicines that help patients prevail over serious diseases. For more information,
please visit http://www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.
Philips Healthcare C03:12
Medizin Systeme GmbH
Hewlett-Packard-Str. 2
71034 Boeblingen
Germany
Tel: +49 703 146 329 13
Fax: +49 703 146 322 02
Email: Melanie.Sarantos@philips.com
Web Site: http://www.healthcare.philips.com/goto/motiva
Motiva – Empower Patients with Long Term Conditions.
Philips Motiva is an interactive healthcare platform that connects patients with chronic conditions,
e.g. heart failure, diabetes and COPD, to their healthcare providers – via the home television and a
secure network connection.
Motiva automates disease management activities, and engages patients with personalized daily
inter-actions and education delivered through the home television. The system enables healthcare
providers to motivate behaviour change, helping them meet goals for improved patient compliance,
telehealth program efficiency, and lower healthcare costs.

EXHIBITORS
ResMed Europe C04:01
Fjordveien 1
1363 Høvik
Norway
Tel: +47 671 188 50
Fax: +47 671 188 55
Email: post@resmed.no
Web Site: www.resmed.com
ResMed is a leading developer, manufacturer and marketer of products for the screening, treatment
and long-term management of sleep-disordered breathing (SDB) and other respiratory disorders.
ResMed is committed to increasing education and awareness by supporting leading physicians
and researchers exploring the link between SDB and life-threatening diseases as heart failure,
hypertension, and stroke.
RespiCardia, Inc. C03:07
12400 Whitewater Drive, Suite 150
Minnetonka, MN 55343
United States of America
Tel: +1 952 540 4470
Fax: +1 952 540 4485
Email: info@respicardia.com
Web Site: www.respicardia.com
RespiCardia, Inc. is a privately held, development staged medical device company located in
Minneapolis, MN USA. RespiCardia is developing an implantable stimulation therapy to treat Central
Sleep Apnea in heart failure patients.
Robert Bosch Healthcare GmbH C01:05
Stuttgarter Straße 130
71301 Waiblingen
Germany
Tel: +49 711 8110
Email: info-bosch-healthcare@bosch.com
Web Site: www.bosch-telemedizin.de
Bosch Healthcare is presenting an innovative range of products from patients terminals, through
fast and secure transmission of vital signs, to comprehensive evaluation software for healthcare
professionals. Bosch Telehealth Plus enables interactive monitoring of patients with long-term
conditions. The system helps healthcare professionals to identify even gradual changes in a patient´s
condition so that treatments can be quickly modified to prevent serious health complications.
153
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
154
EXHIBITORS
SERVIER C02:10
35, rue de Verdun
92284 Suresnes
France
Tel: +33 1 55 72 38 59
Fax: +33 1 55 72 52 95
Email: marie-pascale.eon@fr.netgrs.com
Web Site: www.servier.com
Servier is a private independent pharmaceutical company.
Servier has developed drugs for the treatment of hypertension, cardiac ischemia, and heart failure.
Procoralan (ivabradine), Vastarel MR (trimetazidine), Coversyl (perindopril), Coveram (perindoprilamlodipine),
Preterax (perindopril-indapamide), and Natrilix SR (indapamide) are our major
cardiovascular drugs.
Procoralan (ivabradine), the first If inhibitor on the market, is indicated for the symptomatic treatment
of chronic stable angina. The SHIFT study of the efficacy of Procoralan in the management of heart
failure patients was presented at the last ESC congress. Procoralan is now being evaluated by the
EMA for approval in this new indication.
Thoratec Corporation C01:02
6035 Stoneridge Drive
Pleasanton, CA 94588
United States of America
Tel: +1 925 847 8600
Fax: +1 925 847 8574
Email: sandie.hastings@thoratec.com
Web Site: www.thoratec.com
Thoratec® Corporation innovates and delivers technologies that enable a full range of therapies to
save, support and restore failing hearts, allowing patients to reclaim their lives. With over 18,000
patient implants and three decades of experience, Thoratec offers the broadest portfolio of ventricular
assist devices. Thoratec’s product line includes HeartMateII® LVAD, Thoratec PVAD and IVAD.

EXHIBITORS
Vifor Pharma Ltd. C02:02
Flughofstrasse 61
P.O. Box
8152 Glattbrugg
Switzerland
Tel: +41 588 518 000
Fax: +41 588 518 001
Email: info@viforpharma.com
Web Site: www.viforpharma.com
Vifor Pharma is one of the world leaders in iron preparations for the treatment of iron deficiency and
iron deficiency anaemia. Vifor Pharma’s intravenous iron product Ferinject® (ferric carboxymaltose)
is expected to address unmet clinical needs and optimise the management of iron deficiency and
iron deficiency anaemia.
Wisepress Medical Bookshop C01:11
25 High Path
Merton Abbey
SW19 2JL London
United Kingdom
Tel: +44 208 715 1812
Email: bookshop@wisepress.com
Web Site: www.wisepress.com
Wisepress.com, Europe’s leading conference bookseller, has a complete range of books and journals
relevant to this meeting including Heart Failure: A Companion to Braunwald’s Heart Disease and
Hurst’s The Heart. Books can be purchased at the stand or, if you would rather not carry them,
posted to you.
ZOLL CMS GmbH C03:11
Emil-Hoffmann-Str. 13
50996 Koeln
Germany
Tel: +49 223 687 8725
Fax: +49 223 687 8779
Email: lifevest-deutschland@zoll.com
Web Site: www.zollmedical.de
The ZOLL® LifeVest® wearable defibrillator protects patients at risk of sudden cardiac arrest, during a
patient’s changing condition and when permanent SCA risk has not been established. The LifeVest
provides patients constant monitoring, immediate protection, and peace of mind.
155
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
Name / Page Number
156
SESSIONS
Abstract Award Sessions
Nursing Investigator Award.................................................................................................................................................................................. 23
Young Investigator Award for Clinical research .............................................................................................................................. 29
Young Investigator Award for Basic Science........................................................................................................................................32
Basic Science, Basic Science translated for the clinician
The energy crisis of the failing heart ........................................................................................................................................................... 20
MicroRNAs on their way to the clinic ......................................................................................................................................................... 22
New biological heart failure mechanisms or twists to old ones? ................................................................................ 28
Inflammation in heart failure: biomarker, bystander or mediator ...............................................................................31
New drugs on the horizon for heart failure ........................................................................................................................................74
Systems medicine approaches in translational heart failure research .................................................................... 82
New drug targets in heart failure – from EUGeneHeart ...................................................................................................... 85
Highlights of the congress: Basic Science translated for the clinician ..................................................................124
Cardiac regeneration and repair – What’s new ...........................................................................................................................126
Co-morbidities and heart failure
Elderly patients with heart failure - What is different? .............................................................................................................19
Do heart failure patients need guts? ......................................................................................................................................................... 28
Chronic heart failure and chronic obstructive pulmonary disease: ignored common duel! ........ 30
Anemia and iron deficiency ...................................................................................................................................................................................73
The unstable patient who needs neurohormonal blockade ............................................................................................73
Case based interactive session
Systemic problems in cancer patients .........................................................................................................................................................76
Controversies in the optimal management of ischaemic heart failure ...................................................................77
Joint Session with the Argentinian and Brazilian Working Groups on Heart Failure
Therapeutic controversies in patients with diabetes ................................................................................................................. 82
Managing patients with hyperkalaemia during RAAS-blockade .................................................................................84
Case based interactive session
Sleep apnea - the need to synchronize the heart, the lung and the brain ...................................................124
Devices and Technology for heart failure in 2011
The Presidents debate: controversial issues in heart failure device treatment ...............................................13
Joint session with the Heart Failure Society of America (HFSA)
Imaging heart failure ....................................................................................................................................................................................................14
Joint session with the European Association of Echocardiography (EAE)
Impact of the new atrial fibrillation guidelines on heart failure management ..............................................19
Joint session with the European Heart Rhythm Association (EHRA)
Surgery and device intervention for the elderly with heart failure: assessing the need ................... 22
Novel device therapies for heart failure .................................................................................................................................................. 30

SESSIONS
Name / Page Number
Devices and Technology for heart failure in 2011
TeleMonitoring for heart failure - Latest evidence .........................................................................................................................74
Implantable cardioverter-defibrillator (ICD) therapy: risks and complications ................................................75
Management of heart failure patients guided by implantable sensors ................................................................84
Education and Guidelines
Heart failure with preserved ejection fraction (HFPEF) - Is it really heart failure? ......................................14
Update on anticoagulation therapy in heart failure ...................................................................................................................19
Patient-reported outcomes - What and how to measure? ................................................................................................. 20
Pulmonary hypertension in heart failure ............................................................................................................................................... 20
What should you know about exercise training? .........................................................................................................................21
Acute heart failure: assessment and management of the difficult patient ........................................................27
The value of the heart failure registries ....................................................................................................................................................27
Difficult cases in heart failure with preserved ejection fraction .................................................................................... 30
How to talk to your patients .................................................................................................................................................................................31
Palliative care for patients with end-stage heart failure .........................................................................................................73
Preventing heart failure in women pre and post partum ....................................................................................................74
Management of difficult cardiac patients in the emergency room ...........................................................................75
Update on the treatment of chronic heart failure 2011 ..........................................................................................................75
Diuretics in heart failure, friend or foe? ................................................................................................................................................... 82
The failing right heart ................................................................................................................................................................................................. 85
Personalised medicine and person-centred care - What is the difference? .................................................. 123
Using biomarkers to sort out the complex patient ................................................................................................................... 123
The dynamic social media wave: Twitter, Facebook, Internet etc. ..........................................................................126
Industry symposia
Identification and treatment of central sleep apnea in heart failure ........................................................................15
Mini-Satellite Symposium organised by RESPICARDIA
Personalizing biomarker strategies in heart failure management................................................................................15
Satellite Symposium organised by Abbott, Alere & BG Medicine
Improving the lives of patients with chronic heart failure: iron matters ..............................................................24
Satellite Symposium organised by Vifor Pharma
The role of mineralocorticoid receptor (MR) antagonists throughout ..................................................................24
the heart failure continuum: evidence from laboratory to clinical practice
Satellite Symposium organised by Pfizer, Inc.
Cardiac resynchronization therapy: from patient selection to patient management ............................25
Satellite Symposium organised by Medtronic
Patient-physician touch points: sharing perspectives and unmet needs in heart failure ...................25
Satellite Symposium organised by Novartis Pharma AG
157
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
Name / Page Number
158
SESSIONS
Industry symposia
Are ventricular assist devices ready for the mainstream? ......................................................................................................26
Satellite Symposium organised by Thoratec Corporation
Ivabradine: a SHIFT paradigm in heart failure management .......................................................................................... 33
Satellite Symposium organised by SERVIER
Solutions for heart failure management: the ever-growing role of device therapy ............................... 33
Mini-Satellite Symposium organised by Boston Scientific
Remote disease management in the HF patient ............................................................................................................................78
Satellite Symposium organised by St. Jude Medical
Stroke prevention in atrial fibrillation: challenges and opportunities.......................................................................78
Satellite Symposium organised by Bristol-Myers Squibb/Pfizer
Improving heart failure risk assessment ....................................................................................................................................................79
Satellite Symposium organised by GE Healthcare
Point-of-care biomarkers in the real world of practice: managing the patients ...........................................79
from the hospital to home
Satellite Symposium organised by ALERE
Transcatheter mitral valve repair therapy, a novel approach for heart failure patients ......................80
suffering from mitral regurgitation
Mini-Satellite Symposium organised by Crossroads, the Abbott Vascular education network
Latest Updates
Drug therapy in heart failure: has the emphasis shifted? ....................................................................................................21
Late Breaking Trials - Session I .............................................................................................................................................................................27
Award Ceremony followed by a Symposium .....................................................................................................................................81
New medical treatment in acute heart failure ..................................................................................................................................81
Late Breaking Trials - Session II ...........................................................................................................................................................................84
How to interpret the recent trials with expert statisticians .............................................................................................. 123
New biomarkers for diagnosis and prognosis in heart failure ......................................................................................125
Mortality or morbidity as target in acute heart failure trials ............................................................................................126
Moderated Posters sessions
Moderated Posters Session 1 ............................................................................................................................................................................... 36
Moderated Posters Session 2 .............................................................................................................................................................................54
Moderated Posters Session 3 ...............................................................................................................................................................................88
Moderated Posters Session 4 ............................................................................................................................................................................104
Moderated Posters Session 5 ............................................................................................................................................................................ 129

SESSIONS
Name / Page Number
Oral Abstract Sessions
Judges choice: Basic Science................................................................................................................................................................................76
Judges choice: Clinical treatment research ......................................................................................................................................... 83
Judges choice: Clinical research ......................................................................................................................................................................86
Poster Sessions
Poster Session 1..................................................................................................................................................................................................................38
Poster Session 2...................................................................................................................................................................................................................55
Poster Session 3 ................................................................................................................................................................................................................ 89
Poster Session 4 .............................................................................................................................................................................................................105
Poster Session 5...............................................................................................................................................................................................................130
Special Sessions
Best Papers 2010/2011 and What did I miss at ESC10, AHA10 and ACC11........................................................13
Opening Ceremony .....................................................................................................................................................................................................16
Update from the industry ........................................................................................................................................................................................21
Highlights of the congress ...................................................................................................................................................................................125
159
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
160
CHAIRPERSONS / SPEAKERS
Name Page(s)/Programme Nr(s) Name Page(s)/Programme Nr(s) Name Page(s)/Programme Nr(s
A
Adamson P.: 75
Adamson P.: 698
Andersson B.: 21
Andersson B.: 573
Anker S.D.: 21, 25, 74, 76, 125
Anker S.D.: 5, 36, 107, 682, 656
Atar D.: 626
Auricchio A.: 31, 154, 71, 184
B
Baaijens F.: 1145
Balligand J.L.: 706
Bauersachs J.: 22
Bauersachs J.: 142, 92
Bax J.J.: 701, 661
Beattie J.M.: 584
Bech-Hanssen O.: 7, 51
Birks E.J.: 17, 155, 623
Bohm M.: 25
Bohm M.: 2, 149, 65, 100, 179,
1125
Boman K.O.A.: 73, 82
Borggrefe M.: 153
Brannstrom M.: 582
Braunschweig F.: 8, 30, 696, 697,
1133
Brostrom A.: 1115
Brunner-La Rocca H.P.: 39, 1108
Brutsaert D.L.: 14, 32
Brutsaert D.L.: 675
Burri H.: 71, 697
C
Camm A.J.: 78
Camm A.J.: 29, 606, 624
Ceriello A.: 664
Cider A.: 62
Clark A.L.: 30
Clark A.L.: 63, 160, 1111, 1130
Cleland J.G.F.: 15, 75
Cleland J.G.F.: 18, 21, 3, 34, 588
Coats A.J.S.: 54
Coats A.J.S.: 118, 60
Collins S.: 103
Cowie M.R.: 33, 84
Cowie M.R.: 41, 99, 182, 1114
Cuppen E.: 674
D
Dahlstrom U.G.: 14, 19
Dahlstrom U.G.: 129
Dargie H.J.: 26, 29 ,79
Dargie H.J.: 108, 635, 639
Daubert J.C.: 25
Daubert J.C.: 96
De Ferrari G.M.: 124
De Windt L.J.: 589
Deaton M.C.: 23, 126
Dickstein K.: 73
Dickstein K.: 19, 32, 67, 97, 1141
Diez Martinez J.: 168, 1126
Doehner W.: 47, 613
Doevendans P.A.F.M.: 85
Drozdz J.: 104
Drozdz J.: 131
E
Eikelboom J.: 627
Ekman I.: 84
Ekman I.: 42, 659, 1110
El-Armouche A.: 704
Engelhardt S.: 74, 140
Eriksson P.J.: 50
Eschenhagen T.: 32, 85, 126
Eschenhagen T.: 675, 1109
F
Felix S.B.: 170
Filippatos G.S.: 27, 76, 81
Filippatos G.S.: 35, 87
Force L.: 126
Force L.: 610
Ford I.: 1103
Franzen O.W.: 648
Frenneaux M.P.: 20
Frenneaux M.P.: 15, 48
Fu M.: 31
Fu M.: 167
G
Gaillard C.: 593
Gheorghiade M.: 136, 652, 1101,
1135
Goumans M.J.: 1144
Granger B.: 30, 123
Granger B.: 44, 73, 703
Grinfeld l.: 36, 77, 83
Guan K.: 1143
Guazzi M.: 52
Gullestad L.: 28
Gullestad L.: 683
Gustafsson F.: 111
H
Hansson G.K.: 166
Hasenfuss G.: 74, 82
Hasenfuss G.: 15, 684, 1146
Hauptman P.: 22
Hauptman P.: 4, 699
Hawkins N.M.: 158, 575
Heinzel F.R.: 151, 138
Hilfiker A.: 1145
Hilfiker-Kleiner D.: 76, 594

CHAIRPERSONS / SPEAKERS
Name Page(s)/Programme Nr(s) Name Page(s)/Programme Nr(s) Name Page(s)/Programme Nr(s
Hillege H.: 29
Hillege H.: 576, 670
Hirsch E.: 28
Hirsch E.: 169, 707
Hobbs F.D.R.: 102
Hoes A.W.: 19, 23
Hoes A.W.: 164
Huebner N.: 671
I
Ingle L.: 69
J
Jaarsma T.: 20, 24
Jaarsma T.: 85, 581, 1140
Jankowska E.A.: 19
Jankowska E.A.: 578
Janssens S.: 22, 32
Janssens S.: 141, 705, 1121
Javaheri S.: 24
Jourdain P.: 183
K
Kalarus Z.: 31
Kikkenborg Berg S.: 608
Kjekshus J.K.: 20, 73
Kleber F.X.: 638
Kober L.: 123
Kober L.: 38
Koehler F.: 586
Komajda M.: 19
Komajda M.: 178
Krum H.: 25
Krum H.: 68, 101, 105, 579
Kuck K.H.: 647
L
Lainscak M.: 133, 612
Lancellotti P.: 14
Lancellotti P.: 16
Landmesser U.: 126
Landmesser U.: 662
Laugwitz K.-.L.: 1142
Linde C.: 19
Lip G.Y.H.: 605
Logeart D.: 125
Logeart D.: 110
Lund L.H.: 70, 574
M
Maack C.: 32, 124
Maack C.: 46
Macdougall I.: 592
Maggioni A.P.: 13, 75
Maggioni A.P.: 132, 1132
Magne J.: 14
Maier L.S.: 129
Maier L.S.: 591
Maisel A.: 75
Maisel A.: 587, 1127, 1105
Mamas M.: 150, 672
Mareev V.: 29, 36, 86
Mareev V.: 665
Martensson J.: 163
Massie B.M.: 13
Massie B.M.: 1, 149, 33, 654, 1136
Mayr M.: 77, 673
McDonagh T.A.: 66, 88, 700
McDonald K.: 21, 79
McDonald K.: 640
McMurray J.J.V.: 21, 24
McMurray J.J.V.: 11, 90, 91, 95,
573, 653, 602
Mebazaa A.: 75
161
Mebazaa A.: 116, 157, 1137
Metra M.: 82
Metra M.: 598, 682, 1134
Mohacsi P.J.: 22, 28
Mohacsi P.J.: 702
Mueller C.: 81
Mueller C.: 115, 599, 636, 1125,
1106
N
Nanas J.: 73, 88
Neubauer S.: 14
Newman S.: 165
Neyses L.: 29, 30, 82, 129
Nieminen M.S.: 27
O
O’Connor C.: 123
O’Connor C.: 61, 663, 1136
Oldenburg O.: 1113
Omerovic E.: 30
Omerovic E.: 685
P
Pacher R.: 20, 30
Papp Z.: 20, 76, 83, 124
Papp Z.: 590
Parissis J.T.: 123
Parissis J.T.: 161, 601
Parving H.: 667
Paulus W.J.: 10, 620
Peker Y.: 1116
Petrie M.: 622, 660
Philipson H.: 134
Piepoli M.F.: 88
Piepoli M.F.: 135
Pieske B.M.: 14, 30, 76, 124
Pieske B.M.: 37, 657, 1131
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
162
CHAIRPERSONS / SPEAKERS
Name Page(s)/Programme Nr(s) Name Page(s)/Programme Nr(s) Name Page(s)/Programme Nr(s
Pinto Y.: 75
Pitt B.: 604, 669
Pocock S.J.: 1102, 1136
Ponikowski P.: 13, 15, 80, 81
Ponikowski P.: 25, 115, 180, 86,
580, 646, 658
R
Regitz-Zagrosek V.: 74
Regitz-Zagrosek V.: 595
Ribeiro J.P.: 19
Ribeiro J.P.: 621
Riegel B.: 23, 31, 73
Riegel B.: 162, 609
Riley J.: 6, 43, 1129
Ronco C.: 576, 637, 1107
Roos-Hesselink J.W.: 597
Ruschitzka F.: 15, 125
Ruschitzka F.: 23, 117, 651, 607
Russell S.: 109
Rutten F.H.: 159
Ryden L.: 664, 666
Ryder M.: 23, 85, 123
Ryder M.: 583
S
Samani N.: 674
Schaufelberger M.: 74, 82
Schnell O.: 667
Schultheiss H.P.: 31
Schultheiss H.P.: 600
Seferovic P.: 29, 77, 82
Seferovic P.: 666, 596
Senni M.: 80
Senni M.: 650
Settergren M.: 156
Shah A.M.: 28, 32
Shah A.M.: 139, 675
Sliwa-Hahnle K.: 27
Sliwa-Hahnle K.: 596
Solomon S.: 13, 152, 701, 661, 1101
Squire I.B.: 106
Stromberg A.: 104
Stromberg A.: 1138
Strueber M.: 72
Swedberg K.: 13, 24, 33, 73,
78, 81, 125
Swedberg K.: 177, 85, 603, 625,
628, 1102
T
Taegtmeyer H.: 45, 1119
Tavazzi L.: 20, 27, 33
Tavazzi L.: 181
Teerlink J.R.: 4, 104, 579, 668
Thum T.: 74
Thum T.: 78, 1128
Tousoulis D.: 1124
Trochu J.-.N.: 26
Trochu J.-.N.: 130, 112, 114
Tschoepe C.: 576
V
Vahanian A.: 649
Van Der Wal M.H.L.: 31
Van Der Wal M.H.L.: 64
van Veldhuisen D.J.: 21, 84
van Veldhuisen D.J.: 20, 9, 93, 598
Von Haehling S.: 137, 611
Voors A.A.: 12, 655, 577, 1123
W
Warner Stevenson L.: 74
Warner Stevenson L.: 4, 40, 696,
585
Wedel H.: 674, 1104
Wijns W.: 660
Wikstrom G.: 85
Wikstrom G.: 49
Willems R.: 98
Wingate S.: 73, 1140
Wolf A.: 1139
Z
Zannad F.: 15, 24, 84
Zannad F.: 22, 90, 94, 95, 604,
669, 1112

AUTHORS
A A.G. : P456
Abbate R. : 146
Abdel Hady Y. A. : 676, P796
Abderazzak S. : P204, P219, P339,
P447
Abderrazak S. : P1291
Abdul Rahman A.R. : P1206
Abdulasisov O. : P1218
Abdullaev T.A. : P1177, P1215, P241,
P430, P761, P959
Abdusattarov U. : P959, P960,
P238
Abecasis J. : P1187, P239, P417,
P549
Abenza S. : 618
Aboudan M. : P730
Abreu A. : P1015, P1073, P484,
P818
Abreu A.C. : P1335
Abreu R.F.S. : P1014, P441, P511
Abreu-Gonzalez P. : P1033, P202
Abroug J. : P839
Accogli M. : P279
Acosta A. : P378
Adam F.C. : P1266, P1338, P272,
P336, P924
Adamopoulos S. : P827, P831
Adams P. : P503
Adamyan K.G. : P940
Adeniran A. O. : P793
Adlbrecht C. : P348
Admon D. : P790, P874
Adnot S. : P350, P351
Adoh A.M. : P400, P401
Adoubi K. A. : P400, P401
Adragao P. : P1189
Afanasiev S. : P1295
Afonso J. : P220
Ageev F. : P224, P470, P836
Ageev F.T. : P1241, P994
Agladze R. : P915
Agosti S. : P228
Agoston-Coldea L. : P477
Agostoni P. : P714, P483
Agren S. : P1054, P856, P858
Aguiar C. : P1080, P1187, P1236,
P1307, P221, P467
Ahmatov Y.A. R. : P960
Ahmed A. : P958
Ahn M.S. : P944
Ahn T.H. : P525
Ajuluchukwu J. N. : P205
Akagami T. : 616, P297, P771
Akashi H. : P1023, P494, P825
Name / Index Number
Akay Y. : P1180, P282, P358, P528,
P548
Akbarzadeh Najar R. : P733
Akchurin R. S. : P937, P1018
Akhmetov R. : P1254, P491
Al Mallah M. : P270
Al Qaseer M. : P998
Alaves A. : P1278
Albackr H. : P1290, P727
Albaladejo-Oton M.D. : P331
Albernaz M. : P857
Albertsson P. : P925
Albino-Teixeira A. : P220
Albuquerque A. : P1326, P194,
P566, P567
Alcocer L. : P203, P460
Alderman M.H. : P834
Alehagen U. : P721
Aleixo A. : P1187, P239, P417, P549
Aleksandriya L. : P1219
Aleksova A. : P754
Alessandroni L. : P805
Alexandria L. : P1254, P491
Alexanian I. : P724, P1093
Alexopoulos G. : P1203
Alfaleh H. : P1290, P727
Alhabib K. : P1290
Alhabib K. F. : P727
Alhosaini H. : P990
Alhous H. : P234
Alibaz Oner F. : P288
Alissafi T. : P257
Aljabri M.B. : P312
Al-Khateeb M. : P270
Alkmim-Teixeira R. : P1184
Almarichi S. : P935
Almeida A.G. : P1092, P532, P889,
P978
Almeida I. : P1201, P1209, P1244,
P478, P561, P764, P766, P808,
P987, P991
Almeida P.B. : P1329, P285
Almeida R. : P285
Almenar L. : P1265
Almenar-Bonet L. : P1027, P255,
P328, P444, P828
Al-Mohammad A. : P473
Alnemer K. : P727
Alonso Briales J.H. : P878
Alqaseer M. : P1069
Alradhi A. : P844
Al-Said S. : P312
Alshaer F. : P1290
Altenberger J. : P1261
163
Alter P. : P503
Altimir S. : P277, P390, P893
Altimira M. : P871
Alunni G. : P866
Alvarez E. : P1176
Alves S. : P1015
Alves T. : P1015
Amano A. : P825
Ambrosio G. : P866
Amin A. : P822
Amirimoghadam Z.M. : P340
Ammirati F. : P185
Amodeo A. : P1025
Amorim S. : P1313, P821
Amorim S. M. R. : P1013, P425
Anaclerio M. : P569
Anagnostou D. : P301
Anastasiou-Nana M. : 678, P395,
P719, P860, P971, P1262,
Anastasiu M. : P1266, P1338, P336,
P924, P985
Ancsin B. : P259, P752, P885, P945
Andor M. : P1100
Andrade L. : P962
Andreae C. : P1055
Andreasen T.V. : P312
Andreassen A. : P1075
Andreev S.L. : P1096
Andrei C. : P985
Andrei C.L. : P1266, P1338, P272,
P336, P924
Andreou C. : P860
Andric V. : P1053
Anelli-Monti M. : P449
Angermann C.E. : P778
Aniceto Silva J. : P1236
Anisimov S.V. : P1043, P848
Anjo D. : P1310, P230
Anker S.D. : P264, P341, P385,
P386, P436, P908 P970
Antelmi A. : P482
Anton G. : P1044
Anton M. : P1044
Antonazzo V. : P910
Antoni G. : P850
Antony R. : P1320, P380
Antunes M. : P1327
Antunes N. : P230
Anzouan-Kacou J.B. : P400
Apor A. : P1298
Apostolakis S. : P888
Apostolovic S. : P192, P862, P883,
P948
Arandjelovic A. : P1003, P1006
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
Arao M. : P1181, P225
Araujo F. : P1160
Araujo I. : P1214, P976
Araujo J.P. : P1079
Araujo L. : P1331
Araujo V. : P1038, P1247, P1250,
P485, P506, P816, P817
Arcopinto M. : 144, P311
Ardissino A.D. : P1238
Arenas M. : P1287
Arestedt K. : P1054, P1055, P856
Ariano C. : P435, P465
Ariely R. : P1289, P526
Arnaudis B. : P1212
Arnold J.M.O. : P1067, P1297, P919
Arnold R. : P1191, P325, P788, P986
Aronson D. : P193
Arra C. : P1182
Arroja I. : P239, P417, P549
Arroyo-Ucar E. : P1033, P202
Arsalan M. : P819
Arsenjeva Y.A. : P1096
Arslan A.G. : P300
Arutyunov G.P. : P1163, P762,
P779, P975
Arvanitakis S. : P218, P492
Asai K. : P201
Asanin M. : P512, P843
Asensio-Lopez M.C. : 618, P1224,
P455
Ashfield K. : P950
Ashour Z.I.E.N.A.B. : P806
Asif A. : P207, P451, P718, P729,
P930
Asirvatham S.A.M. J. : P258, P448,
P947
Ata N. : P1157, P281
Atak R. : P1190
Atanaskovic V. : P1162
Atay Y. : P897
Athanasopoulou E. : P724
Atroshtchenko E. : P1094, P1323,
P373, P563
Attisano T. : P273
Aukrust P. : 172, P1314, P472
Aupperle H. : P819
Avanzas P. : P1033, P202
Avdeeva E.V. : P1195
Averin E. : P902
Avila M.S. : P826
Avila Samuel M. : P308
Axente L.N. : P1266, P1338, P336
Aygun F. : P282
Ayik M.F. : P897
Name / Index Number
Ayub Ferreira S.M. : P1071
Ayub S.F. : P1169
Ayub-Ferreira S. : P1249
Ayub-Ferreira S.M. : P1024, P1028,
P1082, P1179, P251, P276, P308,
P826, P962, P982
Azargashb E. : P733
Azizova A.G. : P1241, P994
Azuaje F. : 713, P1153
Azzouzi L. : P1199, P461, P942,
P980
Baaddy N.A.I.M.A. : P1167, P792
Babcak M. : P316
Babich P. : P1316, P876
Bacal F. : P1024, P1028, P1071,
P1082, P1179, P1259, P251, P276,
P308, P374, P826, P962, P982
Bacchelli S. : P802
Badabhagni M. : P855
Badila E. : P1336, P344
Baena J.M. : P1221
Baghdady Y. M. B. : P796
Bago J.R. : P1148
Bahs G. : P781
Baker S. : P1297
Bakhshande H. : P822
Baklanova N. : P1273
Balakhonova T. V. : P524, P984
Balandina Y. : P479
Balbarini A. : P1229, P951
Baldasseroni S. : 679
Balderas-Diaz K. : P253, P777
Baldi A. : 619
Balligand J.L. : P322
Balling L. : P463
Ballotta A. : P992
Balogh A. : 175, P1039
Banasiak W. : P1228, P200, P264,
P296, P396, P487, P717, P773,
P791, P815, P887, P970, P977
Banaszak-Bednarczyk M. : P571
Bandhari S. : P383
Bania J. : P1171, P1172, P739, P977
Banicevic S. : P906
Banovic M. : P291, P420, P841,
P884
Banovic Marko M.B. : P1021
Banya W. : 83
Baptista F.G. : P1169
Bara C. : P408
Baraldo S. : P910
Baranova E. : P1034, P314
Baranowski R. : P486
Barasa A. : P538
164
AUTHORS
Barassi B.P. : 617
Barauskiene Vilija V.B. : P912
Barbarash L.S.B. : P1052, P1324
Barbarash O.L. : P1318
Barbarash O.L.B. : P1052, P1324,
P321, P891
Barbati G. : P500, P754, P756,
P757
Barbieri A. : P1182
Barbosa G. : P1329
Barilla’ F. : P206
Barinov V.G. : P362
Barlagiannis D. : P218, P492
Barlow M. : P1066
Barnett D. : P473
Baron O. : P1029, P934
Barquero-Perez O. : P864
Barra S. : P1201, P1245, P1312,
P475, P861, P879
Barretto A.C.P. : P859, P943
Barrier P. : P954
Barrigoto I. : P371
Barron A. : P1074
Barros L.N. : P441, P511
Barros L.S.N. : P1014
Bart B. : P247, P510
Barten M.J. : P306
Bartha E. : P416
Barthez O. : 711
Bartos D. : P1336, P344
Bartunek J. : P295
Baruah R. : P229
Basso S. : P1331
Bastos A.F. : P1014
Bataiosu C. : P1097, P837
Batista G.L. : P982
Batistela V. : P353
Battaglia D. : P1248
Battimelli A. : P273
Battler A. : P1026
Bauernfeind T. : P259
Baugh J. : P1277, P330
Baugh J.A. : P853
Bay M. : P450
Bayes-Genis A. : P1148, P1272,
P1287, P1317, P212, P277, P390,
P533, P893, P966, P968
Bazhenova E. : P1034, P314, P890
Bdeir M. B. : P270
Beattie J.M. : P333
Beauvais F. : P918
Becker D. : P1298
Begg G.A. : P741
Beigi Harchegani A. : P733

AUTHORS
Beillard E. : P765
Beirao I. : P1322, P896
Beitnes J. O. : P472
Belenkov U.N. : P898
Belenkov Y. N. : P1213, P531
Belenkov Y.U. : P1273, P320, P466
Belenkova Y.A.B. : P321
Beleslin B. : P291, P293, P884
Belfiore R. : P754
Belicza E. : P1298
Belinchon J. C. : P254
Bell J. : P1285
Belli J.F.C. : P1012, P1249
Bellini F. : P1229
Bellwon J. : P546
Belmourida F. : P942
Beltran G. : P871
Belu E. : P1097, P837
Belyaeva O. : P1034, P314
Belyavskaya T. M. : P1018
Belyavskiy E. : P278
Ben Gal T. : P1026
Ben Hamda K. : P839
Bencardino G. : P1088
Benedek I. S. : P1242
Benedek I.S. : P289, P809
Benedek Jr I. : P1242, P289, P809
Benedek T. : P1242, P289, P809
Benhalla H. : P204, P728
Benicio A. : P1024, P1259
Benjaminsen J. : P312
Benjelloun K. : P901
Benjelloun M.K. : P242, P955
Bennett A. : P536
Bennis A. : P1008, P1164, P1199,
P1291, P204, P208, P219, P242,
P339, P428, P447, P461, P728,
P763, P942, P955, P980
Bennis A.B. : P452, P981
Bennis A.H. : P1167, P792
Bentkowski Z. : P791
Bento H. : P274
Beramendi Calero J.R. : P1332
Berdeaux A. : P932
Beregi J.P. : P1279
Beresina A.V. : P1226, P307
Berezin A. : P266, P310, P787
Berezina A. : P1034, P314
Berge K. : P472
Berge R. K. : P472
Bergmann M. W. : P768
Bergmann Sverrisdottir Y. : P925
Berkovich O. : P1034, P314
Berkovich O.A. : P890
Name / Index Number
Berliner D. : P778
Berlinghieri N. : P547
Bermingham M. : P1232
Bernard Y. : P1231, P1235
Berns S.A. : P1318
Berry M. : P1304, P262, P504
Bertaux G. : 711
Bertelli M. : P334
Bertens L. : P798
Bertero A. : 174
Bertero G. : P228
Berthel R. : P343, P870
Bertomeu V. : P1031, P1265, P1267,
P835
Berton E. : P483
Besaga E. : P1020, P294
Bestetti R. : P261
Bettari L. : P342, P541
Bettari L. : P1086
Bettencourt N. : P849
Bettencourt P. : P1079, P220
Bhadada S.V. : P961
Bhagra S.K. : P1066
Bhutta U. : P1282
Biadi O. : P231
Biagioli P. : P866
Bianchi B.G. : 617
Bianco N. : P260, P315
Bianco S. : P1332
Biasioli B. : P500
Bibi T. : P732
Biegus J. : P200, P396
Bierhaus A. : P755
Biermann J. : P335, P869
Bieseviciene M. : P807
Bilbao P. : P223
Bilgin M. : P281
Bilibina A.A. : P1043
Bilinska M. : P486
Bilkhu H. : P1066
Bilostotska O.O. : P1197
Bilovol A.N. : P803
Binder D. : P385
Binder T. : P348
Birchall A. : P473
Birdane A. : P1157, P281
Birk E. : P1026
Birkner E. : P427
Biscottini E. : P866
Bistola V. : 678, P860
Bitter T. : P213, P438
Bittner H.B. : P306
Bize A. : P932
Bjorck L. : P534
165
Bjornsson E. : P877
Bjurman C. : P1085, P554
Blanco J. : P1148, P966
Blanco-Palacios G. : P1033, P202
Blankova Z. : P1241, P470, P836,
P994
Bliksoen M. : 172, P931
Bloch K.D. : P1154, P846
Blondhaim D. : P207, P451, P718,
P729, P930
Bobbio E. : 144, 619, P311, P992
Bobbo M. : 148
Bobescu E. : P555
Bobier C. : P1063
Bobylev D. : P408
Boccardi L. : P384
Bocchi E.A. : P1012, P1024, P1028,
P1071, P1082, P1169, P1179, P1249,
P1259, P251, P276, P308, P353,
P374, P826, P859, P962, P982
Bochorishvili I. : P915
Bock M. : P875
Bodi V. : P1159, P1217, P250, P928
Boesgaard S. : P1258
Boeti L.B. : P1238
Bogalho C. : P422, P751, P857
Bohm M. : 695, P797, P873
Bollen H. : P304
Boman K. : P364
Bomholt T. : P1258
Bonadies M. : P1202, P217, P974
Bonanad C. : P1159, P928
Bonanno C. : P185
Bonaque-Gonzalez J.C. : P331
Boncagni F. : P545
Bondermann D. : P348
Bongiorni M.G. : P231
Bonin M. : P946
Bonios M. : P1165, P301
Boonman-De Winter L.J.M. :
P1068, P1269
Boonman-Winter L.J.M. : P439
Borbely A. : P1039
Borelli G. : P1229, P231, P564, P965
Boren J. : P210, P758
Boren J.A.N. : P236, P936
Borer J.S. : 695, P797
Borger M.A. : P306
Borghi C. : P714, P786, P802
Borghi G. : P910
Boriani G. : 677, P187
Boricic M. : P420, P841
Boricic Marija M.B. : P1021
Borisov K.V. : P953
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
Bormane I. : P781
Borodulin-Nadzieja L. : P887
Boronat-Garcia M. : P331
Boroni C. : P830
Borsanyi T. : P752, P885, P945
Bosiljka Vujisic-Tesic B.V. : P1021
Bosnjakovic P. : P1270
Bossone E. : 144, P311, P992
Botelho A. : P1312, P1327, P215,
P764, P879, P938
Botezatu A. : P1044
Botto G. L. : P187
Bousquenaud M. : P327
Boutley H. : P327
Boyer L. : P350
Boyne J.J.J. : 82
Bozinovic N. : P948
Bracho M. : P1264
Brady P.E.T.E.R. : P258, P448, P947
Bragos R. : P968
Bramanti F. : P1251
Brambatti M. : P1192
Brancaccio G. : P1025
Brancaccio M. : 174
Brancalhao E.C.O. : P736
Brand S.M. : 680
Bratis C. : P1047
Braun-Dullaeus R. : P845
Braunschweig F. : P271, P300,
P392
Breidthardt T. : P1200, P715
Brennan A. : P381
Brenner S. : P778
Brewer A. : P958
Briand F. : P1235
Briceno S. : P1264
Brie D. : P748
Brinkley J. : P990
Brito D. : 709, P345
Brito J. : P1080
Brito J. D. : P1189
Broadhurst P. : P234
Broch K. : P1075, P1314
Brockmeyer B. : P1081
Brodehl A. : 173
Bronze L. : P549
Broos P. : P552
Brostrom A. : 79, 80
Brown M.R. : P1256, P499
Bruckner I. : P1044, P745
Brugts J.J. : P415
Bruguera J. : P1220, P1221, P248,
P388
Brunelli C. : P228
Name / Index Number
Brunetti L. : P904
Brunner-La Rocca H.P. : P1049,
P1070, P552, P880
Bruno P. : P805
Bryce J. : P536
Buchanan J. : P950
Buckley N. : P473
Bucur O. : P809
Buehler K. : P211
Buga L. : P1320, P355
Bugatti S. : P799
Buhari S. : P1208
Buiatti A. : P500
Buiciuc O. : P832
Buja L.M. : P958
Bullert K. : P438
Bunay A. : P863
Burazor I. : P1162, P1270
Burazor M. : P1162, P1270
Burger A. : P193
Burkard N. : P1001
Burkard T. : P880
Burnos S. N. : P1019
Bussani R. : P756, P757
Butylin P.A. : P848
Byczkowska K. : P1193
Bylova N. : P1163, P779, P975
Cabanes R. : P1287, P1317, P277,
P390, P533, P893
Cachofeiro V. : P740
Caeiro D. : P1326, P194, P566,
P567, P849
Caetano F. : P1201, P215, P475,
P938
Cagirci G. : P1000
Caiado L. : P230
Calabuig J.R. : P1031, P1265, P1267
Caldarola P. : P964
Cale R. : P1080
Caliendo L. : P992
Calija C.B. : P1095
Calisto C. : P1092, P371, P532
Callahan Mark M.C. : P1021
Calmon G. : P1264
Calvert M. : P535
Calvier L. : P740
Calvo Jambrina R. : P269
Camandaroba P.J.P. : P441, P511
Caminiti G. : P1248, P482, P814
Camm J. : P797
Campeanu A. : P867
Campelo M. : P1013, P1313, P1329,
P425, P821
Campia U. : P1065, P508
166
AUTHORS
Campolo J. : 680, P830
Campomori F. : P786, P802
Campos E.P. : P441
Campos J. : P409
Canani L.H. : P838, P840
Canic J. : P1053
Cano L. : P1287, P1317, P277, P390,
P533, P893
Cano-Perez O. : P328
Cantatrione S. : P435, P465
Cao Y. : P1208
Capelozzi V.L. : P196
Capotosto L. : P805
Caprio M. : P482
Capucci A. : P1192, P545
Capulzini L. : P279
Caragnano V. : P823
Carballo S. : P988
Carbonara S. : P904
Cardinalli-Neto A. : P261
Cardoso G. : P1236, P1307
Cardoso G.C. : P221, P467
Cardoso J.N. : P735, P736, P943
Carlsen C.M. : P450
Carlsson K. : P850
Carluccio A. : P814
Carluccio E. : P866
Carmeliet P. : 171
Carmo P. : P1189
Carneiro M. S. : P1334
Carnevale D. : 174
Carp A. : P352
Carpena N. : P1031, P1265
Carpi A. : P322
Carrasco Sanchez F.J. : P1051
Carrasco-Ortiz O. : P253, P501,
P777, P892
Carrie D. : P1304, P954
Carriere C. : P754
Carrilho-Ferreira P. : P345, P371,
P422
Carrillo-Perez Tome M. : P1033,
P202
Carroll S. : P886
Carroll-Hawkins C. : P249
Carr-White G. : P521
Carubelli V. : P547
Caruso R. : P830
Carvalho De Sousa J. : P1092, P532
Carvalho R. : P1326, P194, P566
Carvalho S : P1307
Carvalho V.O. : P1012, P1249
Casacuberta J.M. : P1220, P1221
Casali V : P1202, P974

AUTHORS
Casalino L. : P228
Cascio W.E. : P990
Casiraghi B. : P570
Casscells S.W. : P958
Cassiano K.M. : P1056
Castagno D. : P191, P359
Castedal M. : P877
Castillo-Judez M. : P1332
Castillo-Martinez L. : P253, P501,
P777, P892
Castro Fernandez A. : P269
Castro P. : P223
Castro-Chaves P. : P530
Castro-Ferreira R. : P530
Catalin G. : P1222, P265
Catanescu G.I. : P555
Catanzariti D. : 677
Catanzaro R. : P916
Cattabiani A.C. : P1238
Cavaco D. : P1189
Cavalcanti A. C. : P1056
Cavallino C. : P753
Cavusoglu Y. : P1157, P281
Cay S. : P1000, P1190
Cecaro F. : P483
Cederin B. : P1040
Ceia F. : P1214, P976
Celik S. : P498, P755
Celikyurt U. : P1180, P358, P548
Cellamaro T. : P564, P965
Cencarik J. : P316
Centeno A. : P1147
Cerqueira J. : P1084
Cerrito A. : P814
Cesana B. : P1065, P508
Cha Y.O.N.G.-M. : P258, P448,
P947
Chabbert V. : P954
Chae C.C. : P1161
Chae J. : P354
Chae S.C. : P403, P542, P774
Chaker L. : P839
Chalazonitis A. : P1207
Chalikias G. : P888
Chamontin B. : P1304, P504
Chan H. : P932
Chan M. : P1067
Chan T. : P1149
Chandrakala A.N. : P1050, P852
Chandrasekaran B. : P233
Channer K. : P292
Chapman C.M. : 712
Chassany O. : 695
Chekneva I. : P898
Name / Index Number
Chen C.Y. : P1205
Chen M.F. : P1205
Chermont S.S.M.C. : P1014
Chernaya Z.A. : P779
Chernyavina A. : P1233, P963
Cherubini A. : P946
Chiacchio M. : 619
Chiaki S. : P338
Chiang C.H. : P1205
Chiarella F. : 679
Chiari C. : P1010
Chioffi M. : P217
Chioncel O. : P352
Chioncel V. : P985
Chioncel V.P. : P1266, P1338, P272,
P336, P924
Chitu M. : P1242, P289, P809
Chizzola P.R. : P308, P1024, P1028,
P1071, P1082, P1179, P251, P276,
P826, P962
Chlopicki S. : P1170, P738
Cho E.J. : P1009
Cho M.C. : P199, P403, P542, P774
Cho M.S. : P1161
Choe K.H. : P944
Choi C.O. : P811
Choi D.J. : P1161, P199, P403, P542,
P774
Choi I.S. : P525
Choi J.J. : P811
Chokshi A. : P494
Chopard R. : P1231, P1235
Chorro F.J. : P1159, P1217, P722,
P928
Choy A.M. : P189, P190
Chraibi K. : P1199
Chraibi K.H. : P204, P728
Christersson C. : P1091
Christiaens L. : P1063
Christodorescu R. : P1100
Chryssanthakopoulos S.N. : P257
Chu P.-H. : P406
Chung N. : P558, P921
Chung W.-J. : P525
Chursina T. : P509
Ciccarelli A. : P435, P465
Ciccarese C. : P1315, P361
Ciccone M.M. : P432, P823, P904
Cifelli G. : 174
Cioffi G. : P384
Cioppa C. : P435, P465
Ciro A. : 710
Citro R. : P992
Cittadini A. : 144, 619, P311, P992
167
Cladellas M. : P248, P388
Claridge S. B. L. : P521
Clark A.L. : P1320, P355, P380,
P536, P886
Cleland J.C.G. : P355
Cleland J.G. : P1320, P380, P536,
P886, P383
Clements I. P. : P1076
Clopton P. : P366
Cocora M. : P1097
Coelho C. : P857
Cohen H.W. : P834
Cohen-Solal A. : P918
Coisne D. : P1063
Cokkinos D.V. : P1047
Colantonio C. : P995
Colin-Ramirez E. : P253, P501, P777
Coll Barroso M. : P454
Coll R. : P277, P390, P893
Collerton J. : P286, P907
Collier P. : P1277, P330, P853
Colombo F. : 679
Colombo G. : P714, P786, P802
Colucci A. : P1268, P750
Comerci G. : P1088, P1268, P750
Comin-Colet J. : P1220, P1221,
P248, P388, P908
Comisso J. : P377
Conboy T. : P270
Conceicao-Souza G.E. : P1024,
P1028, P1071, P1082, P1179, P251,
P353, P374, P826, P859, P962
Conceica-Souza G.E. : P276
Concepcion R. : P223
Condorelli G. : 619
Conlon C.M. : P983
Constadoulakis P. : P1047
Continanza G. : P805
Cooper T.J. : P908
Coppola C. : P1182
Corbi M. : P1185, P326
Coric V. : P1042
Cornellussen R. : P229
Corno A. : P830
Correia A. : P1084
Correia A.S. : P1011, P1077, P1174,
P1247, P1250, P285, P485, P527,
P743, P816, P817
Correia C. E. : P1306, P557, P760
Correia E. : P1322, P357, P394,
P397, P896
Correia H. : P1322, P896
Correia M.J. : P1187, P239, P417
Correia S. : P1038
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
Corsten M.F. : 171
Cortes R. : P1027, P1031, P828,
P835
Cortez-Dias N. : 709, P345, P751,
P857
Cosentino E. R. : P714, P786, P802
Costa A. : P1160
Costa F. : P1189, P239
Costa F.M. : P221, P467, P1236
Costa L. : P1061, P1062
Costa L. : P1160
Costa M. : P1280
Costa R. : P1184, P334, P419
Costanzo P. : P380
Cosulschi M. : P837
Cotez-Dias N. : P422
Coufal Z. : P313
Coutinho P. : P1327
Cowburn P. J. : P232
Cowie M.R. : 83, P233, P378, P749
Cox C. : P958
Cozma D. : P476, P543
Cozma D. C. : P742
Cozzi L. : P830
Cramer L. : P385
Cramer M.J.M. : P1068, P1269
Creagh F. M. : P473
Creemers E. : 171
Crespo E. : P1287
Crevelari E.S. : P334, P419
Crijns H.J : P552
Cristea A. : P935
Cruz F. : P308
Cruz F.D. : P1028, P1071, P1169,
P1179, P374
Cruz F.D.C. : P1169
Cruz Fernandez J.M. : P269
Csajbok E. : P810
Csanady M. : P426, P810
Csato V. : P905
Cunnigham A. : P458
Cunningham A. : P556
Cvjetan R. : P1053
Cwetsch A. : P854
Czarnowska E. : P1032, P1193
Czolbe M. : P1001, P847
Czuriga D. : 175
D Amico E.A. : P859
Daamen M. : P1070
Dabic P.D. : P1095
Daffarra C. : P1260
D’agostino C. : P187
Dahl A. : 79, 80
Dahlstrom U. : P1300, P721
Name / Index Number
Daiter I.I. : P1163
Dal Ferro M. : P946
Dalmay F. : P1230
D’aloia A. : P799
Daly M. J. : P950
Daly N. : P458, P556
Damjanov N.D. : P565
Damjanovic S. : P1003, P1006
Damvopoulou E. : P1004
Damy T. : P1166, P350, P351, P355
Dan R. : P1057, P476, P543
Dandel M. : P497
Danielyan M. : P224, P466
Danilogorskaya J.A. : P898
Dankovtseva E.N. : P362
Dankowski R. : P1223, P505
Dany F. : P1230
Danzmann L.C. : P838, P840
Daraban A.M. : P1336
Daragon C. : P1230
Dargie H.J. : P1066
D’ascanio M. : P805
Dasoveanu M. : P1266, P1338,
P272, P336, P924
Datcu G. : P555
David C. : P456, P889
Davidson J. : P458, P556
Davidson J. : P1237
Davies A.D.M. : P775
Davies J. : P1285
Davies K. : P529
Davies S.W. : P227
Davis R. : P535
Davos C.H. : P257
Dawkins I. : P1232, P464, P785,
P983
Dawkins I.R. : P1225, P453, P853,
P996, P469
Dawson G.F. : P730
De Angelis S. : P273
De Antonio M. : P1287, P1317,
P277, P390, P533, P893
De Benedetti S. : P1248
De Biasio M. : 679
De Blasio E. : 174
De Braganca A.C. : P962
De Caro F. : P564, P965
De Cicco V. : P805
De Greef M.H.G. : P481
De Groot P.G. : P324
De Groote P. : P1279
De Haan F. : P869
De La Fuente Galan L. : P1191,
P325, P986
168
AUTHORS
De Lorenzo C. : P1182
De Maio M. : P805
De Marco E. : P1088, P1268, P750
De Maria R. : 680, P263
De Masi De Luca A. : P279
De Masi De Luca G. : P279
De Sousa C. : P1247
De Sutter J. : P295
De Teresa Galvan E. : P878
De Vecchi F. : P753
De Vecchis R. : P435, P465
De Vincentiis C. : P311
De Vito G. : 710
De Weerd G.J. : 82
De Winther M. : 171
De Wit R. : 82
Deaton C. : P813
Degli Esposti D. : P714, P786, P802
Degroote P. : P1166, P868
Degryse J. : P246, P346, P437
Dei Cas L. : P1065, P1315, P361,
P508, P547, P799
Dekany M. : P259, P752, P885,
P945
Dekleva M. : P1030
Del Carlo C.H. : P735
Del Principe G. : P1025
Delahaye F. : P1166
Delfino P. : P1202, P974
Delgado J. : 678, P719
D’elia E. : P1202, P974
Deljanin Ilic M. : P1036, P299
Demir A.D. : P1190
Demir E. : P897
Deng M. : P1023, P825
Dengler T.J. : P498, P755
Denisevich T. L. : P267
Denisova T. : P1210, P393
Deshko M.S. : P363
Desmoulin F. : P262, P504
Dettori O. : P805
Devaux Y. : 713, P1149, P1152,
P1153, P327, P767, P770
Devecchi P. : P753
Dexler B. : P1200
Dexter J. : P249
Dhein S. : P819
D’hooge J. : P1154
Di Bello V. : P951
Di Biase G. : P435, P465
Di Chiara A. : P946
Di Donato M. : P1253
Di Lenarda A. : 148, P384, P754,
P946

AUTHORS
Di Pasquale G. : 679
Di Stefano P. : P187
Diaconu C. : P440
Diakos N. : P1165
Diakov C. : P1063
Diamantino N. N. : P1160
Diamantino T. C. : P1160
Dias Ferreira N. : P849
Dias P. : P489, P490
Diaz-Guemes I. : P212
Diby K.F. : P401
Dickstein K. : P908
Dieijen-Visser M.P. : P552
Dieterle T. : P211
Diez C. : P1317, P277, P390, P533
Diez M.D. : P537, P872, P894
Diez Manglano J. : P1305
Dilenarda A. : P756, P757
Dimitriadis Z. : P438
Dimkovic S. : P192
Dinca G. : P265
Dinh W. : P454
Diomande M. : P401
Dionisio O. : P394
Dixon L. : P1237, P950
Djokovic A. : P1042, P1083, P1308,
P906
Djokovic L.J.T. : P1095
Djordjevic Dikic A. : P293, P884
Djordjevic Radojkovic D. : P862
Djordjevic V. : P883
Djukic T. : P1042
Dmitrieva R.I. : P1043
Dobre D. : P873
Dobreanu D. : P555
Dobrovolsky A. B. : P524, P782
Dobson J. : 708
Doehner W. : P341, P385, P386,
P436, P970
Doesch A. : P498, P755
Doherty R. : P950
Doi T. : 616, P297, P771
Doka B.F. : P555
Doll H. : P292
Dolotovskaya P. : P393, P544
Domingo M. : P1220, P1221, P1272
Dominguez Franco A.J. : P878
Dominguez Rodriguez A. : P1033,
P202
Dominici T. : P206
Domuschiev K. : P1293
Donal E. : P868
Donati F. : P564, P965
Dong Q.-T. : P769
Name / Index Number
Donova T.I. : P462
Dontje M.L. : P481
Dor V. : P1253
D’orazio S. : P805
Dores H. : P1187, P239, P417, P549
Dormi A. : P786
Dorobantu M. : P344
Doroshenko E.M. : P363
D’ortho M.P. : P350
Dossi H. : P918
Doughty R. : 708
Douskou M. : P1047
Dovgalevskiy Y. : P544
Draganic G. : P841, P1021
Dragu R. : P193
Dragulescu D. : P476
Dragulescu S.I. : P1194, P742
Dragulescu S.T. : P748
Dresselaers T. : P1154
Drexler B. : P715
Drighil A. : P428
Droogne W. : P304
Drouot X. : P350
Duarte Faria R. M. : P394
Duarte J.A. : P1278
Dubois-Rande J.L. : P351, P355
Dubovik T. : 681
Duckett S. : P521
Dudas K. : 81
Duengen H.D. : P192, P343, P870,
P518
Duffy H. : P535
Dujardin J.J. : P868
Dumitrescu A. : P748
Dumitrescu L. : P1178
Duray G.Z. : P752
Dusceac D. : P867
Dusek L. : P1158, P923
Duval S. : 145, P747
Duveau D. : P1029, P934
Duvinage A. : P518, P995
Dvoryashina I. : P1216, P256
Dyakova M. : P1325
Dyatchuk L. : P1218
Dykman N.A. : P890
Earle N. : 708
Eberhard J. : P343, P870
Ebner N. : P341, P436
Echeverria Garcia T. : P1332
Eckman P. : 145, P747
Edelmann F. : P192, P518, P995
Eden M. : 614
Edes I. : P1039
Edmunds L. : P1285
169
Edner M. : P1300, P721
Eek C. : P1314
Egan S. : P998
Egstrup M. : P332, P463
Ehlermann P. : P349, P387, P540,
P498
Eicher J.C. : 711, P1166
Eitan A. : P193
Ejdeback J. : P1040
Ekman I. : 695, 81, P1060
Ekren H. : P1180, P548
El Honsali Z. : P242
El Naggar W.A.E.L. : P806
El Tayeeb A. : P270
Elasfar A. : P1290, P727
Elbaz M. : P954
Elder D. : P189, P190
Elesin D. : P1183
Eletribi D.R. : P844
Elez J. : P1053
Elhonsali Z. : P452, P981
Elksne K. : P781
Elmokadem M. O. E. : P796
Elosua R. : P248, P388
Elrasheed O. : P1282
Emani S. : P952
Emdin M. : 146, P1251, P812
Emre E. : P282, P358, P528, P548
Engin C. : P897
Enseleit F.E. : P495
Erakovic V. : P1270
Erbel R. : P335
Eremenko K. : P1325
Ereminiene E. : P807
Erguney M. : P288
Erickson M. : P271
Ermolina O. V. : P524
Erne P. : P1049
Ernens I. : P1152, P767, P770
Ersgard D. : P271
Ertas G. : P1180, P282, P358, P528,
P548
Ertl G. : P778
Ertugay S. : P897
Escamilla R. : P1212
Escande Beillard N. : P765
Escande M. : P765
Eschenhagen T. : P192
Escher F. : P391
Eshpulatov A.S. : P1177
Esis C. : P1264
Esmaelzade M. : P822
Espevik T. : 172
Ess M. : P244, P720
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
Estlinbaum W. : P1049
Estornell J. : P1185, P326
Estrada S. : P850
Eurlings L.W. : P552
Evdokimov V. : P222
Evdokimova A. : P222
Evdokimova M.A. : P362
Exadactylos N. : P218, P492
Fabbri G. M. T. : 679
Faber J. : P332
Fabregat O. : P1185, P326
Fabri Jr J. : P195
Facchin D. : P377
Fadili S. : P1167, P792, P792
Faganello G. : 148, P946
Fagyas M. : P1039
Fal A. : P717
Fantini F. : P1253
Farah I. : P270
Fard A. : P366
Faria R. : P1276, P357, P397
Farinola G. : P1204
Farkas Lainscak J. : P252
Farmakis D. : P724
Farr M. : P1023, P494
Fartouce S. : P1187
Fast A. : P348
Fatini C. : 146
Faustino A. : P1280, P215, P938
Faustino C. : P1201, P475, P861,
P879
Favale S. : P1204, P432, P569,
P823, P916
Favaloro F.L. : P537, P872, P894
Favaloro F.R. : P537, P872, P894
Fay R. : P723
Fedorco M. : P313
Fedotov P.A. : 147
Fejfar T. : P562
Feldman A. : P1149
Feliciano J. : P1073, P484, P818
Felker M. : P342, P541
Felsoci M. : P313, P772
Feola M. : P1283, P523
Feraco A. : P482
Fernandes L. C. M. : P1294
Fernandez S. : P871
Fernandez-Fernandez A. : P331,
P864
Fernandez-Vivancos Marquina C.
: P269
Ferradaes P. : P1078
Ferramosca E. : P714
Ferrandi F.M. : 617
Name / Index Number
Ferrando M. : P326
Ferrara F. : P992
Ferrari P. : 617, P263
Ferrazzi P. : P496
Ferreira E. : P1079
Ferreira J. : P1236, P1307, P221,
P467
Ferreira L. : P484, P818
Ferreira P. : P357
Ferreira R. : P1015
Ferreira R.C. : P484, P818, P1073
Ferreira S.A. : P1012
Ferrieres J. : P262
Fertin M. : P1279
Fiegehenn C. : P845
Figueiredo A. : P1322, P896
Figueiredo E. L. : P1334
Figueroa C. : P203, P460
Filipiak K.J. : P559
Filippatos G. : P1262, P395, P724,
P860, P908, P971
Filippi A. : P263
Finocchiaro G. : P756, P757
Fiocchi R. : P496
Fiorelli A.I. : P1024, P1259, P826
Firouzi A. : 83
Fitzgerald K.A. : 172
Fiuzat M. : P342, P541, P917
Fjellner A. : P572
Fleig A. : P1330
Flemme I. : P1054
Flessas N. : P1093
Floch F. : P895
Florescu N. : P837
Floriano E.M. : P1275, P513
Florio F.M. : 617
Foadoddini M. : P931
Foeldes G. : P341, P436
Follath F. : 678, P719
Fonseca C. : P1214, P417, P549,
P849, P976
Fonseca M. : P1084
Fontana A. : P263, P496
Fontana M. : P812
Fontelonga Bento M.M. : P1214,
P976
Fontes De Carvalho R. : P567
Fontes-Carvalho R. : P530, P849
Ford I. : 695, P797
Forleo C. : P432, P916
Fornarelli F. : P904
Forster T. : P426, P810
Fosshaug L. E. : P472
Fouad F.O.U.A.D. : P979
170
AUTHORS
Fourcade J. : P1304
Fracchioni I. : P1202, P217
Fracchioni Y. : P974
Franca C. : P274
Franchini A. : P1248, P814
Francis D. : P1074, P229
Franke J. : P349, P387, P540
Frankenstein L. : P349, P387, P498,
P540, P755
Frattini S. : P384
Fredriksson M. : 80
Freemantle N. : P535
Freiberger T. : P240
Freilikhman O.A. : P848
Freitas J. : P1077, P1174, P527, P743
Frey N. : 614
Frick M. : P244, P720
Friedman P. : P258, P448, P947
Frigerio M. : P830, P910
Frigiola A. : P992
Frigola E. : P1188, P1198, P398,
P410, P716
Froehlich G. M. : P495
Frogoudaki A. : P860
Frreira F. : P1073
Frunza S.A. : P344
Frutuoso C. : P285, P409
Fu L. : P235
Fu M. : P1300, P553, P554, P783,
P877, P1085
Fuelster S. : P386
Fuentes S. : P1221
Fueth R. : P454
Fujiki H. : P993
Fujimoto T. : P1311
Fujino M. : P1072, P725
Fujita M. : P1173
Fujiwara H. : P1022, P833
Fukunami M. : P1168, P1311, P929
Furman N. : P393, P544
Furukawa Y. : P1311
Fusco A. : P465
Fux T. : P300
Gaber R. : P1005, P1271
Gabinsky J. : P1155
Gabriele L. : P231
Gabrielli F.A. : P1268, P750, P1088
Gackowski A. : P1255, P280
Gaertner A. : 173
Gaitani S. : P1262, P971
Gajek J. : P1172
Gajin P.G. : P1095
Gala A. : P1196, P427
Galan A. : P1317, P893

AUTHORS
Galati A. : P279
Galimzyanova L. : P468
Galinier M. : P1166, P1212, P1304,
P262, P504, P868, P954
Galisteo Almeda L. : P1051
Galjee M.A. : P1046, P515
Galofre N. : P871
Galvao Braga C. : P1084
Galvez E. : P871
Galvez-Monton C. : P1148, P212,
P966, P968
Galyavi R. : P457, P468, P550
Galyavich A. : P550, P457, P468
Gama P. : P357, P397
Gama V. : P1326, P194, P566, P567,
P849
Gambazza N. : P863
Gandara F. : P417
Gandhi R. : P473
Ganieva I. : P1288
Garbade J. : P306, P819
Garces E. : P223
Garcia De Burgos F. : P520
Garcia Moran E. : P1191, P325,
P788
Garcia P. : P1185
Garcia-Alberola A. : P864
Garcia-Martin R. : P1332
Garcia-Ramon R. : P722
Garin N. : P988
Garramone B. : P1088, P1268,
P750
Garrido-Bravo I.P. : P1224, P455,
P899
Gartner F. : 173
Gaspar A. : P1084
Gaspariano-Flores E. : P892
Gasparini M. : 677, 680, P187
Gastelurrutia P. : P1272
Gato Varela M. : P978
Gatta L. : P482
Gatzoulis M. : 83, P257
Gaudio C. : P206
Gavaller H. : P810
Gavazzi A. : P263, P496
Gavini B. : P1229
Gavrielatos G. : P724
Gavris C. : P555
Gayat E. : 713
Gayda S. : 173
Gazdic P. : P316
Gazdic T. : P829
Gebhardt C. : P1001
Geens J. : P304
Name / Index Number
Gelbrich G. : P192, P335, P343,
P518, P870
Geller L. : P1298
Gencer E. : P1157, P281
Gendlin G. : P1288
Genth-Zotz S. : P436
George J. : P189, P190
Gerloni R. : P754
Germano M. : P1061, P1062
Germany R.E. : P972
Gero D. : P416
Gerstel E. : P988
Gertsen M. : P442
Geshi T. : P434, P445
Gesualdo M. : P1204, P904, P964
Ghaderian S. M. H. : P733
Ghaleh B. : P932
Ghellab D. : P1008, P428, P461,
P763, P980
Gheorghe G. : P935
Gheorghiade M. : P1065, P508,
P799
Gherli T.G. : P1238
Ghiorghe S. : P344
Ghosh S. : P249
Giannakoulas G. : P1004
Giannattasio C. : 710
Giannoni A. : P1251
Giannopoulos G. : P724
Giasi A. : P435, P465
Gibelin P. : P1007, P1166
Gibson M. : P813
Gierula J. : P741
Giga V. : P293
Gigantino A. : P273
Gigantino G. : P273
Gil K. : P1193
Gil R.J. : P1032, P1193
Gilis-Januszewski J. : P1081
Gilis-Januszewski T. : P1081
Gill P.S. : P1099, P535
Gillijns H. : P846
Gimelli A. : P1186
Ginguliak M. : P509
Giordano A. : P910
Giordano F. : P206
Giovagnoli A. : P1192
Giudice R. : P273
Giudici V. : P570
Gkouziouta A. : P827
Glantz H. : P1040
Glasnovic J. : P1162
Glavatskiy A. : P310
Glechan A. : P984
171
Glezeva N. : P330
Glockner J. : P429
Glowczynska R. : P559
Goda A. : P303
Goehler A. : P869
Goeminne C. : P1279
Goerge G. : P869
Goetze J.P. : P332, P463
Goh P.P. : P1208
Goldhammer E. : P1278
Golebiewska R. : P280
Golovciner G. : P446
Golovenko E.N. : P1227
Golovko M. : P247
Gomah D.R. : P844
Gomes C. : P1310, P230
Gomes P. : P1201, P1245, P1312,
P475, P861
Gomez C. : P722
Gomez M. : P1220
Gomez Salvador I. : P1191, P325,
P788, P986
Gomulka K. : P717
Goncalves A. : P1087, P285, P409,
P485, P489, P490, P506, P527
Goncalves P. : P1307
Goncalves S. : P422, P751
Goncalvesova E. : P1302, P1321,
P421
Goncharov I. : P1254, P491
Goncharova N. S. : P372
Gondi S. : P958
Gonzalez A. : P1264
Gonzalez B. : P1287, P1317, P277,
P390, P533, P893
Gonzalez Juanatey J.R. : P1031,
P1176, P1267, P835
Gonzalez M. : P722
Gonzalez M.C. : P834
Gonzalez Robledo G. : P248
Gonzalez-Ares J.A. : P871
Gonzalez-Robledo G. : P388
Goode K. : P355, P1320, P886
Gorenek B. : P1157, P281
Goretti E. : P1153
Gorgels A.P.M. : 82, P1070
Gori M. : P263
Gori S. : P384
Gorican K. : P226
Gorislavets N. : P496
Gorobets E. : P353
Gotenko I. : P1252
Goto Y. : P1072, P725
Gotsman I. : P790, P874
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
Gottwik M.G. : P869
Gouveia J.L. : P274
Gouziouta A. : P831
Goya-Esteban R. : P864
Goyal B.R. : P903
Goyal R.K. : P903
Goyault G. : P1279
Grajek S. : P1246, P237, P298, P302
Grammatico A. : 677
Granger C.B. : P191, P359
Grapsa E. : P382
Grassi L. : P261
Greco O. T. : P1335
Gregoire T. : P715
Grieco A. : 710
Griffiths C. : P333
Grigorean V.T. : P272
Grigorian L. : P1265
Grigorian Shamagian L. : P1176
Grigoryan S. : P940
Grillo M. : P217
Grip L. : P516
Grosu A. : P263
Gruchala M. : P546
Grupi C.J. : P374
Grutter G. : P1025
Gualandro D.M. : P195
Guan H.S. : P769
Guarascio B. : P866
Guardiani S. : P1192
Gude E. : P1075
Guder G. : P778
Gudkova A.Y. : P1043
Gudmundsson K. : P392
Gueffet J.P. : P1029, P895
Guendouz S. : P350, P351
Gueret P. : P351
Guerra F. : P1192, P545
Guha K. : P233, P749, P949
Guida P. : P432, P964
Guideri S. : P263
Guimaraes G. : P1012, P1249,
P1028, P1071, P1179, P374, P826,
P962
Gujejiani L. : P915
Gullestad L. : P1075, P1314, P472
Gummert J. : 173
Gungor H. : P897
Guo W. : P235
Gupta R.C. : P1151, P969
Guray Y. : P1000
Gurbuz O.Z. : P288
Gurovich V. : P207, P451, P718,
P729, P930
Name / Index Number
Guschina V. : P1288
Gusetu G. : P1299, P471
Gustaffson F. : P383
Gustafsson D. : P783
Gustafsson F. : P1258, P332, P463
Gustafsson I. : P332, P463
Gutierrez-Rodriguez A. : P892
Gutiu I.A. : P1178
Gutiu L.I. : P1178
Gutleben K.J. : P213
Gutschi E.M. : P1156
Gutz I.G.R. : P982
Guzzi G. : P1260
Gwilkowska J. : P571
Gwizdala A. : P1246, P298, P302
Haacke K. : P875
Haas B. : P1152
Haatainen K. : P1059
Habbal R. : P1199, P461, P980
Habibi H. : 83
Hack A. : P349, P387
Hack D. : P880
Haddad H. : P1067, P1297
Hagerman I. : P1239
Hagiwara N. : P737
Haim M. : P446
Hajib H.S. : P1240
Hajib S. : P242, P901
Halle M. : P995
Hallhuber M. : P1001
Halmai L. : P426
Halmosi R. : P416
Hamad E. : P1149
Hamad H. : P1073
Hama-Murad A.L. : P369
Hamano G. : P197, P198
Hamdi S. : P839
Hamers J.P.H. : P1070
Hamm C.W. : P956
Hammarsten O. : P1085, P553,
P554, P783
Han S.W. : P1161, P199, P403
Hanatani A. : P275
Hannah A. : P234
Hansen P.B. : P1258
Harjola V.P. : P1090
Harjola V.-P. : P539, P734
Harmancey R. : P262
Hasan A.K. : P952
Hasdai D. : P446
Hasegawa K. : P1173
Hasenfuss G. : P518
Hashemizadeh H. : P323, P568
Hashimoto S. : P305
172
AUTHORS
Hashimura K. : P305, P922
Hasselberg N. : P908
Hata N. : P201
Hatala R. : P421
Haver Y. : P909
Haverich A. : P408
Haverkamp W. : 615
Haydock P. : P726, P411
Hazarapetyan L.G. : P940
Hedde P.N. : 173
Hegarova M. : P829
Heilmeyer P. : P319
Heintze J. : P213
Heinzel F.R. : P1156, P449
Heitmair-Wietzorrek K. : P720
Hellab S. : P955
Helle-Valle T. : P1075
Hellgren L. : P407
Heltai K. : P317
Henkel D. : P429
Herijgers P. : P322
Herlitz J. : P1040
Hernandez Garcia J.M. : P878
Hernandez P. : P878
Hernandez-Garcia C. : P1033, P202
Herold J. : P845
Herrera J. A. : P404
Herrera J. E. : P404
Herrera Paz J.J. : P863
Hersi A. : P1290, P727
Hess G. : P454
Hetzer R. : P497
Hewer A. : P869
Heydari A. : P522
Heymans S. : 171
Hidalgo Urbano R.J. : P269
Hiemann N. : P497
Higuchi M.L. : P1259
Hildebrandt B. : P385
Hildebrandt P. : P463, P332
Hill L. : P1237, P950
Hillebrand S. : P776
Hilligehekken A.M. : P776
Hillis G. : P234
Himmelreich U. : P1154
Hinic S. : P906
Hirai M. : P338, P459
Hirooka K. : P197, P198
Hirsch E. : 174
Hisatome I. : P459
Hittinger L. : P350, P351, P355,
P932
Hjelm C. : 79, 80, P1055
Hobkirk J. : P355, P380, P886

AUTHORS
Hochadel M. : P349, P540
Hodge D. : P258, P448, P947
Hodge D.O. : P1076
Hodorogea A. : P935
Hoes A.W. : P1068, P1269, P356,
P439, P474, P744, P776, P778, P798
Hohmann C. : P875
Hollander M. : P439, P744
Holley J. : P795
Holmatova K. : P1216, P256
Holmstrom A. : P1300, P553, P783
Holvoet P. : P322
Hong N. : P558, P921
Honsali Z. : P447
Horakova K. : P772
Horgan S. : P853
Hori M. : P1168, P929
Horstkotte D. : P1081, P213, P438
Horszczaruk G.J. : P854
Hoskova L. : P829
Houston-Feenstra L. : P989
Howlett J. : P1067, P1297
Hozayen S. : 145, P747
Hriz H. : P839
Hsu H.C. : P1205
Huang A. : P334
Huang F.Q. : P1243
Huber S. : P405, P926, P927
Huber T. : P784
Hude P. : P240
Huelsmann M. : P348
Huerta C.H. : P537, P872, P894
Hugues T. : P1007
Huica R. : P1222, P265
Huica S. : P1222
Hulek P. : P562
Hulinska D. : P914
Hundertmark M. : P847
Hussein G. A. : P727
Iacopino S. : P187
Iacoviello M. : P1204, P432, P569,
P823, P904, P916
Iacovoni A. : P263, P496
Iaffaioli R.V. : P1182
Iakobishvilli Z. : P446
Iakovleva A. : P1216, P256
Iancu I.V. : P1044
Iannielli A. : P965
Ianula R. : P985, P1266, P1338,
P272, P336, P924
Ibatov A. : P337, P560, P746
Icarlim Network Members M. :
P1230
Iellamo F. : P814
Name / Index Number
Ifteni G. : P555
Iglesias R. : P1147
Ignaszewski A. : P1067, P1297
Ihm S.H. : P1009
Ikonomidis I. : 678, P719
Ilic B. : P299
Ilic I. : P862, P883
Ilic S. : P1036, P299
Iliesiu A. : P867
Ilyukhin O. V. : P493
Inan N. : P528
Indrigo S. : P377
Inkrot S. : P343, P870
Inui H. : P197, P198
Ionac A. : P1057, P1194, P476,
P543, P748
Ionescu D.-D. : P1097, P837
Iorio A. : 148
Iqbal N. : P366
Irisov D. : P413, P414
Isacoff D. : P1044, P745
Isakov A. : P283
Isgaard I. : 144
Ishida K. : P338, P459
Ishii H. : P737
Ishmetova T. : P468
Isnard R. : P1166, P868
Israeli M. : P1026
Issa V.S. : P1012, P1024, P1028,
P1071, P1082, P1169, P1179, P1249,
P251, P276, P308, P826, P962,
P982
Ivanenko V.V. : P493
Ivanov S.G. : P1041
Ivanova T. : P314
Ivanovic B. : P376, P565
Iwanaga Y. : P993
Iwao H. : P275
Iwasaki Y. : P1311
Izaguirre-Yarza A. : P1332
Izumi T. : P1045, P1168, P929
Izumi Y. : P275
Jaarsma T. : 143, P1016, P1286,
P379, P481, P789, P858, P911
Jabara R. : P790
Jablonska M. : P1170, P738
Jachec W. : P1196, P427
Jacob J.L.B. : P1335
Jacobs L.H. : P552
Jacobs S.J. : P304
Jacomelli I. : P206
Jaffe A.S. : P329
Jakhutashvili N. : P915
Jako B. : P1242, P289, P809
173
Jakovljevic B. : P291, P884
Jalolov B.Z. : P939
Jamal R. : P1206
James K. : P972
Jamsheer A. : P1069
Jander S. : P900
Janenaite Jurate J.J. : P912
Jang Y. : P558, P921
Janin S. : P1231, P1235
Janiszewski A. : P1171, P1172, P739
Jankovic N. : P1042
Jankovic Tomasevic R. : P862, P883
Jankowska E. : P436
Jankowska E. A. : P1171, P1172,
P1228, P200, P264, P296, P396,
P487, P717, P739, P773, P791, P815,
P887, P970, P977
Janssens S. : P1154, P846
Jany B. : P778
Jaraj D. : P572
Jardi N. : P942, P1167
Jarkovsky J. : P1158, P313, P772,
P923
Jarosz A. : P1211, P1303, P881
Jasinski R. : P487
Jasionowska A. : P571
Jaszewski R. : P900
Javorsky G. : P1256, P499
Jeanty C. : P1153
Jelic S. : P1083
Jensen J. : P1085
Jeon E.S. : P1161, P199, P403, P542,
P774
Jeon H.K. : P1009
Jeong J.W. : P290, P811
Jesus I. : P551, P842, P1276
Jimenez J. : P326
Jimenez Navarro M.F. : P878
Joerg L. : P880
Johansson B. : 79, 80
Johansson J. : P407
Johansson P. : P911
John D. : P211
Jondeau G. : P868
Jongbloed J. D. H. : P1150
Jonsson Å. : P1300
Jordan A. : P1031, P835
Jorge B. A. L. : P1294
Jorge C. : P1092, P345, P371, P456,
P751
Jorge F. : P1080
Jorge-Perez P. : P1033, P202
Josefsson A. : P877
Josiak K. : P487
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
Jourdain P. : P868
Juarez-Prera R. : P1033, P202
Jung H.O. : P1009
Jung L. : P354
Jung P. : P784
Jurka A. : P781
Kachnov V. : P804
Kadivec S. : P252
Kafarskaya L.I. : P779
Kahraman G. : P1180, P282, P358,
P548
Kala P. : P1292
Kalai T. : P416
Kalaitzakis E. : P877
Kalapos A. : P810
Kalarus Z. : P1211, P1303, P881
Kalasz J. : P1039
Kaldara E. : P1203, P1207, P360,
P382
Kaldoglou N. : P719
Kalim H. : P731
Kallryd A. : P1040
Kallvikbacka-Bennet A. : P355
Kalogirou A. : P1093
Kalra A. : P795
Kamimura D. : P1098
Kamperidis V. : P1004
Kampouridis N. : P888
Kanaganayagam G.S. : P521
Kanagaratnam P. : P229
Kanakakis J. : P1203, P360
Kanazirev B. : P1293
Kanesawa N. : P1058
Kang S. M. : P558, P921
Kang W.C. : P525
Kanzaki H. : P1072, P725
Kapelios C. : P301, P360
Kaplinsky E. : P871
Karatzas D. : P971
Karcher G. : P327
Kardos A. : P426
Karelkina E. : P759
Karia D. : P315
Karimi P. : P424
Karlsson H. : P392
Karonova T. : P314
Karpov R.S. : P1035, P824
Karvounis H. : P1004
Kas K. : P715
Kashour T. : P1290, P727
Kashtalap V.V.K. : P1052, P1324,
P321, P891
Kasim M. : P731
Kastner J. : P188
Name / Index Number
Katarzynska A. : P298, P302
Katarzynska-Szymanska A. : P237
Katerenchuk O. : P1333
Kato M. : P338, P459
Kato T.S. : P922
Katsaros L. : P1165, P1207
Katsoulas T. : P971
Katus H.A. : 614, P349, P387, P498,
P540, P755
Katzke S. : P875
Kautzner J. : P243, P914
Kavanaugh E. : P381
Kavoliuniene A. : P807
Kawasaki M. : P1311
Kawashima M. : P1022, P833
Kawecka-Jaszcz K. : P1296
Kazakovtseva M. : P283
Kazatsker M. : P207, P451, P718,
P729, P930
Keavney B. : P286, P907
Kelleher C. : P983
Kelly D. : 713
Kemper D. : P497
Kemppainen V. : P1059
Kenny A. : P286, P907
Keren A. : P790, P874
Kerschbaum J. : P433
Khaleva O. : P1320, P380, P536
Khalifa E. A. : P806
Khalique Z. : P233, P749
Kharlamov A. N. : P1155
Khawaja T. : P494
Kherad B. : 615
Khudhair H. : P1069
Khusanov S.H.S. : P413, P414
Kiczak L. : P1171, P1172, P739, P977
Kiema M. : P1059
Kikuchi Y. : P318
Kilic T. : P1180, P358
Kim B.R. : P525, P774
Kim C. O. : P558
Kim H.Y. : P1009
Kim J.J. : P1161, P199, P403, P774
Kim J.Y. : P542, P944
Kim M.J. : P1009
Kim N.H. : P290, P811
Kim S. H. : P1161, P199
Kim S. Y. : P558, P921
Kim S.J. : P811
Kim W. : P354
Kim Y.D. : P1009
Kim Y.K. : P1009
Kimura K. : P1098
Kimura T. : P1173
174
AUTHORS
King D. : P775
Kingston A. : P286, P907
Kinoshenko K.Y.U. : P1197
Kinugasa Y. : P338, P459
Kirbas A. : P282
Kirienko A. I. : P524
Kirk V. : P450
Kirkpatrick R. : P950
Kirkwood T. : P286, P907
Kirthi V. : P227
Kisilevich L. : P1252, P514
Kisko A. : P316
Kiss R.G. : P259, P752, P885, P945
Kistorp C. : P463
Kistorp C.N. : P332
Kitahara Y. : P1181, P225
Kitakaze M. : P1072, P305, P725,
P922
Kitamura M. : P201
Kiyakbaev G. : P1218
Kjellstrom B. : P271, P300
Klauke B. : 173
Klauss V. : P784
Klautz R.J.M. : P324
Klein T. : P1026
Klevtzova N. : P222
Klima T. : P1200
Kloch-Badelek M. : P1296
Klompstra L. : P1286
Kmec J. : P316
Knyazkova I. : P803
Ko J. : P354
Kobalava Z. : P491
Kobalava Z.H. : P1218
Kobayashi M. : P1045
Kobayashi N. : P201
Kober L. : 708, P1258, P450
Kocijancic A. : P1003, P1006
Kocik M. : P226
Koc-Zorawska E. : P264
Koenig A. : P784
Koenig G. : P1081
Koetsier W. : P1150
Koffi D. : P401
Kofflard M.J.M. : P415
Koide M. : P197, P198
Kok W.E.M. : P1086
Kokin E.A. : P1163
Kolevatova G. : P283
Kolodina D. : P1034
Kolokathis F. : P1262, P971
Kolomoiets M. : P509
Kolovou G. : P1047
Koltsov A. : P800, P804

AUTHORS
Komajda M. : 695, P797
Komar E. : P854
Komlev A. E. : P937
Kongo M. R. : P942
Kongo R. : P1008, P428, P461,
P763, P980, P1240
Koniari K. : P395
Konin C. : P401
Konjarova N. : P1293
Konoplyannikov A. G. : P1018
Konstandin M. : P755
Konstantakis E. : P360
Konstantinides S. : P888
Kontoyannis D. : P1207
Koomen M. : P1086
Kopec A. : P717
Koppelstaetter C. : P244
Koracevic G. : P862, P883
Korkmaz S. : P1000
Kortekaas K.A. : P324
Kosaka T. : P265
Kosevic D. : P1095
Kosheleva N. A. : P1301, P882
Kosnik M. : P252
Kostareva A.A. : P848
Kostic T. : P948
Kostin S. : P1045
Kostkiewicz M. : P1337
Kostopoulou A. : P827
Kotb N.E.S.R.E.N. : P1005, P1271
Kotovskaya Y. : P1254, P491
Kouame J. : P400, P401
Koulev B. : P470, P836
Kovacs A. : P259
Kovacs I. : P1242, P289, P809
Kovalenko E. : P222
Koyama S. : P1022, P833
Kozdag G. : P1180, P282, P358,
P528, P548
Kozhukhov S. : P1234, P399
Koziolova N. : P1089, P1233, P1309,
P216, P412, P963
Kozlovskiy V. : P803
Kraaier K. : P1046
Kragten J. : 82
Kraigher-Krainer E. : P995
Krakowiak B. : P296, P773, P815
Krasnov V. : P999
Krasnova O.A. : P1041
Krejci J. : P240
Kremastinos D. : P724, P1262, P971
Krievina G. : P781
Krljanac G. : P512, P843
Kroetz F. : P784
Name / Index Number
Krotin M. : P1030, P1083, P1308,
P906
Krstic N. : P948
Krum H. : 694
Krylova N.S. : P1195
Krylova Y. : P999
Krzemien-Wolska K. : P1196
Kubanek M. : P243, P914
Kuehl U. : P391
Kujacic Vuk V.K. : P1021
Kulcsar I. : P352
Kung T. : P385, P386, P436
Kurabayashi M. : P1058
Kuramoto Y. : P1311
Kurbanov N.A. : P238, P241, P430,
P431, P761, P959, P960
Kurbanov R.D. : P413, P414
Kurian B. : P1228
Kurlianskaya A. K. : P267
Kuryata O.V. : P245
Kushnir S. : P801
Kusnies H. : P446
Kustrzycka-Kratochwil D. : P717
Kutlesic Kurtovic D. : P862, P883
Kutschka I. : P1017
Kuznetsova T. : P1296
Kwasiborski P.J. : P854
Kwiatkowski P. : P852
Kylhammar D. : P370
Kyriacou A. : P229
Kyyak Y.U. : P1263, P502
La Rovere M.T. : P1064
La Sala A. : P482
Laba O.V. : P402
Lacolley P. : P740
Ladeiras-Lopes R. : P530
Lagarto V. : P1310, P230
Lage R.L. : P195
Lagioia R. : P1204, P964
Lago M.R. : P1335
Lagoeiro Jorge A.J. : P1294
Lahera V. : P740
Lainscak M. : P192, P252, P908
Lair M.L. : 713
Lairez O. : P1212, P1304, P262,
P954
Lamblin N. : P1279
Lamiral Z. : P873
Lammers K. : P203, P460
Lanas F. : P223
Landman M.J. : P1068, P1269
Landmesser U. : P1017
Landolina M. : 677, 680, P185
Lang C.C. : P189, P190
175
Langenstroth E.M. : P306
Langstrom B. : P850
Lankisch M. : P454
Lanz J.R. : P1169
Lanzieir P. G. : P1294
Lapina Y.U. : P1273, P320
Laragh J.H. : P834
Laraibi S. : P955
Lara-Padron A. : P1033, P202
Larina V. : P247, P510
Larionova V.I. : P1041
Laroy W. : P715
Lasica L. : P512
Lasica R. : P843
Lassner D. : P391
Lassus J. : 713, P1090, P539, P734
Latronico L. : P863
Lattarulo S. : P432, P916
Latypov R.S. : P937
Laukaitiene Jolanta J.L. : P912
Laurent G. : 711
Lausevic Vuk L.J.V. : P1095
Lau-Walker M. : 83
Lauwers C. : P520
Lax A. : 618, P1224, P455, P899
Lazarova M. : P186
Leal S. : P1187, P239, P549
Lebedev D.S. : P214, P307
Leblanc M.-H. : P1067, P1297
Leborgne L. : P832
Lebreiro A. : P1011, P1038, P1077,
P1079, P1087, P1174, P1247, P1250,
P1329, P409, P506, P527, P743,
P816, P817, P821
Ledakowicz-Polak A. : P507, P900
Ledwidge M. : P1232, P1277, P330,
P464, P469, P785, P983, P1225,
P1282, P453, P853, P855, P996
Lee E.M. : P290
Lee J.D. : P434, P445
Lee J.W. : P542, P944
Lee K.H. : P525
Lee M.M. : P403, P542, P774
Lee S. : P354, P354, P542, P944
Lehmann S. : P306
Lehmkuhl H.B. : P497
Leitao A. : P1214, P976
Leitao Marques A. : P1201, P1327,
P1331, P475, P764, P1280, P1312,
P861, P879
Leitao Marques A.M. : P1245, P215,
P938
Leite-Moreira A. : P530
Leitner L. : P188
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
Lejczak A. : P487, P977
Lelyavina T. : P1226, P307
Lelyavina T.A. : P1226, P307
Lembo G. : 174
Lemmers R. : P552
Leners B. : P1153
Lenoir B. : P767
Lensi M. : P195
Leonard F. : P1152, P1153, P770
Leonard S. : P458, P556
Leong K. T. G. : P1208
Leontiades E. : P831
Lequeux B. : P1063
Lercher P. : P449
Lesman - Leegte G.A.T. : P911
Lesniak-Sobelga A. : P1337
Lesny P. : P1302, P1321
Lestuzzi C. : P384
Letsas K. : P1093
Levin M.-D. : P415
Levy F. : P832
Levy Y. : P207, P451, P718, P729,
P930
Lewinter C. : P355
Lewis C.C. : P1284
Libianto R. : P190
Licio F. V. : P1294
Liebetrau C. : P956
Lieffrig E. : P770
Liem A.H. : P1068, P1269
Lien E. : 172
Liepieieva O. : P973
Liesting C. : P415
Lighezan D. : P1100, P742
Liljeroos M. : P858
Lim P. : P351
Lim S. : P1208
Lim T. : P190
Lima M.V. : P736
Limongelli G. : P311
Lin G.R.A.C.E. : P258, P448, P947
Lind L. : P1286
Lindbom M. : P758
Linde C. : P271, P300, P392
Lindeman J.H.N. : P324
Linder R. : P1289, P526
Lindner D. : P389
Linhart A. : P1158, P313, P923
Lip G.Y.H. : P1099, P443, P535,
P780, P967
Liska B. : P1302, P421
Liu F. : P235
Liu M. : P947
Liu M.Y. : P258, P448
Name / Index Number
Liu P. : P1067, P1297
Livanis E. : P827
Livi U. : P1260
Lizak M. K. : P1211, P1303, P881
Llacer A. : P1159, P1217, P250,
P722, P928
Llewellyn-Griffiths H. : P997
Llucia Valldeperas A. : P966, P1148,
P212, P968
Locatelli A. : P570
Lofberg E. : P300
Lofman I. : P1239
Lofsjogard J. : P572
Loftus L. : P775
Logeart D. : P1166, P868, P918
Logvinov Y. : P509
Lokau S. : P386
Lombardi C. : P1315, P361, P547,
P799, P917
Lombardo E. : P1283, P523
Lombroso S. : P910
Lonardi G. : P187
Londono Sanchez O. : P1188,
P1198, P398, P410, P716
Longo S. : P279
Longobardi S. : 144, 619
Lopatin Y. : P902
Lopatin Y.M. : P493
Lopatin Y.U. : P224
Loperfido F. : P1088, P1268, P750
Lopes J. P. : P1073
Lopes R. : P1087, P285, P489, P490,
P821
Lopez Aguilar R. : P1051
Lopez Diaz J. : P1191, P325, P788,
P986
Lopez-Andres N. : P740
Lopez-Ayala J.M. : P331
Loshkarev U.V. : P975
Lotan C. : P790, P874
Lotfi_Tokaldany M. : P287
Lotrionte M. : P1088, P1268, P750
Louca L. : P831
Loukides S. : P724
Lourenco A.P. : P1087
Lourenco P. : P1077, P1079, P1250
Lousada N. : P1209, P1244, P1319,
P284, P365, P478, P561, P766,
P808, P987, P991
Lousinha A. : P1073
Lozano T. : P1267, P520
Lozovaya T. : P1034, P314
Lu C. : P951
Lu F. : P951
176
AUTHORS
Luaces M. : P254
Lucas E. : P1185
Lucci D. : 679
Ludka O. : P480
Ludwikowska K. : P773
Luescher T.F.L. : P495
Lukashenko V. I. : P1019
Luknar M. : P1302, P1321
Lunati M. : 680, P185
Lund L.H. : P1239, P303
Lund T. : P312
Lupi L. : P1315, P361
Lupon J. : P1220, P1221, P1272,
P1287, P1317, P277, P390, P533,
P893
Lupu S. : P477
Luscher T.F. : P908
Lutay Y. : P399
Lutsak O. : P876, P1316
Lux A. : P1154
Luz Rodrigues H. : P456, P889
Luzzi G. : P569
Lyashenko A. : P1316
Lynga P. : P392
Ma L. : P1085
Ma L. : P1300
Maatouk F. : P839
Macarie C.E. : P352
Macdougall I.C. : P264
Macedo F. : P285
Maciel M.J. : P1011, P1013, P1038,
P1077, P1087, P1174, P1247, P1250,
P1313, P1329, P285, P409, P425,
P485, P489, P490, P506, P743,
P816, P817, P821, P527
Maddicks-Law J. : P1256
Madeira H. : 709
Madero S. : P250
Maechler H. : P405, P926, P927
Maeder M.T. : P1049
Maestri R. : P1064
Magalhaes A. : P345
Magalhaes D. : P489, P490
Magalhaes S. : P1084
Magga J. : P1090
Maggioni A. : 679, 708, P974
Magnani A. : P753
Magyar K. : P416
Mahfoud F. : P873
Mahjoub S. : P424
Mahon N.G. : P381
Maia K. A. : P1334
Maiandi C. : P547, P799
Maiani M. : P1260

AUTHORS
Maisch B. : P503
Maisel A. : P366
Majda J. : P970
Mak G. : P464
Makar O. : P1263, P502
Makhiyanova E. : P550
Maksimchuk N. : P283, P479
Malacky T. : P421
Malek F. : P309, P313
Malek I. : P243, P829, P914
Maleki M. : P822
Malev E. G. : P369
Malinova L. : P1210, P393, P544
Malizia G. : 144, P311
Maluskova J. : P914
Malynovska I. : P1252, P514
Malyszko J. : P264, P264
Malyutina S. : P1296
Mamas M. : P813
Mammi C. : P482
Mammini C. : P1251, P812
Mancini D. : P1023, P494, P825,
P303
Manerba A. : P1065, P508, P547
Mangia R. : P279
Manginas A. : P827, P831
Mangini S. : P1071, P1259, P982
Manhaes M.A.R. : P441, P511
Mantione L. : P1025
Mantziari A. : P749, P949
Mantziari A. : P1004
Manzano Fernandez S. : P331,
P864
Maounis T.H. : P827
Marachet M.A. : P954
Marangelli V. : P916
Marazzi G. : P814
Marcal R. : P274
Marcelo J.R. : P1012
Marchal P. : P954
Marchesini M. : P1192
Marchiori G. : P1067, P1297, P919
Marcondes Braga F.G. : P195,
P1071, P308, P982
Marcun R. : P252
Mard S. : P347, P368
Mardanov B.U. : P1177, P1215,
P241, P430, P431, P761, P959
Mareev V. : P1273, P224, P278,
P320, P466
Mareev V.Y. : P984, P517
Marek T. : P243
Marenzi G. : P714
Margari Z. : P301
Name / Index Number
Margarit L. : P350
Margitfalvi P. : P421
Marie P.Y. : P327
Marinakis N. : P218, P492
Marinas I. : P1097
Marinkovic D. : P299
Marino P. N. : P753
Mariotti R. : P1229, P231, P564,
P965
Markus R. : P259
Marosi E. : P885
Maroz-Vadalazhskaya N. : P375
Marques F. : P1214, P976
Marques J. E. : P404
Marques M. : P220, P274
Marques N. : P1276, P551, P842
Marra A. M. : 144
Marrero J. : P254
Marsden P. : P458, P556
Marsoubian L. : P765
Marta D. : P867, P1222, P265
Martens A. : P1017
Martensson J. : 79
Martin U. : P1017
Martinelli Filho M. : P334, P419
Martinelli M. : P1184
Martinez Dolz L. : P520
Martinez E.Z. : P1275, P513
Martinez Martinez-Espejo M.D. :
P864
Martinez-Dolz L. : P1027, P255,
P328, P444, P828
Martinez-Hernandez P. : P1224,
P455, P899
Martinez-Ruiz A. : P1224, P455,
P899
Martinez-Sales V. : P444
Martinez-Salez V. : P255
Martin-Fernandez B. : P740
Martins A. : P417
Martins E. : P1013, P1087, P1313,
P425, P821
Martins L.M. : P419
Martins P. : P857
Martins S. : P1184
Martins W.A. : P1014, P1056, P441,
P511
Marzegalli M. : P910
Marzilli M. : P231, P951
Marzullo P. : P1186
Mascaranhas J. : P1079
Mascherbauer J. : P348
Mascio G. : 174
Maskali F. : P327
177
Massa L. : 148, P946
Masuyama T. : 616, P297
Matarazzo M. : P311
Matassini M.V. : P1192
Matejka G. : P925
Mateo-Martinez A. : P331
Mathe A. : 711
Mathei C. : P346, P437
Mathieu G. : 679
Matic M. : P1042, P1308, P512,
P843
Matsuo Y. : P1058
Matsuzaki M. : P1168, P929
Matz I. : P1026
Maurea N. : P1182, P384
Maurer G. : P348
Mavrogeni S. : P1047
Mayer G. : P433
Mayet J. : P1074, P229
Mazic S. : P293
Mazin S.C. : P513
Mazzetti S. : P1202, P217
Mc Donald K. : P983, P1225,
P1282, P453, P853, P855, P996
Mc Gorrian C. : P381
Mcadam B. : P1284, P998
Mccartney M.W. : P189
Mcdonagh T. : P233, P749
Mcdonald K. : P1232, P1277, P330,
P464, P469, P785
Mcintyre H.F. : P726, P411
Mckeag N. : P1237
Mckee S. : P1066
Mckenzie S. C. : P1256
Mcmurray J.J.V. : 708, P191, P359
Mcmurray J.M. : 694
Mebazaa A. : 678, P715, P719
Medalion B. : P1026
Meder B. : 614
Medunjanin S. : P845
Mehta A.A. : P903
Meili-Butz S. : P211
Meireles A. : P1310, P230
Meisel S. : P207, P451, P718, P729,
P930
Melao F. : P489, P490
Melin J. : P539
Melin M. : P572
Mello L. : P1014
Mellwig K.-P. : P1081
Meln I.A. : P848
Melo D.S.B. : P943
Melo R. D. : P1334
Memeo R. : P569
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
Mena A. : P1220, P1221
Mendes M. : P1080, P1187, P1189,
P1236, P1307, P221, P239, P417,
P467, P549
Mendoza I. : P404
Meneveau N. : P1231, P1235
Menicanti L.A.M. : P1253
Menichetti F. : P231
Meray I. : P1218
Meregalli P.G. : P1086
Merkely B. : P1298, P317
Merkert S. : P1017
Merlo M. : 148, P500, P756, P757,
P946
Merlos P. : P250
Mesko Brguljan P. : P252
Mesquita E.T. : P1014, P1078, P441,
P511, P913, P1294
Metra M. : P1086, P1315, P361,
P547, P799
Mettini S. : P863
Meyer P. : P988
Meyns B. : P304
Miani D. : P1260, P377
Michailov G.V. : P214
Michalakeas C. : P1262
Michalski M. : P1223, P505
Michaylusova M. : P247
Michel M. : P1029
Michelinakis N. : P301, P382
Michelson E.L. : P191, P359
Michielon G. : P1025
Mieiro M. : P371
Mielke A. : P343, P870
Miettinen K. : P1090
Miguel A. : P722
Mijatovic A.Z.R.A. : P1175, P936
Mikelsone I. : P781
Mikhailov A. : P1147
Mikhaliev K. : P509
Mikheeva K. : P801
Miklik R. : P1158, P313, P772
Mikulak M. : P316
Milasinovic G. : P420
Milesi G. : P1065, P508, P547
Milincic I. : P1053
Miljanovic A. : P209, P210, P236
Miller W. : P429, P329
Milting H. : 173
Mimish L. : P727
Mimoso J. : P1276, P551, P842
Minana Escriva G. : P1159, P722
Minana G. : P1217, P250, P928
Mincu D. : P924, P985, P1266,
Name / Index Number
P1338, P272
Minichiello S. : P273
Miniello V. : P904
Minnetdinov R. : P457, P468, P550
Minullina I.R. : P1043
Mirizzi G. : P1251, P812
Miro V. : P1031, P1265, P1267
Mirolyubova O. : P1216, P256
Miroshnichenko A.G. : P1096
Miroshnichenko A.O. : P245
Mirra M. : P273
Mirzamukhamedova S.T. : P1177
Mirzarakhimova S.T. : P431
Mischie A.N. : P272, P336, P924
Miszalski-Jamka T. : P1337
Misztal M. : P1255
Mitrofanova L.B. : P214
Mitrovic V. : P956
Mitsuke Y. : P434, P445
Miura H. : P197, P198
Miwa S. : P1232
Miyamoto T. : P1022, P833
Miyazaki K. : P197, P198
Miyazaki S. : P993
Mizuno K. : P201
Mocan T. : P477
Moellenberg M. : P1081
Mohammed A. : P958
Mohd Noor H. : P1206
Mohd Yusof A.K. : P1206
Mohr F.W. : P306, P819
Moiseev V. : P1218, P1219, P1254
Moiseeva O. : P759, P372
Moldoveanu E. : P1222, P265, P867
Molina L. : P1220
Molina Mora M.J. : P878
Molina R. : P1184
Molinari M.I. : 617
Molini S. : P1192
Molnar A. : P752
Molon G. : P187
Monge J. : P239, P549
Monitillo F. : P1204, P432, P823,
P904, P916, P964
Montana R. M. : P788, P986
Montanari A.M. : P1238
Montano-Hernandez P. : P501
Montera M.W. : P913
Monti M.G. : 619
Morais G. : P566
Morales M.-A. : P1186
Morato M. : P220
Mordarska M. : P765
Moreira D. : P1322, P357, P394,
178
AUTHORS
P397, P896
Moreira D. A. : P1306, P557, P760
Moreira L.F. : P374
Moreira M. C. : P1160, P920
Morelli M. : P1192
Morelloni S. : P228
Morgado F. : P1189, P1187
Morgado L. : P220
Morgado P.C. : P735, P943
Morgan K. : P1284
Morillas P. : P1265, P1267, P520,
P835
Morimoto T. : P1173
Morishita T. : P434
Morita T. : P1311
Morita Y. : P1098
Mornos A. : P1057, P1194, P476,
P543
Mornos C. : P1057, P1194, P476,
P543, P742, P748
Morooka H. : P993
Moroshkin V. : P759
Mortara A. : P1202, P217, P974
Mortensen S.A. : P1258
Mosa S. : P1229, P965
Moscoso Costa F. : P1080, P1307
Moser C. : P1258
Moser D. : P1054
Mosrati M. : P839
Most P. : 614
Mosterd A. : P356, P776
Mostov S. : P446
Mota Gomez P. : P986
Mota M. : P220
Mota P. : P1280, P1327, P1331,
P215, P764
Mota-Garcia R. : P409
Motylevska T. : P941
Mouquet F. : P1279
Moura B. : P1013, P1313, P425
Moure Gonzalez M. : P1176
Moutafi A.C. : P257
Mozzone M. : P523
Mpakirtzi N. : P382
Mrdovic I. : P512, P843
Mueller C.H. : P1200, P715
Mueller M. : P784
Mueller S. : P1017, P498, P755
Mueller-Tasch T. : P335
Muk B. : P885, P945
Mukhtar A. : P270
Mullabayeva G. U. : P1002
Munhoz R.T. : P735
Munoz Garcia A.J. : P878

AUTHORS
Munoz M.A. : P1220, P1221
Munoz-Giner B. : P1027, P828
Muntaner C. : P1198
Munteanu D. : P745
Muraru M. : P1044, P745
Murataliev T. : P794
Muro T. : P275
Murphy N. : P1282, P785
Murphy-Arteaga C. : P253, P777
Murray P.T. : P381
Murrone A. : P866
Murtagh G. : P1225, P453, P464,
P855, P996
Murthy D. : P1297
Musetescu R. : P1097, P837
Musiari M.L. : P1238
Musil V. : P480
Mussayab Y. : P1069
Musschoot A. : P1279
Mustafa R. : P837
Mutlu F. : P1157
Muzarelli S. : P1049
Nacci F. : P569
Naderi N. : P822
Nadir M. A. : P189, P190
Nadiradze A. : P1157, P281
Nahum J. : P351
Naito T. : P1311
Najih H. : P1291, P339, P447
Naka T. : 616, P297, P771
Naka Y. : P1023, P494, P825
Nakajima I. : P305
Nakajima T. : P1045
Nakamura Y. : P275
Nakano A. : P434, P445
Nakazone M.A. : P261
Nalbantgil S. : P897
Nanas J. : P1165, P1203, P1207,
P301, P360, P382
Nanea I.T. : P935
Nanea M. : P935
Napalkov D.A. : P1227
Narciso M. : P377
Narkiewicz K. : P1296
Narusov O. : P1273, P320
Nascimento C. : P397
Nascimento J. : P215, P938
Nasierowska-Guttmejer A. : P1193
Nassi G. : P812
Natali R. : P1088, P1268, P750
Navarro-Mateo A. : P328
Navarro-Navarro A. : P253, P501,
P777, P892
Nawrocka S. : P200, P396
Name / Index Number
Neagu O. : P555
Nedejkovic I. : P1003
Nedeljkovic I. : P1006, P291, P293,
P420, P841, P884, P1021
Nedeljkovic M. : P291, P293
Neder J.A. : P1012, P1249
Nedogoda S. : P224
Nedzelskiene I. : P807
Negrao C.E. : P374
Nekljudova Y. N. : P794
Nelles M. : P349, P387
Nemes A. : P810
Nepoklonov M. : P1048, P851
Neri P. : 710, P570
Neskovic A. : P192
Nessler B. : P268, P280
Nessler J. : P1255, P268, P280
Neuder Y. : P1166
Neuhaus M. : P880
Neuhold S. : P348
Neumann A. : P335, P869
Neumann T. : P335, P869
Neuzil P. : P309
Neves J.S. : P530
Nevzorov R. : P446
Neyses L. : P813
Ng L.L. : 713
Ngoo Abdullah M.H. : P1206
Nguyen H. : P366
Nickl W. : P454
Nicolas C. : P1153, P770
Nicolin M. : P1194
Nielsen F. : P347
Nielsen F.E. : P368
Nielsen O.W. : P450
Nieman F.H.N. : 82
Nieminen M.S. : P1090, P539, P734
Nienhaus G.U. : 173
Nieto M. L. : P788, P986
Nieuwenhuis M.M.W. : 143, P789
Nifontov C. : P314
Nifontov E. : P1034
Nikitin A. : P804
Nikolaou M. : 678, P1262, P719,
P860, P971
Nikolaychuk E. : P1034, P890
Nikolic V. : P299
Nikolopoulou K. : P719
Nikonova J. : P216, P412
Ninkovic N. : P1083, P906
Nishioka S.A.D. : P1184, P419
Noack C. : P768
Noad R. : P1237
Nodari S. : P1065, P508, P547,
179
P799
Noel A. : P767
Noelker G. : P213
Noguero M. : P1272
Noiman E. : P451
Noll G.N. : P495
Nonogi H. : P1072, P725
Noroc A. : P350
Nosir Y. F. M. : P423
Noszczyk-Nowak A. : P1171, P739
Novaes K.R. : P736
Novakovic C. : P909
Noveanu M. : P1200
Nowalany-Kozielska E. : P1196,
P427
Nowicka A. : P1223, P505
Nozaki A. : P201
Nozzoli C. : 679
Ntalianis A. : P1165, P1203, P1207,
P301, P360, P382
Nunes Diogo A. : P1092, P345,
P371, P422, P456, P532, P857,
P889, P978
Nunes L. M. : P1306, P557, P760
Nunez E. : P1217, P250, P928
Nunez J. : P1159, P1217, P250,
P722, P928
Nyolczas N. : P259, P752, P885,
P945
O’ Connell R. : P1225
O Driscoll S.A. : 712
O’ Hanlon R. : P1225, P1282, P453,
P469, P853, P855, P996
O’ Louglin C. : P983
O’ Shea D. : P1282
Obermayer-Pietsch B. : P405
O’callaghan P. : P418
Occhetta E. : P753
Ochiai M.E. : P735, P736, P943
Ochotny R. : P237, P298, P302
O’connell R. : P464
O’connor C. : P342, P541, P917
Odeh R. : P270
Oezcelik C. : 615
O’farrell J. : P1284
Oganezova L. G. : P762
Ogawa H. : P1098
Ogbonnaya A. : P1289, P526
Ogino K. : P459
Oh B.-H. : P774
Oh J. : P558, P921
Oh S.K. : P290, P811
O’hanlon R. : P1232, P464
Ohyanagi M. : 616, P297, P771
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
Oie E. : P472
Okano T. : P737
Oke D. A. : P205
O’keefe C. : P952
Okelly N.I. : P249
Okonko D. O. : P1074
Oko-Sarnowska Z. : P237
Olah G. : P416
Olaison L. : P554
Olausson M. : P877
Oldenburg O. : P213, P438
Olimulder M. : P1046, P515
Oliva F. : 677, P185, P187
Oliva S. : P384
Olivares M. : P1159, P1217, P250,
P928
Oliveira A. : P978
Oliveira A.C. : P913
Oliveira A.I. : P943
Oliveira E. : P1015
Oliveira E.S. : P276
Oliveira J. : P1278
Oliveira Jr M.T. : P195
Oliveira Jr R.M. : P334, P419
Oliveira L.B. : P1014, P441, P511
Oliveira M.D.C. : P920
Oliveira M.G. : P511
Oliveira M.S. : P1275, P513
Oliveira S. : P1011, P1077, P1087,
P1174, P1250, P1329, P409, P506,
P743, P817, P1247, P489, P490,
P527, P816
Oliver M. : P997
Olofsson M. : P364
Olsen P.S. : P1258
Olsson L.-E. : 81
Omer E. : P785
Omer H. : P270
Omerovic E. : P209, P210, P516,
P758, P925, P1175, P236, P936
Oner E. : P288
Opdahl A. : P1075
Opolski G. : P559
Ordiene R. : P807
Orea-Tejeda A. : P501
Orea-Tejeda J. I. A. : P253, P777,
P892
Oriol J. : P871
Oropeza F. : P203, P460
Orosa P. : P1267, P520, P835
Ortega L. : P871
Ortiz Lopez E. : P1051
Orynchak M. A. : P488
Osawa E.A. : P276
Name / Index Number
Osmolovskaya Y. : P984, P1048,
P851
Osokina A.V. : P1318
Ostadal P. : P309
Ostojic M. : P1003, P1006, P291,
P293, P512, P841, P843, P884
Ostojic Miodrag M.O. : P1021
Ostrovskiy I. : P375
Ostrovskiy Y. : P1257
Othman Z. : P1206
O’toole L. : P473
Ottenblad E. : P1239
Oudejans I. : P356
Ovchinnikov A.G. : P1241, P994
Ozabalova E. : P240
Ozbaran M. : P897
Ozeke O. : P1190
Pabari P. : P229
Pacheco R. : P223
Pacher R. : P348
Pacreu S. : P1188, P1198, P398,
P410, P716
Padeletti L. : 677
Paez Rubio M.I. : P1051
Pagava Z. : P915
Paiva L. : P1201, P1280, P1331,
P1312, P861, P879
Paiva M. : P1011, P1013, P1038,
P1077, P1174, P1250, P1313, P285,
P425, P485, P527, P743, P816, P817
Pajak A. : P1223, P505
Palanca V. : P326
Palau P. : P1159, P1217, P250, P722
Palau Sampio P. : P928
Palisch H. : P909
Palma Dos Reis R. : P1209, P1319,
P365, P561
Palma G. : P1182
Palma Reis R. : P1244, P284, P478,
P766, P808, P987, P991
Palomino S. : P1259
Pamouki S. : P218, P492
Pamukcu B. : P443, P780, P967
Panasenko T. : P266, P787
Panaszek B. : P717
Panchenko E. P. : P524, P782
Panchetti L. : P1186
Pankow K. : 176
Pankuweit S. : P335
Panteleon A. : P972
Panther F. : P1001, P847
Pantsios C. : P1203
Papadakis I. : P395
Papadimitropoulos M. : P1047
180
AUTHORS
Papadopoulos I. : P218, P492
Papadopoulos K. : P395
Papadopoulou E. : P1047
Papageorgiou A. : 171
Papaioannou N. : P382
Papalois A. : P1165
Papazoglou D. : P888
Papp Z. : 175, P1039, P905
Pappas L. : P724
Parada F. : P1011, P1038, P1250
Parada-Pereira F. : P817
Parapid B. : P293
Paraskevaidis I. : P395
Paraskevaidis J. : P860
Paraskevaidis S. : P1004
Paravati V. : P206
Pardaens S. : P295
Paredes L. : P398
Pareek N. : P233
Parenica J. : P1158, P1292, P313,
P772, P923
Parisi F. : P1025
Parissis J. : 678, P719, P1262, P395,
P860, P971
Park C.S. : P1009
Park S. : P558, P921
Park Y. : P354
Parker J.D. : P232
Parkhomenko A. : P1234, P399
Parodi O. : 680, P830
Parola M. : P523
Parolini M. : 680, P830
Parra E.R. : P196
Parthasarathy S. : P1050, P852
Pascoalino L.N. : P1249
Pascual T. : P1317, P533
Pascual-Figal D.A. : 618, P1224,
P331, P455, P864, P899
Pashuk O. : P1094, P1323, P373,
P563
Paslawska U. : P1171, P1172, P739
Pasquet A. : P246, P346, P437
Passino C. : 146, P1251, P812
Pastormerlo L. E. : P1251, P483,
P812
Pastor-Perez F. : 618, P1224, P455,
P899, P864
Pasztor E.T. : 175, P905, P1039
Patacho M. : P1079
Patel A.K. : P853
Patel B.M. : P961
Patel N.A. : P952
Pathak A. : P1212, P1304, P262
Patle A. : P855, P983

AUTHORS
Pattier S. : P1029
Paulino A. : P350
Paulo C. : P1079
Paunovic N. : P1053
Pavlides G. : P1047, P827, P831
Pavlovic M. : P862, P883, P948
Pavlyukova E. : P1035, P824
Pawlak A. : P1032, P1193
Paya R. : P1185
Pedretti R. : P1204, P964
Pedro M. : P978
Pedrosa A.A.A. : P1184
Pego-Fernandes P.M. : P374
Peixoto G.L. : P1184
Peker Y. : P1040
Pelaez V. : P203, P460
Pellicano M. : P206
Pellicori P. : P1320, P380, P536
Peltier M. : P832
Pelzer U. : P385
Pena G. : P203, P460
Penciu O. : P1299, P471
Peradejordis M.P. : P537, P872,
P894
Perchatkin V. : P1295
Pereira Barretto A. C. : P735
Pereira E. : P1326, P194, P566,
P567, P849
Pereira F.P. : P485, P506, P816
Pereira G.A.M. : P441, P511, P1014
Pereira J.M.V. : P1056
Pereira S. : P551, P842
Pereira-Barretto A.C. : P736
Pereira-Parada F. : P1247
Peres L.C. : P513
Perez Bosca J.L. : P835
Perez Calvo J.I. : P1051
Perez J. : P1188, P326
Perez Martin A. : P254
Perez-Martinez M.T. : 618, P455,
P899
Perichon R. : P329
Perisic Z. : P948
Perl S. : P449
Pernicka E. : P348
Perrier A. : P988
Perrot A. : 615
Persson H. : P572
Perunicic J. : P512, P843
Pescariu S. : P1057, P1194, P748
Pessoa De Melo L.M. : P353, P859
Peter M. : P880
Peters N. : P229
Peterson K. L. : P211
Name / Index Number
Pethig K. : P909
Petrescu L. : P1057, P476, P543,
P742
Petrie M.C. : P1066
Petrillo V. : 619
Petrini N. : P206
Petrovic I. : P420, P1095
Petrovic M. : P1003, P1006, P291,
P841, P884, P1021
Petrovic M.T. : P420
Petrovic M.Z. : P420
Petrovic O. : P291
Petruzelka L. : P226
Peuhkurinen K. : P539, P734, P1090
Pezawas T. : P188
Pezzali N. : P1315, P361, P799
Pfeffer M.A. : P191, P359
Pfister O. : P880
Pfisterer M. : P1049, P880
Pfuetzner A. : P319
Phelan D. : P1282
Phelps M.A. : P329
Philipson H. : P1060
Piacenti M. : P1186
Pianciola F. : P863
Piazzi E. : 710
Piccolo S. : P1283, P523
Pichler M. : P1261
Piepoli M. : P483
Pierantozzi A. : P185
Pieske B. : P1156, P405, P518, P926,
P927, P995, P449
Pina I. : P989
Pinamonti B. : 148, P756, P757
Pineda-Juarez J. : P892, P501
Pinho T. : P1329
Pinna G. D. : P1064
Pinto Y. : 171, P1086, P552
Piotrowicz E. : P486, P571
Piotrowicz R. : P486, P571
Piotrowska M. : P486
Piovanelli B. : P1315, P361
Pipa J. : P1322, P357, P397, P896,
P394
Pires De Morais G. : P567
Pires S. : P1092, P371
Piriou N. : P895
Pirola A. : P1185
Pirra P. : P523
Pisowodzka I. : P546
Pitt B. : 694, P383, P723, P873
Piwowarska W. : P1255
Platts D. : P499
Platts D.G. : P1256
181
Plieva I.M. : P1163
Pljesa-Ercegovac M. : P1308
Pocock S. : 708
Podesser B. : 175
Podnar G. : P1053
Podolec J. : P1337
Podolec P. : P1337
Podzimkova M. : P829
Poelzl G. : P1261, P244, P433, P720
Poggio D. : P217
Poh K. : P1208
Pokrajac R. : P906
Pokreisz P. : P1154, P846
Pokrovskiy U.A. : P779
Pokushalov E. : P1183
Polak L. : P507
Poletti R. : P812
Polgar B. : P945
Poloczek M. : P1292
Polselli M. : P1229
Polyanskaya E. : P1309, P1089
Pomerantzeff P.A.M. : P1024
Pomerantzeff P.M. : P1028
Pomerantzeff P.M.A. : P1259
Pongas D. : P932
Pongiglione G. : P1025
Ponikowska B. : P887
Ponikowski P. : P1171, P1172, P1228,
P200, P264, P296, P396, P487,
P717, P739, P773, P791, P815, P887,
P908, P970, P977
Ponomariova G. : P801
Pons C. : P398
Ponte M. : P1326
Pontes M.R. : P838, P840
Pop D. : P1299, P471
Popa A.I. : P1266, P1338, P272,
P336, P924
Popovic D. : P1003, P1006, P420
Poppe K. : 708
Portelinha D. : P1061, P1062
Porter A. : P446
Portoles M. : P1027, P1031, P1265,
P1267, P328, P828, P835
Posafalvi A. : P1150
Posch M.G. : 615
Post H. : P405, P926, P927
Potapenko A. : P1218
Poteshkina N.G. : P1195
Potocki M. : P1200, P715
Poussier S. : P327
Powierza S. : P887
Pozdisek Z. : P480
Pozios I. : P1165
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
Prat-Vidal C. : P1148, P212, P966,
P968
Prenner G. : P449
Preux P.M. : P1230
Primak G. : P801
Primo J. : P1326, P194, P566
Pringle S.D. : P189, P190
Prins M. : P552
Prinz C. : P213
Privalova E.V. : P898
Proclemer A. : 677, P187, P377
Prohna L. : P1252, P514
Prokhorova D. : P1183
Prokovas E. : P218, P492
Pronicki M. : P1032
Providencia R. : P1201, P1245,
P1280, P1312, P475, P861, P879,
P215, P938
Prucha M. : P309
Psarogiannakopoulos P. : P395
Psatheris G. : P218, P492
Pucciarelli A. : P435
Puchalski W. : P546
Pudil R. : P562, P957
Puerto Sanz A. : P1191
Puig R. : P736
Pujol De La Llave E. : P1051
Pulkki K. : P734
Punnonen K.R. : P1090
Puspoki Z.S. : P885
Putrova O. : P1295
Puzzovivo A. : P432, P569, P823,
P916
Pyrgakis V. : P724
Qasim A. : P1290
Qian H.Y. : P769, P820
Qu R. : P235
Quadrini F. : P569
Quesada A. : P1185, P326
Quintal N. : P215, P938
Quintao M.M.P. : P1014
Quinzani F. : P361
Quirino B.E. : P1334
Raamunddal T. : P210
Rabadiya S. : P961
Rabinovich P. : P207, P718, P729,
P930
Rachok L. : 681
Radegran G. : P370
Radi B. : P731
Radoi M. : P555
Radovanovic S. : P1042, P1083,
P1308, P906
Radovanovic Z. : P1270
Name / Index Number
Radulescu F.S. : P1178
Radzevich A. : P222
Rafouli-Stergiou P. : 678, P1262,
P971
Ragone G. : P1182
Raimondo R. : P1204, P483, P964
Rainbow R.D. : P1037
Rajda M. : P1067
Rakhimova Y.K. : P431
Raleigh C. : P998
Ramachandran P. : P730
Ramalingam V. : P795
Ramires J.A.F. : P1184, P353, P735,
P859, P943
Ramirez-Martinez J.A. : P388, P248
Ramos B. : P203, P460
Ramos S.G. : P1275, P513
Ramos V. : P1084
Ramshev K.N. : P462
Ramunddal T. : P758, P925
Randt A. S. : P1334
Rangel I. : P1011, P1038, P1077,
P1087, P1174, P1329, P409, P485,
P506, P743, P816, P821
Ranghi F. : P1248
Ranheim T. : 172
Ranjel I. : P527
Raposeiras Roubin S. : P1176
Rappeneau S. : P351
Rastan A. : P306
Rastogi S. : P1151, P969
Ratto R.R. : P872
Rau T. : P192
Rauchhaus M. : P385, P909
Rauwolf T. : P875
Raybould A. : P997
Rea D. : P1182
Rea R.O.B.E.R.T. : P258, P448, P947
Rebellato L. : P377
Rebrov A. P. : P1301, P882
Rebrova T. : P1295
Recio Mayoral A. : P269
Recio Platero A. : P1191, P325, P788
Reczuch K. : P717
Redfors B. : P209, P210
Rees I. : P418
Rega F. : P304
Reganon-Salvador E. : P255, P444
Reichlin T. : P1200
Reihmane D. : P781
Reina Couto M. : P220
Reina R.C. : 617
Reinders M.E.J. : P324
Reis H. : P1310, P230
182
AUTHORS
Reis M.M. : P1259
Reis Santos K. : P1189
Rekhraj S. : P189, P190
Rekovets O. : P801
Religa L. : P505
Repasos E. : P1203, P382
Repin A. : P1295
Repp J. : P498
Revilla Orodea A. : P325, P788,
P986
Rezaei Farimani A. : P733
Rezaie G. : P733
Reznichenko N.E. : P362
Reznik E. : P1288
Rezvanfard M. : P287
Rezzoug N. : P346, P437
Rhee K. : P354
Rhee S.J. : P290, P811
Ribas N. : P1272
Ribeiro J. : P849
Ribeiro M. L. : P1294
Ribeiro S. : P1084, P371, P532
Ribeiro Santos F. : P1013
Ribeiro V. : P1174, P489, P490, P743
Ricci G. : P904
Ricci R. P. : P185
Richter M. : P1045
Ricken W. : P909
Rickenbacher P. : P1049
Rickli H. : P1049
Riding A. : P726
Ridocci Soriano F. : P1185, P326
Rieber J. : P784
Riegelnik V. : P449
Rienzo M. : P932
Rieth A. : P956
Rihova D. : P186
Riley J. : 712, 83, 84, P378, P529
Rilo Miranda I. : P1332
Rinaldi E.R. : P714, P786, P802
Ritter O. : P1001, P847
Rivera M. : P1031, P1265, P1267,
P520, P835
Rivera-Otero M. : P1027, P328,
P828
Rivlin Y. : P1278
Rizos J. : P860
Rizzi G.R. : P495
Rizzo M. : P248, P388
Robalo Martins S. : P1092, P371,
P456, P532, P889, P978
Robbi E. : P1064
Robertson W.T.M. : P249
Robinson C. : P1277

AUTHORS
Rocca P. : P570
Rocha A. : P1011, P1038, P1247,
P1250, P485, P506, P816, P817
Rocha C.S. : P195
Rocha S. : P1084
Rochitte C.E. : P913
Rodino Janeiro B.K. : P1176
Rodius S. : P1152
Rodrigues B. : P1322, P357, P394,
P397, P896, P1306, P557, P760
Rodrigues R. : P489, P490
Rodriguez Bago J. : P966
Rodriguez Bailon I. : P878
Rodriguez De Leiras S. : P269
Rodriguez M. : P1287
Roebiono P.S. : P731
Roest M. : P324
Rogers J. : P917
Rogozea L. : P555
Rojas Hernandez S. : P1017
Rojo-Alvarez J.L. : P864
Rolf A. : P956
Rolland-Turner M. : P1152, P1153,
P770
Romandini A. : P1192
Romanenko O. : P1281
Romanov A. : P1183
Romaszkiewicz M. : P546
Rominger M.B. : P503
Romuk E. : P427
Roncalli J. : P1212, P1304, P954
Rondinini L. : P1229, P231, P564,
P965
Roque C. : P1310, P230
Roque E. : P1082
Roque J.M. : P1249
Rosano G. : P1248, P814, P482
Rosario I. : P239, P417, P549
Rose H. : P1285
Rosello E. : P1031, P1265, P1267,
P520
Rosello-Lleti E. : P1027, P828
Rosenbaum A. : 145, P747
Rosengren A. : P538
Rosengren M. : P534
Rosengren S. : P850
Rosenqvist M. : P392
Rosenschein U. : P1278
Rosenthal A. : P367
Rossel V. : P223
Rossi A. : P1186
Rossi E. : P866
Rossi M.A. : P513
Rossi P. : P1229
Name / Index Number
Rossignol P. : P383, P723, P740,
P873
Rotman B. : P449
Rottbauer W. : 614
Rouet P. : P262, P504
Roukoz H. : 145, P747
Roura Ferrer S. : P1148, P966
Roura S. : P212, P968
Rousseau H. : P954
Roussel J.C. : P1029, P934
Roy A. : P381
Roy-Giocosa J. : P895
Rubio J. : P325
Rubio N. : P1148
Rubis P. : P1337
Rudnicki M. : P244, P433
Rudzinska E. : P487
Ruhparwar A. : P498
Ruiz M.A. : P1335
Ruiz S. : P248, P388
Ruiz-Llorca C. : P328
Rupp H. : P503
Ruppert A.D.P. : P196
Ruschitzka F.R. : P495
Rusinaru D. : P832
Russell S. : P1285, P418, P997
Russo G. : P384, P946
Rutten F. H. : P439, P744, P798
Rutten F.H. : P1068, P1269, P474,
P776, P778
Rutter M.K. : P813
Ryabceva O. : P470, P836
Ryabikov A. : P1296
Rybinska I. : P1172
Rydlewska A. : P977
Rynkiewicz A. : P546
Ryu K.H. : P1161, P199, P403, P542,
P774
Rzezak J. : P1193
Sabbah H.N. : P1151, P969
Sacra C. : P279
Sadeghian H. : P287
Saeed E. : P458, P469, P556, P556
Safarova A. : P1254, P491
Safina E. : P468
Safir Mardanloo A. : P287
Safka V. : P562
Sagiv M. : P1278
Sahin T. : P1180, P548
Saidova M.A. : P937
Sainis G. : P301, P360
Sai-Sudhakar C. : P852
Sakiewicz W. : P1296
Sakoda T. : 616, P297, P771
183
Salah K. : P1086
Salazar F. : P1209, P1244, P478,
P561, P766, P808, P987, P991
Saldamarco L. : 144, 619
Saldanha C.F. : P838, P840
Saldiva P. : P982
Saleh H. : P428
Salehi Omran M.T. : P424
Salih A. : P942
Salih H. : P1008, P219, P461, P763,
P955, P980
Salinger Martinovic S. : P862, P883
Salinger S. : P948
Saltzberg M. : P260
Salvador A. : P520, P835
Salvador-Sanz A. : P1027, P255,
P328, P444, P828
Salzano A. : 144, 619, P311, P992
Sambin L. : P932
Samoilenko L. E. : P1018
Samoylenko L. : P1048, P851
San Roman Calvar J.A. : P1191,
P325, P788, P986
San Vicente L. : P871
Sanchez B. : P968
Sanchez I. : P520
Sanchez Lazaro I. J. : P1027, P255,
P328, P444, P828
Sanchez-Gomez J.M. : P1027, P828
Sanchez-Margallo F.M. : P212
Sanchez-Martinez M. : P331
Sanchez-Mas J. : 618, P1224, P899
Sanchez-Ramirez A. : P501
Sanchez-Santillan R. : P253, P501,
P777, P892
Sanchez-Tembleque C. : P269
Sanchez-Vidal G. : P253, P777,
P892
Sanchis J. : P1159, P1217, P250,
P722, P928
Sancho-Rodriguez N. : P455, P899
Sancho-Tello M.J. : P328
Sandanger Ø. : 172
Sandek A. : P341, P386, P436
Sander K. : P1258
Sandor A. : P259
Santagostino M. : P753
Santer D. : 175
Santi F. : P714, P802
Santini M. : 677, P185
Santobuono V.E. : P569
Santoro A. : P714
Santoro D. : P964
Santos De Sousa C. : P1209, P1319,
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
P274, P365, P561, P1244, P478,
P766, P808, P987, P991
Santos J. O. : P1306, P557, P760
Santos J.M. : P1187
Santos L. : P532
Santos L.F. : P1322, P357, P397,
P896, P1306, P557, P760
Santos M. : P1189, P1307, P1310
Santos N. : P1015
Santos O. : P1322, P357, P394,
P397, P896
Santos P. : P1307
Santos P.G. : P1080
Santos W. : P551, P842
Saoudi N. : P1007
Sapelnikov O.V. : P937
Sapozhnikova I. : P479
Sarbu-Pop I.A. : P1242, P289, P809
Sargento L. : P1209, P1244, P1319,
P274, P284, P365, P478, P561,
P751, P766, P808, P987, P991
Saric J. : P1083, P906
Saric M. : P1149
Sasaki N. : P197, P198
Sasaki T. : P1058
Sasov M. : P421
Satendra M. : P1209, P1244, P1319,
P274, P284, P365, P478, P561,
P766, P808, P987, P991
Satlykova D. : P517
Sato Y. : P1022, P833
Satoh T. : P434, P445
Satue J.A. : P254
Saulle D. : P432, P916
Savic L. : P512, P843
Savic-Radojevic A. : P1308
Savino G. : P1268
Savino M. : P1088, P1268, P750
Savitsky S. : P801
Sawa T. : P1022, P833
Saxton J. : P292
Sbardellini A. : P523
Sbroggio’ M. : 174
Scalvini S. : P910
Scardina G. : P217
Scardovi A.B. : P483
Scelza N. : P564
Schaper J. : P1045
Scharin Tang M. : P209, P210, P516
Schaufelberger M. : 81, P534,
P538, P1060
Scheffold T.H. : P454
Schejbalova M. : P309
Schellenberger U. : P329
Name / Index Number
Schernthaner C. : P1261
Schetinkina I. : P544
Schiele F. : P1231, P1235
Schiller P. : P407
Schmalgemeier H. : P438
Schmeisser A. : P845
Schmidinger H. : P188
Schmidt A. : P1081, P213, P995
Schmitz B. : 680
Schneeweiss A. : P387
Schoenberger J. : P847
Schols J.M.G.A. : P1070
Scholten M.F. : P1046
Schou M. : P332, P463
Schroen B. : 171
Schukro C. : P188
Schultheiss H.P. : P389, P391
Schultz C. : P227
Schultz T. : P925
Schulze P. : P1023, P494
Schuster T. : P319
Schwanke K. : P1017
Schwarzl M. : P405, P926, P927
Schwiebs A. : 176, P519
Scicchitano P. : P823
Scipioni A.R. : P735
Scott A. : P473
Scott C.G. : P1076
Scridlevskaya E. A. : P1018
Scrutinio D. : P1204, P964
S-E Hagelind S.E.H. : P1060
Sealey-Laragh J.E. : P834
Sebastian M. : P410
Sebastiani R. : P496
Seca L. : P764, P879
Sedej S. : P1156
Seden V. : P266
Seguro L.F.B.C. : P195
Seitz K. : P1330
Sekiguchi K. : P1072
Sekine H. : P737
Selekler M. : P528
Sen S. : P229
Senage T. : P1029, P934
Senderek T. : P1337
Senges J. : P349, P540
Senni M. : P263
Seoane Blanco A. : P1176
Sepp R. : P426
Sepulveda Morales L. : P223
Serban I. : P1222, P1222, P265
Serban M. : P265
Seredenina E. : P470, P836
Sergienko V. : P851, P517
184
AUTHORS
Seronde M.F. : P868, P1231, P1235
Serra W. : P1238
Serrano C.J.R. : P196
Sessa G. : P273
Setsuta K. : P1181, P225
Sevic L.J. : P1053
Seyfarth M. : P454
Sfirakis P. : P831
Sgaraglia S.F. : P441, P511
Shabanov V. : P1183
Shafranskaya K.S.S. : P1052, P1324,
P321, P891
Shahzad K. : P1023, P825
Shaidullina A. : P457
Shakarishvili R. : P915
Shanahan M.K. : P1232
Shantsila E. : P1099, P443, P780,
P967
Shao Y. : P1175, P210, P236, P758,
P936
Shaporova N.L. : 147
Sharashidze N. : P915
Sharma R. : P233, P749, P949
Shashkova N. : P1048, P851
Shatynska-Mytsyk I. : P1263, P502
Shavgulidze C.B. : P975
Shaw A.R. : P972
Shaw L. : P342, P541
Sheikh Fathollahi M. : P287
Sherwi N. : P1320, P536
Shi H. : 694
Shiels P. : P458, P556
Shigemasa C. : P459
Shigemasa T. : P1098
Shilova Y. : P216, P412
Shimada K. : P275
Shimatsu A. : P1173
Shimizu M. : P1098
Shimizu T. : P737
Shin E.K. : P525
Shin I.S. : P290
Shin M.S. : P1161, P525, P774
Shin S.N. : P290, P811
Shinada T. : P201
Shipchanova L. : P1293
Shipulin V.M. : P1035
Shirakabe A. : P201
Shirolkar S. : P342, P541
Shitov V.N. : P937
Shkurat I. : P1020, P294
Shlyakhto E. : 147, P1041, P1226,
P307, P1034, P314, P759, P999,
P1043, P848
Shmidt E.A.S. : P1318

AUTHORS
Shochat M. : P207, P451, P718,
P729, P930
Shotan A. : P207, P451, P718, P729,
P930
Shumakov A. : P1234
Shumakov V. : P1252, P514
Sideris A. : P1093
Sidorenko I. : 681, P1257
Siebermair J. : P188
Siegbahn A. : P1091
Siegel I. : P343, P870
Siems W.-E. : 176
Sierra E. : P1264
Sigurjonsdottir R. : P1300, P553,
P783
Siirila-Waris K. : P1090, P539, P734
Silina T. : P1210
Silva Cardoso J. : P1313
Silva D. : 709, P345, P422, P751,
P857, P889
Silva E. : P1264
Silva E.E. : P913
Silva G. : P1326, P194, P566, P567,
P849
Silva J. : P1327, P764
Silva J.C. : P285, P489, P490, P821
Silva K.R. : P334, P419
Silva M.E. : P978
Silva Marques J. : P1092, P345,
P371, P456, P532, P889, P978
Silva S. : P1015, P484, P818
Silva S.M. : P1079
Silva-Cardoso J. : P1013, P425
Silva-Marqes J. : P751
Silva-Marques J. : P422
Silvestre O. : P195
Sim V. : P997
Simic A. : P1030
Simic D. : P1042, P1308
Simic T. : P1042, P1083, P1308
Simic V.D. : P1083
Simoes L. : P1326, P194, P566, P567
Simoes Marques Assuncao Caetano
F. : P1327, P1331, P764
Simonenko G. : P393
Sims M.W. : P1037
Sinagra G. : 148, P500, P754, P756,
P757, P946
Sinescu C. : P985, P1266, P1338,
P272, P336, P924
Singh P. : P494
Siniawski A. : P302
Siniawski H. : P497
Sinikova M.Y. : 147
Name / Index Number
Siniorakis E.-T. : P218, P492
Sinke R. J. : P1150
Sinnakirouchenan R. : P795
Sinyutina E. : P1219
Sipos J. : P1328
Siqueira M. H. : P1334
Siqueira S. : P1184
Sirenko Y. : P801
Sirotkova A. : P240
Siskas P. : P382
Siswanto B.B. : P731
Sitar Taut A. : P1299, P471
Sitnikova M. : P999, P307
Sitnikova M.Y.U. : P1041, P1226
Siwolowski P. : P200, P396
Skaardal R. : P1314
Skali H. : P191, P359
Skandalakis N. : P218, P492
Skorka T. : P1170, P738
Skotnikov A. : P1274
Skrzep-Poloczek B. : P427
Skrzypek A. : P268
Skulstad H. : P1314
Skvortsov A. : P1048, P466, P851
Slama M. : P832
Small G. : P234
Smerdova N. : P283
Smih F. : P262, P504
Smiseth O.A. : P1075
Smith A. : P726
Smith B. : P950
Smith J. : P249
Smith S. : P730
Snezhitsky V.A. : P363
Snygg-Martin U. : P554
Soares R. : P484, P818
Soares R.M. : P1015, P1073
Sobral M. : P334
Sobral S. : P422, P751, P857
Socrates T. : P1200
Soeiro A.M. : P196
Soeriasaputra S.H. : P731
Sohn H.-Y. : P784
Sokolski M. : P396
Soler-Botija C. : P1148, P212, P966,
P968
Solik P. : P1302, P1321
Solomakhina N. : P1213, P531
Solomon S.D. : P191, P359
Solti I. : P416
Song L. : P769
Song M. : P354
Song S. H. : P473
Soos P. : P1298
185
Sorensen J. : P850
Sorocoumov V. : P999
Sosdean R. : P748
Sosner P. : P1063
Sosnitska T. : P1234
Sousa A. : P1011, P1038, P1077,
P1079, P1087, P1092, P1174, P1247,
P1250, P1329, P409, P485, P506,
P527, P743, P816, P817, P821
Sousa C. : P1011, P1038, P1077,
P1087, P1174, P1329, P284, P409,
P485, P506, P527, P743, P817, P821
Sousa G.C. : P1012, P1249
Sousa J. : P422, P751, P857
Sousa J.D. : P1247
Sousa O. : P1326, P194, P849
Sousa P. : P1080, P551, P842
Sousa T. : P220
Sousonis V. : P360
Souza A. : P1335
Souza G.E. : P859
Soya O.V. : P245
Spargias C. : P1047
Spasic T.P. : P1095
Specchia G. : P1202, P217, P974
Sperzel J. : P956
Spinar J. : P1158, P1292, P313,
P480, P772, P923
Spinarova L. : P1158, P240, P923
Sposato B. : P1248
Springer J. : P436
Squire I.B. : 713, P1037
Sramko M. : P914
Stachura M. : P854
Staessen J. : P1296
Stahlberg M. : P1239
Stahrenberg R. : P518
Stakos D. : P888
Stalhammar J. : P1289, P526
Stamenko S. : P1162
Stanescu Cioranu R. : P352
Stankovic S. : P841
Stanojevic D. : P862, P883, P948
Stanojlovic T. : P948
Startari U. : P1186
Startseva X.S. : P495
Stasinos V. : P395
Stasko J. : P316
Steendijk P. : P405, P926, P927
Stefanadis C. : P257
Stefaniak T. : P739
Stegemann B. : P234
Steiger J. : P1200
Steinacher R. : P1261
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
Stenin I. : P1183
Stenner E. : P500
Stepanovic J. : P293, P884
Stepanyan A.A. : P940
Stepura A. : P1234, P399
Stern L. : P1289, P526
Stern R. : P343, P870
Stevanovic A. : P1030, P1053
Sticchi E. : 146
Stiefel P. : P408
Stiegler P. : P449
Stitt L. : P1067
Stitt L.W. : P919
Stix G. : P188
Stoerk S. : P335
Stoica E. : P352
Stoickov V. : P1036
Stojanov V. : P1003, P1006
Stojanovic I. : P862, P883
Stolarz-Skrzypek K. : P1296
Stolf N.A.G. : P1028, P334, P419
Stolf N.G. : P1259
Stoll F. : P503
Stopczynska I. : P546
Stork I. : 173
Stork S. : P778
Storozhakov G. : P1288
Stoskute N. : P807
Stout M. : P292
Straat E. : P572
Straburzynska-Migaj E. : P1246,
P237, P298, P302
Strajean B. : P867
Strasberg B. : P446
Strasen J. : P1001
Strasser R.H. : P875
Strohmer B. : P1261
Stromberg A. : 79, 80, P1016,
P1054, P1055, P1286, P379, P856,
P858
Strunz C.M.C. : P859
Struthers A.D. : P189, P190
Studer D. : P880
Studer M. : P880
Stupin I. : P958
Styliadis I.H. : P1004
Such Martinez M. : P878
Suchon E. : P1337
Suciu Z. : P1242, P289, P809
Sudano I.S. : P495
Sugihara S. : P338, P459
Sugiyama Kato T. : P1023, P305,
P494, P825
Sulimov V.A. : P1227
Name / Index Number
Sumegi B. : P416
Sun B. : P852
Sunagawa S. : P1173
Sund R. : P734
Suprun L. : P509
Surinya Z.S. : P1328
Surovtseva M. : P1233, P963
Sustic A. : P252
Suvakov S. : P1042
Svensson E. : P911
Sventzouri S. : P1203, P1207
Svetlosak M. : P421
Svirida O. : P470, P836
Swan L. : P917
Swedberg K.S. : P1060, 694, 695,
708, 81, P191, P359, P538, P797
Szabo A. : P259, P752
Szabo B. : P259, P752, P885, P945
Szabo C.S. : P416
Szabo T. : P341
Szachniewicz J. : P200
Szalai G. : P1328
Szczecinska R. : 84
Szczepanska-Sadowska E. : P933
Szuksztul M. : P1337
Szymanowska K. : P1223, P505
Szymkiewicz S. : P260, P315
Szyszka A. : P1223, P505
Tabatabaei Panah A.S. : P733
Taborska E. : P1292
Taborsky M. : P186
Tacke M. : P386
Taddei F. : P496
Tadic M. : P565
Tadic M.T. : P376
Taft C. : 81
Taghavi S. : P822
Taglieri C. : P1283, P523
Tahirovic E. : P343, P870
Takama N. : P1058
Takase T. : P993
Takatsu Y. : P1022, P833
Takaya T. : P1173
Takayama H. : P1023, P494, P825
Takiya C. : P913
Tala S. : P383, P723, P873
Talajic M. : P797
Talavera M. L. : P537, P872, P894
Tallon E. : P1225, P453, P996
Tamaki W.T. : P334, P419
Tamaki Y. : P993
Tan M. : P1208
Tan R.S. : P1243
Tanada Y. : P1022, P833
186
AUTHORS
Tanaka K. : P1311
Taniguchi R. : P1022, P833
Taniguchi T. : P197, P198
Tapia Ballesteros C. : P1191
Tapp L.D. : P443, P780, P967
Tarantini L. : P384
Tarasova O.V. : P1043
Tarlovskaya E. : P283, P479
Tarlovsky A. : P283
Tarlovsky K. : P479
Tarone G. : 174
Tatarsky R. : P214
Taub P. : P366
Tavares B.A. : P261
Tavazzi L. : 695, P797
Tayiem A. : P270
Teixeira M. : P1209, P1244, P478,
P561, P766, P808, P987, P991
Tek M. : P1157, P281
Teles R. : P1080
Templin C. : P1017
Tepes Piser I. : P352
Terajima Y. : P737
Tereshenko S. : P1048, P851
Tereshkevych L. : P514
Tereshkevysh L. : P1252
Termisultanova T.H. : P493
Terrovitis J. : P1165, P1203, P1207,
P301, P360, P382
Terzi A. : P496
Tesic M. : P841
Tettamanti M. E. : P1191, P325,
P788, P986
Tew G. : P292
Thanaraj A. : P1100
Thanopoulos V. : P257
Thomaidi A. : P888
Thomas M. : P1074
Thonn V. : P845
Thornton E.W. : P775
Thunstrom E. : P1040
Tichy M. : P957
Tierney S. : P813
Tikhonoff V. : P1296
Tiroch K. : P454
Tirziu C.M. : P344
Titaeva E. V. : P524, P782
Toader D. : P1097
Tocchetti C. G. : P1182
Todic B. : P906
Tokunaga K. : P1045
Tolonen J. : P734
Tomandl J. : P1292
Tomandlova M. : P1292

AUTHORS
Tomaszek A. : P1171, P1172, P739,
P977
Tomcikova D. : P923
Tomescu M. : P1100
Tomita K. : P201
Torabi A. : P380, P536, P886
Tornel-Osorio P.L. : P1224, P455,
P899
Torrado M. : P1147
Torres D. : P990
Torres L. : P716
Torres S. : P1310, P230
Torromeo C. : P206
Toste A. : P1073, P484, P818
Toth A. : P1039, P905
Toth K. : P416
Toth L. : P1328
Tournoux F. : P918
Tousoulis D. : P257
Toyo-Oka L. : P1045
Toyo-Oka T. : P1045
Trabulo M. : P1080, P1236, P1307,
P221, P467
Tracey C. : P381
Trajic S. : P1030
Treilhauld M. : P1029
Tretjakovs P. : P781
Triantafyllidi H. : P860
Tribouilloy C. : P832
Tridico C. : P910
Trifunovic D. : P291, P293, P420,
P841, P884, P1021
Triggiani M. : P1065, P508
Trigo J. : P1331, P215, P938
Trimech T. : P839
Tripodi T.G. : 617
Trochu J.N. : P1029, P1166, P868,
P895
Trocino G. : 710
Trojnarska O. : P237
Trubina E.V. : P824
Trukshina M.A. : P307
Truschnig-Wilders M. : P926, P927
Tsagalou E. : P360
Tsamatsoulis M. : P1165
Tscheliessnigg K.H. : P449
Tschoepe C. : P389, P391
Tscholl V. : P343, P870
Tseliou E. : P1165
Tseluyko V. : P1281, P1197, P402,
P941
Tsitlakidis K. : P1262
Tsoi I.A. : P1215
Tsougos E. : P1093
Name / Index Number
Tsourelis L. : P831
Tsui S. : P934
Tsujino T. : 616
Tsuruyama S. : P737
Tuchin V. : P393
Tuda R. : P863
Tufano N. : P273
Tuhtina A.S. : P975
Turagam M. : P795
Turkieh A. : P262, P504
Turolla A. : P379
Tursi V. : P1260
Tutuianu C. : P742
Tuxen C.D. : P332
Tyrankiewicz U. : P1170, P738
Tyrenko V. : P800, P804
Tytova G. : P973
Tziakas D. N. : P888
Uchida A.H. : P943
Uchino K. : P1098
Ueland T. : P1314
Ufnal M. : P933
Ukena C. : P873
Ulmer H. : P244, P720, P983
Umemura S. : P1098
Unalir A. : P1157, P281
Ural D. : P1180, P282, P358, P528,
P548
Urdapilleta M. : P863
Uribe-Echeverria E. : P1332
Urrutia A. : P1287, P1317, P277,
P390, P533, P893
Uscoiu G. : P867
Ushenko O. : P509
Usim O. E. : P205
Usoltseva E.N.U. : P1052
Utreras-Lagunas M. : P777
Uzui H. : P434, P445
Vado A. : P1283, P185
Vaes B. : P246, P346, P437
Vaikhanskaya T. : P1257
Vait E. : P186
Vakalyuk I.I. : P488
Vakalyuk I.P. : P488
Vakrou S. : P1203, P1207, P301
Valdes M. : 618, P331, P864
Valdman A. : P1026
Vale W. W. : P211
Valen G. : 172, P931
Valente B. : P1073, P484, P818
Valente M. : P422, P751, P857
Valentova M. : P386
Valk M. J. M. : P776
Valle A. : P1185, P326
187
Valleix F. : P895
Vallet F. : P1063
Valsecchi S. : P185
Vamadevan P. : P521
Van Assche T. : P322
Van Asselt T. : P1049
Van Buuren F. : P1081
Van De Veire N. : P295
Van De Vrie M. : 171
Van Den Berg M. P. : P1150
Van Den Berghe G. : P322
Van Den Bossche K. : P304
Van Der Palen J. : P1046, P515
Van Der Schans C.P. : P481
Van Der Veer E.P. : P324
Van Der Wal M.H.L. : 143, P481,
P789
Van Der Zwaag P. A. : P1150
Van Es J. : P1046, P515
Van Holten T.C. : P324
Van Langen I. M. : P1150
Van Le A. : P329
Van Mourik Y. : P439, P798
Van Pottelbergh G. : P246, P346,
P437
Van Riet E.E.S. : P744, P474
Van Spaendonck-Zwarts K. Y. :
P1150
Van Tintelen J. P. : P1150
Van Tooren R.M. : P474
Van Veldhuisen D.J. : 143, 694,
P789, P911, P1150
Van Wijk S. : P1049, P552
Vandenwijngaert S. : P1154
Vandenwijngeart S. : P846
Vanderheyden M. : P295
Vanderper A. : P322
Vandor L. : P317
Vanhorebeek I. : P322
Vanoli E. : P974
Vanoverschelde J.L. : P346, P437
Vanpoucke G. : P715
Varela Roman A. : P1176
Varga I. : P1302, P1321
Varounis C. : P395
Vasatova M. : P957
Vaschylko A. : P801
Vashakidze Z.S. : P941
Vasilenko L. : P207, P451, P718,
P729, P930
Vasiljevic Z. : P512, P843
Vaskelyte J. : P807
Vassalle C. : 146
Vassanelli C. : P1010
EXHIBITORS
& INDEX

EXHIBITORS
& INDEX
Vassilikos V. : P1004
Vausort M. : 713, P1152, P770
Vaziri Farahani K. : P279
Vazquez Garcia I. : P1051
Vazquez-Duran M. : P892
Vecerova A. : P226
Vechersky Y. : P1096, P1325
Vedin O. : P850
Velagapudi P. : P795
Velasco I.T. : P962
Velikanov A. : P999
Vendramin I. : P1260
Ventosa A. : P1236, P221, P467
Ventoulis I. : P1004
Ventura S. : P1159
Verbovenko J. : P781
Verde A. : P830
Verdonq C. : P351
Verdu J.M. : P1220, P1221, P388,
P248
Vereb M. : P316
Vergaro G. : 146
Verheijden Klompstra L.S.M. :
P1016, P379
Verhesen W. : 171
Veritti U. : P496
Verleysen K. : P715
Vertkin A. : P1274
Veselova V. : P1155
Vetrugno L. : P1260
Viana P. : P1013, P1313, P425
Vicente W.V.A. : P1275, P513
Vieira C. : P1084
Vieira G.C.A. : P1056
Vieira J. : P1169, P1024, P1082,
P308, P826
Vieira M. : P1310
Vieira M.L.C. : P374
Vieira P. : P1310, P230
Vigorito C. : P483
Vik H. : P472
Vila Liante V. : P444, P255
Vilaplana C. : P248, P388
Vilas-Boas F. : 678, P719
Vilchez J.A. : P1224
Villacorta H. : P1078
Villanueva I. : P863
Villasmil J.J. : P1264
Villevalde S. : P1254
Vincent J. : 694
Vincenzi A. : 710
Vinge L.E. : 172, P472
Vintila A.-M. : P745
Virot P. : P1230
Name / Index Number
Virtova R. : P243
Viscardi L. : P570
Vitale C. : P482
Vitarelli A. : P805
Vitlianova K.D. : P462
Vitovec J. : P1158, P240, P923
Vitrella G. : P754
Vizzardi E. : P1315, P361, P547,
P799
Vodolazhskiy I. : P375
Voelkers M. : 614
Vogt J. : P213
Voight J.U. : P846
Vojacek J. : P562, P957
Vojinovic-Culafic V. : P1053
Volterrani M. : P1248, P482, P814
Von Bibra H. : P319
Von Birgelen C. : P1046, P515
Von Haehling S. : P264, P341,
P385, P386, P436, P970
Vondrakova D. : P309
Voon K.J. : P1282, P855
Voors A.A.:. : P911
Vorobyeva N. M. : P524, P782
Voronkov L. : P1020, P1316, P294,
P876
Voska L. : P829
Voudris V. : P827, P831
Vranova J. : P309
Vrijhoef H.J.M. : 82
Vriz O. : P311, P992
Vujisic-Tesic B. : P1003, P1006,
P291, P420, P841, P884
Vuk V.F. : P1095
Vukajlovic Z.V. : P1095
Vukasovic J. : P223
Vuolteenaho O. : P1090
Vytykacova M. : P316
Waagstein F. : P192
Wachowiak-Baszynska H. : P237
Wachter R. : P335, P518, P995
Wada H. : P1173
Waderrahmane F.Z. : P204, P728
Wadrahmane F. : P1164, P1240,
P208, P901
Wadrahmane F.Z. : P1291, P219,
P339
Wagenaar L.J. : P1046, P515
Wagner D.R. : 713, P1149, P1152,
P1153, P327, P767, P770
Wakula P. : P1156
Waldron Z.L. : P741
Wallemacq P. : P246, P346, P437
Walravens A.S. : P846
188
AUTHORS
Walter J. : P730
Walther T. : 176, P519, P819
Wang G. : P235
Wang M. : P969, P1151
Wang S. : P958
Wang Y. : 176, P519
Warnier M.J. : P798
Warriner M. : P473
Wasem J. : P335, P869
Watanabe L. : P1082
Watanabe M. : P922
Waterhouse D.F. : P853
Watson C. : P330, P785, P1277,
P1282, P853
Wegrzynowska-Teodorczyk K. :
P487
Weinert S. : P845
Wergeland R. : P1314
Werner G. F. : P1334
Westerheide N. : P213
Westermann D. : P389, P391
Westermark P. : P850
Westlund R.W. : P972
Weston J. : P380
Whalley G.A. : 708
Whinnett Z. : P229
Wichmann K. : P385
Widimsky P. : P1158, P313, P923
Wiemann S. : 614
Wiemer M. : P1081
Wierzchowiecki M. : P1223, P505
Wijesekera V. : P499
Wiklund A. : P370
Wikstrom G. : P1091, P1289, P526,
P850
Wiktorowicz M. : P546
Wilczynski J. : P487
Will R. : 614
Willenheimer R. : P908
Williams T. : P1001, P847
Willich S.N. : P869
Wilson J.M. : P958
Winkler R. : P540
Witkowska A. : P264, P970
Witte K. : P741
Wittmann T. : P810
Wojciechowska C.A. : P1196, P427
Woldman S. : P1074
Wolf A. : 81
Wolf J.-E. : 711
Wolfrum M.W. : P495
Wolter J.S. : P387, P540
Wolzt M. : P188
Won H. : P558, P921

AUTHORS
Wood C.M. : P329
Woodroofe N. : P292
Wozniewski M. : P487
Wrigley B.J. : P443, P780, P967
Wulf G. : P319
Xu H. : P820
Xu M. : P1277
Xue Y. : P366
Yaari V. : P1026
Yagdi T. : P897
Yaici K. : P1007
Yakupov I. : P457
Yalug I. : P528
Yamada T. : P1311
Yamamoto E. : P1022, P833
Yamamoto T. : P825
Yamato M. : P197, P198
Yamazaki K. : P737
Yamazaki T. : P275
Yamoul N. : P242, P1199
Yanagihara K. : P338, P459
Yang Y.J. : P769, P820
Yanus O. : P1252
Yari M. : P865
Yarlagadda H. : P730
Yassin A. : P1320, P536
Yasumura Y. : P197, P198, P922
Yaymaci M. : P1180, P358, P548
Yeo Y. : P1208
Yildiz A. : P1000
Yndestad A. : 172
Yokoyama H. : P1072, P725
Yokoyama S. : P201
Yoo B.S. : P542, P944
Yoo N.J. : P290, P811
Yoon H. : P354
Yoshida C. : P297
Yoshiyama M. : P275
Youn H.J. : P1009
Yousaf F. : P286, P907
Yousef Z.R. : P1285, P418, P997
Youssef M. : P1290
Ytrehus K. : P312
Yun K.H. : P290, P811
Yusuf S. : P191, P359
Zaccone G. : P228
Zacharski M.W. : P1171, P1172, P739
Zahin M. : P226
Zahn R. : P349, P540
Zajaczkowski C. : P1228, P791
Zaja-Simic M. : P1308
Zak A. : P226
Zakirov N.U. : P413, P414
Zakliczynski M. : P1211, P1303,
Name / Index Number
P881
Zaman N. : P1074
Zambon E. : P377
Zambrano A. : P863
Zamora E. : P533
Zannad F. : 694, P383, P723, P740,
P873
Zanolla L. : P1010
Zanotto G. : 677
Zapatero A. : P254
Zaritskey A.Y. : P1043, P848
Zateyshchikov D.A. : P362
Zatolokin V. : P1325
Zawodnik A. : P988
Zdravkovic M. : P1083, P1308,
P906
Zdrenghea D.T. : P1299, P471
Zdunek D. : P454
Zecchin M. : P754
Zelarayan L.J. : P768
Zembala M. : P1211, P1303, P881
Zemora Z. : P790
Zemtsovsky E. V. : P369
Zera T. : P933
Zhadan A. : P1281
Zhang C. : P235
Zhang J. : P1320, P380, P536, P886
Zhang L. : P1153
Zhang R. : P408
Zhebrun D.A. : P848
Zheleznykh E.A. : P898
Zhitnyaya J. : P470, P836
Zhoubrina E. : P470, P836
Zhu X. : 176, P519
Zhujko E. : 681
Ziaee E. : P522
Zidova K. : P923
Zieba B. : P546
Zielinska M. : P507, P900
Zieroth S. : P1297
Zimovjanova M. : P226
Zito A. : P1204, P964
Zivanovic I. : P1083
Zivkovic M. : P948
Zivkovic N.Z. : P376
Zlatanovic M.Z. : P565
Zmudka K. : P1255
Zolotareva E. : P222
Zoltan G. : P752
Zotos P. : P1207
Zoubeir N. : P1291, P219, P339,
P447
Zoubir N. : P1164, P208
Zucca F. : P909
189
Zuchi C. : P866
Zucker N. : P1026
Zugck C. : P349, P387, P498, P540,
P755
Zuiko A.N. : P442
Zuithoff N.P.A. : P356
Zuschratter W. : P845
Zventsova V.K. : P794
Zwas D. : P790, P874
Zweigerdt R. : P1017
Zykov M.V.Z. : P891
Zymlinski R. : P200, P396
Zysko D. : P1171
EXHIBITORS
& INDEX

ISHR
International Society for Heart Research
European Section

Iron. Liberated.
• Ferinject® = improved physical performance 1
• Ferinject® = improved symptoms 1
• Ferinject® = improved quality of life 1
1. Anker et al. N Engl J Med 2009; 361: 2436-48.
Ferinject®: abbreviated prescribing information
Note: Before prescribing, please read full prescribing
information. Pharmaceutical form: Ferric carboxymaltose
as solution for injection/infusion.
Indications: Ferinject® is indicated for treatment of
iron deficiency when oral iron preparations are
ineffective or cannot be used. The diagnosis must be
based on laboratory tests. Administration: The dose
of Ferinject® is expressed in mg of elemental iron and
must be administered I.V. The adequate cumulative
dose of Ferinject® must be calculated for each patient
individually. Ferinject® may be administered up to a
maximum single dose of 1000 mg of iron, not
exceeding 15 mg of iron per kg body weight or the
calculated cumulative dose. Do not administer
1000 mg of iron more than once a week.
Contraindications, Warnings, Overdose: The use is
contraindi cated in cases of known hypersensitivity to
Ferinject® or any of its excipients, anaemia not
attributed to iron deficiency, iron overload or
disturbances in utilisation of iron, pregnancy in the first
trimester. Parenterally administered iron pre parations
can cause hyper-sensitivity reactions including
anaphylactoid reactions, which may be potentially
fatal. Therefore, facilities for cardio-pulmonary
resuscitation must be available. In patients with liver
dysfunction, parenteral iron should only be
administered after careful risk/benefit assessment.
Mastering the art of iron therapy
Monitoring of iron parameters such as serum ferritin
and transferrin saturation may assist in recognising
iron accumulation. Undesirable effects: Common
(1% to < 10%): Headache, dizziness, nausea, abdominal
pain, constipation, diarrhoea, rash, injection site
reaction, transient blood phosphorus decreased,
alanine aminotransferase increased. Legal category:
POM. Date of preparation: 07/09.
Adverse events should be reported, for further
information please contact our local represen-
tative or Vifor Pharma Ltd., Flughofstrasse 61,
P.O. Box, CH-8152 Glattbrugg, Switzerland,
safety@viforpharma.com.
To check the approval status and reimbursement situation in your country, please contact the local Vifor Pharma affiliate or partner company. Vifor Medical
Information on medinfo@viforpharma.com will provide you the contact details.
Date of preparation: January 2011
www.irontherapy.org
HQ/FER/CARD/AD/01.2011/440